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Summary 
Primary care management of risk of type 2 diabetes in women with a history 
of gestational diabetes – Rebecca Dennison 
Gestational diabetes (GD) is defined as diabetes with an onset or first diagnosis during 
pregnancy, and blood glucose returning to normal after delivery. It is one of the most common 
pregnancy conditions, and puts mother and baby at increased risk of pregnancy complications. 
After delivery, GD is associated with an increased risk of type 2 diabetes (T2D), which can 
lead to cardiovascular disease, renal disease, limb amputation and blindness. This thesis 
concerns reducing the risk of T2D in mothers with a history of GD. 
Specifically, my thesis aims to inform strategies to improve care for mothers after a pregnancy 
affected by GD. I describe the incidence of T2D postpartum, and identify approaches to both 
increase uptake of diabetes screening after pregnancy and enable mothers to make behaviour 
changes to reduce T2D risk factors. 
The first study is a literature review, meta-analysis and study-level meta-regression of the 
incidence of T2D after GD. I included 129 studies of 310,214 women with a history of GD. 
They were 8.3 (95% confidence interval 6.5 to 10.6) times more likely to develop T2D than 
women with normoglycaemic pregnancies. Overall 17.0% (15.1 to 19.0%) women developed 
T2D after GD, although there was significant heterogeneity. The relative percentage diagnosed 
with T2D was 12% (8 to 16%) higher for each additional year after pregnancy; a third 
developed T2D within 15 years. Development of T2D was significantly higher in non-White 
European populations compared to other populations, and in those with higher BMI at follow-
up. These findings emphasise the need for both sustained follow-up after GD through screening 
and interventions to reduce modifiable risk factors for T2D. 
Currently, screening for T2D is recommended at six to 13 weeks after a GD pregnancy, then 
subsequently at regular intervals. Historically, uptake of screening has been low. Through a 
review of medical records at Cambridge University Hospitals NHS Foundation Trust, in my 
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second study I identified that between October 2014 and March 2017 141/556 patients (25.4%) 
did not undergo a postpartum test. Women with lower parity and receiving insulin for GD were 
more likely to attend. To explore reasons for this in more depth, in a third study I conducted a 
qualitative systematic literature review and thematic synthesis of 16 studies. I found that (1) 
mothers’ relationship with healthcare, such as the attitude of their clinicians, could conflict 
with or reinforce prioritisation of screening, (2) practical aspects of both the appointment and 
the glucose test itself affected the opportunity to attend, (3) family-related practicalities could 
act as barriers to attendance, and (4) level of concern regarding diagnosis of diabetes was a key 
factor affecting motivation to attend screening. 
Despite the increased risk of T2D and associated complications, it is also known that many 
mothers find it challenging to maintain a healthy lifestyle after a GD pregnancy, and do not 
make changes to their diet or activity levels to reduce their risk. In my fourth study, a qualitative 
systematic literature review and thematic synthesis of 21 studies, I reported six themes that 
could act as barriers or facilitators to a healthy lifestyle in this population: (1) role as mother 
and priorities, (2) support from family and friends, (3) demands of life, (4) personal preferences 
and experiences, (5) diabetes risk perception and information, and (6) finances and resources. 
Based on these two qualitative syntheses, I developed recommendations to promote screening 
attendance, healthy diet and physical activity. In my fifth study, I used qualitative interviews 
to elicit an evaluation of these suggestions from 20 mothers with a history of GD in 
Cambridgeshire and Peterborough, in addition to their own ideas for improving postpartum 
support (the DAiSIeS study). These mothers thought that additional advice about how to eat 
healthily and exercise when they were busy, and tips for sustaining these changes, would most 
help them to reduce their risk. Many wanted more specific information about their long term 
T2D risk, but they often knew enough about the universal benefits of a healthy lifestyle. Both 
the participants who had strategies to remember to book their annual diabetes test and those 
who were not aware that they were eligible for any postpartum test felt that being invited to 
attend by a clinician would facilitate screening, particularly if they could choose the location. 
Collectively, these studies highlight that women with GD are an easily-identifiable group at 
high risk of T2D, and there is a need for interventions to manage this risk. In this thesis, I 
provide evidence to support and inform such interventions, which could include feasible 
adaptation to current practice, to improve care. Future research is needed to refine, test and 
evaluate these strategies.
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I begin this thesis by introducing gestational diabetes, describing the epidemiology as well as 
diagnosis and management of the condition. Although the focus of my thesis is on postpartum 
management, Section 1.1 provides important context for understanding the condition itself, the 
magnitude of the problem as well as a brief understanding of the lived experience of gestational 
diabetes. I then focus on the long-term risk of type 2 diabetes after gestational diabetes, where 
I describe type 2 diabetes in Section 1.2 and current practices in diabetes risk management in 
Section 1.3. 
1.1 Gestational diabetes 
Gestational diabetes (GD) is defined as diabetes (hyperglycaemia or high blood glucose) that 
is diagnosed during the second or third trimester of pregnancy and that was not overt diabetes 
before pregnancy (1,2). Blood glucose control usually returns to normal after delivery, although 
this is not required for a diagnosis of GD (3). It was first observed in the late 1800s and later 
defined as ‘gestational diabetes’ in 1957 (4,5). Since then, the prevalence of GD has increased 
so that GD is considered by many as a significant public health challenge (6). 
1.1.1 Pathophysiology of gestational diabetes 
Hyperglycaemia is observed when the beta cells of the pancreas are unable to produce 
sufficient insulin to meet increased requirements during pregnancy (7). From mid-pregnancy 
until delivery, placental hormones, increasing maternal adiposity and changes in other organs 
lead to increasing resistance to insulin in the mother (summarised in Figure 1.1A) (8,9). During 
a normal pregnancy, pancreatic beta cells increase insulin secretion in order to compensate for 
insulin resistance. However, in GD, the pancreas is not able to meet this increased requirement 
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and hyperglycaemia is observed (10). Figure 1.1B illustrates this: insulin sensitivity is lower 
during the third trimester than postpartum despite insulin secretion being higher during the 
third trimester than postpartum, and both insulin secretion and insulin sensitivity are lower in 
a GD pregnancy compared to a pregnancy without GD.  
 
 
Figure 1.1: (A) Causes of insulin resistance in gestational diabetes and (B) the relationship between insulin 
sensitivity and insulin secretion in pregnant women affected and unaffected by gestational diabetes. 
Reproduced from Plows et al. 2018 (Figure 3) (8) and Buchanan 2001 (Figure 3) (11). 
ROS: Reactive oxygen species. 
Different causes of insulin resistance have been suggested, but a distinction is not made 
between them in current practice. In 5 to 10% of cases, pancreatic beta cells are destroyed by 
the immune system similar to what happens in type 1 diabetes (T1D), and an even smaller 
proportion of cases are attributed to genetic mutations that affect the functioning of the 
pancreas and are first detected during pregnancy (9). Compared to autoimmune and monogenic 
GD, chronic insulin resistance, like type 2 diabetes (T2D) pathology, is by far the most 
prevalent form (9). Gestational diabetes insipidus is a very rare condition that is not related to 
1.1  Gestational diabetes 
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blood glucose control (12), therefore throughout this thesis I use the abbreviation ‘GD’ to refer 
to gestational diabetes mellitus.  
GD is usually asymptomatic. Before diagnosis, affected women may experience increased 
thirst and tiredness, yet these symptoms are common during a healthy pregnancy. 
Consequently, GD is usually diagnosed through screening all pregnant women, those with risk 
factors or if hyperglycaemia is suspected due to accelerated fetal growth. 
1.1.2 Diagnosis of gestational diabetes 
GD is diagnosed using a blood test during pregnancy in women without pre-existing diabetes. 
However, which women are screened and the cut-offs used to define GD have changed over 
time and vary according to which guidelines are used.  
An oral glucose tolerance test (OGTT) is usually used to diagnose GD. This requires collection 
of blood (plasma, serum or capillary/venous whole blood) after an overnight fast, followed by 
consumption of a glucose solution and blood collection at subsequent intervals. It is most 
common nowadays to use 75g glucose and three measurements (fasting plasma glucose [FPG], 
1 hour and 2 hours) although 100g glucose and four measurements (FPG, 1 hour, 2 hours and 
3 hours) were recommended previously. As described below, different glycaemic cut-offs have 
been defined such that a high result at one or more time points suggests a diagnosis of GD.  
Early glycaemic cut-offs were based on higher-than-average results in an OGTT during 
pregnancy (specifically two standard deviations above mean values), which were then modified 
according to the risk for the mother developing T2D after pregnancy (13). Subsequently, the 
O’Sullivan and Mahan criteria, then the Carpenter and Coustan criteria and the National 
Diabetes Data Group (NDDG) criteria were developed in response to the change in laboratory 
practice from whole to plasma blood testing (13). Other parts of the world used different criteria 
to the US, and the World Health Organization (WHO) used the non-pregnant cut-offs for 
impaired glucose tolerance to define GD (13). 
The most significant change in GD criteria came as a result of the multinational Hyperglycemia 
and Adverse Pregnancy Outcome (HAPO) study published in 2008, which found a continuous 
relationship with no obvious threshold between the results of the 2 hour OGTT and adverse 
pregnancy outcomes (including macrosomia, neonatal hypoglycaemia and caesarean section) 
(14). The International Association of Diabetes In Pregnancy Study Groups (IADPSG) 
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therefore determined cut-offs associated with an odds ratio of adverse pregnancy outcomes of 
1.75 (15). This was controversial because studies that use the IADPSG criteria consistently 
report a significantly higher GD prevalence than other studies (16), and may double or triple 
the prevalence of GD (17,18). This is associated with more women experiencing medicalisation 
of pregnancy and significant investment of resources, despite questionable benefits of GD 
treatment at that time (19). Furthermore, the trustworthiness of a single test result was 
discussed. Many but not all organisations have adopted or adapted these guidelines including 
the American Diabetes Association (ADA) and WHO (13,20). Table 1.1 shows the most 
frequently used guidelines and their different glycaemic cut-offs.  
Table 1.1: Diagnostic criteria used for estimating gestational diabetes. 
 Fasting 1 hour 2 hours 3 hours 
Criteria mg/dl mmol/l mg/dl mmol/l mg/dl mmol/l mg/dl mmol/l 
Early         
O’Sullivan and Mahan (21)*  90 5.0 165 9.2 143 7.9 127 7.1 
NDDG (22) 105 5.8 190  10.6 165 9.2 145 8.1 
Carpenter and Coustan (23) 95 5.3 180 10.0 155 8.6 140 7.8 
Current         
ADA/ACOGiii 2003 (3) 95 5.3 180i 10.0i 155 8.6 140 7.8 
ADA/ACOGiii 2018 (1) 95 5.3 180i 10.0i 155 8.6 140 7.8 
ADIPS 2014 (24) 92 5.1 180i 10.0i 153 8.5 - - 
DCCPiv 2018 (25) 95 5.3 - 10.6 - 9.0 - - 
DIPSIv 2014 (26) - - - - 140 7.8 - - 
EASD 1991 (27) 110i/126 6.1i/7.0   162i/180 9.0i/10.0   
FIGO 2015 (28) 92 5.1 180i 10.0i 153 8.5 - - 
WHO 1998 (29) 110ii/126 6.1ii/7.0 - - 120ii/140 6.7ii/7.8 - - 
WHO 2013 (30) 92 5.1 180i 10.0i 153 8.5 - - 
IADPSG 2010 (24) 92 5.1 180i 10.0i 153 8.5 - - 
NICE 2015 (2) - 5.6 - - - 7.8 - - 
Early guidelines reproduced from Coustan 2013, Table 1 (13). Current guidelines reproduced from 
International Diabetes Federation Diabetes Atlas, 9th Edition, 2019 (31). 
ACOG: American College of Obstetricians and Gynaecologists; ADA: American Diabetes Association; 
ADIPS: Australasian Diabetes in Pregnancy Society; DCCP: Diabetes Canada Clinical Practice; DIPSI: 
Guidelines Diabetes in Pregnancy Society Group India; EASD: European Association for the Study of 
Diabetes; FIGO: International Federation of Gynaecology and Obstetrics; IADPSG: International 
Association of the Diabetes and Pregnancy Study Groups; NDDG: National Diabetes Data Group. NICE: 
National Institute for Health and Care Excellence; WHO: World Health Organization. 
*Using venous whole blood. 
 i There are no established criteria for the diagnosis of diabetes mellitus in pregnancy based on the 1-h post-
load value. 
ii Refers to whole blood glucose level. 
iii Recommends either the IADPSG one-step or two-step approach; initial screening by measuring plasma or 
serum glucose concentration after 1 h 50g oral glucose load (GCT). Those exceeding the cut-off perform 
either a 100g OGTT or 75g OGTT, requiring two or more venous plasma concentrations to be met or exceed 
the threshold. 
iv Listed is the preferred approach, the alternate approach is the IADPSG uses a non-fasting 75g OGTT. 
v Uses a non-fasting 75g OGTT. 
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In light of the HAPO study, the National Institute for Healthcare and Clinical Excellence 
(NICE) updated the UK guidelines for GD diagnosis in 2015 (2). The cut-off for GD based on 
a FPG of 5.6 mmol/l is higher than that of the IADPSG criteria, whereas the 2 hour cut-off of 
7.8 mmol/l is lower (Table 1.1). NICE considered the economic impact of diagnosing a higher 
percentage of pregnancies with GD as well as the findings of the HAPO study; a recent 
economic evaluation confirmed that the NICE guidelines are more cost-effective than the 
IADPSG criteria given the prevalence of these risk factors in the UK (32). This has also been 
controversial; one study found that 387 of 25,543 pregnancies examined would have been 
diagnosed with GD using the IADPSG criteria but not the NICE 2015 criteria, but more 
importantly that these pregnancies had a significantly higher risk of macrosomia (large for 
gestational age [LGA] baby), caesarean delivery and polyhydramnios compared to clearly non-
GD pregnancies (33).  
Further disparities remain across guidelines regarding whom to screen for GD, such as pregnant 
women with risk factors, those who fail a preliminary test, or everyone. NICE recommends 
screening with a 2 hour OGTT for GD in women with one or more of the following risk factors: 
BMI greater than 30 kg/m2, previous LGA baby (weighing 4.5 kg or more), previous pregnancy 
affected by GD, family history of diabetes, and ethnicity with a high prevalence of diabetes 
(2). Screening usually takes place at 24 to 28 weeks gestation. Conversely, the ADA 
recommends either a single 2 hour OGTT (one-step strategy) or a non-fasting glucose challenge 
test followed by a 3 hour OGTT in those identified with hyperglycaemia initially (two-step 
strategy) (1). A recent Cochrane review suggested there is currently insufficient evidence 
(based on two studies) to compare the benefits of universal versus risk factor-based screening 
based on outcomes for mothers and babies (34).  
The changing diagnostic criteria and outstanding controversy mean that trends in GD 
prevalence are unclear. Increasing sensitivity of the definition of GD (lower glycaemic cut-
offs) as well as in increase in risk factors and changes to screening protocols over time has 
contributed (31). This adds complication to longitudinal research into GD. I have taken the 
pragmatic approach of considering GD by any definition throughout this thesis; that is, any 
woman who has been treated and managed as having GD in her pregnancy. 
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1.1.3 Prevalence of gestational diabetes 
GD is one of the most common disorders of pregnancy, although a wide range of prevalence 
estimates have been reported. This is partly explained by differing diagnostic protocols, as 
discussed above, in addition to increasing risk factors that mean that the ‘true’ prevalence of 
GD is increasing. 
Across the world, an estimated 17.8 million live births were affected by GD in 2015 (35). 
According to a systematic review of GD prevalence (shown in Figure 1.2, including 77 studies 
from 36 countries), it is clear that estimates vary within and between regions and countries (36). 
The Middle East and North Africa have the highest prevalence at a median 12.9% of 
pregnancies affected (range 8.4 to 24.5%) and Europe had the lowest prevalence at 5.8% (range 
1.8 to 22.3%). More recent systematic reviews have estimated similar prevalences in more 
precisely-defined regions, such as 9% in sub-Saharan Africa (95% confidence interval [CI] 7 
to 12%) (37), 10.1% in Eastern and South-Eastern Asia (95% CI 6.5% to 15.7%) (37), and 
11.7% in the Eastern Mediterranean region (95% CI 10.7 to 12.6%) (38). 
 
Figure 1.2: Estimates of the prevalence of gestational diabetes by World Health Organization region, 2005 to 
2015. 
Median prevalence and interquartile range are reported. Reproduced from Zhu and Zhang 2016, Figure 1 (36). 
In the UK in 2015, NICE reported that approximately 4% of pregnancies were affected by GD: 
of the estimated 700,000 pregnancies in England and Wales each year, 5% were affected by 
diabetes, of which 88% was GD (2). A range from 1.1% prevalence (95% CI 0.9 to 1.3, using 
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the WHO 1980 criteria in a cohort of 12,005 White European and Asian participants receiving 
routine pregnancy care in Leicester, 1980s) (39) to 24.3% prevalence (95% CI 22.6 to 26.0, 
using the more sensitive IADPSG criteria in a cohort of 2,376 participants taking part in a study 
in Manchester, 2000 to 2006) (40,41) have been reported. The prevalence of GD in women 
accessing maternity care at the Rosie Hospital in Cambridge in 2018 and 2019 was 10.0% (of 
1,906 women tested) (42). 
The prevalence of GD continues to rise as a consequence of increasing levels of obesity, 
sedentary lifestyles and poor quality diet (31,43). Comparisons between studies are challenging 
for a number of reasons: changing or poorly recorded screening strategies (screening of 
pregnant women has increased in recent years), diagnostic cut-offs (which have been increasing 
in sensitivity) and assessment of whether GD was in fact pre-existing, undiagnosed T2D (43). 
Screening more women and using more sensitive diagnostic criteria leads to more GD 
diagnoses. Nevertheless, increases in prevalence are consistently observed in individual 
longitudinal studies with more consistent testing protocols.  
For example, the Northern California Kaiser Permanente study reported the age- and ethnicity-
adjusted yearly prevalence of GD as 3.7% in 1991 and 6.6% in 1997, remaining at 6.2% in 
2000; an increase of 68% (total 14,175 pregnancies) (44). This study used laboratory glucose 
results in order to apply consistent GD diagnostic criteria and assessed changes in screening 
practices. Prevalence also increased in one study in South Australia from 1988 to 1999 by 72% 
in non-Aboriginal women and 12% in Aboriginal women (although the diagnostic criteria 
changed during this period) (45). Using a medical database, the Colorado Kaiser Permanente 
study reported that GD prevalence nearly doubled between 1994 and 2002 (total 36,403 
pregnancies) (46). 
Approximately half of women with GD have GD again in a subsequent pregnancy (95% CI 41 
to 54%; based on a random-effects meta-analysis including 18 studies and 19,053 participants) 
(47). Perhaps unexpectedly, this reoccurrence rate is notably lower in women of non-Hispanic 
White ethnicity and primiparous women (47). These findings may reflect the GD risk factors 
and the cumulative effect of GD pregnancy on insulin resistance.  
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1.1.4 Risk factors for gestational diabetes 
Modifiable and non-modifiable risk factors for GD reflect those for T2D (Section 1.2.3) and 
include ethnicity, advanced maternal age, elevated body mass index (BMI), and a family 
history of diabetes (48). Overweight and obesity has recently been found to be most strongly 
associated with GD (49), and are considered to be important before pregnancy as well as during 
it due to the impact on insulin resistance (50). The risk factors interact, such that age and BMI 
are particularly important in women of non-White European ethnicity (51). In the absence of 
risk factors, the incidence of GD is low (48). 
Ethnicity has long been recognised to be associated with risk of GD. In 1992 in the UK, Indian 
women were found to have a relative risk of GD of 11.3 (95% CI 6.8 to 18.8) compared to 
White European women; in South East Asian women this risk was 7.6 (95% CI 4.1 to 14.1) 
and in Black women it was 3.1 (95% CI 1.8 to 5.5) (52). These associations have been observed 
consistently and are independent of other risk factors and particularly BMI (53–55). 
Higher BMI is associated with higher prevalence of GD (Figure 1.3A) (56). A meta-analysis 
reported that overweight women had over double the odds of a GD diagnosis: compared to 
women with a normal BMI, the unadjusted odds ratios were 2.1 for overweight women (95% 
CI 1.8 to 2.5), 3.6 for obese women (95% CI 3.1 to 4.2), and 8.6 (95% CI 5.1 to 16.0) for 
severely obese women (57). It has been suggested that half of the cases of GD could be 
prevented if all pregnant women were of normal weight (55,56).  
Similarly, increasing maternal age is associated with significantly higher GD risk (Figure 1.3B) 
(58). One meta-analysis reported an adjusted relative risk of 10.9 (95% CI 7.7 to 15.3) for 
women aged 35 to 39 years, and 15.9 (95% CI 10.6 to 23.8) for women over 40 years compared 
to 20 to 24 year olds (58). Although the risk is higher with increasing age, the highest number 
of cases is still contributed by younger women due to the greater numbers of pregnancies 
among younger women (59).  
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Figure 1.3: Prevalence of gestational diabetes according to (A) mothers’ pre-pregnancy BMI and (B) age 
category. 
(A) Pregnancy Risk Assessment Monitoring System, 7 US states, 2004–2006. Reproduced from Kim et al. 2010, 
Figure 1 (56). 
(B) Northern California Kaiser Permanente, 1991–2000. Birth cohort years: ♦: 1946–1955, ▪: 1956–1965, ▴: 
1966–1975, —: 1976–1985. Grey line: non-Hispanic White (n=136,673), black line: Asian (N=40,493). African 
American and Hispanic ethnicities are also reported in the paper. Reproduced from Ferrara 2007, Figure 2 
(43). 
More recently, lifestyle GD risk factors have been investigated, although many of these studies 
have methodological limitations such as the error and bias associated with self-reported 
lifestyle measures (50,60). The Nurses’ Health Study II found that a diet high in fruit, green 
leafy vegetables, poultry and fish was associated with lower GD risk than a diet that was high 
in red and processed meat, refined grains, fast food and sweets (61). Similarly, higher fat intake 
and lower carbohydrate, vitamin C and vitamin D intake during pregnancy have also been 
associated with increased risk of GD (62,63). Physical activity increases insulin sensitivity to 
protect against T2D in the general population (64). The women who were most active before 
pregnancy had up to half the likelihood of developing GD compared to women who were least 
active; the association is weaker for exercise performed during pregnancy (50,60,65). 
In addition, some studies have reported associations, albeit less convincingly or consistently, 
between GD and maternal birth weight, parity, smoking during pregnancy, socioeconomic 
status, stature, and weight gain during pregnancy (66). 
1.1.5 Management of gestational diabetes during pregnancy 
Once diagnosed with GD, a pregnant woman is closely managed with the aim of reducing 
glycaemia and therefore minimising the consequences of hyperglycaemia, particularly with 
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regards to the baby’s growth (13,67). This involves blood glucose monitoring, diet and 
exercise, and sometimes insulin and metformin medication. They are also invited to additional 
monitoring such as of fetal growth and gestational weight gain (2). 
Women are required to test their own capillary blood glucose, usually four times a day, and 
should aim for a fasting reading of less than 5.3 mmol/l taken first thing in the morning and 7.8 
mmol/l or 6.4 mmol/l one or two hours after a meal (2). A major benefit of self-monitoring is 
the opportunity to record blood glucose levels during the normal daily life and routine, rather 
than on one unrepresentative day when the woman needs to attend the laboratory (13).  
Diet has been described as the ‘cornerstone of management of a GD pregnancy’, aiming to 
balance blood glucose control, weight gain and avoid ketones in the urine (68). Compared to 
usual diet, a modified diet has been associated with improved glycaemic control and lower 
medication requirements (69). Again, there is controversy over recommended calorie intake 
and composition: more recent studies suggest that although the traditional approach of reducing 
total calorie intake can be effective, more careful macronutrient control through complex 
carbohydrates and low fat can improve blood glucose control in a more acceptable and 
manageable way (70,71). Exercise during GD is also recommended to improve glycaemic 
control and general wellbeing, although there is no clear evidence for improvements in 
pregnancy outcomes (72). In the UK, all women with GD are referred to a dietician where they 
are advised to eat a healthy, low glycaemic index diet and to exercise regularly (walking for 30 
minutes after a meal to improve blood glucose control is suggested in the NICE guidelines) 
(2).  
If women are not able to achieve the blood glucose targets through diet and exercise within a 
couple of weeks of diagnosis, they are offered metformin and then insulin if this does not lead 
to sufficient improvement in accordance with the NICE guidelines (2). Metformin is an oral 
antidiabetic agent, making it much more acceptable than insulin, which needs to be injected. 
Metformin has been reported to be effective for glycaemic control and safe (with the exception 
of an association with preterm delivery) (73,74). However, the authors of these recent 
systematic reviews highlighted that many women go on to require treatment with insulin (half 
of the population in one of the largest trials (75)), plus that large randomised controlled trials 
(RCTs) with long-term follow-up of children as well as mothers are required to understand the 
long-term implications (73,74). Other pharmacological agents such as sulfonylureas (e.g. 
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glibenclamide/glyburide) and alpha-glucosidase inhibitors (e.g. acarbose) may also be used 
during pregnancy (13). 
1.1.6 Experience of gestational diabetes 
The experience of GD is frequently described as distressing and lonely (76–78). Affected 
women report moving from a healthy pregnancy to being under specialist care very quickly, 
and have a short window of time to try to control blood glucose by diet before some move onto 
medication (79). These feelings are often stronger in populations with low health literacy and 
language barriers, and if following the recommendations is challenging to their cultural norms 
(80,81).  
Many women feel initial shock and fear at a GD diagnosis, particularly if they lose their identity 
as someone who was healthy and low risk before pregnancy (76,79,81–85). Initially, they might 
deny their own test result or question the trustworthiness of the definition of GD due to the 
variation in testing protocols (83). Women with GD sometimes blame themselves for the 
diagnosis, and feel stigmatised if they are overweight (84). Most are anxious about the health 
of their baby, and worry that GD will harm them (77,78).  
Most women, at least those who participate in qualitative research, learn the GD blood glucose 
targets and are diligent in their attempts to achieve them (85). Measurements that fall above 
their targets can cause them to feel as though they are failing despite their best efforts, leading 
to feelings of desperation (84). Healthcare providers monitor them closely, which is both 
reassuring and restrictive (84). In particular, the clinicians’ focus on quantitative measurements 
(e.g. blood glucose measurements and weight gain) can contribute towards feeling out of 
control and that their ability as a mother is determined by their blood glucose level (78,82). 
One participant and her husband felt that “it’s not your child, it’s their [the hospital’s] child!” 
(84). Support, both in education from the doctors and social support at home, are vital 
(76,81,86). 
Attempting to control their blood glucose by diet and exercise leads many women to learn a lot 
about nutrition, although many struggle with hunger and feeling like they cannot eat ‘anything’, 
particularly at the beginning (85). The strict diet can be perceived as counterintuitive to the 
nutritional needs of a growing baby (81), yet many women follow it closely to avoid 
medication, particularly insulin, which would add to the medicalisation of pregnancy and 
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burden of GD (79,85). Others find that medication brings relief and reduces the pressure that 
they feel (79). Other women report a sense of empowerment to take control of their health for 
the sake of their baby, wider family and themselves (77,78).  
These attitudes tend to continue and affect behaviour in the postpartum period, as described 
later in this thesis. For instance, mothers may feel guilty for having had GD so that they need 
to ‘make it up’ to their child, and some women who recognise their risk of developing T2D in 
the future are more likely to intend to make lifestyle changes (77,78,87). 
1.1.7 Consequences of gestational diabetes 
In the short term, GD doubles the risk of several adverse pregnancy outcomes for both mother 
and baby (15). The higher the levels of hyperglycaemia, the greater the associated risks, hence 
management is vital (88). Both are at long-term risk of future obesity, glucose intolerance and 
development of T2D (89,90). Again, the HAPO study has been key in understanding the 
consequences of GD. 
During pregnancy, GD has similar implications for the fetus as pre-existing T2D or T1D due 
to higher glucose levels being transferred across the placenta (13). The fetus responds by 
making more insulin, which increases their rate of growth and leads to macrosomia (15). In 
turn, they are at higher risk of delivery injuries such as shoulder dystocia, or problems 
associated with prematurity if they are induced (15). Immediately after delivery, the baby is 
monitored for neonatal hypoglycaemia because they are no longer exposed to high blood 
glucose from the mother but have not yet reduced their own insulin production. 
In order to avoid the risks associated with delivering a large baby, GD is associated with higher 
likelihood of caesarean delivery (91). In addition, there is a higher risk of gestational 
hypertension, preeclampsia, and eclampsia in mothers with GD (92). 
The long-term increased risk of cardiometabolic disease in children after pregnancy is 
considered to be due to a combination of genetic susceptibility and the in utero environment, 
plus further modulation by the postnatal environment (88,93). For example, offspring of 
mothers with GD have a 1.4 to 2.3-times higher risk of becoming overweight and 1.5 to 3.6-
times higher risk of becoming obese, and consistently higher risk of glucose intolerance 
conditions (94). Similarly, the HAPO study showed continuous associations between the 
degree of maternal hyperglycaemia and offspring outcomes in adolescence (95,96). 
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It has long been recognised that mothers affected by GD are at higher risk of metabolic 
syndrome themselves, which may be because GD is a physiological test that identifies those 
with increased risk. Recently, this has been estimated to be a four-fold higher risk (95% CI 3.0 
to 5.3) (97). In particular, mothers’ risk of future diabetes has been a focus, as discussed below; 
GD has been described as the single most important risk factor for the development of T2D 
(36,98,99). They also have a higher risk of cardiovascular disease (CVD), independent of 
progression to T2D and in the first ten years after pregnancy (100). 
1.2 Type 2 diabetes 
T2D is hyperglycaemia caused by chronic insulin resistance, whereby the body cannot 
effectively use insulin and, over time, pancreatic beta cells cannot meet these increased 
requirements (31,101). As described below, it is the most common form of diabetes and 
prevalence is increasing. Although the causes of T2D are not fully understood, there is a strong 
association between T2D and environmental or lifestyle risk factors (specifically overweight 
and older age) as well as genetic predisposition (such as that indicated by family history and 
ethnicity). In 2007, the United Nations General Assembly declared diabetes to be an 
international public health issue and designated World Diabetes Day to promote awareness 
(Resolution 61/225). 
Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) are also hyperglycaemia, 
but that which is below the diagnostic threshold for T2D. These conditions are clinically 
important because they indicate individuals at high risk of progressing to T2D and who are 
beginning to experience the consequences of hyperglycaemia (described in Section 1.2.5). As 
a result, interventions to reduce blood glucose in those with IGT and/or IFG are important. 
T1D results from autoimmune destruction of pancreatic beta cells, causing inadequate or no 
insulin to be produced (31). Because GD is primarily associated with increased risk of T2D, I 
will focus on T2D herein this thesis. 
1.2.1 Diagnosis of type 2 diabetes 
Currently in the UK, T2D is usually diagnosed by a glycated haemoglobin (HbA1c) of 48 
mmol/mol (6.5%) or more (102). Like for GD diagnosis, this threshold is based on the linear 
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risk of microvascular complications and has changed over time. In patients with symptoms 
(specifically thirst, polyuria, blurred vision, weight loss, recurrent infections, and tiredness), 
one elevated HbA1c measurement is considered diagnostic, whereas those without symptoms 
should have a second test. In people for whom HbA1c testing is inappropriate, a FPG test with 
a cut-off of 7.0 mmol/l or greater is used. This includes pregnant women, those who are acutely 
ill or have conditions such as acute pancreatic damage, chronic kidney disease and human 
immunodeficiency virus (HIV) infection; an HbA1c result should be interpreted with caution in 
those with abnormal haemoglobin or red blood cells. 
Previously, the OGTT was used to diagnose T2D. However, HbA1c is now recommended by 
the WHO in light of ‘moderate’ quality systematic review evidence (103), which informed the 
NICE guidelines (102). It has a comparable sensitivity and specificity to FPG and OGTT tests 
for predicting diabetic retinopathy in different populations, in addition to the advantages of a 
reduced burden on the patient (no need to fast, take a glucose solution or wait for two hours), 
irrelevant day-to-day variability of blood glucose values (e.g. caused by stress or illness) 
because glycaemia over eight to 12 weeks is assessed, and fewer pre-analytical concerns (e.g. 
time to analysis). However, HbA1c testing is less easily available or analysis is less standardised 
in some regions, it is associated with a greater cost, and it is not suitable in some individuals 
(as reported above) (1,102–104). Because the HbA1c test measures glycaemia in the previous 
eight to 12 weeks, it is not appropriate for use in diagnosing GD or T2D immediately after GD. 
1.2.2 Prevalence of type 2 diabetes 
The International Diabetes Federation (IDF) estimated that there were 352 million adults with 
diagnosed or undiagnosed diabetes worldwide in 2019 (31). Figure 1.4 shows the age-adjusted 
prevalence of T2D, indicating a similar distribution to GD prevalence due to the shared 
distribution in risk factors. Asia has been described as the 'diabetes epicentre' of the world 
(105), with 9.1% of adults in China with T2D in 2000 to 2014 (106) and a range in prevalence 
from 1.9% to 25.2% in India in studies published from 1994 to 2018 (107).  
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Figure 1.4: Estimates of the age-adjusted prevalence of type 2 diabetes in adults (aged 20 to 79 years) in 2019. 
Reproduced from International Diabetes Federation Diabetes Atlas, 9th edition, 2019), Map 3.2 (31). 
The total number of people affected by diabetes more than doubled between 1980 and 2008, 
and is projected to increase by 130 million affected people in the next 25 years (to 486 million 
people with diabetes in 2045) (31,108). Prevalence in middle-income countries is estimated to 
increase the most. This is attributed to an ageing population and improved survival of patients 
with diabetes, but also the rise in obesity and sedentary lifestyles. Of particular concern is the 
increase in T2D in young adults and children due to the longer duration they will have the 
disease for (105), including women with GD who may progress to T2D relatively early. 
NICE reported a prevalence of T2D of 6% in adults in England in 2013 (101), doubling the 
estimate from 2000 (109). Crude prevalence was higher in Asian (7.7%, 95% CI 7.5 to 7.9) 
and Black (5.6%, 95% CI 5.4 to 5.8) ethnic groups compared to White (5.0%, 95% CI 5.0 to 
5.1) and Mixed/Other ethnic groups (3.4%, 95% CI 3.2 to 3.7) (110).  
1.2.3 Risk factors for type 2 diabetes 
A range of modifiable and non-modifiable risk factors for T2D have been reported. Due to the 
shared pathophysiology (Section 1.1.1), there is significant overlap with the risk factors for 
GD. The most important factors are reported in Table 1.2. 
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Table 1.2: Modifiable and non-modifiable risk factors for type 2 diabetes. 
Modifiable risk factors Non-modifiable risk factors 
 Overweight or obesity 
 Physical inactivity 
 Sedentary behaviour 
 Dietary factors 
 Smoking 
 Previously identified IGT and/or IFG 
 Abnormal lipid levels 
 Hypertension 
 Inflammation 
 Intrauterine environment 
 Age 
 Sex 
 Ethnicity (African, African-Caribbean and 
South Asian ethnicity in particular) 
 Family history of T2D 
 History of GD 
 Polycystic ovary syndrome 
Adapted from Chen et al. 2012, Box 1 (105). 
IFG: impaired fasting glucose; IGT: impaired glucose tolerance. 
A study based on the Finnish population modelled that 82% (95% CI 70 to 90%) of diabetes 
cases were attributable to failure to observe a low-risk lifestyle (there defined as BMI less than 
25 kg/m2, ‘adequate’ exercise, ‘moderate’ alcohol consumption, non-smoking, and a 
‘satisfactory’ vitamin D level) (111). Overweight and obesity was the most important risk 
factor with a relative risk of 5.9 (95% CI 3.5 to 9.8) (111). Similarly, a study in a Chinese 
population reported that 73% of incident diabetes cases were attributable to BMI, waist-to-hip 
ratio, diet and physical activity (112).  
Importantly, maintaining a low-risk lifestyle is challenging in the present obesogenic 
environment, where ‘the surroundings, opportunities, or conditions of life’ cumulatively 
promote obesity (113). Those with low socioeconomic status and high deprivation face 
particularly obesogenic environments. 
1.2.4 Management of type 2 diabetes 
Management of T2D is principally undertaken in primary care, where education, screening for 
complications and interventions to reduce the risk of complications can occur regularly. As in 
T2D prevention, promotion of a healthy lifestyle is of primary importance (31). In particular, 
this includes a healthy diet, regular physical activity, smoking cessation and maintenance of a 
healthy weight. As part of individualised patient education about T2D, NICE recommends a 
focus on dietary advice, physical activity and weight loss of 5 to 10% of initial body weight in 
those who are overweight (101). 
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NICE also suggest a long-term target HbA1c of 48 mmol/mol (6.5%), measured at up to six-
monthly intervals (101). If HbA1c rises to 58 mmol/mol (7.5%) or higher, metformin may be 
initiated or drug treatment intensified. Current NICE guidelines emphasise that these targets 
should be implemented on a case-by-case basis, such that a frail patient may have less 
stringently-controlled T2D (corresponding to higher glycaemic cut-offs) in order to avoid 
overtreatment, for example. 
1.2.5 Consequences of type 2 diabetes 
T2D is associated with a range of health implications, and a 15% increased risk of all-cause 
mortality (114). Hyperglycaemia affects the microvascular and macrovascular systems, 
increasing cardiovascular risk and reducing quality of life and life expectancy (101). 
Microvascular complications include retinopathy, nephropathy, neuropathy and gum or foot 
problems that can lead to amputation. Macrovascular complications include a wide range of 
CVDs. 
One large collaboration suggested that diabetes independently doubled the risk of CVD (115). 
CVD was found to affect a third of people with T2D, and accounted for half of observed deaths 
recorded in cohorts studies (116). Furthermore, FPG level was non-linearly associated with 
cardiovascular outcomes, even at non-diabetic levels (115). 
Management of T2D and its complications are associated with a significant economic cost. The 
highest proportion of healthcare spending has been attributed to diabetes (in the US), with an 
estimated worldwide cost of US$1.3 trillion in 2015 (117,118). NICE estimated that at least 
5% of UK healthcare expenditure is spent on diabetes, and up to 10% of expenditure in the 
National Health Service (NHS) (101). 
1.2.6 Risk of type 2 diabetes after gestational diabetes 
Although maternal glucose control usually returns to normal after delivery, GD has been 
described as the single most important risk factor for the development of T2D in the future in 
this population (36,98,99,119).  
As early as 1991, O’Sullivan published a review reporting that 6 to 62% women were 
diagnosed with T2D up to 28 years after GD, although almost no consistency in diagnostic 
criteria was reported at that time (120). In an influential systematic review by Kim et al. 
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published ten years later, incidence of T2D ranged from 2.6% at six weeks after GD to over 
70% up to 28 years postpartum (99). Of note, this study reported that women of different 
ethnicities progressed to T2D at similar rates, and that that risk was highest during the first five 
years after a GD-affected pregnancy. This justified interventions that focused on the early 
postpartum period. More recently, Vounzoulaki et al. conversely reported that cumulative 
incidence of T2D increased steadily over time (121). In addition, there were non-significant 
differences in cumulative incidence across ethnicities: 16.5% (95% CI 16.2 to 16.8%) in mixed 
ethnicity populations, 15.6% (95% CI 13.3 to 17.9%) in non-White populations and 9.9 (95% 
CI 9.4% to 10.4%) in White populations. Both Kim et al. and Vounzoulaki et al. included 
twenty studies, giving low power to describe how progression to T2D varies according to co-
variates such as ethnicity with statistical significance. 
Relative risk of T2D after GD has been reported by several studies, suggesting that women 
with GD may have an up to ten-times higher T2D risk than women who did not have diabetes 
in pregnancy: 
 Bellamy et al. 2009 reported a relative risk of 7.4 (95% CI 4.8 to 11.5) (98); 
 Song et al. 2018 reported a relative risk of 7.8 (95% CI 5.1 to 11.8) (122); 
 Benhalima et al. 2019 reported a relative risk of 7.4 (95% CI 6.0 to 9.2) (123); 
 Vounzoulaki et al. 2020 reported a relative risk of 9.5 (95% CI 7.1 to 12.7) (121). 
I describe these reviews in more detail in Chapter 4. 
Maternal and pregnancy factors such as elevated BMI, multiparity, poorer pregnancy glucose 
tolerance, use of insulin during the pregnancy, and earlier gestational age at GD diagnosis have 
been suggested to further increase this risk of T2D after GD (124–126). Another meta-analysis 
suggested that pregnancy glucose tolerance (including OGTT results, HbA1c results and use of 
insulin during pregnancy) and BMI are associated with the highest relative risks of T2D; for 
example, BMI greater than 25 kg/m2 had a relative risk of 3.2 (95% CI 2.0 to 5.2; five studies 
and 4,795 women with GD) and use of insulin during pregnancy had a relative risk of 3.7 (95% 
CI 2.8 to 4.8; 24 studies and 7,723 women with GD) (126). 
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1.3 Management of type 2 diabetes risk after gestational diabetes  
After the baby is born, glucose levels return to normal in the majority of affected women. 
However, because of the heightened risk of developing diabetes in the future, screening for 
glucose intolerance and behaviour change to manage risk factors are recommended.  
1.3.1 Postpartum diabetes screening 
After delivery, guidelines recommend that women have an OGTT, FPG test or HbA1c test to 
identify glucose intolerance. This should take place soon after delivery, and at regular intervals 
going forward. Although it is improving in many settings, uptake of the test has been poor.  
Postpartum screening is referred to by different terms including glucose or glycaemic testing, 
or by the names of the test. Throughout this thesis, I will refer to this practice as diabetes 
screening. 
1.3.1.1 Rationale 
Postpartum diabetes screening is recommended in order to detect glucose intolerance and 
diabetes earlier than would occur by only testing those who become symptomatic. As a result, 
management through lifestyle changes or medication can begin sooner, decreasing exposure to 
hyperglycaemia.  
Although the overall benefits of screening for diabetes in the general population are unclear 
(127), diabetes screening and cardiovascular risk assessment has been associated with reduced 
risk of longer-term complications and all-cause mortality, although effective intervention is 
key (128). However, there have been no comparable studies in women with recent GD, who 
tend to be much younger than other high-risk populations. Long-term studies are yet to compare 
the benefits of different screening strategies, although OGTTs every three years were suggested 
to be most cost-effective in the US (129,130). 
1.3.1.2 Guidelines 
National and international guidelines recommend that pregnant women are screened for 
glucose abnormalities at around six weeks postpartum to exclude persisting diabetes (1,2). 
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They should subsequently be screened at regular intervals, in order to monitor glucose levels 
and to identify those at highest risk of progressing to diabetes (1,2).  
There is currently little agreement between diabetes screening guidelines. As shown in Table 
1.3, the guidelines vary according to which test to use, when it should be performed, T2D 
criteria (not reported), and whether subsequent testing is specifically recommended. This 
variability has been found to have a greater impact on diagnosis of glucose intolerance 
disorders (IGT and IFG) than on diagnosis of T2D directly (131). 
Table 1.3: Diabetes screening guidelines after a pregnancy affected by gestational diabetes. 
 First postpartum test Subsequent testing 
Criteria Timeframe Test  Timeframe Test  
NICE 2015 (2) 6 to 13 weeks 
postpartum 
FPG 
(75g 2 hour OGTT not 
recommended) 
If normal, annually HbA1c (13 weeks 
postpartum and on)  




4 to 12 weeks 
postpartum 
75g 2 hour OGTT 
(HbA1c not recommended 
at 4 to 12 weeks 
postpartum) 
If normal, every 1 
to 3 years 
(depending on risk 
factors) 
Ongoing evaluation with 




4 to 12 weeks 
postpartum 
FPG or 75g 2 hour OGTT If normal, every 1 
to 3 years; if 
IFG/IGT, annually 
FPG or 75g 2 hour OGTT 
5th IWCGDM 
2007 (133) 
6 to 12 weeks 
postpartum 
75g 2 hour OGTT NR NR 
CDA 2018 
(25) 
6 weeks to 6 
months 
postpartum 
75g 2 hour OGTT NR NR 
RACGP 2016 
(134) 
6 to 12 weeks 
postpartum 
75g 2 hour OGTT Every 3 years FPG or HbA1c 
ADIPS 2014 
(24) 
6 to 12 weeks 
postpartum 
75g 2 hour OGTT NR NR 
Adapted from Vounzoulaki et al. 2020, Table 1 (135). 
ACOG: American College of Obstetricians and Gynaecologists; ADA: American Diabetes Association; 
ADIPS: Australasian Diabetes in Pregnancy Society; CDA: Canadian Diabetes Assicociation; IWCGDM: 
International Workshop-Conference on Gestational Diabetes Mellitus; NICE: National Institute for Health 
and Care Excellence; RACGP: Royal Australian College of General Practitioners. 
FPG: fasting plasma glucose; OGTT: oral glucose tolerance test; NR: not reported. 
In 2015, NICE advised that women in the UK should be screened using FPG at six to 13 weeks 
postpartum followed by annual HbA1c testing, and not routinely offered the OGTT (2). Annual 
testing usually occurs in general practice, while the first postpartum test may occur at the 
hospital or in general practice. NICE based these recommendations on 51 studies that reported 
the incidence of T2D after GD at different postpartum time points in order to estimate the 
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screening interval that would most effectively identify those at highest risk of developing 
diabetes. However, all of these studies were found to be very low quality. The incidence of 
T2D after GD and optimal intervals for screening are therefore uncertain.  
Furthermore, NICE outlined the following classification for T2D risk (2): 
 FPG less than 6.0 mmol/l or HbA1c less than 39 mmol/mol (5.7%) suggests a moderate 
risk of T2D; 
 FPG 6.0 to 6.9 mmol/l or HbA1c 39 to 47 mmol/mol (5.7 to 6.4%) suggests a high risk 
of T2D; 
 FPG more than 7.0 mmol/l or HbA1c more than 48 mmol/mol (6.5%) indicates that they 
are likely to have T2D and should be referred for T2D care (if based on FPG, they are 
offered a further test to confirm the diagnosis).  
1.3.1.3 Comparison of tests used 
The 75g 2 hour OGTT consistently diagnoses more cases of T2D than FPG and HbA1c tests: 
for example, in two recent studies in the high risk, general population, 6% of an overweight 
White European population were diagnosed with T2D using an OGTT but not HbA1c (1,241 
participants) and 9% of an overweight Thai population were diagnosed with T2D using an 
OGTT but not HbA1c (521 participants) (136,137). However, discrimination in postpartum 
women after GD varies in very small studies. Agreement between the two tests has been found 
to be ‘poor’ (114 participants, six to 12 weeks postpartum, which may have been too soon 
postpartum because HbA1c
 measures glycaemia in the previous eight to 12 weeks) (138), ‘fair’ 
(54 participants, six weeks to 36 months postpartum) (139), or identified more cases than an 
OGTT (141 participants, up to one year postpartum) (140). Similarity, postpartum FPG after 
GD has been found to have inconsistent sensitivity (14 to 100%), and may miss a quarter of 
T2D cases (141,142). 
However, single blood tests are more acceptable than the OGTT, which is an important 
consideration given the context of poor attendance described in the following section. They put 
less demands on new mothers’ time, and do not require unpleasant glucose loading (143).  
Other testing strategies have been discussed, such as testing women for glucose intolerance 
before they are discharged from hospital in order to increase coverage. A recent study 
suggested that a normal OGTT at this time would exclude T2D at up to three months 
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postpartum, but not identify women with IGT or IFG (144). Although the acceptability was not 
reported, this could be a beneficial approach in certain circumstances. As explained above, use 
of HbA1c tests at this time would not be suitable. 
1.3.1.4 Attendance 
Uptake of postpartum screening is highly variable, but is usually suboptimal at less than 50% 
(130,145–148), even being described as ‘abysmally low’ (149). One systematic review 
reported that 34 to 73% women with GD were screened postpartum in 11 studies published 
between 2008 and 2010, considering any type of test or time since delivery (148). More 
recently, this range was 13 to 82% in Asian women in 27 studies published between 2003 and 
2016 (150). A single large study in France reported attendance of 22% by three months 
postpartum and 56% within the first year in 2013 (151). Small but statistically significant 
increases were observed in attendance within the first year from 2007 to 2013 but not earlier 
time points (151).  
Women at highest risk of diabetes are less likely to attend diabetes screening, therefore 
delaying diabetes management. Younger women with other children and of lower 
socioeconomic status attend less frequently, particularly if they received little perinatal care or 
their GD was managed by diet alone (148). Sometimes overweight and non-Asian or Hispanic 
ethnicity are associated with lower screening attendance (152). 
Uptake of screening in the UK has been similarly variable, although reporting of different 
timeframes makes comparison challenging and there is a paucity of data on long term follow-
up. An analysis of national primary care medical records reported that only 58% of women 
attended diabetes screening in the first year postpartum, and less than 40% attended in the 
second and third years (153). Another study in 127 general practices in England reported half 
of this attendance: 19% attendance up to six months postpartum, 26% attendance within a year, 
and 20% attendance at annual screening (154). However, half of women with GD had no 
diabetes screening test within five years postpartum and less than 1% were tested every year, 
as recommended, between 2006 and 2010 (154). Considering more recent but smaller studies, 
38% women with GD in primary care in Leicester were screened by 13 weeks postpartum, and 
16% had annual tests (155). In Oxford, 51% women were screened by 13 weeks postpartum, 
and 8% had annual tests based on hospital records (156). In Sheffield, 75% women were 
screened by 13 weeks postpartum according to a local maternity database (157). Within these 
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studies, higher risk women, particularly those with higher deprivation, were consistently 
reported to have lower attendance (155–157). However, interestingly, over 80% of clinicians 
reported to test their patients within six weeks postpartum, although general practitioners (GPs) 
reported challenges in knowing whether their patient had had GD and only 39% recalled 
women for annual testing (158). 
Reasons such as the unpleasant procedure or its inconvenience have been suggested for missing 
testing (87,143,147). Other explanations include women not recognising the risk, being afraid 
of a positive diagnosis, or the demands of caring for their baby on their time. This is likely to 
be confounded by the transition from secondary to primary care (149). Understanding 
explanations of poor attendance will inform approaches to increase uptake, such as through 
changes to the process as a whole or to support specific groups of women with GD. 
Small studies have reported some improvement in screening attendance through targeted 
interventions. These tend to involve more proactive contact, such as phone calls, education 
programs, or postal reminders (145,146,149). For example, a single counselling session during 
the third trimester of pregnancy increased screening attendance from 33 to 53% in one US 
study (159), while introduction of a central coordinator increased uptake by 12% (160). 
Reminders for mothers or healthcare professionals are the most frequently anticipated to 
increase uptake, which may be a more resource-efficient approach (145). However, some of 
the benefits may be a result of participation in a trial or signing up to a register, as opposed to 
the intervention itself (161,162). Contact from an individual general practice may be more 
effective than a general register in the long term (161). Further intervention development and 
evaluation is required to optimise the effectiveness and long-term sustainability of such 
approaches. 
1.3.2 Postpartum behaviour change 
In addition to participating in regular diabetes screening, women are advised to adopt and 
maintain a healthy lifestyle in order to reduce their T2D risk factors. This requires most women 
to make conscious changes to their habitual behaviour. A healthy lifestyle focuses on a healthy 
diet and increasing physical activity. 
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1.3.2.1 Rationale 
The risk of T2D can be reduced in women with a history of GD. The American Diabetes 
Prevention Programme (DPP) has been a valuable RCT to provide evidence supporting 
lifestyle behaviour change: high risk women with a history of GD who were offered intensive 
lifestyle counselling had approximately 50% lower incidence of T2D over three years and 35% 
over ten years compared to the placebo group that received standard lifestyle recommendations 
(350 participants) (163,164). This was comparable to the risk reduction observed in those 
receiving metformin (163). The lifestyle intervention aimed to maintain a weight reduction of 
7% and at least 150 min of moderate intensity exercise each week through regular personalised 
educational meetings, with additional support for those who did not meet the goals within the 
specified time frame (165). 
Systematic reviews of other smaller studies, including RCTs and observational studies, 
similarly show a reduction in progression to T2D through dietary and lifestyle interventions 
(166–168). One meta-analysis of four studies (including 951 women with GD at one to five 
years postpartum) found a statistically significant absolute risk reduction of 5.0 cases per 100 
(95% CI -9.2 to -0.8) (166), and another reported a clinically and statistically significant 25% 
risk reduction when eight RCTs were combined (169). However, these effects can be small or 
limited, particularly if engagement with the intervention is poor. 
1.3.2.2 Guidelines 
In the UK, NICE advises that women are given lifestyle advice about weight control, diet and 
exercise after GD and managed according to the guidelines for preventing T2D through primary 
care (2,170). Those at moderate diabetes risk (according to their current glucose control) are 
given advice about risk factors and offered brief interventions such as access to a weight loss 
programme. Those at high diabetes risk are additionally referred to intensive lifestyle change 
programmes. These should be person-centred and empathy-building, offer ongoing tailored 
advice, support and encouragement, and use established behaviour change techniques. These 
programmes were developed for the general population, which tends to be older and not have 
young families, therefore may present avoidable barriers to attendance for women who recently 
had GD. Furthermore, they are considered for these interventions based on the results of 
diabetes screening tests, assuming they have attended, rather than their history of GD. 
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1.3.2.3 Experiences and challenges 
In practice, lifestyle behaviour change in an obesogenic environment is challenging. According 
to a national random-sample telephone survey in the US in 2003, approximately half of women 
with previous GD reported that they were attempting to lose weight, although obese women 
with GD were half as likely to be attempting to lose weight as obese women without GD (171). 
They were also inactive and more likely not to meet fruit and vegetable consumption guidelines 
(172), therefore maintaining lifestyles that increase their diabetes risk. Another more recent US 
survey (2007 to 2014) similarly reported that women with GD tended not meet healthy lifestyle 
guidelines (173). These observations are explained by one of the conclusions of Jones et al. 
2009, that there is often inconsistency between T2D risk perception and diet and exercise 
behaviour (174). However, diet and exercise in women with a history of GD is unreported in 
the UK. 
Qualitative or mixed methods reviews have explored women’s postpartum views on reducing 
diabetes risk as part of broad investigations into their experience of GD (77,87,147,174). A 
wide variety of views and determinants have been presented: positive attitudes towards 
behaviour change and knowledge of how to improve T2D risk is often observed, particularly 
when it is understood to reduce diabetes risk and when women have support and self-efficacy 
for change. However, some women feel that they lack information regarding how to care for 
themselves while others report overwhelming barriers such as lack of time, energy and 
resources. 
There have been many studies that aim to promote behaviour change after GD, although these 
have tended to be pilot or feasibility studies, and heterogeneous designs make comparisons 
challenging (e.g. timing postpartum, intensity, mode of delivery, target behaviours, and follow-
up duration). Most have targeted both diet and physical activity, and include education, goal 
setting and/or monitoring (166). A recent mixed methods review identified that provision of 
childcare, social and community support, and culturally-appropriate interventions are likely to 
be most effective in promoting physical activity after GD, whereas education about the risk of 
T2D only and use of pedometers is less likely to be effective (175). Face-to-face recruitment 
during pregnancy or early postpartum may be most effective, if integrated into existing care 
pathways (176). 
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1.4 Summary 
Due to increasingly unhealthy lifestyles, more women are being affected by GD during 
pregnancy. GD identifies women at high risk of progression to T2D, with long-term 
consequences for their quality of life and cardiovascular health. Despite numerous benefits of 
increasing dietary quality, physical activity and periodic monitoring of blood glucose, many 
women do not act in response to their risk. As a result, there is a clear need to reduce diabetes 
risk factors and therefore incidence in women who have had GD. In some ways, they represent 
a particularly challenging population for behaviour change due to the additional demands of 
raising young children, yet in other ways they may be more motivated than the general 
population to be healthier after experiencing GD. Current protocols and interventions can be 
unsuitable for women with GD, vague or absent in the UK primary care setting. We urgently 
need to better understand the risk factors and timescales for developing T2D in order to inform 
screening programmes, and to describe and understand women’s behaviour after GD in order 





 Aims and overview of the thesis 
2.1 Aims 
The overall aim of this thesis is to better describe the problem of progression to T2D after a 
pregnancy affected by GD, and to identify primary care-based approaches that can be used to 
manage the risk of T2D in this population. 
I am therefore conducting this work with the view to develop recommendations and 
interventions related to postpartum diabetes screening so that blood glucose control can be 
monitored in this population, and to promote a healthy lifestyle to reduce T2D risk. I use both 
literature reviews and primary research using qualitative and quantitative approaches. 
This thesis is composed of three streams of work: 
 The aim of the first stream is to improve understanding of the magnitude and nature of 
this problem including risk factors for development of T2D after GD by better 
describing the incidence of T2D in women with a history of GD;  
 The aim of the second stream is to describe and understand attendance at postpartum 
diabetes screening in order to inform the development of interventions to promote 
uptake of screening; 
 The aim of the third stream is to understand determinants of and influences on healthy 
diet and physical activity after GD in order to inform the development of interventions 
to promote healthy lifestyles among women with GD. 
This work falls within the first stage of the Medical Research Council’s (MRC) guidelines for 
developing and evaluating complex interventions (177). The four key elements of this process 
are development, feasibility and piloting, evaluation, and implementation. The guidelines 
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suggest that interventions should be developed systematically, be based on the best available 
evidence and use relevant theory. In particular, I have strengthened the evidence base before 
moving on to preliminary or initial evaluations of the intervention elements identified. I have 
taken a person-based approach as developed by Yardley et al., focusing on understanding the 
perspectives of the target population through systematically investigating the beliefs, attitudes, 
needs and individual circumstances of women with a history of GD (178,179). 
2.2 Thesis outline 
Figure 2.1 depicts the structure of this thesis and how the earlier work informs later studies. 
In Chapter 3, I present the methods used in Chapters 4 to 8.  
The next chapter of my thesis is a large systematic literature review and meta-analysis of 
studies published up to October 2019 that report diagnoses of T2D in women with GD (Chapter 
4). This study provides more data supporting the value of this thesis by more accurately 
describing the seriousness of GD in terms of T2D risk, and confirming or reinforcing the 
importance of sustained screening for T2D after pregnancy and making lifestyle changes to 
reduce diabetes risk factors. 
I then report two studies on the topic of postpartum diabetes screening after GD. Chapter 5 
describes attendance at the six week screening test, such as what types of tests were used and 
factors associated with increased likelihood of attendance in a local cohort of women. The 
second study, Chapter 6, is a qualitative synthesis, using the same literature search used in 
Chapter 4, understanding women’s views towards attending diabetes screening after GD. Here 
I also report recommendations for increasing uptake that form part of my interview schedule 
for qualitative data collection (Chapter 8). 
Chapter 7 is a parallel qualitative synthesis to Chapter 6. I examine women’s views towards 
making changes to their diet and physical activity to reduce their risk of developing T2D, 
including barriers and facilitators to behaviour change. Again, I made recommendations for 
promoting healthy lifestyles based on these findings, and considered these during the 
qualitative interviews. 
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Finally, Chapter 8 is an interview study where I sought to interpret some of the findings from 
the other projects in the context of women in the UK. In particular, I wanted to ask them what 
support they would suggest to improve their risk of diabetes and evaluate the suggestions that 
I made as a result of the qualitative syntheses. These findings are brought together in the 
conclusion and discussion of Chapter 9. 
  




In this chapter, I describe the methods used to conduct the research projects that form my thesis. 
More specific details are provided within each chapter. Firstly, I describe the literature reviews 
that form the basis of Chapters 4, 6 and 7. I then describe the cohort and analyses used for the 
cohort study in Chapter 5, and conclude with a description of the qualitative interview study 
conducted for Chapter 8. 
3.1 Systematic literature reviews 
Each of the systematic literature reviews described in Chapters 4, 6 and 7 followed the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
(180). This is a checklist of items to include when reporting a systematic review to ensure that 
the methods, findings, and strengths, limitations and potential sources of bias in the review are 
clear. Furthermore, I prospectively registered each review protocol on PROSPERO 
(www.crd.york.ac.uk/prospero). PROSPERO is a database of planned and in-progress 
systematic reviews. Publication of protocols on this website aims to avoid duplication and 
minimise reporting bias. I reference the PROSPERO record at the start of each systematic 
literature review chapter. 
The three literature reviews presented in my thesis originated from one literature search that 
was conducted in September 2017. I then re-ran the search strategy in October 2019 for the 
incidence of T2D after GD review. Figure 3.1 shows how the reviews overlap. After planning 
the multiple reviews together as a research team (see Section 3.1.1), Rebecca Ward developed 
a search strategy to identify published studies relating to GD in the month before I started my 
doctoral research. These included the incidence of T2D after GD (Chapter 4) and the views of 
affected women on postpartum testing and lifestyle behaviours (Chapters 6 and 7), plus reviews 
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led by Rebecca Ward on diabetes risk factors in women with GD and interventions to prevent 
diabetes. This approach was taken because we anticipated that the studies included to answer 
each review question would overlap.  
As described below, when we first reviewed the titles and abstracts of citations identified by 
the search, we allocated the citations a label according to the review to which they were 
relevant. The qualitative reviews were completed first.  
3.1.1 Research team 
I worked alongside multiple colleagues for these literature reviews: my PhD supervisors (Prof 
Simon Griffin and Dr Juliet Usher-Smith), an NIHR Academic Clinical Fellow (Dr Rebecca 
Ward), a senior statistician (Stephen Sharp), and six fourth and fifth year medical students from 
the University of Cambridge (Eileen Chen, George Farmer, Rachel Fox, Madeline Green, 
Deeya Kotecha, and Chloe Legard). Rachel Fox worked on the qualitative review of views 
towards postpartum screening, and the other medical students worked on the incidence of T2D 
after GD review. The contribution of each colleague is described below. 
Including more than one person at each stage of a systematic review reduces bias and increases 
rigor. A second reviewer independently assessing citations for inclusion and exclusion, 
extracting data and assessing the quality helps to ensure that this is done consistently 
throughout the process and reduces individual error or bias. In qualitative syntheses in 
particular, multiple reviewers are vital for interpreting the findings. 
In addition, Isla Kuhn and members of the University of Cambridge Clinical School Library 
supported us to develop the search strategy and access full text manuscripts. Zhirong Yang, 
Hannah Harrison, Julia Mannes and Parto Forouhi were valuable in helping to extract data or 
verify extractions from non-English language papers. 
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3.1.2 Justification 
Systematic literature reviews are considered to be the highest level of scientific evidence and 
are useful for summarising complex issues (181). Synthesising the finding through meta-
analyses can increase the precision of effect estimates and help to resolve discrepancies (181), 
which was particularly important for my review on the incidence of T2D after GD. Qualitative 
systematic reviews and syntheses draw together the findings of individual studies so that the 
result is greater than the sum of its parts. This is can be used to informing interventions, policy 
and the direction and quality of future research (182). 
3.1.3 Search strategy 
The search strategy was developed and performed on 28 September 2017 by Rebecca Ward to 
identify all published literature considering GD and postpartum T2D. As reported in Table 3.1, 
the first element of the search considered terms analogous to T2D therefore rows one to six 
were combined using ‘OR’. Secondly, terms associated with GD or diabetes in pregnancy were 
used in rows eight to 14. The remaining rows searched for terms associated with development, 
or descriptors of development, of diabetes. Finally, each key element was combined using 
‘AND’. Explosions and MeSH headings were used to increase the likelihood of identifying all 
relevant studies.  
Five electronic medical databases were searched: Medline, Embase, PsychInfo, CINAHL and 
the Cochrane Library. No limits (such as publication language) were enforced in order to access 
papers published in relevant journals.  
Table 3.1: Medline search strategy developed for the group of literature reviews.  
1. type 2 diabetes.mp. or Diabetes Mellitus, Type 2/  36. yoga.mp. or Yoga/ 
2. T2DM.mp.  37. postnatal.mp. 
3. NIDDM.mp. or Diabetes Mellitus, Type 2/  38. diet.mp. or Diet/ 
4. non insulin dependent diabetes.mp.  39. healthy eating.mp. or Healthy Diet/ 
5. glucose tolerance.mp.  40. behaviour.mp. 
6. insulin resistance.mp. or Insulin Resistance/  41. physical activity.mp. or Exercise/ 
7. 1 or 2 or 3 or 4 or 5 or 6  42. lifestyle.mp. or Life Style/ 
8. gestational diabet*.mp.  43. manag*.mp. 
9. diabetes in pregnancy.mp.  44. screening.mp. or Mass Screening/ 
10. Pregnancy/ or pregnancy.mp.  45. hypoglycaemic agents.mp. 
11. type 2 diabet*.mp.  46. hypoglycaemics.mp. 
12. 10 and 11  47. health promotion.mp. or Health Promotion/ 
13. gestation*.mp.  48. medication.mp. 
14. 11 and 13  49. medical therapy.mp. 
15. postpartum diabet*.mp.  50. rate.mp. 
16. postpartum.mp. or Postpartum Period/  51. predictor*.mp. 
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17. 8 or 9 or 12 or 14 or 15 or 16  52. risk*.mp. 
18. prevent*.mp.  53. factor*.mp. 
19. progress*.mp.  54. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 
or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 
or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 
or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 
20. develop*.mp.  
21. advanc*.mp.  
22. incidence.mp. or Incidence/  
23. avoidance.mp.  55. follow-up.mp. 
24. prohibit.mp.  56. postpartum.mp. or Postpartum Period/ 
25. establish.mp.  57. qualitative.mp. 
26. health promotion.mp. or Health Promotion/  58. Interview/ or interview.mp. 
27. Exercise/ or exercise.mp.  59. focus group*.mp. 
28. active living.mp.  60. health service.mp. or Health Services/ 
29. metformin.mp. or Metformin/  61. belief*.mp. 
30. weight.mp. or "Weights and Measures"/  62. opinion*.mp. 
31. risk factors.mp. or Risk Factors/  63. survey.mp. 
32. Insulin/ or insulin.mp.  64. 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 
or 63 33. exercise therapy.mp. or Exercise Therapy/  
34. intervention.mp.  65. 7 and 17 and 64 
35. interven*.mp.   
Search strategy developed by Rebecca Ward. 
The citations identified were downloaded and imported into Mendeley reference manager. 
Duplicates repeated in or across electronic databases were removed using the deduplication 
function in the reference manager. I replicated the search on 14 October 2019 to identify recent 
papers for the incidence review (Chapter 4).  
In addition, I reviewed the list of references cited by each paper included in the qualitative 
reviews in order to identify additional studies. I reviewed the lists of studies included in 
previous reviews on the risk of T2D after GD for the incidence review (36,98,99,122), although 
it was not practical to review the reference lists of the included studies for this review due to 
the high number of studies included.  
3.1.4 Inclusion and exclusion criteria  
For all the reviews, I included studies that were published as a primary research article in a 
peer-reviewed journal. Conference abstracts, posters and comments or opinion pieces were 
excluded, as were protocols and literature reviews that did not report primary research data. 
Participants must have had a history of GD. 
Specific inclusion criteria were applied to the incidence of T2D review. For inclusion, the 
papers needed to report: 
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1. Quantification of diabetes diagnoses after GD. 
The paper must have quantified development of diabetes, such as cumulative 
incidence, survival analyses or percentage diagnosed with diabetes at a specified 
time after pregnancy. The total or a random sample of a population exclusively 
with GD must have been followed up (that is, studies that followed up a population 
with a selected characteristic were excluded). It was not necessary for the study to 
distinguish between T2D and T1D, but diagnoses of overt diabetes must have been 
reported.  
2. Longer than six months follow-up after GD. 
Assessment of diabetes status must have occurred at an average six months or 
longer after the GD-affected pregnancy in order to assess long-term development 
of diabetes in those whose GD resolved after delivery. Persistent postpartum 
glucose intolerance suggested that the participant had pre-existing undiagnosed 
diabetes before the pregnancy.  
3. Diagnostic method and criteria for GD and T2D. 
The method and/or criteria used to diagnose both GD and T2D must have been 
reported. The diagnostic method described how participants were identified for the 
current study (for example, reviewing medical records or testing pregnant women 
with an OGTT). The diagnostic criteria described how GD and T2D were defined 
by the diagnostic method (for example, local or WHO glycaemic cut-off values in 
a diagnostic test). This information was required due to the different definitions of 
GD and T2D used over time and in different locations. 
4. More than 50 participants with GD followed up. 
We introduced an ad hoc criterion of a sample size of 50 or more participants with 
GD to reduce the number of small studies relevant to the review that would have 
had a small impact on summary incidence estimates. Studies with any number of 
participants without GD (including zero) were eligible. 
5. Any study design was eligible. 
We included both observational and experimental studies. 
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For the qualitative literature reviews, I only included qualitative research in which qualitative 
data were defined as data arising from qualitative methods and analysis approach. For example, 
interviews or free text of surveys that were analysed using thematic synthesis. For the review 
in Chapter 6, I included studies that examined women’s views and experiences of postpartum 
glucose tolerance testing or T2D screening. For the review in Chapter 7, I included studies that 
examined women’s postpartum lifestyle experiences (focusing on diet and exercise) following 
GD; for example, facilitators or barriers to participating in a T2D prevention programme with 
a lifestyle intervention. Studies exclusively reporting views of healthcare providers were 
excluded. 
3.1.5 Title and abstract review 
In the first stage of the title and abstract review, Rebecca Ward and I screened the studies for 
general relevance (such as excluding unrelated diseases or reporting of animal experiment 
studies) due to the large numbers of studies identified. We both independently reviewed 
approximately 10% of citations to assess discrepancies between authors’ decisions when more 
carefully applying the inclusion criteria to the remaining studies. Any differences were 
discussed and if a consensus could not be reached, Simon Griffin and/or Juliet Usher-Smith 
were asked to provide an additional opinion. Once the inclusion criteria and their application 
were agreed, Rebecca Ward and I reviewed approximately half of the citations each.  
We categorised the included citations for potential relevance to questions about incidence of 
T2D after GD, risk factors for T2D after GD, interventions to prevent T2D after GD, or 
qualitative studies. These citations were reviewed against the specific inclusion and exclusion 
criteria described above for each study. When additional researchers (the medical students) 
joined the title and abstract review, 10% of citations were compared to ensure consistency. Any 
citation where it was unclear whether it fulfilled the inclusion criteria, such as insufficient 
information, was included at this stage.  
We conducted the title and abstract review by putting the citations in different folders in 
Mendeley for the earlier reviews and used Rayyan for the update to the incidence review in 
2019. Rayyan is a software tool designed to facilitate title and abstract screening, and is 
particularly helpful for comparing inclusion decisions between team members (180,183). 
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3.1.6 Full text review 
Full text articles were acquired (downloaded or purchased if access was not available through 
the existing subscriptions of the University of Cambridge) and rechecked against the selection 
criteria. Two authors reviewed each full text for the qualitative reviews (myself and Rachel 
Fox or Juliet Usher-Smith) whereas a 10% overlap in citations was again applied for the 
incidence review (myself, Eileen Chen, George Farmer, Madeline Green, Deeya Kotecha, or 
Chloe Legard). Queries were discussed with the co-authors, and any article that was not clearly 
relevant was excluded at this stage. Reasons for exclusion were recorded in a Microsoft Excel 
spreadsheet. 
3.1.7 Data extraction and analysis 
3.1.7.1 Meta-analysis of studies of the incidence of diabetes after gestational diabetes 
I developed a data extraction form to facilitate systematic extraction of study-level 
characteristics, incidence and demographic information from the included citations (including 
a control group without GD, if reported). Data were extracted by two authors independently 
(primarily myself and one of Eileen Chen, George Farmer, Madeline Green, Deeya Kotecha, 
or Chloe Legard, but sometimes by two medical students). Any initial differences were 
resolved by discussion in order to minimise error.  
After extracting the basic details of each study, I sought to identify whether the same study 
population had been reported by multiple publications, again with help from the medical 
students. I did this by first comparing location of the study and time of recruitment, before 
looking at other details such as the author lists and number of participants if it was still unclear. 
When overlap occurred, I only included the publication with the most person-years of follow-
up of women with GD. Similarly, if progression to T2D was reported at multiple timepoints 
within one citation, I extracted data at the timepoint with the most person-years of follow-up. 
I translated non-English language articles with the aid of an online translation tool 
(www.translate.google.co.uk), and verified the data extraction and details required for quality 
assessment with a native or fluent speaker of that language where possible. If the online 
translation was unclear, the native speaker completed the full text review and data extraction 
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using a simple form to guide them through this process. This tended to be colleagues in the 
University of Cambridge or their associates, as noted in Section 3.1.1. 
Study-level characteristics were categorised as described in Chapter 4.3.4. The cut-offs used to 
define each category were based on the average (mean or median) of the study-level data or 
clinically-relevant cut-offs, and were discussed and agreed by the research team. 
I performed the analysis using STATA 15.1, with statistical advice from Stephen Sharp. I 
grouped studies according to each of the characteristics, and combined these groups of studies 
using random-effects meta-analysis of the log odds of T2D. For absolute risk, effect estimates 
tended to be skewed below 50%, resulting in disproportionate weighting of studies with the 
lowest estimates (due to correspondingly low variance) and negative lower confidence intervals 
(where it is not possible to have incidence estimates less than 0%) (184). I therefore used a 
logit transformation to conduct the meta-analysis, then back-transformed the output to the 
percentage or odds ratio scales for interpretation (184,185). This transformation is very stable 
except for small studies (e.g. n less than 50), which were excluded according to the study 
selection criteria. Random-effects analyses were used due to the assumption of residual 
heterogeneity not explained by the potential effect modifiers (186). I used meta-regression to 
model the association between study-level characteristics and log odds of T2D. I then extended 
the model to investigate the extent to which any of the study and maternal characteristics 
described above explained the heterogeneity between studies, adjusting all models for ethnicity 
(majority White European or other) and categorised duration of follow-up. Meta-regression 
was weighted by the inverse of the sum of the within and between study variance, as is standard 
in a random-effects meta-analysis. I also calculated the relative risk of diabetes in studies that 
had a comparator population and combined these across studies using random-effects meta-
analysis, overall and stratified by study and maternal characteristics. I used a fixed continuity 
correction of 0.5 where no cases of T2D were reported. Heterogeneity between studies was 
quantified using the I2 statistic throughout. 
3.1.7.2 Qualitative syntheses of studies of views on screening for type 2 diabetes and 
lifestyle behaviours after gestational diabetes 
I developed a data extraction form to facilitate systematic extraction of the characteristics of 
each included study. This included the sample size, setting (country), relevant study aims, 
recruitment strategy, key inclusion and exclusion criteria, and time and method of data 
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collection. Myself plus Rachel Fox or Juliet Usher-Smith independently extracted data from 
each study and compared the data extraction forms to ensure agreement. 
The qualitative findings were analysed using the thematic synthesis approach described by 
Thomas and Harden 2008 (187) with the aid of NVivo 11 (NVivo qualitative data analysis 
software; QSR International Pty Ltd, version 11 [2015]). This method for qualitative synthesis 
was selected in order to stay true to the content of the original data while moving beyond it in 
interpretation, and for the outcome to be applicable in practice (187,188). I imported the 
publication file into NVivo and used the software to manage the data; it allowed me to develop, 
modify and organise a coding scheme and review all data that I had coded under each code. 
I defined data as text or tables labelled as ‘Results’ (or equivalent) that resulted from qualitative 
methods. Thomas and Harden (187) suggest also including the abstract in this definition but I 
soon found that such a concise summary did not contribute to my understanding of the content 
of the codes therefore decided not to code the abstract. 
After carefully reading and re-reading each primary study, I coded the findings, organised these 
codes into related areas to develop descriptive themes and then developed analytical themes, 
as summarised in Figure 3.2. An example of each coding scheme and summary of the process 
are presented in the corresponding chapters of this thesis. I developed the initial coding scheme 
by focussing on two or three papers: I labelled or annotated the findings to develop a list of 
codes and discussed these codes with Rachel Fox or Juliet Usher-Smith, who had also 
annotated two papers. I then applied the coding scheme line by line to the rest of the data, 
adding new codes as necessary. Rachel Fox or Juliet Usher-Smith independently coded a subset 
of papers at multiple stages to check consistency. In the next stage, concepts were translated 
from one study to another by making summaries and comparisons, and new concepts were 
developed. This process allowed me to move beyond the descriptive findings to gain further 
insight into the phenomena reported, such as inferring barriers and facilitators to the particular 
behaviours, informed by other studies.  
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Figure 3.2: Summary of thematic synthesis used in the qualitative syntheses. 
I developed the analytical themes through an iterative process involving reading each code and 
summarising in a few words on a hand-written note. For example, for the review on lifestyle 
behaviour to reduce T2D risk, I summarised similar ideas from different categories on the same 
note. For instance, I summarised the role of “support” from my “actual barriers to healthy diet” 
category then added how support could be a facilitator to healthy eating, how women thought 
that they could have a healthy diet if they had more support, etc. This led to the creation of 
approximately 20 notes. I used these notes by grouping and ordering them in different ways; 
trying to make connections helped me to see how different ideas fitted together and how 
descriptive themes contributed to the analytical themes that I was beginning to develop. 
However, diagrams of connections were too complicated to interpret therefore I further 
summarised the notes and ideas – once for healthy diet and once for physical activity (using a 
similar approach to the ‘one sheet of paper method’ (189)). I then highlighted these two 
summaries to indicate where influences operate in the same way for diet and physical activity, 
or were specific to one behaviour. This allowed me to fit the key points into six distinct but 
highly connected themes (plus a seventh on the format of interventions).  
A very similar approach was used for the analysis of views towards postpartum testing. Data 
were less diverse so it was not necessary to categorise the data before coding it, and I worked 
closely with Rachel Fox to complete the analysis.  
Chapter 3  Methods 
62 
Finally, I developed recommendations for improving behaviour based on the findings of each 
review (that is, to support healthy diet and exercise, and increase attendance at diabetes 
screening). I did this in order to make sure that the reviews had clear practical implications. 
These included both where participants reported being able to carry out healthy behaviour and 
benefitted from support, and where they suggested that more support was necessary. I mapped 
these onto the standardised behaviour change technique taxonomy by suggesting mechanisms 
by which the recommendations could be put into practice (190). I evaluated these 
recommendations, as described in Section 3.1.9. 
While I developed the initial and analytical themes and recommendations, I also discussed 
them with the co-authors at regular intervals. 
3.1.8 Quality assessment 
I assessed the quality of each study included in the literature reviews in order to consider biases 
in the conclusions. I used, or based the quality assessment on, published checklists that were 
appropriate to the design of each included study. The quality assessment checklist was 
completed independently by at least two of the authors who had completed the data extraction 
for each study, and any differences were discussed and the appropriate score agreed. No studies 
were excluded based on quality. 
3.1.8.1 Quantitative studies 
Shamliyan et al. reviewed tools used to assess the quality of observational studies of disease 
incidence, prevalence and risk factors (191). However, none were suitable for use in the 
incidence review because they could not be applied across different study designs, were not 
simple enough for use in many studies, and did not consider the elements we identified as most 
likely to introduce bias in measuring risk of T2D after GD. For example, the tool used by 
Nguyen et al. 1999 could be applied to the studies of incidence and prevalence but had 28 
questions, and each had a different scoring system to give a total score out of 100 (192). We 
considered this to be too time consuming and complicated to apply to a high number of studies. 
Others such as Scholten-Peeters et al. 2003 had a simpler scoring system of yes/no/don’t know, 
but had several questions that would not be relevant to progression to T2D after GD because it 
was developed to assess prognostic factors (such as follow-up of at least 12 months, description 
of treatments and data presentation of most important outcome measures) (193). 
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As a result, I evaluated the risk of bias in each study included in this review using a checklist 
adapted from the Critical Appraisal Skills Programme (CASP) and Newcastle-Ottawa Scale 
checklists (194,195). There is a CASP checklist for each type of study design (including 
randomised controlled trials and cohort studies, which were most relevant for this review). 
There are between ten and 12 questions addressing study validity (research question and 
recruitment), design (exposure and outcome assessment, confounding and follow-up) and the 
results (trustworthiness and implications). “Yes”, “can’t tell” or “no” is given in response. 
Similarly, the Newcastle-Ottawa Scale for cohort studies examines participant section, 
comparability of exposed and non-exposed cohorts, and outcomes. One or no ‘stars’ are given 
according to the response to each question, and studies are classified as good, fair or poor 
quality according to the number of ‘stars’ received across the three domains. 
From these checklists, I selected six key questions (Table 3.2) to assess possible bias in the 
incidence estimate across all study designs. I used a simple scoring system to maintain 
comparability and internal validity with numerous studies. Studies scored one point for “yes” 
and zero points for “unclear” or “no”; scores of five or six were considered as high quality 
studies, three or four were medium quality, and scores less than three were low quality. Quality 
assessment was independently completed by at least two authors (myself and one of Eileen 
Chen, George Farmer, Madeline Green, Deeya Kotecha, or Chloe Legard) for each study. 
Queries and disagreements discussed with Simon Griffin. 
3.1.8.2 Qualitative studies 
For the qualitative reviews, myself and Rachel Fox or Juliet Usher-Smith assessed the quality 
of each study’s qualitative findings against the CASP checklist designed for qualitative 
research (Table 3.3) (196). This checklist was selected due to its comprehensiveness and 
because the same questions could be applied to different qualitative methods. We awarded 
scores of 0, 0.5 and 1 for answering ‘no’, ‘unclear’ and ‘yes’ to each of the ten questions. 
During this process, I focused on internal consistency and recorded my justification for each 
answer. This facilitated discussion of the findings with a second reviewer, particularly when 
the assessment was uncertain. 
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Table 3.2: Quality assessment checklist for the incidence of type 2 diabetes after gestational diabetes review, 
based on the Newcastle-Ottawa Scale (194) and Critical Appraisal Skills Programmes (CASP) checklists 
(195). 
 Score Explanation 
Recruitment   
1. Was the cohort recruited in an acceptable way?  
Yes – representative or somewhat representative of a defined 
population; e.g. a whole hospital cohort (1 point) 
No – selected or unrepresentative group; e.g. a population with a 
particular characteristic (0) 
Can’t tell – no description of the derivation of the cohort (0) 
  
Exposure and outcome ascertainment   
2. Was the exposure accurately measured to minimise bias?  
Yes – objective measurements for study or from records (1) 
No – subjective measure; e.g. self-report history of GD (0) 
Can’t tell – no description (0) 
  
3. Was it demonstrated that outcome of interest was not present at start of 
study? 
Yes – steps taken to exclude pre-existing T2D; e.g. self-report, 
medical records or 6 week postpartum test (1) 
No (0) 
Can’t tell (0) 
  
4. Was the outcome accurately measured to minimise bias?  
Yes – objective measurements; e.g. independent blind assessment by 
call back for OGTT or HbA1c (1) 
No – subjective measure; e.g. self-report or record linkage (0) 
Can’t tell – no description (0) 
  
Follow-up   
5. Was the follow-up (for the incidence extracted) long enough for outcomes 
to occur?  
Yes – greater than approx. 5 years (1) 
No – less than approx. 5 years (0) 
[Unclear – exclude] 
  
6. Was the follow-up (for the incidence extracted) adequate?  
Yes – complete follow up with all subject accounted for (1), OR 
Yes – 40–80% subjects followed up and those lost to follow-up are 
unlikely to introduce bias (persuaded that there is no difference 
between followed up and lost to follow-up) (1) 
No – follow up rate less than 80% and no description of those lost (0) 
Unclear – no statement (0) 
  
Total  /6 
Class  
High (5 or 6), 
medium (3 or 4), or 
low (0, 1 or 2) 
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Table 3.3: Critical Appraisal Skills Programmes (CASP) checklist for qualitative research (196) used in the 
qualitative literature reviews. 
 Score Explanation 
Are the results valid?   
1. Was there a clear statement of the aims of the research?  
Hint: Consider 
 What was the goal of the research 
 Why it was thought important 
 Its relevance 
Yes/ 
can’t tell/  
no 
 
2. Is a qualitative methodology appropriate? 
Hint: Consider 
 If the research seeks to interpret or illuminate the actions and/or 
subjective experiences of research participants 
 Is qualitative research the right methodology for addressing the 
research goal 
Yes/ 
can’t tell/  
no 
 
Is it worth continuing?   
3. Was the research design appropriate to address the aims of the research? 
Hint: Consider 
 If the researcher has justified the research design (e.g. have they 
discussed how they decided which method to use) 
Yes/ 
can’t tell/  
no 
 
4. Was the recruitment strategy appropriate to the aims of the research?  
Hint: Consider 
 If the researcher has explained how the participants were selected 
 If they explained why the participants they selected were the most 
appropriate to provide access to the type of knowledge sought by 
the study 
 If there are any discussions around recruitment (e.g. why some 
people chose not to take part) 
Yes/ 
can’t tell/  
no 
 
5. Was the data collected in a way that addressed the research issue? 
Hint: Consider 
 If the setting for the data collection was justified 
 If it is clear how data were collected (e.g. focus group, semi-
structured interview etc.) 
 If the researcher has justified the method chosen 
 If the researcher has made the methods explicit (e.g. for interview 
method, is there an indication of how interviews are conducted, or 
did they use a topic guide) 
 If methods were modified during the study. If so, has the 
researcher explained how and why 
 If the form of data is clear (e.g. tape recordings, video material, 
notes etc.) 
 If the researcher has discussed saturation of data 
Yes/ 
can’t tell/  
no 
 
6. Has the relationship between researcher and participants been adequately 
considered?  
Hint: Consider 
 If the researcher critically examined their own role, potential bias 
and influence during (a) formulation of the research questions (b) 
data collection, including sample recruitment and choice of 
location 
 How the researcher responded to events during the study and 
whether they considered the implications of any changes in the 
research design 
Yes/ 
can’t tell/  
no 
 
What are the results?   
7. Have ethical issues been taken into consideration? 
Hint: Consider 
Yes/ 
can’t tell/  
no 
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 If there are sufficient details of how the research was explained to 
participants for the reader to assess whether ethical standards 
were maintained 
 If the researcher has discussed issues raised by the study (e.g. 
issues around informed consent or confidentiality or how they 
have handled the effects of the study on the participants during 
and after the study) 
 If approval has been sought from the ethics committee 
8. Was the data analysis sufficiently rigorous?  
Hint: Consider 
 If there is an in-depth description of the analysis process 
 If thematic analysis is used. If so, is it clear how the 
categories/themes were derived from the data 
 Whether the researcher explains how the data presented were 
selected from the original sample to demonstrate the analysis 
process 
 If sufficient data are presented to support the findings 
 To what extent contradictory data are taken into account 
 Whether the researcher critically examined their own role, 
potential bias and influence during analysis and selection of data 
for presentation 
Yes/ 
can’t tell/  
no 
 
9. Is there a clear statement of findings? 
Hint: Consider 
 If the findings are explicit 
 If there is adequate discussion of the evidence both for and against 
the researcher’s arguments 
 If the researcher has discussed the credibility of their findings 
(e.g. triangulation, respondent validation, more than one analyst) 
 If the findings are discussed in relation to the original research 
question 
Yes/ 
can’t tell/  
no 
 
Will the results help locally?   
10. How valuable is the research? 
Hint: Consider 
 If the researcher discusses the contribution the study makes to 
existing knowledge or understanding (e.g. do they consider the 
findings in relation to current practice or policy, or relevant 
research based literature 
 If they identify new areas where research is necessary 
 If the researchers have discussed whether or how the findings can 
be transferred to other populations or considered other ways the 
research may be used 
  
Total  /10 
3.1.9 Confidence in the findings 
In the final part of each qualitative synthesis, I used the Grading of Recommendations 
Assessment, Development and Evaluation-Confidence in Evidence from Reviews of 
Qualitative research (GRADE-CERQual) approach to evaluate my confidence in each of these 
recommendations (197). GRADE-CERQual considers the relevance, coherence, adequacy and 
methodological limitations of data contributing to each recommendation, informing the 
confidence in its effectiveness.  
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I therefore had more confidence that a suggestion will support women to change their 
behaviour when the data that informed it came from primary studies that asked the same 
question as our review question in a comparable population (relevance), when most of the data 
available supported the point made and there were few disparities in views (coherence), when 
the data were reported in detail from multiple studies (adequacy), and when the contributing 
studies had low risk of bias (methodological limitations).  
These assessments were recorded using the table suggested by Lewin et al. (197), and are 
reported in the appendices of this thesis. I completed these tables and discussed them with 
Rachel Fox and Juliet Usher-Smith. 
3.2 Cohort study 
In this cohort study, I used medical records from the Rosie Hospital to examine uptake of 
diabetes screening within one year after a pregnancy affected by GD. 
This was a secondary analysis of a convenience sample from a dataset created for another 
purpose. It allowed me to report diabetes screening attendance and associations between 
attendance and variables recorded in the medical record. This was a quite large dataset (556 
records) and no additional burden was placed on the patients or medical staff to collect data for 
research purposes. However, as a retrospective cohort, there were missing data and some 
variables that I would have included if I had designed the study were not collected. 
3.2.1 Research team 
The data for this study were provided by Dr Catherine Aiken, a Consultant in Obstetrics and 
Fetal Medicine at the Rosie Hospital. Catherine Aiken and Dr Claire Meek (Honorary 
Consultant Chemical Pathologist and Metabolic Physician with a special interest in GD) 
provided details about GD care at the Rosie Hospital. The study was designed by myself 
alongside Catherine Aiken, Claire Meek and my supervisors; Matthew Barclay provided 
further statistical advice. 
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3.2.2 Overview of the cohort 
The Rosie Hospital is a maternity hospital that is managed by the Cambridge University 
Hospitals NHS Foundation Trust. It offers maternity and neonatal services to the local 
population and specialist services to the eastern region in the UK (such as high risk obstetrics 
and neonatal intensive care) (198). 
As part of routine care at the Rosie Hospital, women with a history of previous GD are offered 
an OGTT shortly after booking at 12 to 14 weeks of pregnancy. Women at higher GD risk, 
such as older age or family history of diabetes, are offered an OGTT at 24 to 28 weeks while 
others will be offered if they become symptomatic.  
All women diagnosed with GD are seen every two to four weeks at multidisciplinary clinics. 
They are encouraged to monitor their blood glucose levels and offered lifestyle counselling. 
Those with evidence of persistent hyperglycaemia are offered treatment with insulin, 
metformin or both. All patients are advised verbally during the antenatal period that they should 
attend for postpartum glucose testing at six to eight weeks following delivery. Blood collection 
can take place at the hospital or the women’s own GP practice. All blood samples are processed 
by Cambridge University Hospitals NHS Foundation Trust so the results are available on the 
Rosie Hospital electronic records. 
For this study, Catherine Aiken identified women diagnosed with GD who delivered a 
singleton infant at a viable gestation (over 24 weeks) at Cambridge University Hospitals NHS 
Foundation Trust between October 2014 and March 2017 from electronic medical records. We 
only included the first pregnancy if women had several eligible pregnancies.  
3.2.3 Definition of variables 
I defined GD according to modified IADPSG criteria (15) used at the hospital at that time: FPG 
≥5.3 mmol/l, or ≥10.0 mmol/l after 60 minutes or ≥8.5 mmol/l after 120 minutes in the 75g 
OGTT. T2D and IGT were defined using the 2006 WHO criteria (103,199): FPG ≥7.0 mmol/l 
or ≥11.1 mmol/l after 120 minutes, and FPG <7.0 mmol/l and ≥7.8 and <11.1 mmol/l after 120 
minutes in the 75g OGTT, respectively.  
The general practice where each woman was registered was included in the dataset. I manually 
linked data from each participant to their general practice’s characteristics that were available 
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on the internet, including size and deprivation score, diabetes Quality and Outcomes 
Framework (QOF), GP Patient Survey, and National Diabetes Audit indicators. Use of these 
variables are justified in Table 3.4. I used data from 2015/2016 from Public Health England’s 
National General Practice Profiles, and the 2015 Index of Multiple Deprivation (IMD) (200). 
Table 3.4: Description and justification of the variables relating to the participants’ general practice for the 
cohort analysis. 




Size of the general practice in 2016 GD follow-up care may vary between 
size of general practice (for example, 
larger practices may have more 
specialist GPs but not know their 
patients so well) 
Practice IMD 
score 
Indication of deprivation of the general 
practice’s area in 2015, including measures of 
income, employment, health and disability, 
education, skills and training, housing and 
services, and living environment and crime 
Deprivation has been associated with 
healthcare availability 
General performance 
Total QOF score The percentage of all QOF points achieved, 
across all domains 
Indication of the quality of care 




Percentage of general practice population who 
would recommend the practice  
Indication of overall patient 
satisfaction with their general 
practice 
Diabetes care performance 
Percentage with 
blood test 
The percentage of patients with diabetes who 
received a blood test (for HbA1c) within the 
preceding 15 months 
Process measure of diabetes care 
Percentage with 
foot examination 
The percentage of patients with diabetes with a 
foot examination and risk classification 
recorded within the preceding 12 months 




The percentage of patients with diabetes with 
HbA1c less than 59 mmol/mol (7.5%) within 
the preceding 12 months  




The percentage of patients with newly 
diagnosed diabetes who have a record of being 
referred to a structured education programme 
within 9 months within the preceding 12 
months 
Process measure of diabetes care 
IMD: Index of Multiple Deprivation; QOF: Quality and Outcomes Framework. 
Personal and pregnancy characteristics were extracted from the medical record. Of note, pre-
pregnancy BMI was based on measurements recorded in the community at the antenatal 
booking visit at eight to 12 weeks. Gestational weight gain was calculated by subtracting pre-
pregnancy weight from the last recorded clinic weight in pregnancy (at 36 weeks for the 
majority). Gestational age at delivery was calculated using the crown-rump length measured 
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on ultrasound scan in the first trimester. Gestation-specific birthweight z-scores were based on 
the INTERGROWTH-21st Estimated Fetal Weight Standards (201).  
I searched the dataset for the result of any OGTT or HbA1c test performed within one year after 
delivery, and used a test result as a proxy for attendance at testing.  
The study was approved as a service evaluation, and the Institutional Review Board granted 
approval for further analysis of the data for research purposes. 
3.2.4  Analysis  
I used STATA 15.1 to run univariable and multivariable two-level mixed-effects logistic 
regression analyses to identify factors associated with the odds of postpartum testing for 
diabetes by an OGTT, HbA1c or either test.  
This type of model was selected to account for clustering by GP practice; i.e. to model what is 
actually happening rather than removing any differences between general practices. I used the 
‘melogit’ command to predict the fixed-effect of individual-level variables (personal 
characteristics) on screening attendance because these were not anticipated to have differential 
effects across practices. The random-effect described differences across practices in the 
likelihood of attending screening. The odds ratio of attending screening after a caesarean 
delivery, for example, is therefore the conditional odds ratio of attending screening after a 
caesarean delivery compared to someone who did not have a caesarean delivery in the same 
practice.  
In order to meet the assumptions for logistic regression (202), I selected variables for which 
the errors are independent and were not collinear (such as BMI and weight). I ensured the 
absence of highly influential outliers by examining the data, and ensured linearity for 
continuous variables by plotting each continuous variable against the logit‐transformed 
variable in order to identify a linear relationship.  
Continuous variables were centred about the mean to aid interpretation. The multivariable 
analyses were adjusted for variables that were significant in the univariable analysis or we had 
strong a priori rationale to include (explained in Chapter 5). This was a complete case analysis. 
No statistically significant differences between the characteristics of the original cohort and the 
complete case cohort were observed, therefore I did not impute missing data. 
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Odds ratios and 95% confidence intervals are reported. 
3.3 Qualitative interview study  
For the last part of my doctoral research, I completed a qualitative interview study. ‘DAiSIeS’ 
is the Diet, Activity and Screening after gestational diabetes: an Interview Study. The study 
materials are provided in the appendices. This study was approved by the West London and 
GTAC Research Ethics Committee (reference 19/LO/0441). 
The methods are reported in this chapter and Chapter 8 in line with recommendations such as 
those by Anderson 2010 (203) and the Consolidated Criteria for Reporting Qualitative 
Research (COREQ) checklist (204). The COREQ checklist ensures thorough reporting of the 
research team and reflexivity (personal characteristics and the relationship with the 
participants), study design (theoretical framework, participant section, setting and data 
collection), and analysis and reporting. 
3.3.1 Research team 
This study was designed by myself alongside Dr Juliet Usher-Smith, Professor Simon Griffin, 
Dr Claire Meek and Dr Catherine Aiken. Claire Meek was particularly involved in contributing 
to development of the study materials, gaining ethical approval and identifying research nurses 
to recruit participants through her clinical connections with the Rosie and Peterborough 
Hospitals. Rachel Fox contributed as the second author by coding a subset of the interviews, 
creating charts and discussing the provisional findings. All authors were involved in the final 
interpretation of the data. 
3.3.2 Justification 
A qualitative approach was used in order to explore and understand the experiences, views and 
opinions of women with a history of GD on the research topic (i.e. diet, exercise and screening 
behaviours after GD). Qualitative research is suitable for developing a deeper, detailed 
understanding of the phenomenon of interest than can be elicited by a survey or questionnaire 
that quantifies the responses. It allows the participants to open up and share their own story; 
that is, their thoughts on support for GD follow-up given their current postpartum context and 
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own experience of pregnancy. On the other hand, qualitative research utilises a small sample 
size that tends not to be generalizable to the wider population and is time- and resource- 
intensive. 
Semi-structured interviews were selected for data collection. This allowed me to direct the 
topics covered in the interviews but also to diverge from the interview schedule to follow-up 
and further investigate ideas in order to develop a deeper understanding (205). Compared to 
focus groups, interviews were considered to be a suitable method for data collection because 
they allowed each participant to share their personal experiences in-depth and were anticipated 
to be easier for women with young children to attend since they could be conducted at a time 
and place of their choice. However, interviews do not allow interactions between the 
participants, such that they could respond and react to the other participants (206). 
3.3.3 Recruitment 
The study sample, women with a history of GD, was recruited via the Rosie Hospital 
(Cambridge University NHS Foundation Trust) and Peterborough Hospital in Cambridgeshire 
in the East of England. These locations were selected because they were accessible for me to 
travel to, enabling me to arrange the interviews at the time most suitable for the participant. In 
general, Peterborough has a more diverse population than the area served by the Rosie Hospital 
with regards to education level, income, ethnicity and therefore experience of GD. 
Research nurses from the two hospitals identified eligible participants via their medical records. 
They posted or emailed a customised invitation letter and participant information sheet to them 
describing the purpose and procedure of the interviews (Appendices 1 and 2). Participants 
replied to research nurses if they wanted to take part, who then passed their contact details onto 
me using the secure ‘nhs.net’ email to arrange an interview and answer any questions they had. 
I contacted the participants using telephone calls, email and text messages and I attempted to 
speak directly to each participant before the interview. Potential participants were sent up to 
one reminder to respond, and those who initially expressed interest were sent up to three 
reminders to arrange the interview. 
Additionally, we displayed posters (Appendix 3) introducing the study at hospital antenatal 
clinics so that potential participants could become aware of the study before receiving an 
invitation letter.  
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3.3.4 Inclusion criteria 
Mothers over 18 years old were eligible if they had been diagnosed with GD during any 
previous pregnancy. They must have been 12 weeks to four years postpartum in order to have 
settled with their new baby and attend postpartum follow-up, and be cared for during the period 
covered by the 2015 NICE guidelines for GD management (2).  
They needed to be considered suitable to take part in a qualitative interview by the research 
staff who had access to their medical records (for example, ability to understand the interview 
procedure and give informed consent). I did not have the resources to interview participants 
who did not speak fluent English in this study. 
Potential participants were not invited to take part if they did not have a successful, 
uncomplicated pregnancy and full-term birth (over 37 weeks gestation) in order not to cause 
undue distress. Defining whether each pregnancy was uncomplicated was delegated to the 
research nurses who had the necessary information and clinical expertise. Women who had 
participated in a pregnancy- or postpartum-related intervention were also not invited in case 
this led to a very different experience of pregnancy with more contact with medical teams than 
the general population. They must not have been diagnosed with diabetes before having GD 
but those who had developed T2D following GD were eligible. 
I anticipated interviewing 20 to 25 women in order to reach data saturation, based on the 
relatively low information power predicted (207). This is because this study had a broad aim, 
sparse sample specificity but used purposive sampling, was a cross-case analysis and I had not 
conducted qualitative interviews before. A key aspect of the interviews was structured around 
pre-defined recommendations. 
3.3.5 Interview process 
Participants were invited to a face-to-face interview at a time and private place of their choice 
(their home or a room in the hospital were suggested). I made clear that children were welcome 
to be present during the interview so that alternative childcare would not be needed, which 
could have increased selection bias.  
I began the interview by introducing myself to the participants as a non-clinical PhD student 
who wanted to listen to their experiences in order to improve support for mums, not to judge 
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or give advice. They were told that they were welcome not to disclose anything that they did 
not want to, could pause or stop the interview at any time, and were given an opportunity to 
ask any questions. Participants then gave written informed consent by signing the consent form, 
confirming that they understood the purpose and procedure of the study, and permitting it to 
be audio-recorded. 
I developed the interview guide with reference to the gaps in the literature identified in the 
qualitative syntheses (Chapters 6 and 7). The guide was discussed and refined with the wider 
researcher team, including a clinician with recent GD. Written feedback from a patient and 
public involvement and engagement group (PPI group; mothers with GD) was incorporated 
into the final version, which was further refined after reflection on the first interviews. For 
example, I began the first interview by asking the participant to describe their diet, expecting 
this to be an easy topic to begin with. However, they had been expecting to talk about their 
recent pregnancy, therefore I began subsequent interviews by asking participants to share their 
experience of GD, which helped to build rapport by allowing me to understand some of the 
context for participants’ current behaviours and attitudes.  
Participants were then asked to describe their current eating habits and physical activity, and 
whether they felt that having had GD had influenced these. We then moved on to discuss any 
support for healthy behaviours that they would like/have liked, and how this could be delivered 
effectively. Participants were asked about their own ideas first, then asked to provide feedback 
on suggestion cards I provided; for example, whether they agreed or disagreed with each 
suggestion and if there was anything they would add. The 20 suggestions were based on the 30 
recommendations that I developed in the two qualitative literature reviews that are described 
in Chapters 6 and 7 (208,209). I did not use all of the recommendations developed in the 
literature reviews in order to reduce the burden on the participant, which could cause them to 
disengage with the interview, but selected or adapted recommendations that I considered to be 
most relevant to participants, rather than clinicians for example. I also grouped them according 
to similar concepts, such as information or the family, and generally presented them in the same 
order for each interview. During some interviews, I considered that it was not appropriate to 
share certain suggestion cards. Most often, this was where participants were not aware of the 
need for any or annual diabetes screening therefore to ask them what would facilitate 
attendance may be upsetting. 
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If participants had said that they did not want to make any changes themselves, they were asked 
what they thought might help others with GD based on their own experience. These questions 
were then repeated for attending diabetes screening: whether they had been, plans for future 
screening, and what might help them attend. Prompts were given as necessary.  
The final interview schedule is presented in Table 3.5. 
Table 3.5: DAiSIeS interview schedule and suggestion cards. 
Introduction 
- Introduce researcher and the purpose of the interview 
- Explain the interview procedure 
- Informed consent 
- Begin recording 
As I said, I am particularly interested in post-pregnancy, but perhaps you could start by telling me a little 
about what your GD pregnancy was like for you? 
Understand current lifestyle 
To help us understand any lasting impact GD might have had, please tell me a bit about your current diet. 
What was your diet like before your GD pregnancy? [How] do you think this has changed? What helped 
you make these changes? 
Please tell me a bit about anything that you do to stay active.  
Did you do any exercise before your GD pregnancy? [How] do you think this has changed?  
To summarise, do you think GD has had an impact on you, making any lasting changes? 
[If any,] what other changes to your diet/exercise would you like to make? Why do you say this? 
Ideal lifestyle intervention 
What would help you most to have a healthier lifestyle/to make the changes we’ve spoken about? 
Introduce suggestion cards 1–10. Are there any that would be beneficial to you? Any that wouldn’t be? 
Anything that you would add? 
Is there anything else that you would like to add about diet and exercise? 
Understand current screening behaviour 
Have you had a test for diabetes since your pregnancy? What made you go/what prevented you from going? 
How do you feel about having regular diabetes tests in the future? 
Ideal screening intervention 
What would help you most to attend diabetes testing? (At 6 weeks postpartum and annually) 
Introduce suggestion cards 11–20. Are there any that would be beneficial to you? Any that wouldn’t be? 
Anything that you would add? 
Close 
- Today I wanted to talk to you about diet, exercise and screening for T2D after GD, and what might 
help with this. Is there anything else that you would like to discuss or ask? 
- Complete questionnaire 
- End  
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Suggestion cards 
1. More information about the impact of healthy 
diet/exercise on your diabetes risk 
2. More information about the impact of healthy 
diet/exercise on your wider health (e.g. stress, 
weight) 
3. More information about the impact of healthy 
diet/exercise on your family 
4. Suggested ways for your children and wider 
family to be healthier 
5. Help for you to exercise with others 
6. Advice about how to have a healthy diet (food 
shopping, cooking, healthy substitutions, etc.) 
7. Advice about how to exercise with a busy 
schedule (e.g. around the home) 
8. Advice about how to keep going with healthy 
changes to your diet/exercise 
9. Advice about saving money and healthy 
diet/exercise 
10. Monitoring your progress 
11. Doctors talking more about postpartum tests 
while you were pregnant 
12. Invitations and reminders for tests 
13. Your GP knowing more about your pregnancy 
14. More opportunities to understand gestational 
diabetes 
15. More child-friendly clinics/waiting rooms 16. Being able to get tested at a place of your choice 
17. Shorter, more pleasant tests 
18. Combining glucose testing with other 
appointments 
19. A better understanding of the purpose of glucose 
testing 
20. Not being able to monitor your blood sugar 
yourself 
Finally, the participants were asked to complete a short questionnaire (Appendix 4) to provide 
background information relevant to their health-related lifestyle choices and their 
demographics (because no information was extracted from the medical record). This also 
provided an opportunity to give written feedback on the interview. 
As soon as possible after each interview, I recorded field notes. These included initial 
reflections on the interview, such as strong or surprising opinions. I also made notes that might 
be relevant to interpretation of the interview but were not explicitly captured by the audio-
recording or survey: such as relevant information or context discussed before the start of the 
formal interview (e.g. while the participant was making drinks), any disruptions or distractions 
that took place, and the setting. One interview took place at the participant’s place of work, 
which may have led to the participant being distracted from the interview. 
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3.3.6 Analysis 
Interview recordings were transcribed by a professional transcription service 
(www.typeout.co.uk). I checked the transcripts for accuracy against the recordings, and 
pseudo-anonymised them by removing names, places and dates.  
The interviews were analysed using an iterative process that began after completion of the first 
few interviews using the framework analysis approach (210,211). Framework analysis is 
particularly useful for comparing within and between cases thereby allowing distinction 
between participants to be maintained throughout the analysis process and each perspective 
kept in context. It maintains transparency between the raw interview data and final 
interpretation.  
This involved the following steps: 
 Familiarisation with the data through listening to the audio-recordings, reading the 
transcripts and field notes, and making notes about participants and emerging themes. 
Familiarisation was particularly important to inform development of the framework 
after completing the first few interviews. 
 Identifying a thematic framework. Because this analysis focused on approaches to 
improve support after GD to reduce T2D risk, the original framework was based on the 
suggestion cards and interview schedule, and then was refined upon coding the first 
interviews to reflect where the ideas were similar. I added codes developed inductively 
from repeated themes in the interviews (such as the need for advice to be given in a 
positive, non-judgemental way). I considered developing a framework around a 
behavioural theory (such as the Health Belief Model, Transtheoretical Model, 
Theoretical Framework of Acceptability, Social Cognitive Theory or Social Ecological 
Model) but found that the interview schedule itself was more appropriate to the aim of 
this study. I retained a distinction between suggestions initiated by participants and 
those in response to the suggestion cards. The thematic framework is reported in Table 
3.6. 
 Coding the content of each interview according to the thematic framework. I coded all 
of the interviews and Rachel Fox coded four interviews to ensure agreement. 
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 Developing charts to summarise each participant’s transcript that was relevant to each 
section of the framework. One row was used for each participant interviewed, and one 
column was used for each code within the framework. After reviewing the relevant 
interview data, I summarised it and made references to the original transcript where 
there were exemplary quotes. An excerpt from one of the charts is reported in Table 
8.1. Rachel Fox also charted the four interviews that she had coded in order to ensure 
the summary of the interview was appropriate to the data. 
 Mapping and interpretation of the data to answer the research question. This involved 
studying each chart carefully to identify characteristic views shared between the 
participants or groups of participants. Where differences and deviant cases were 
observed, I attempted to understand in which ways they were different and why, 
according to the information provided. I made additional research notes and discussed 
the emerging interpretations with the other authors who had read some or all of the 
transcripts, charts and analysis notes. We considered our clinical (obstetrics and general 
practice) and non-clinical backgrounds. Reflexivity is reported in Section 8.5.3. Finally, 
I wrote up the findings in detail, describing and explaining the phenomena observed. I 
also invited the participants to provide feedback on a summary of the findings and 
incorporated their responses into the final version. 
NVivo 12 (NVivo qualitative data analysis software; QSR International Pty Ltd, version 12 
[2018]) was used for coding transcripts, and the ‘Framework Matrix’ tool was used for 
generating the summary charts: this allowed me to view all coding under a certain code for a 
transcript and concurrently summarise it by typing in the adjacent table. I then exported the 
charts into Excel.  
Additionally, I categorised the participants’ responses to the suggestion cards as ‘Strongly 
agree’, ‘Agree’, ‘Disagree’, ‘Strongly disagree’ or ‘Not shown card and no related comments’ 
in order to order to demonstrate overall agreement/disagreement and where there were 
discrepancies across the participants. Where it was unclear, I discussed the classification with 
a second author. 
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Table 3.6: Thematic framework used to analyse the DAiSIeS interviews. 
A. Diet and exercise 
a. Diet 
i. General comments 
ii. Prompted suggestion card #6 Advice about how to have a healthy diet 
iii. Unprompted suggestions 
b. Exercise 
i. General comments 
ii. Prompted #5 Help for you to exercise with others 
iii. Prompted #7 Advice about how to exercise with a busy schedule 
iv. Unprompted suggestions 
c. Information and understanding 
i. General comments 
ii. Prompted #1 More information about the impact of healthy diet/exercise on your 
diabetes risk 
iii. Prompted #2 More information about the impact of healthy diet/exercise on your 
wider health 
iv. Unprompted suggestions 
d. Family 
i. General comments 
ii. Prompted #3 More information about the impact of healthy diet/exercise on your 
family 
iii. Prompted #4 Suggested ways for your children and wider family to be healthier 
iv. Unprompted suggestions 
e. Money 
i. General comments 
ii. Prompted #9 Advice about saving money and healthy diet/exercise 
iii. Unprompted suggestions 
f. Sustainability 
i. General comments 
ii. Prompted #8 Advice about how to keep going with healthy changes to your 
diet/exercise 
iii. Unprompted suggestions 
g. Monitoring 
i. General comments 
ii. Prompted #10 Monitoring your progress 
iii. Unprompted suggestions 
B. Diabetes screening  
a. Why attended or did not attend 
i. Why attended or haven't 
ii. Other 
b. Booking 
i. General comments 
ii. Booking first test and prompted #11 Doctors talking more about postpartum tests 
while you were pregnant 
iii. Prompted #12 Invitations and reminders for tests (follow-up) 
iv. Unprompted suggestions 
c. Combining appointments  
i. General comments 
ii. Prompted #18 Combining glucose testing with other appointments 
iii. Unprompted suggestions 
d. GP awareness 
i. General comments 
ii. Prompted #13 Your GP knowing more about your pregnancy 
iii. Unprompted suggestions 
e. Self-testing 
i. General comments 
ii. Prompted #20 Not being able to monitor your blood sugar yourself 
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iii. Unprompted suggestions 
f. Test used 
i. General comments 
ii. Prompted #17 Shorter, more pleasant tests 
iii. Unprompted suggestions 
g. Child-friendly clinics 
i. General comments 
ii. Prompted #15 More child-friendly clinics/waiting rooms 
iii. Unprompted suggestions 
h. Understanding GD and postpartum glucose testing 
i. General comments about understanding GD 
ii. Prompted #14 More opportunities to understand gestational diabetes 
iii. Unprompted suggestions about understanding GD 
iv. General comments about understanding glucose testing 
v. Prompted #19 A better understanding of the purpose of glucose testing 
vi. Unprompted suggestions about understanding glucose testing 
i. Test location 
i. General comments 
ii. Prompted #16 Being able to get tested at a place of your choice 
iii. Unprompted suggestions 
C. Other 
a. Pregnancy 
b. Mode of delivery 
c. Source and who 
d. When 
e. Suggested content of a postpartum appointment 
f. Sensitivity and non-judgemental attitude 
g. General postpartum experience  
h. Other 
When reporting the findings, I was careful to maintain the anonymity of the participants. I 
removed data that could link the participants to a precise location, and the age and gender or 
their children. Pseudonyms were carefully selected to be similar to the participants’ names (for 
example, where Chinese participants used their adopted name in English in the interview, I 
selected another English name that was popular at a similar time). It was not possible to ask 
participants to select their own pseudonyms nor to check their acceptability. Participants’ ages 
were randomly assigned within the appropriate age category. 
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 The incidence of type 2 diabetes after 
gestational diabetes 
A systematic review and meta-analysis in over 310,000 affected women 
In this chapter, I describe a systematic review of the percentage of women diagnosed with T2D 
after a pregnancy affected by GD. This updates previous estimates of both absolute and relative 
risk by including more studies and longer follow-up, and investigates heterogeneity. The 
findings both inform and underscore the importance of the chapters that follow in this thesis: 
postpartum testing to diagnose emerging glucose intolerance (Chapters 5, 6 and 8) and 
behavioural changes to reduce weight as a risk factor for T2D (Chapters 7 and 8).  
The study described in this chapter was published in 2020 (212): Dennison RA, Chen ES, 
Green ME, et al. The absolute and relative risk of type 2 diabetes after gestational diabetes: A 
systematic review and meta-analysis of 129 studies. Diabetes Res Clin Pr. 2020; doi: 
10.1016/j.diabres.2020.108625. 
4.1 Background 
As described in Chapter 1, GD increases the risk of adverse pregnancy outcomes for both 
mother and baby. There is also an association with higher long-term risk of future obesity, 
glucose intolerance and development of T2D (89). Factors such as elevated BMI, multiparity 
and poorer pregnancy glucose tolerance have been suggested to further increase T2D risk 
(125,126), while breastfeeding may have a protective effect (213). 
Estimates of T2D risk will be important for clinicians, patients and policy makers in postpartum 
care after GD. As well as highlighting the importance of follow-up, accurate estimates of risk 
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and time to T2D development will inform the timing and intensity of screening strategies and 
lifestyle interventions.  
Relative risk, or the risk ratio, reports the likelihood of being diagnosed with T2D following a 
pregnancy affected by GD compared to the likelihood of diagnosis for women with unaffected 
pregnancies. Conversely, absolute risk reports the percentage chance of diagnosis. As 
described by Noordzij et al. 2017 in their paper titled “Relative risk versus absolute risk: One 
cannot be interpreted without the other”, an exposure can have a quite large effect on the 
relative risk, while both populations still have low baseline incidence in absolute terms (214). 
As such, although the relative risk summarises the risk in both populations, it tends to 
exaggerate the effect of an exposure because absolute risk is concealed. Absolute risk, such as 
number of cases expected in a thousand people, is advised in risk communication because it is 
often easier to interpret (215). 
Several literature reviews have described development of T2D after GD (36,98,99,121–123). 
Kim et al. previously reviewed absolute risk, including studies published from 1965 to 2001 
(99). The key finding from this review is that cumulative incidence of diabetes ranged from 
2.6% to more than 70% in studies that examined women six weeks postpartum to 28 years 
postpartum. Incidence was reported to increase fastest during the first five years after 
pregnancy. These findings have been used to support development of T2D risk-reduction 
interventions and screening regimes in the postpartum period. It is therefore appropriate to 
update these estimates in light of more recently published studies with longer follow-up and 
changing protocols for GD and T2D diagnosis and management. Furthermore, they did not 
formally combine incidence estimates. Since registering and starting my review, Vounzoulaki 
et al. have compared progression rates to T2D in women with GD and healthy controls between 
2000 and 2019 (registered on PROSPERO in January 2019) (121). Twenty studies were 
included in the meta-analysis, and the authors concluded that they did not have sufficient power 
to identify associations between co-variables and T2D progression. 
Bellamy et al. 2009 and Song et al. 2018 (which specifically aims to update Bellamy et al. with 
data from the subsequent ten years) are large systematic reviews that investigate relative risk 
by many study level subgroups (98,122). They report that women who have had GD are nearly 
eight-times more likely to develop T2D than women who have not had affected pregnancies, 
whereas Vounzoulaki et al. reported a nearly ten times higher risk (121).  
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4.2 Aim 
In this study, I aimed to synthesise all available data from published observational and 
experimental studies concerning the percentage of women developing T2D after GD and the 
relative risk of T2D in women with and without GD, to describe the heterogeneity of estimates 
of progression, and to explore study-level characteristics associated with heterogeneity. 
4.3 Methods 
The full methods for the literature review are described in Chapter 3.1, and the protocol was 
registered on PROSPERO in November 2017 (record ID CRD42017080299). The roles of the 
other researchers involved in the review are described below. 
4.3.1 Search strategy 
A literature search was conducted in September 2017 by Rebecca Ward. The search strategy 
in Table 3.1 was used to identify studies reporting diagnoses of T2D in women with a history 
of GD. I updated this search in October 2019 to identify studies published in the last two years. 
Additionally, I screened the reference lists of previous similar literature reviews and tested the 
studies they included against our inclusion criteria. 
4.3.2 Inclusion criteria and study selection  
I, along with five medical students at the University of Cambridge under my supervision 
(Eileen Chen, George Farmer, Madeline Green, Deeya Kotecha and Chloe Legard), screened 
the titles and abstracts and then the full texts according to our inclusion criteria. We 
independently screened an overlapping 10% to ensure consistency in the decision making, and 
discussed any discrepancies with Simon Griffin. We included studies: 
 That quantified development of diabetes after GD, 
 That indicated time after pregnancy of T2D assessment, 
 That followed up the total or a random sample of a population with GD, 
 Where diabetes diagnosis was assessed at an average six months or longer after GD-
affected pregnancy, 
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 That reported diagnostic method and/or criteria for both GD and T2D, and 
 With a sample size of 50 or more participants with GD followed up. 
4.3.3 Quality assessment  
Two authors independently assessed the quality of the included studies using a checklist of six 
questions assessing recruitment, exposure and outcome ascertainment, and follow-up (Table 
3.2). 
4.3.4 Statistical analysis 
Two authors independently extracted key data into an Excel spreadsheet. Definitions of the 
study-level characteristics of the studies and participants analysed are explained in Table 4.1. 
The analysis was performed using STATA 15.1. I used random-effects meta-analyses to 
summarise the percentage of women developing T2D overall and according to the subgroups. 
I then used meta-regression to quantify the extent to which a diagnosis of T2D was associated 
with the values of one or more study level characteristic. I also calculated the relative risk of 
diabetes in studies that had a comparator population and combined these across studies using 
random-effects meta-analysis, overall and stratified by study and maternal characteristics. 
Table 4.1: Definitions of the study-level variables used in the meta-analysis of the incidence of type 2 
diabetes after gestational diabetes.  




Region Geographical region to represent the 
ethnic makeup of each region and, 
additionally, facilitate distribution of 
data where possible 
Australasia, Europe, 
Western Pacific, North 
America, Middle East 
and South Asia, Africa, 
Central and South 




Mean, median or planned interval 
between delivery and assessment of 
T2D; if only the range or upper limit 
was reported, I estimated the mid-point 
(estimated follow-up was only used as a 
categorical variable) 
<3.0, 3.0–5.9, 6.0–8.9, 
9.0–11.9, or ≥12.0 years 




Whether glycaemic tests were 
performed within the study to identify 
GD (e.g. OGTT), or whether other 
sources such as medical records from 
hospitals, insurance data or self-report 
were used 
Medical records or self-
report, or glycaemic test 
NA 




GD diagnostic criteria classified as low 
sensitivity (FPG ≥5.8 mmol/l), high 
sensitivity (FPG <5.8 mmol/l), or a 
clinical diagnosis based on author 
consensus. If criteria changed during 
the study, the one used for the greatest 
proportion of time informed sensitivity 
Clinical, low, or high NA 
Method to 
classify T2D 
Whether glycaemic tests were 
performed within the study to classify 
T2D (e.g. OGTT or HbA1c test), or 
whether other sources such as medical 
records from hospitals, insurance data 
or self-report were used 
Medical records or self-




T2D diagnostic criteria classified as low 
sensitivity (FPG ≥7.8 mmol/l), high 
sensitivity (FPG <7.8 mmol/l), or a 
clinical diagnosis based on author 
consensus. If criteria changed during 
the study, the one used for the greatest 
proportion of time informed sensitivity 
Clinical, low, or high NA 
Year of 
pregnancy 
Midpoint of the year of GD diagnosis or 
delivery eligible (the year 2003 was the 
median across the studies, so the year 
2000 was used for the binary variable) 
Before 2000, or 
during/after 2000 






Quality assessment based on a score out 
of 6 
Low quality (score 0–
2/6), medium quality 
(score 3–4/6), or high 
quality (score 5–6/6) 
NA 
Maternal demographics 
Ethnicity Percentage of the study population that 
was White European, Caucasian, non-
Hispanic White (or similar); if 
participants’ ethnicity was not reported, 
it was inferred based on census data for 
the study setting (used in the binary 
variable only) 
Estimated majority White 
European, or estimated 
majority not White 
European 
Percentage of the 
study population 
reported to be 
White European 
 
Age at delivery Average age at delivery; this was 
estimated using age at another timepoint 
if not reported (31.8 years was the mean 
age at delivery across the studies, so 32 
years was used for the binary variable) 




Average age at T2D assessment; this 
was estimated using age at another 
timepoint if not reported (37.7 years 
was the mean age at follow-up across 
the studies, so 38 years was used for the 
binary variable) 




Average BMI before pregnancy (25.9 
kg/m2 was the mean BMI before 
pregnancy across the studies, and 25 
kg/m2 was used to define average or 
overweight) 




Average BMI at T2D assessment (27.8 
kg/m2 was the mean BMI at follow-up 
across the studies, and 25 kg/m2 was 
used to define average or overweight) 
<25 kg/m2, or ≥25 kg/m2 Average BMI at 
follow-up 





Average percentage for which the index 
pregnancy was their first pregnancy or 
delivery (37.6% was the mean 
percentage across the studies, so 35% 
was used for the binary variable) 







Average percentage reporting diabetes 
in their family history (53.4% was the 
mean percentage across the studies, so 
50% was used for the binary variable) 
<50%, or ≥50% Average 
percentage with 
family history of 
diabetes 
FPG: fasting plasma glucose; NA: not appropriate; OGTT: oral glucose tolerance test. 
4.4 Results 
4.4.1 Literature review 
The literature search identified 25,789 studies after removal of duplicates. We reviewed 518 
full texts and included 129 citations from the literature search and reference lists (Figure 4.1). 
Seventy seven studies were excluded because they reported data from the same population as 
an included study. The percentage developing T2D was reported in 310,214 women with a 
history of GD, plus 4,155,247 parous women without GD. Appendix 5 reports details of the 
129 included studies. 
4.4.2 Study-level characteristics 
4.4.2.1 Characteristics of the included studies 
Study-level characteristics are summarised in Table 4.2. Sixty one studies (47%) were based 
in Europe and 61 studies (47%) followed up more than 200 participants with GD. The date of 
pregnancy ranged from 1979 to 2018, and 45 studies (35%) included a non-GD comparator 
group. Thirteen studies involved interventions, mostly during pregnancy. The median duration 
of follow-up was 5.0 years (range 0.6 to 29.9 years). Most studies fell into the less than 3.0 
years or 3.0 to 5.9 years follow-up categories (n=38 [29%] and n=44 [34%], respectively).  
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Figure 4.1: PRISMA diagram for the incidence of type 2 diabetes screening after gestational diabetes systematic 
review. 
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 Sample size with GD (followed up) 129 195 [110–489]  
 Sample size without GD (followed up) 45 388 [71–6,359]  
 Region    
 Africa 1 0.8  
 South Africa 1 0.8  
 Australasia 8 6.2  
 Australia 8 6.2  
 Central and South America 3 2.3  
 Brazil 1 0.8  
 Mexico 1 0.8  
 Trinidad 1 0.8  
 Europe 61 47.3  
 Austria 1 0.8  
 Belgium 1 0.8  
 Croatia 2 1.6  
 Czech Republic 1 0.8  
 Denmark 3 2.3  
 Finland 6 4.7  
 France 2 1.6  
 Germany 5 3.9  
 Greece 1 0.8  
 Ireland 1 0.8  
 Italy 6 4.7  
 Netherlands 2 1.6  
 Norway 1 0.8  
 Poland 7 5.4  
 Portugal 1 0.8  
 Spain 6 4.7  
 Sweden 6 4.7  
 Turkey 3 2.3  
 UK 6 4.7  
 Middle East and South Asia 13 10.1  
 India 4 3.1  
 Iran 4 3.1  
 Israel 1 0.8  
 Saudi Arabia 2 1.6  
 Sri Lanka 2 1.6  
 North America 29 22.5  
 Canada 10 7.8  
 US 19 14.7  
 Western Pacific 13 10.1  
 China 1 0.8  
 Hong Kong 1 0.8  
 Japan 2 1.6  
 Malaysia 1 0.8  
 South Korea 5 3.9  
 Taiwan 2 1.6  
 Thailand 1 0.8  
 Multiple 1 0.8  
 Multiple 1 0.8  
 Average duration of follow-up (years) 108 5.0 [2.1–7.4]  
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 Method to identify GD 
 
  
 Medical records or self-report 93 72.1  
 Glycaemic test 36 27.9  
 Sensitivity of GD diagnosis 
 
  
 Clinical 32 24.8  
 Low 34 26.4  
 High 63 48.8  
 Method to classify T2D 
 
  
 Medical records or self-report 50 38.8  
 Glycaemic test 79 61.2  
 Sensitivity of T2D diagnosis 
 
  
 Clinical 26 20.2  
 Low 16 12.4  
 High 87 67.4  
 Median year of pregnancy 119 2003 [1996–2008]  
 Study quality 
 
  
 Low quality (score 0–2/6) 13 10.1  
 Medium quality (score 3–4/6) 91 70.5  
 High quality (score 5–6/6) 25 19.4  
IQR: interquartile range. 
Most cases of GD were identified by OGTTs performed during the study (n=36 [28%]) or 
recorded in medical records (n=86 [67%]). However, many different diagnostic criteria were 
used (varying by timing, dose of glucose administered, and glycaemic cut-offs); Carpenter and 
Coustan (23), Australasian Diabetes in Pregnancy Society (216), ADA (217–220), and WHO 
(199,221–223) (various years) criteria were frequently reported alongside local protocols. 
According to the definitions described in Table 4.1, 34 studies (26%) used low sensitivity and 
63 (49%) used high sensitivity tests, and the remainder were grouped as clinical diagnoses.  
To assess T2D status, glycaemic tests such as 75g OGTT or HbA1c alongside multiple different 
criteria were used frequently (n=79 [61%]); high sensitivity tests were most common (n=87 
[67%]). Clinical diagnoses included review of medical records, diabetes registers, or 
reimbursement for diabetes medication records.  
Ninety one (71%) studies were medium quality and 25 (19%) were high quality. Median score 
in the quality assessment was 4/6. The most common reasons for reduced quality were high 
loss to follow-up (n=63 [49%]) and no assessment of pre-existing T2D (n=61 [47%]; Figure 
4.2).  
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4.4.2.2 Characteristics of the included participants 
Study-level maternal characteristics are summarised in Table 4.3. Among women with GD, 
average age was 31.8 years at delivery (range 18.7 to 38.5 years; data available in n=103 
studies) and 37.7 years at follow-up (30.2 to 52.2 years; n=96). In studies clearly reporting 
participants’ ethnicity, 44.9% were White European (0 to 100%; n=78). I estimated that 57% 
of studies (n=74) included populations in which the majority of women were White European. 
Participants were often overweight: average BMI before pregnancy was 25.9 kg/m2 (range 21.0 
to 32.4 kg/m2; n=41) while the average at follow-up was 27.8 kg/m2 (range 22.7 to 35.0 kg/m2; 
n=46). At the index pregnancy, 37.6% of participants were nulliparous (range 9.7 to 100.0%; 
n=37). Fifty three percent of participants reported a family history of diabetes (range 7.2 to 
100%; n=60). 










 Average percentage White European 78 44.9 [0.0–100.0]  
 Estimated majority White European 74 57.4  
 Average age at delivery (years) 103 31.8 [18.7–38.5]  
 Average age at follow-up (years) 96 37.7 [30.2–52.2]  
 Average pre-pregnancy BMI (kg/m2) 41 25.9 [21.0–32.4]  
 Average BMI at follow-up (kg/m2) 46 27.8 [22.7–35.0]  
 Average percentage who were nulliparous at index pregnancy 37 37.6 [9.7–100.0]  
 Average percentage with family history of diabetes 60 53.4 [7.2–100.0]  
BMI: body mass index. 
 
Figure 4.2: Summarised results of the quality assessment for the incidence of type 2 diabetes screening after 
gestational diabetes systematic review. 
Table 3.2 shows for full definitions and scoring of quality assessment criteria. 
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4.4.3 Absolute incidence of type 2 diabetes after gestational diabetes 
Overall, 17.0% (95% CI 15.1 to 19.0%; I2 99.3%) of women across the studies developed T2D 
after GD. In the remainder of this section, I describe how this estimate varied according to 
study-level variables. It ranged from 0.0% in a study with an average 1.5 years follow-up (n=68 
followed up) (224) to 93.4% at 29.9 years follow-up in a high-risk population (n=332) (225).  
Percentage developing T2D increased in a near-linear way as study-level duration of follow-
up increased (Figure 4.3). A third of women developed T2D within 15 years of pregnancy.  
Studies in Central and South America and Africa had the highest percentage diagnosed with 
T2D (47.7% [95% CI 31.9 to 63.8%]; I2 84.0%, and 31.3% [95% CI 24.4 to 39.2%]; I2 100.0%, 
respectively) while those in Europe and Australasia had the lowest (12.8% [95% CI 9.7 to 
16.8%]; I2 99.1%, and 12.7% [95% CI 7.5 to 20.8]; I2 96.7%, respectively; Figure 4.4 and 
Figure 4.5). 
 
Figure 4.3: Scatter plot showing the percentage of women developing type 2 diabetes after gestational 
diabetes by average study follow-up duration. 
Size of circle indicates weight given to each study (based on number of women followed up); line of best fit 
and 95% confidence region (grey shaded area) estimated from meta-regression. N=108 studies and 226,497 
women. 
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Figure 4.5 and the corresponding univariable analysis in Table 4.4 show that progression to 
T2D did not clearly vary with GD or T2D diagnostic method or sensitivity, or study quality 
(see Section 4.4.3.1). However, there was a tendency for studies that relied on a clinical or low 
sensitivity diagnosis to report higher percentages with T2D than highly sensitive GD diagnoses. 
Studies in which women were pregnant, on average, before the year 2000 reported higher 
percentages with T2D as shown in Figure 4.6A (22.0% [95% CI 18.9 to 25.5%]; I2 98.6, and 
13.3% [95% CI 11.0 to 15.9%]; I2 99.5, respectively). 
Figure 4.7 and the corresponding univariable analysis in Table 4.4 show the percentage 
developing T2D after GD according to study-level maternal demographics. Diagnosis of T2D 
was higher in studies considering women who were not White European, older at follow-up 
(reflecting longer duration of follow-up), less frequently nulliparous, and had a higher BMI at 
follow-up. Scatter plots showing the percentage of women developing T2D after GD by these 
variables are shown in Figure 4.6B–E. Age at delivery, pre-pregnancy BMI, and the proportion 
of women with a family history of diabetes did not appear to influence the estimates.  
 
Figure 4.4: Map showing the crude percentage and 95% confidence intervals of women with type 2 diabetes 
after gestational diabetes by region, estimated using random-effects meta-analysis. 
Australasia: 8 studies, 7,081 women; Europe: 61 studies, 96,773 women; Western Pacific: 13 studies, 8,416 
women; North America: 29 studies, 183,533 women; Middle East and South Asia: 13 studies, 13,327 women; 
Africa: 1 study, 150 women; Central and South America: 3 studies, 271 women. 




Figure 4.5: Summary random-effects meta-analyses of the percentage of women with gestational diabetes 
developing type 2 diabetes by study-level study characteristics. 
Diamonds indicate summary percentage with T2D and the 95% confidence interval (CI). NA: not 
appropriate; NR: not reported. 







Figure 4.6: Scatter plots showing the percentage of women developing type 2 diabetes after gestational 
diabetes by average study-level (A) year of eligible pregnancies, (B) percentage who were White European 
ethnicity, (C) age at follow-up, (D) BMI at follow-up, and (E) percentage who were nulliparous. 
Size of circle indicates weight given to each study (based on number of women followed up); line of best fit 
and 95% confidence region (grey shaded area) estimated from meta-regression. 
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As indicated by the I2 values in Figure 4.5 and Figure 4.7, heterogeneity was high in subgroup 
analyses, with I2 ≥84.0% for study characteristics and ≥92.4% for maternal demographics. 
After adjusting for follow-up duration and ethnicity in the meta-regression, the associations 
with diabetes development from univariable analysis were slightly attenuated for most 
characteristics (Table 4.4). Overall, ethnicity, follow-up duration and BMI at follow-up had 
greatest influence on estimates of T2D development, although residual heterogeneity remained 
high in these models. Adjusting for follow-up duration, White European populations had 57% 
lower percentage developing T2D compared to non-White European populations. Adjusting 
for ethnicity, percentage developing T2D was 12% higher for each additional year of follow-
up after pregnancy. For each unit higher BMI at follow-up the adjusted percentage developing 
 
Figure 4.7: Summary random-effects meta-analyses of the percentage of women with gestational diabetes 
developing type 2 diabetes by study-level maternal demographic characteristics. 
Diamonds indicate summary percentage with T2D and the 95% confidence interval (CI). BMI: body mass 
index; NR: not reported. 
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T2D was 18% higher (compared to 10% higher for each unit of BMI before pregnancy, which 
was not statistically significant).  
Table 4.4: Associations of categorical and/or continuous study and maternal characteristics with the incidence 
of type 2 diabetes after gestational diabetes. 






Odds ratio  
[95% CI] p value 




Study characteristics       
Region       
Australasia 8 7,081 0.51 [0.22–1.18] 0.114 0.78 [0.35–1.73] 0.541 
Europe 61 96,773 0.54 [0.34–0.86] 0.010 0.95 [0.57–1.57] 0.837 
Western Pacific 13 8,416 0.77 [0.39–1.52] 0.444 0.80 [0.41–1.55] 0.503 
North America 29 183,533 Ref  Ref  
Middle East and South Asia 13 13,327 1.24 [0.62–2.46] 0.539 1.28 [0.65–2.51] 0.467 
Africa 1 150 1.67 [0.21–13.28] 0.624 1.66 [0.25–11.23] 0.600 
Central and South America 3 271 3.39 [0.97–11.83] 0.055 3.51 [1.10–11.23] 0.035 
Multiple 1 663 0.44 [0.056–3.44] 0.430 0.22 [0.03–1.54] 0.125 
Average  
duration of follow-up (per year)* 108 226,497 1.11 [1.07–1.15] <0.001 1.12 [1.08–1.16] <0.001 
<3.0 years 38 28,734 Ref  Ref  
3.0–5.9 years  44 152,531 1.19 [0.75–1.89] 0.458 1.39 [0.91–2.15] 0.129 
6.0–8.9 years  22 7,706 1.49 [0.85–2.60] 0.158 1.75 [1.04–2.93] 0.035 
9.0–11.9 years  13 67,167 1.91 [0.99–3.70] 0.053 2.44 [1.32–4.52] 0.005 
≥12.0 years  12 54,076 3.58 [1.81–7.05] <0.001 5.15 [2.71–9.80] <0.001 
Method to identify GD       
Medical records or self-report 93 303,047 Ref  Ref  
Glycaemic test 36 7,167 0.79 [0.51–1.21] 0.275 0.89 [0.61–1.31] 0.561 
Sensitivity of GD diagnosis       
Clinical 32 248,111 Ref  Ref  
Low 34 15,190 0.93 [0.55–1.57] 0.787 0.81 [0.50–1.33] 0.410 
High 63 46,913 0.63 [0.40–1.00] 0.050 0.76 [0.50–1.17] 0.212 
Method to classify T2D       
Medical records or self-report 50 290,678 Ref  Ref  
Glycaemic test 79 19,536 1.29 [0.87–1.90] 0.202 1.24 [0.87–1.75] 0.232 
Sensitivity of T2D diagnosis       
Clinical 26 253,865 Ref  Ref  
Low 16 3,715 1.58 [0.79–3.13] 0.191 1.37 [0.72–2.61] 0.332 
High 87 52,634 1.22 [0.76–1.97] 0.410 1.08 [0.69–1.71] 0.719 
Median  
year of pregnancy (per year) 119 308,085 0.97 [0.95–0.99] 0.011 0.98 [0.96–1.00] 0.064 
Before 2000 50 71,967 Ref  Ref  
During/after 2000 69 236,109 0.55 [0.37–0.81] 0.003 0.68 [0.46–1.00] 0.047 
Quality assessment score       
Low quality (score 0–2/6) 13 42,826 Ref  Ref  
Medium quality (score 3–4/6) 91 184,308 1.69 [0.88–3.24] 0.116 1.03 [0.56–1.90] 0.920 
High quality (score 5–6/6) 25 83,080 1.60 [0.76–3.38] 0.217 1.18 [0.59–2.35] 0.645 
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Maternal demographics       
Ethnicity  
(per 10% White European) 78 139,398 0.90 [0.85–0.95] <0.001 0.87 [0.83–0.92] <0.001 
Estimated majority not White 
European 55 75,897 Ref  Ref  
Estimated majority White 
European 74 234,317 0.54 [0.37–0.79] 0.001 0.43 [0.30–0.61] <0.001 
Average age at delivery (per year) 103 302,579 0.91 [0.84–0.99] 0.022 0.97 [0.89–1.05] 0.425 
<32 years  56 165,708 Ref   Ref  
≥32 years  47 136,871 0.79 [0.50–1.25] 0.314 0.94 [0.62–1.43] 0.788 
Average 
age at follow-up (per year) 96 224,169 1.09 [1.04–1.14] 0.001 1.04 [0.90–1.20] 0.592 
<38 years  56 61,607 Ref  Ref  
≥38 years  40 162,562 1.94 [1.25–3.00] 0.003 1.20 [0.70–2.05] 0.508 
Average  
pre-pregnancy BMI (per kg/m2) 41 14,904 1.04 [0.91–1.18] 0.593 1.10 [0.93–1.31] 0.566 
<25 kg/m2 14 8,752   Ref  
≥25 kg/m2  27 6,152 1.08 [0.56–2.07] 0.811 1.32 [0.62–2.80] 0.462 
Average  
BMI at follow-up (per kg/m2) 46 12,956 1.25 [1.13–1.39] <0.001 1.18 [1.05–1.34] 0.008 
<25 kg/m2 6 2,072 Ref  Ref  
≥25 kg/m2  40 10,884 1.57 [0.51–4.83] 0.424 1.50 [0.50–4.56] 0.462 
Average percentage who were 
nulliparous at index pregnancy 37 124,252 0.99 [0.97–1.01] 0.318 0.98 [0.96–1.00] 0.061 
<35%  17 67,430 Ref  Ref  
≥35%  20 56,822 0.51 [0.29–0.91] 0.024 0.44 [0.24–0.81] 0.010 
Average percentage  
with family history of diabetes 60 19,428 1.01 [0.99–1.03] 0.222 1.01 [0.99–1.02] 0.313 
<50%  24 10,997 Ref  Ref  
≥50%  36 8,431 1.06 [0.58–1.95] 0.848 1.18 [0.68–2.04] 0.547 
Data were transformed to the logit scale for analyses. Multivariable meta-regression adjusted for whether 
the majority of the study population is White European ethnicity and duration of follow-up (<3.0, 3.0–5.9, 
6.0–8.9, 9.0–11.9, or ≥12.0 years). I2 remained high (87.9–99.4% in the univariable model; 95.8–99.2% in 
the multivariable model).  
* Only adjusted for whether the majority of the study population is White European.  
BMI: body mass index; CI: confidence interval; ref: reference. 
4.4.3.1 Sensitivity analyses 
I conducted two sensitivity analyses: the first to understand the influence of one study with 
long follow-up, and the second to determine whether the overall estimate varied according to 
studies meeting each quality assessment question. 
Only one study had more than 20 years follow-up: Carr et al. 2006 reported a high incidence 
of 93.4% diagnosed with T2D by 29.9 years after GD pregnancy (n=332) (225). I therefore 
investigated how influential this study was by comparing the original analyses to those when 
it was excluded.  
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In the adjusted meta-regression, when 
Carr et al. 2006 was excluded, the 
odds ratio for percentage developing 
T2D for each additional year of 
follow-up after pregnancy was 1.10 
(95% CI 1.05 to 1.15, p<0.001, I2 
98.5%) versus 1.12 (95% CI 1.08 to 
1.16, p<0.001, I2 98.6%) in the 
original analysis. The odds ratio for 
percentage developing T2D for White 
European populations compared to 
non-White European populations was 
0.47 (95% CI 0.33 to 0.66, p<0.001, I2 
99.0%) versus 0.43 (95% CI 0.30 to 
0.61, p<0.001, I2 99.0%) in the 
original analysis. The odds ratio for 
percentage developing T2D for each 
unit higher BMI at follow-up was 1.15 
(95% CI 1.03 to 1.29, p=0.016, I2 
95.6%) versus 1.18 (95% CI 1.05 to 
1.34, p=0.008, I2 96.2%) in the 
original analysis. 
Additionally, I compared the scatter plots showing the percentage of women developing T2D 
after GD by average study follow-up duration with and without Carr et al. 2006 (Figure 4.8). 
Below 15 years follow-up, minimal influence of this study can be seen. At 15 years, the graph 
including Carr et al. has approximately 5% higher percentage with T2D. At 20 years 
postpartum, this difference is approximately 8%. 
I therefore concluded that Carr et al. had a small influence on this analysis, particularly after 
15 years postpartum. 
Furthermore, although I found that most studies were medium quality in the quality assessment, 
I sought to investigate whether quality in each domain assessed affected the effect estimates. 
 
Figure 4.8: Scatter plots showing the percentage of women 
developing type 2 diabetes after gestational diabetes by 
average study follow-up duration (A) with and (B) without 
Carr et al. 2006. 
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Table 4.5 shows the effect of each question for the overall estimate and the adjusted meta-
regression. As can be seen by the overlapping confidence intervals, there was not a significant 
difference between the subgroups (with an exception in the exposure assessment) and estimates 
of risk only changed slightly in the sensitivity analyses compared to the original analysis, which 
increases our confidence in the findings. 
Table 4.5: Sensitivity analysis of overall crude percentage of women with gestational diabetes developing 
type 2 diabetes according to each quality assessment domain. 
 N 
studies 
Overall percentage with 
T2D [95% CI] 
N 
studies 
Odds ratio for incidence 
per year follow-up* 
[95% CI] 
All studies 129 16.96 [15.10–19.00] 108 1.12 [1.08–1.16] 
1. Was the cohort recruited in an acceptable way?  
Yes 77 16.85 [14.28–19.78] 61 1.10 [1.04–1.17] 
No 52 16.98 [13.92–20.54] 46 1.13 [1.07–1.19] 
2. Was GD exposure accurately measured to minimise bias?  
Yes 105 15.83 [13.39–18.64] 87 1.11 [1.06–1.17] 
No 24 22.86 [19.28–26.87] 20 1.13 [1.04–1.22] 
3. Was it demonstrated that T2D was not present at start of study? 
Yes 68 16.72 [13.99–19.86] 55 1.12 [1.06–1.17] 
No 61 17.41 [14.98–20.14] 52 1.13 [1.05–1.21] 
4. Was T2D accurately measured to minimise bias?  
Yes 78 17.59 [14.46–21.23] 69 1.14 [1.09–1.20] 
No 51 15.78 [13.17–18.79] 38 1.06 [0.99–1.14] 
5. Was the follow-up long enough for T2D to occur?  
Yes 75 18.87 [16.09–22.00] 62 1.14 [1.08–1.20] 
No 54 14.47 [12.10–17.22] 45 1.36 [1.08–1.71] 
6. Was the follow-up adequate?  
Yes 66 16.62 [14.18–19.40] 52 1.10 [1.05–1.16] 
No 63 17.17 [14.06–20.80] 55 1.14 [1.07–1.22] 
Table 3.2 shows for full definitions and scoring of quality assessment criteria. 
* Adjusted for ethnicity. 
95% CI: 95% confidence interval.  
4.4.4 Relative incidence of type 2 diabetes after gestational diabetes 
Women who had GD were 8.3 (95% CI 6.5 to 10.6) times more likely to develop T2D than 
women with normoglycaemic pregnancies, as shown in Figure 4.9 (unadjusted relative risk).  
The relative risk by subgroups are shown in Table 4.6. Relative risk was particularly high in 
studies in Europe (16.1 [95% CI 12.4 to 21.0]) compared to studies in other regions, and in 
mainly White European populations (11.2 [95% CI 9.0 to 13.9]) compared to non-White 
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European populations. Relative risk was highest before six years postpartum (15.8 [95% CI 
12.6 to 19.9]), and in studies using clinical diagnosis of T2D (16.5 [95% CI 12.9 to 21.2]).  
Relative risk tended not to vary with other study-level maternal characteristics (measured in 
women with GD), except by BMI before pregnancy. In studies in which the average pre-
pregnancy BMI was less than 25 kg/m2, the relative risk was comparatively low (2.1 [95% CI 
1.4 to 3.4]). 
When three low-quality studies reporting very high relative risks were excluded, the overall 
relative risk remained at 8.1 (95% CI 6.3 to 10.3).  
Thirteen studies reported adjusted relative analyses (odds ratios, relative risks, hazard ratios or 
incidence rate ratios). A history of GD statistically significantly increased T2D risk in all cases, 
but the magnitude of increase was highly variable. In five studies, the pooled adjusted odds 
ratio was 8.1 (95% CI 3.0 to 22.1), and ranged from 2.2 (95% CI 1.5 to 3.1; adjusted for age, 
BMI and family history of diabetes) (226) to 52.5 (95% CI 26.5 to 103.9; adjusted for age at 
delivery) (227). Engeland et al. 2011 reported an adjusted relative risk of 41 (95% CI 35 to 47; 
adjusted for maternal age and parity in women with GD but not preeclampsia) (228) and 
Sreelakshmi et al. 2015 reported an adjusted relative risk of 13.2 (95% CI 1.5 to 116.0; 
variables adjusted for unclear) (229). Five studies reported adjusted hazard ratios but two did 
not report the confidence intervals so could not be pooled. In the remaining three studies, the 
pooled adjusted hazard ratio was 14.2 (95% CI 6.6 to 30.4), and ranged from 5.36 in Canadian 
First Nation women (variables adjusted for unclear) (230) to 40.1 in overweight women (95% 
CI 34.4 to 46.6; adjusted for adjusting for maternal age, preeclampsia, parity, smoking status 
during pregnancy, ethnicity, socioeconomic status and GD in a subsequent pregnancy) (231). 
Daly et al. 2018 reported an adjusted incidence rate ratio of 22.0 (95% CI 18.3 to 26.3; adjusted 
for age, Townsend quintile, BMI and smoking status) (153). 
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Figure 4.9: The crude relative risk of type 2 diabetes after gestational diabetes compared to pregnancies not 
affected by gestational diabetes.  
Annualised incidence rates are not presented for studies that did not report an average follow-up duration. 
Grey diamonds represent the crude relative risk for each study; horizontal lines indicate 95% confidence 
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[95% CI] Weight I2 
Study characteristics  




   
 
  
Australasia 2 5,582 831 4.4 [1.6–12.4] 3.8 19.6% 
Europe 25 83,608 1,737,556 16.1 [12.4–21.0] 44.0 85.6% 
North America 8 113,875 2,136,831 5.2 [3.4–7.8] 26.7 99.8% 
Western Pacific 3 5,616 99,168 3.7 [0.9–15.9] 6.1 78.8% 
Middle East and South Asia 5 11,984 176,545 6.6 [2.2–19.5] 12.9 96.9% 
Central and South America 1 159 370 5.4 [3.5–8.4] 3.2 NA 
Multiple 1 663 3,946 6.7 [4.8–9.3] 3.4 NA 
Duration of follow-up  
   
 
  
<3.0 years 7 15,622 39,902 11.0 [3.4–35.1] 11.3 90.9% 
3.0–5.9 years  11 90,062 2,095,181 18.2 [14.4–23.1] 22.6 94.1% 
6.0–8.9 years  12 3,714 20,493 5.4 [3.8–7.7] 19.9 42.4% 
9.0–11.9 years  7 63,808 1,562,400 8.4 [3.8–18.5] 20.6 99.5% 
≥12.0 years  8 48,281 437,271 5.8 [2.6–12.8] 25.7 99.8% 
Method to identify GD        
Medical records or self-report 33 218,569 4,143,693 8.6 [6.6–11.3] 82.8 99.5% 
Glycaemic test 12 2,918 11,554 7.0 [4.4–11.2] 17.2 47.8% 
Sensitivity of GD diagnosis  
   
 
  
Clinical 15 184,364 3,700,025 8.6 [5.8–12.8] 39.4 99.7% 
Low 11 3,042 11,372 6.8 [3.7–12.5] 25.8 90.1% 
High 19 34,081 443,850 9.0 [6.4–12.8] 34.8 95.8% 
Method to classify T2D        
Medical records or self-report 18 214,597 4,142,947 11.8 [9.2–15.1] 53.9 99.5% 
Glycaemic test 27 6,890 12,300 6.3 [3.6–11.0] 46.1 96.6% 
Sensitivity of T2D diagnosis        
Clinical 13 191,626 3,850,992 16.5 [12.9–21.2] 37.0 99.3% 
Low 3 341 104 2.6 [0.8–9.0] 3.1 15.1% 
High 29 29,520 304,151 6.3 [3.9–10.2] 59.9 98.9% 
Median year of pregnancy        
Before 2000 22 58,102 458,753 7.5 [4.6–12.3] 49.4 99.4% 
During/after 2000 20 162,509 3,694,054 12.1 [8.2–17.6] 42.7 99.4% 
NR 3 876 2,440 2.8 [1.7–4.7] 7.9 47.1% 
Quality assessment score        
Low quality (score 0–2/6) 3 437 841 24.9 [5.9–105.9] 2.2 0.0% 
Medium quality (score 3–4/6) 31 143,193 2,432,843 7.8 [5.9–10.4] 73.0 99.4% 
High quality (score 5–6/6) 11 77,857 1,721,563 8.9 [5.0–15.7] 24.9 99.1% 
Maternal demographics  
   
 
  
Ethnicity (estimated)        
Majority not White European 13 19,947 299,570 5.1 [2.6–9.9] 33.4 99.5% 
Majority White European 32 201,540 3,855,677 11.2 [9.0–13.9] 66.7 98.7% 
Average age at delivery        
<32 years 22 137,766 2,252,083 7.0 [4.5–10.7] 57.7 99.6% 
≥32 years 15 81,904 1,899,964 12.3 [7.7–19.6] 28.5 98.4% 
NR 8 1,817 3,200 8.9 [3.9–20.5] 13.9 80.5% 
Average age at follow-up        
<38 years 18 33,923 528,493 11.0 [6.9–17.7] 33.8 97.9% 
≥38 years 18 111,004 1,778,682 6.6 [4.0–10.8] 45.8 99.6% 
NR 9 76,560 1,848,072 9.4 [5.8–15.2] 20.4 98.2% 
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Average pre-pregnancy BMI        
<25 kg/m2 4 6,047 98,211 2.1 [1.4–3.4] 6.9 15.4% 
≥25 kg/m2 9 1,891 8,730 14.1 [9.1–21.8] 16.9 47.2% 
NR 32 213,549 4,048,306 8.1 [6.2–10.6] 76.2 99.4% 
Average BMI at follow-up        
<25 kg/m2 3 949 248 4.0 [1.1–15.0] 3.5 32.5% 
≥25 kg/m2 14 4,372 9,898 6.7 [3.2–14.0] 27.4 97.9% 
NR 28 216,166 4,145,101 10.2 [8.2–12.8] 69.1 99.2% 
Average percentage who were nulliparous at index pregnancy     
<35% 6 23,515 567,095 9.7 [6.0–15.6] 13.7 97.6% 
≥35% 9 43,540 156,825 6.4 [2.9–14.4] 22.3 99.3% 
NR 30 154,432 3,431,327 9.2 [6.3–13.5] 64.0 99.4% 
Average percentage with family history of diabetes     
<50% 10 7,325 4,388 7.9 [3.7–16.9] 18.3 86.1% 
≥50% 8 2,777 5,712 6.7 [2.1–21.3] 12.1 95.3% 
NR 27 211,385 4,145,147 9.5 [7.5–12.1] 69.6 99.3% 
NA: not appropriate; NR: not reported.       
4.5 Discussion 
These findings show that progression to T2D after GD is both common and highly variable, 
and while the relative risk is highest soon after pregnancy, the number of women diagnosed 
with T2D continues to increase in a near-linear and clinically important way over time. Women 
with GD therefore have a comparable or higher overall relative risk of T2D when compared to 
women who did not have GD in pregnancy than people with IGT or IFG when compared to 
the normoglycaemic population (232). Although having lower relative risk, non-White 
European women have high rates of progression, as do women who are older and overweight 
at follow-up. Nonetheless, many of the differences between populations and studies remain 
unexplained. 
I report considerable heterogeneity in the meta-analysis, which I investigated through stratified 
analyses and study-level meta-regression. The heterogeneity, measured using the I2 statistic, 
did not improve in the multivariable meta-regression, indicating that many of the differences 
between populations and studies were not accounted for. This may be due to variation in study 
design or exposure/outcome assessment that I did not adjust for, or due to diversity within the 
GD population. A proportion of the heterogeneity may be explained by variables that were 
measured in just a few studies, and some may remain unmeasured or unknown. Buchanan and 
Xiang describe different GD phenotypes (autoimmune, monogenic and chronic insulin 
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resistance) that are not currently assessed in GD diagnosis (9). It is possible that these 
phenotypes have different associations with development of diabetes postpartum. 
Nonetheless, my findings support sustained T2D screening after GD; I did not identify a time 
after GD for which screening might become less clinically useful. However, low long-term 
attendance is often reported in routine practice (146,148), including in the UK (153–155). Non-
White European and overweight women developed T2D at higher rates therefore shorter 
screening intervals for these populations may be considered appropriate. Further research 
should be done to improve precision of risk stratification and determine the clinical benefit, 
cost-effectiveness and acceptability of different stratified screening strategies. 
Moreover, consistent with T2D risk factors in the general population, women with high BMI 
at follow-up had higher-than-average progression to and relative risk of T2D. The authors of 
the DPP suggested that participants with GD did not reduce their risk because they lost less 
weight than comparable high-risk women (who had had normoglycaemic pregnancies) (163). 
Other evidence suggests that dietary and physical activity guidelines are not adhered to after 
GD (233), therefore development of effective strategies to help women to manage weight in 
order to reduce T2D risk is important.  
4.5.1 Comparison to existing literature 
Following publication of the protocol for my review, Vounzoulaki et al. reported the incidence 
of T2D after GD in 20 studies (published from 2000 to 2019) (121). This study found that 
cumulative T2D incidence was higher, but not statistically significantly higher, in mixed 
ethnicity and non-White populations than in White populations (up to 16.5% [95% CI 16.2 to 
16.8%]), and was higher in longer study follow-up categories. However, of note, they found 
that effect size was not significantly associated with mean study age, BMI, publication year or 
length of follow-up in the univariable meta-regression analyses and suggested this was due to 
a lack of power. My larger study meant that I was able to examine potential associations 
between these variables and others, concluding that ethnicity, time since pregnancy and BMI 
at follow-up were associated with diabetes risk in a multivariable analysis. 
Prior to Vounzoulaki et al. (121), Kim et al. conducted an influential literature review of the 
cumulative incidence of T2D after GD in 2002 using similar inclusion criteria to mine (99). 
Adjusting for retention, they reported that cumulative incidence increased most quickly during 
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the first five years postpartum, plateauing after ten years. Just one study with more than 11 
years follow-up was included. This is inconsistent with the findings of individual studies, such 
as Lee et al. and Albareda et al. (234,235) as well as Vounzoulaki et al. (121). I have reported 
a more constant increase in the crude proportion developing T2D over time, including 12 
studies with more than 11 years follow-up in the meta-regression, which supports sustained 
follow-up efforts. They discuss how different exclusion criteria, particularly including women 
with symptomatic diabetes in the GD cohorts, might increase T2D diagnoses soon after 
pregnancy, whereas I included more studies after the immediate postpartum period. They also 
reported that women with GD progressed to T2D at similar rates independent of ethnicity. In 
contrast, I found that White European women were less likely to progress than women from 
other ethnic groups. 
My relative risk estimate of 8.3 (95% CI 6.5 to 10.6) is based on more studies and participants 
(45 studies and 4,376,734 women in total) than previous recent reviews, hence is more precise 
but highly comparable. Bellamy et al. reported a relative risk of 7.4 (95% CI 4.8 to 11.5) in 20 
studies published up to 2009 including 675,455 women (98); Song et al. reported a relative risk 
of 7.8 (95% CI 5.1 to 11.8) in 30 studies published up to 2017 including 2,626,905 women, 
alongside an adjusted odd ratio of 17.9 (95% CI 17.0 to 19.0) (122); Vounzoulaki et al. reported 
a relative risk of 9.5 (95% CI 7.1 to 12.7) in 20 studies published between 2000 and 2019 
including 1,332,373 women (121). These data suggest that relative risk may be increasing over 
time, although again this may be explained by other factors such as changes in diagnostic 
thresholds. I observed similar trends across subgroups. Unlike these previous reviews, I also 
considered parity and family history of diabetes but they did not convincingly affect relative 
risk.  
4.5.2 Strengths and limitations 
This meta-analysis is larger than previous ones, in part, because I did not restrict study methods, 
language or publication year, which enabled me to report a percentage estimate of T2D risk in 
a large number of women with GD. This increased the analysis power and consequently the 
opportunity for stratified and multivariable analyses to explore heterogeneity. Furthermore, I 
report longer follow-up than previous reviews by including new studies and updates of studies 
already published. Most of the studies I included had a medium overall risk of bias in relation 
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to T2D outcomes (13/129 [10%] were low quality) and overall estimates of risk only changed 
slightly in the sensitivity analyses, which increases my confidence in the findings.  
There are differing views on the relative merits of ‘lumping’ and ‘splitting’ heterogeneous 
studies in a systematic review. Previous studies have reported T2D risk after GD through a 
narrative synthesis (e.g. Zhu and Zhang 2016 (36)) as well as a meta-analysis (e.g. Vounzoulaki 
et al. (121). I judged that by identifying, synthesising and then pooling all the evidence, I could 
explore heterogeneity and improve understanding of the topic more than would be possible 
through a narrative review. Using meta-regression, I quantified the extent to which a diagnosis 
of T2D was associated with the values of one or more explanatory variables. It was not possible 
to adjust for all study characteristics therefore I adjusted for ethnicity and follow-up duration 
in the meta-regression. When interpreting the findings, I did not report one overall estimate 
without describing the range of estimates. Random-effect analyses were used to allow for 
differences in the effect estimate between studies (236).  
One source of heterogeneity can be attributed to the inclusion of any type of study design, and 
prospective and retrospective studies. I included all study designs because all of the studies 
assessed GD exposure at baseline (i.e. diagnosed during pregnancy or after pregnancy based 
on blood samples that were collected during pregnancy). Follow-up then began at the time of 
delivery and the duration of follow-up was defined from that date of delivery to assessment of 
T2D status, therefore cohorts are represented in this sense. Some studies were described as 
cross-sectional studies but in these studies the cohorts were still defined retrospectively. 
Retrospective and prospective designs have different strengths and weaknesses, and subgroups 
were based on these attributes rather than the design. A retrospective study including all women 
with GD and re-measuring the majority will be less biased in some ways than a prospective 
study with high loss to follow-up. In the quality assessment, retrospective studies scored highly 
on question 6 (completeness of follow-up) but not on questions 2 and 4 (assessment of GD or 
T2D status) if they used medical records or self-report. Conversely, prospective studies scored 
a point for question 6 (completeness of follow-up) less frequently. Incidence estimates did not 
clearly vary by study quality according to the quality domains assessed in this study and 
previous reviews have not reported significant differences in risk by prospective/retrospective 
study design (98,121). 
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Across all of the studies, there may be a difference in outcomes between those that recruited 
women with GD during pregnancy and those that recruited postpartum. This remains an 
unexplored source of heterogeneity. Excluding women who progressed early (such as before 
eight or 13 weeks postpartum) or never remitted from the baseline cohort and therefore 
probably had diabetes in pregnancy rather than GD) would enable a more accurate estimate of 
the true incidence of T2D after GD, whereas identifying T2D diagnoses after any pregnancy 
during which the mother is diagnosed with GD is perhaps more relevant to clinical practice. I 
have taken this second approach in the main analysis. However, excluding studies that did not 
attempt to exclude pre-existing/previously undiagnosed T2D from the GD cohort did not 
significantly affect the overall incidence estimate.  
I only used study-level data. Individual patient data meta-analysis might have improved 
confidence in the findings, but the significant additional work in obtaining individual data from 
129 studies is unlikely to be feasible or to add sufficient value and policy impact to be 
justifiable. The use of crude subgroups reduced accuracy. For example, diagnostic sensitivity 
was grouped as clinical, low or high rather than by specific criteria because numerous different 
criteria were used. Although I investigated incidence by 15 characteristics, some characteristics 
that may have explained heterogeneity were not available or not reported in a usable way for 
all studies. For example, few studies reported data on socioeconomic status or other T2D risk 
factors (e.g. gestational age at onset of GD, or breastfeeding). Breastfeeding may help to 
prevent T2D after GD, although Rayanagoudar et al. did not find a significant association 
(126,213). In the relative risk analyses, subgroups were developed according to characteristics 
of women with GD only and adjusted analyses were limited.  
Studies also varied by quality, as noted above, which may have influenced the analyses. In 
particular, a frequently observed weakness was poor percentage of the study population 
followed up. Previous studies report that women with fewer diabetes risk factors are more 
likely to receive follow-up than women with more risk factors (148), therefore I may have 
underestimated the percentage developing T2D because those at highest risk were not tested 
and T2D remained undiagnosed. However, I did not observe large differences in the estimates 
when only high quality studies were included according to each criteria examined in the post 
hoc sensitivity analysis (Table 4.5). Also, the relative risk of T2D was much higher in studies 
of women with clinical, as opposed to biochemical, T2D diagnoses. Clinical diagnoses are 
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made as part of routine medical care where women presenting with suspected hyperglycaemia 
are tested. This leads to a higher proportion diagnosed with T2D compared to when a whole 
cohort is recalled for a biochemical assessment. 
Most of the included studies had short follow-up therefore many of the women may have been 
yet to develop T2D at the time of assessment. In part because I included the timepoint of studies 
with the most person-years follow-up, Carr et al. was the only study where I reported the 
outcome at more than 20 years follow-up (225). This study was not representative of the general 
GD population because all of the participants had diabetes in first-degree relatives, and inflated 
the estimate after 15 years postpartum. Furthermore, different factors may have confounded 
associations with T2D risk. For example, older studies tend to use lower sensitivity diagnostic 
criteria and include women with higher glucose levels than would be the case with current 
criteria, therefore more of the cohort are likely to develop T2D. These studies also tend to have 
longer follow-up, also increasing risk of developing T2D. The association between follow-up 
duration and development of T2D may also reflect, in part, the change in diagnostic criteria 
with time. Studies with longer and complete follow-up are needed in order to accurately 
describe progression to T2D.  
Risk of diabetes may also be influenced by whether studies distinguished between diabetes in 
pregnancy and GD, for example by recruiting women whose immediate postpartum tests were 
normal. However, excluding studies that did not attempt to exclude pre-existing/previously 
undiagnosed T2D from the GD cohort did not significantly affect the overall incidence estimate 
(Table 4.5). Furthermore, excluding the three studies that were part of a postpartum 
intervention (152,164,237) did not influence the findings.  
4.6 Summary 
In this review, I have described and explored development of T2D after GD. The findings 
strengthen the evidence for T2D risk to remain on the agenda of affected women and the 
clinicians who care for them (akin to glucose intolerance disorders). Unlike previous research 
that suggested risk plateaued over time since pregnancy, the results show that the number of 
women diagnosed with T2D increases each year and underline the need for continued blood 
glucose monitoring over time. This is in line with current guidelines but is not implemented 
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systematically, thus should be promoted as discussed in the following chapters. Also, the 
association I reported between BMI and T2D, which has not previously been highlighted, 
emphasised the need for effective weight management strategies that are appropriate to the 
needs of women with a history of GD. I describe challenges to healthy changes such as these, 




 Factors associated with postpartum 
diabetes screening after gestational diabetes 
In order to understand attendance at postpartum screening in a local setting, I conducted an 
analysis of testing uptake among women diagnosed with GD at the Rosie Hospital, Cambridge 
University Hospitals NHS Foundation Trust. In this chapter, I describe the frequency of glucose 
testing attendance up to one year postpartum, as well as personal and general practice-related 
factors associated with attendance. Understanding current trends in attendance will be useful 
for targeting interventions and informing changes to care protocols to improve uptake. 
5.1 Background 
National and international guidelines recommend that women with GD are screened for 
glucose abnormalities at six to 13 weeks postpartum (1,2). According to the result of the test, 
women not diagnosed with T2D should be offered support for behaviour change or drug 
therapies to reduce their risk while in those women in whom T2D is diagnosed, it can be 
managed in a timely way to reduce exposure to hyperglycaemia. 
Despite small increases in attendance over time, uptake of postpartum screening has remained 
suboptimal, often at less than 50% (145–148). Attendance in the UK is poorly reported, 
particularly using hospital records where early screening often takes place. Women who are at 
higher diabetes risk tend to be less likely to attend, for example, those with higher parity and 
lower socioeconomic status. However, older age, Asian ethnicity and use of insulin during 
pregnancy have all been associated with higher attendance rates (148). Inconsistent 
associations between predictors of attendance in multiple different healthcare settings have 
been reported (148). In particular, associations between general practice factors and attendance 
at postpartum screening had not been investigated in the UK. 
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A better understanding of the factors that influence attendance for postpartum testing could 
inform the adjustment of procedures to increase uptake, and therefore potentially improve 
women’s long-term outcomes.  
5.2 Aim  
I aimed to describe the frequency of and factors associated with postpartum testing in women 
with GD. In addition to personal and pregnancy characteristics, I assessed whether features of 
their general practice, where women are seen at six weeks for postpartum checks, were 
associated with likelihood of testing. 
5.3 Methods 
The complete methods for this analysis are described in detail in Chapter 3.2. The data were 
provided by Catherine Aiken. Catherine Aiken and Claire Meek provided information about 
GD management at the Rosie Hospital. Juliet Usher-Smith and Matthew Barclay provided 
statistical advice. 
5.3.1 Cohort  
I examined postpartum diabetes screening up to one year after pregnancy at Cambridge 
University Hospitals NHS Foundation Trust between October 2014 and March 2017. This was 
a secondary analysis of data that had been extracted from electronic medical records. I used an 
OGTT or HbA1c test result as a proxy for attendance at testing.  
5.3.2 Statistical analysis 
I used STATA 15.1 to run univariable and multivariable two-level mixed-effects logistic 
regression analyses to identify factors associated with the odds of diabetes screening. The 
multivariable analyses were adjusted for variables that were statistically significant in the 
univariable analysis or I had strong a priori rationale to include, as reported in Table 5.1. 
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Table 5.1: Explanation of the variables included in the multivariable logistic regression analysis of attendance 
at diabetes screening after gestational diabetes. 
Variable Justification 
Maternal age A key potential confounder, although not significant in the univariable analysis. 
Maternal deprivation 
(IMD decile) 
A key potential confounder, although not significant in the univariable analysis. 
Parity Significant in the univariable analysis and has previously been found to be 
associated with T2D risk. 
Pre-pregnancy BMI Significant in the univariable analysis and has been found to be associated with 
T2D risk (I did not also adjust for weight, which was significant but BMI is a better 
measure of overweight). 
Birthweight z-score Used as an indirect measure of a difficult delivery (women with more medicalised 
deliveries would take longer to physically recover and might struggle to attend these 
sorts of non-urgent appointments), although not significant in the univariable 
analysis. 
Medication (insulin 
and/or metformin) at 
36 weeks gestation 
Insulin use has previously been found to be associated with attendance, plus is a 
measure of disease severity and medicalisation of pregnancy), although not 
significant in the univariable analysis. 
First OGTT before 22 
weeks gestation 
May be considered a proxy for previous GD because these patients will be offered 
an OGTT soon after booking at 12 to 14 weeks gestation, whereas high-risk and 
symptomatic women were offered testing at 24 weeks gestation (22 weeks gestation 
was selected as the cut-off because this was the lowest point between two peaks, 
suggestive of the above groups, when a histogram of time to first OGTT was 
plotted). 




Significant in the univariable analysis (a measure of patient satisfaction with their 
GP practice). 
Percentage with a foot 
examination 
Significant in the univariable analysis (a measure of the comprehensiveness of 
diabetes management in their GP practice). 
BMI: body mass index; FPG: fasting plasma glucose; GP: general practice; IMD: index of multiple 
deprivation; OGTT: oral glucose tolerance test. 
 
5.4 Results 
5.4.1 Participants and general practices  
We identified 556 women with GD, defined according to the modified IADPSG criteria (17) 
used at the hospital during the study period. Characteristics of the included women and their 
general practices are summarised in Table 5.2. Average (median [interquartile range, IQR]) 
maternal age at delivery was 34.0 (30.2 to 37.8) years and deprivation was lower than the 
average for the UK. On average, the patients were overweight before pregnancy. Forty one 
percent had a caesarean delivery. By 36 weeks gestation, half of the participants controlled GD 
using medication: 156 participants used insulin only, 69 participants used metformin only, and 
68 participants used both insulin and metformin. 
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The women with GD were registered at 93 different general practices, with an average total 
QOF score of 98.1 (96.9 to 99.8) out of 100, indicating high performance. Practice deprivation 
score was lower than the average for the UK (the UK average was 21.8 (200)). Eighty two 
Table 5.2: Characteristics of women with a history of gestational diabetes and their general practices. 
   N Median [IQR] or n (%)  
 Personal and pregnancy characteristics 
  
 
 Maternal age (years) 553 34.0 [30.2–37.8]  
 IMD decile1 (1, most deprived, to 10) 532 7 [6–9]  
 Parity 553 1 [0–1]  
 Pre-pregnancy weight (kg) 430 73.0 [62.0–90.0]  
 Pre-pregnancy BMI (kg/m2) 429 27.4 [23.7–33.3]  
 Preterm birth (less than 37 weeks) 482 40 (8.3)  
 Gestational weight gain (kg) 366 9.1 [5.2–13.5]  
 Caesarean delivery 489 199 (40.7)  
 Baby weight (g) 
  
 
 Boy 262 3,262.5 [2,969.9–3,640.1]  
 Girl 229 3,229.9 [2,939.8–3,504.9]  
 Median birthweight z-score 481 0.3 [-0.3–1.0]  
 GD diagnosis 
  
 
 First OGTT before 22 weeks gestation 555 54 (9.7)  
 FPG at diagnosis (mmol/l) 554 4.8 [4.3–5.3]  
 120 min plasma glucose at diagnosis (mmol/l) 555 7.3 [6.3–8.6]  
 HbA1c at diagnosis (mmol/mol) 497 35 [33–39]  
 GD treatment by or at 36 weeks gestation 556 293 (52.7)  
 Insulin  556 224 (40.3)  
 Metformin 556 137 (24.6)  
 Postnatal glucose testing     
 Postnatal OGTT or HbA1c (any test) 556 415 (74.6)  
 Postnatal OGTT (±HbA1c) 415 372 (89.6)  
 Postnatal HbA1c (±OGTT) 415 150 (36.1)  
 Time of postnatal OGTT (weeks) 370 6.4 [6.0–7.3]  
 Practice characteristics and performance in the preceding 12 to 15 months2  
 Number of registered patients 93 10,593 [7,607–14,333]  
 Practice IMD score1 (range 3 to 66, most deprived)  93 10.8 [8.7–15.1]  
 Total QOF score 93 98.1 [96.9–99.8]  
 Percentage recommending practice 93 81.9 [76.1–86.5]  
 Percentage with HbA1c blood test3 86 96.7 [95.5–97.1]  
 Percentage with foot examination3 93 86.0 [81.1–89.0]  
 Percentage with HbA1c <59 mmol/mol (7.5%)3 93 61.6 [58.7–64.6]  
 Percentage referred to education programme3 93 75 [60.5–83.3]  
Median and IQR presented for continuous variables; n and percentage presented for categorical variables. 
1 IMD is weighted and considers income, employment, education, skills and training, health and disability, 
and living environment deprivation, crime, and barriers to housing and services. 2 See Table 3.4 and 
https://fingertips.phe.org.uk/profile/general-practice for full definitions. 3 Percentage of diabetic patients with 
measure. 
IMD: Index of Multiple Deprivation; IQR: interquartile range; N/n: number of participants; QOF: Quality and 
Outcomes Framework. 
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percent of all patients registered across the 93 practices would recommend their practice. In 
terms of diabetes care, 97% of diabetic patients across the practices had had an HbA1c blood 
test and 62% had HbA1c controlled at less than 59 mmol/mol (7.5%). 
5.4.2 Uptake of postpartum testing 
Four hundred and fifteen participants (74.6%) had undergone a postpartum test: 265 (63.9%) 
were tested by OGTT alone, 43 (10.4%) by HbA1c alone and 107 (25.8%) had both tests within 
one year of delivery (Figure 5.1). None of the participants had a single FPG test documented 
in the medical record.  
OGTTs were performed at 6.4 (6.0 to 7.3) weeks 
after delivery (range 0.5 to 26.4 weeks), and the 
time of HbA1c tests was not reported separately. 
Two hundred and ninety four OGTTs were recorded 
within the recommended six to 13 weeks 
postpartum window: 70.8% of all of the postpartum 
tests performed and 53.2% of all eligible 
pregnancies. 
Six patients (1.4%) were diagnosed with T2D and a 
further nine (2.2%) met the criteria for IGT at the 
postpartum test. 
5.4.3 Characteristics associated with attendance 
The associations between personal or practice characteristics and odds of completing a diabetes 
screening test are shown in Table 5.3. Appendix 6 shows these associations for OGTTs and 
HbA1c tests separately.  
In the univariable analyses, higher parity, pre-pregnancy weight, pre-pregnancy BMI, and FPG 
at GD diagnosis were associated with lower odds of testing at each practice. The percentage of 
the total population registered at the practice who would recommend the practice (patient 
satisfaction) and the percentage of those with diabetes receiving a foot examination were 
positively associated with higher odds of testing.  
 
Figure 5.1: Type of test used for diabetes 
screening after gestational diabetes in this 
cohort. 
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In the multivariable analysis, greater parity was associated with a third lower odds of testing 
(odds ratio 0.68, 95% CI 0.53 to 0.87). Compared to women whose GD was not treated with 
medication, women who received insulin and/or metformin treatment were more than twice as 
likely to undergo testing (odds ratio 2.35, 95% CI 1.22 to 4.55). Some variables associated with 
higher risk of diabetes, such as higher pre-pregnancy BMI and FPG, were also associated with 
lower odds of testing but not statistically significantly. Higher patient satisfaction was 
associated with higher odds of testing (odds ratio 1.04, 95% CI 1.01 to 1.07 per percentage of 
patients recommending the practice). 
Similar associations were seen when testing by OGTT was considered alone (Appendix 6), 
although no practice-related variables were independently associated with testing and higher 
pre-pregnancy BMI was additionally associated with lower odds of an OGTT in the 
multivariable analysis (odds ratio 0.93, 95% CI 0.89 to 0.96 per kg/m2). In contrast, practice-
related characteristics were more frequently associated with HbA1c testing. In the univariable 
analysis, four practice-related variables had significant odds ratios (percentage who would 
recommend the practice, and percentage of patients with diabetes who had had a blood test, 
foot examination and HbA1c less than 59 mmol/mol [7.5%]). A higher patient satisfaction was 
the only predictor of HbA1c testing in the multivariable model (odds ratio 1.05, 95% CI 1.02 to 
1.09 per percentage) when the variables listed in in Table 5.1 were included. 
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5.5 Discussion 
In this population, three-quarters of women had a diabetes test up to six months after a GD-
affected pregnancy, of which 90% included an OGTT. Half of the total population had an 
OGTT within six to 13 weeks postpartum, in accordance with the timing recommended by 
NICE (2).  
Attendance was more strongly associated with patient satisfaction and individual 
characteristics, particularly parity and use of medication during GD, than other practice factors. 
Practice-related factors were more frequently associated with testing by HbA1c than OGTT, 
which is recommended after 13 weeks postpartum therefore is more likely to take place in 
general practice. Overall, women at highest diabetes risk (125,126) and registered at lower-
rated practices were more likely to be those not attending testing and should be prioritised. 
5.5.1 Strengths and limitations 
In this analysis, I assessed associations with routinely-available general practice data in 
addition to personal factors that other studies have considered, adding to the sparse UK 
literature on this topic. These included practice demographics (such as size and area 
deprivation) and both diabetes outcome and process measures (such as percentage of the 
diabetic population with good glycaemic control and referred to education programmes, 
respectively). Two-level mixed-effects analyses retained the distinction between general 
practices rather than removing any effects through adjustment. 
However, some variables that other studies have reported associations for (147,148) were not 
available due to the use of a routine dataset that was created for another purpose. These include 
ethnicity, individual socioeconomic status and previous history of GD (therefore I used the 
time of the OGTT to indicate this). Whether women were invited for testing was also missing, 
as was the time that postpartum HbA1c tests were performed. HbA1c tests are recommended 
after 13 weeks postpartum (2), therefore it is unclear from this analysis whether these were 
performed appropriately. 
In addition to missing variables, there were missing data. BMI and birthweight were the 
variables that were most frequently missing. This could have led to bias in the associations 
with testing attendance if missing was not at random, such as if weight was less likely to be 
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recorded in the medical record of those who were overweight. However, the complete case 
cohort was representative of the original cohort with regards to the characteristics included so 
missing data were not imputed.  
In 2015, NICE recommended not to routinely offer postpartum OGTTs but to use the FPG test 
(2). Although I did not access delivery date in order to protect patient confidentiality, OGTTs 
were available to all postpartum women both before and after the change in guidelines at this 
hospital between 2014 and 2017. This reduces the generalisability of the findings to the rest of 
the UK. Not accessing the date of delivery also meant that I could not use practice variables 
specific to the year of delivery.  
I assessed uptake of screening up to one year after a GD pregnancy as recorded in hospital 
medical records. The first postpartum test tends to occur in secondary care, although mothers 
are anticipated to be seen for a general health check with their baby at six weeks postpartum 
by their GP (the six week mother-and-baby check (238)), providing an opportunity for the GP 
to ensure they have had the diabetes screening test. Some women will have a postpartum test 
in the community, which is anticipated to be included in the hospital record, although it is 
unclear whether this occurs in every case. As a result, more women could have undergone 
testing than recorded here.  
5.5.2 Comparison to existing literature 
5.5.2.1 Uptake of screening and diabetes diagnoses 
I observed similar rates of testing and slightly lower incidence of T2D and IGT after GD than 
comparable studies in the UK have reported. The small differences in diagnoses of glucose 
intolerance disorders may reflect the differences in demographics between settings. Table 5.4 
shows a comparison of attendance at the first postpartum diabetes screening test after GD based 
on hospital records in the UK.  
Since 2000, uptake has ranged from 51% to 80%. However this comparison is based on five 
similar studies and small numbers of participants (2,449 records in total). Comparisons across 
hospital cohorts are challenging due to heterogeneous designs including different local 
protocols for GD diagnosis (e.g. Cambridge University Hospitals NHS Foundation Trust used 
modified glycaemic cut-offs based on the IADPSG criteria whereas Oxford University 
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Hospitals NHS Foundation Trust used the original IADPSG criteria (156), neither of which are 
recommended by NICE (2)), methods for informing or inviting women to attend testing (e.g. 
there were pre-arranged six week follow-up appointments booked for women in Sheffield 
(157)), and different postpartum testing protocols that may include OGTTs, FPG tests and/or 
HbA1c tests. Nevertheless, these differences reflect attendance rates in routine practice 
therefore are of value. 
Table 5.4: Comparison of attendance at the first postpartum diabetes screening test after gestational diabetes 
based on hospital records in the UK. 
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NR: not reported. 
Screening attendance recorded in hospital records tend to be higher than that recorded in 
primary care records. In 2018, one study reported 58% attendance up to one year postpartum 
across approximately 675 general practices (9,118 records in 1990 to 2016 [62% attendance 
since 2010]) (153). In contrast, uptake of testing was reported to be 19% up to six months 
postpartum, with most attending at approximately three months, in a previous general practice 
audit in England (788 records in 2006 to 2009) (154). Wide regional variation was reported, 
although this was not sufficient to explain the differences observed between community and 
hospital records. Reasons for the stark differences in attendance remain unclear, although some 
may be explained by the poor transfer of information between maternity and primary care. 
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5.5.2.2 Factors associated with screening attendance  
Previous reviews, not including UK-based studies, report variable and inconsistent associations 
between specific characteristics and non-attendance at testing, including some factors that 
increase diabetes risk (147,148). Like this study, a multi-centre US study found that obesity 
and higher parity were associated with lower screening completion by postpartum OGTT (152). 
According to the above study of a Sheffield hospital, the following categorised variables were 
associated with lower attendance: higher deprivation, smoking, unemployment, under 25 years 
of age, high parity and not breastfeeding (157). In comparison, I reported associations with 
parity, pre-pregnancy weight and BMI, and FPG at GD diagnosis using continuous variables. 
I also found that use of GD medication predicted follow-up in the multivariable analysis, like 
Walsh 2019 (239) and the Black, Asian and minority ethnic subgroup in Castling and Farrell 
2019’s analysis (157). Conversely, no statistically significant associations between test 
attendance and the personal characteristics assessed were reported in the study in Southampton 
(use of GD medication was not examined) (240), nor did uptake of HbA1c testing vary by 
personal factors in one UK centre, although details of the methods were unavailable (241). 
As noted above, explanations for the differences in associations are challenging due to 
important differences between clinical practice, the cohorts and study designs. For example, 
Castling and Farrell used a binary overweight cut-off of level II obesity (BMI greater or less 
than 35 kg/m2 (242)) that may be too crude to observe differences according to BMI, and did 
not report when BMI was measured (157). Also, the population in Cambridgeshire may not 
have had enough diversity in IMD scores to identify differences in attendance according to 
deprivation. Overall, there is most consistent evidence that use of medication during GD is 
associated with higher postpartum screening attendance, which is logical since this is likely to 
be associated with a better understanding of the need for follow-up through more clinical 
contact and a more pronounced experience of diabetes. 
No previous studies have examined associations with the mothers’ general practice. My 
findings are consistent with the broader literature that suggests that patients’ experience of their 
general practice is associated with health outcomes, albeit with often weak associations (243). 
For example, patients who felt that they had enough support from local services to manage 
their long-term conditions tended to have better managed T2D (244) whereas overall 
experience was not associated with emergency hospital admissions (both recorded in the 
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national General Practitioner Patient Survey) (245). Overall experience is most strongly 
associated with interpersonal quality of care provided by the GP, rather than factors like ease 
of booking appointments and opening hours, which might be expected to be more strongly 
associated with attendance at screening after GD (246). 
5.5.3 Implications  
In addition to the novel finding that patients’ satisfaction with the practice was related to uptake 
of postpartum diabetes screening in this region, the results of this analysis contributes to 
describing diabetes screening after GD in the UK.  
Because I found that women with higher parity and higher BMI (in the univariable analysis 
and for OGTT attendance), were less likely to attend screening and these are the women who 
are at highest risk of diabetes, interventions to improve attendance could be focused on these 
women. It might be particularly important to facilitate them to bring their older children to the 
appointment, for example. In addition, the importance of screening should be promoted in those 
who controlled GD symptoms by diet alone, and may perceive themselves to have a lower risk 
than women who needed medication.  
In the longer term, future research should address reasons why women at high risk of diabetes 
were more likely to not attend testing. Some of the reasons given for missing testing, such as 
the unpleasant testing procedure (87), are universally applicable. Other possible explanations 
include not recognising risk or being afraid of positive diagnoses. Interventions focused on 
improving awareness and acceptability of diabetes screening postpartum, particularly in 
practices with lower patient satisfaction, could therefore potentially improve uptake of 
screening and women’s long-term outcomes in turn. 
5.6 Summary 
Through an analysis of medical records from Cambridge University Hospitals NHS Foundation 
Trust between 2014 and 2017, I found that a quarter of eligible women missed out on diabetes 
screening in the first year after a GD pregnancy. Lower parity, use of medication and overall 
patient satisfaction (indicated by the percentage that would recommend their general practice) 
were associated with higher attendance. However, not all the variables that might explain 
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attendance were available for analysis, and this hospital used a GD follow-up protocol that is 
no longer recommended by NICE. 
Further research is needed to understand why women with these characteristics are less likely 
to attend and how to improve attendance, and the role that their general practice plays in 
screening or promoting screening. In the next chapter, I report women’s views towards diabetes 
screening through a synthesis of published literature, and examine approaches to improve 




 Women’s views on screening for type 2 
diabetes after gestational diabetes 
A systematic review, qualitative synthesis and recommendations for 
increasing uptake. 
In order to better understand the reasons for poor attendance at postpartum diabetes screening 
that have been reported in the literature and that I described at the Rosie Hospital in Chapter 5, 
I conducted a synthesis of qualitative studies of women’s views concerning postpartum testing.  
Previously published reviews examined postpartum care and health seeking in general. I 
attempted to distinguish between views towards attending appointments after pregnancy and 
the diabetes screening test itself. Views towards healthy diet and physical activity after GD 
pregnancy are considered in Chapter 7, although some studies are included in both reviews. 
The findings from this review and the recommendations that I suggested for increasing uptake 
informed the study in Chapter 8. 
The study described in this chapter was published in 2019 (208): Dennison RA, Fox RA, Ward 
RJ, Griffin SJ, Usher-Smith JA. Women’s views on screening for type 2 diabetes after 
gestational diabetes: A systematic review, qualitative synthesis and recommendations for 
increasing uptake. Diabetic Medicine. 2020;37(1):29–43. 
6.1 Background 
As explained previously, national and international guidelines recommend that women are 
screened for glucose abnormalities at one to three months after GD to exclude persisting 
diabetes, followed by lifelong screening to monitor glycaemia and to identify those who have 
developed diabetes (1,2). Earlier detection of T2D and effective management of ‘pre-diabetes’ 
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decreases the duration of exposure to hyperglycaemia and hence reduces risk of longer-term 
complications (247). 
There is currently variation between guidelines regarding which screening tests and schedules 
to use. For example, the ADA recommends using the 75g OGTT at the first postpartum test 
followed by either a FPG test, OGTT or HbA1c test at least every three years (1). In 2015, NICE 
advised that women in the UK should be screened using FPG postpartum followed by annual 
HbA1c testing, and should not be routinely offered an OGTT (2).  
Frequency of postpartum screening varies by population but remains suboptimal; many studies 
report just 50% uptake (145–148). Attendance tends to be highest for the first postpartum test, 
and declines with time since pregnancy. In the UK, for example, analysis of medical records 
in The Health Improvement Network (THIN) database found that 58% of women attended 
diabetes screening in the first year postpartum (9,118 records; 1999 to 2016), and less than 
40% attended in the second and third years (153). Two small, local studies suggest even lower 
annual rates of 16% and 20% thereafter (154,155). Younger women with other children and 
those of lower socioeconomic status attend less frequently, particularly if they received little 
perinatal care or their GD was managed by diet alone (148).  
A previous systematic review of both qualitative studies and surveys found that healthcare 
seeking after GD can be constrained by the maternal role (meaning prioritising the needs of 
children and constraints associated with childcare), failures of the healthcare system, and 
women’s perspectives towards testing (87). However, only studies published up to 2013 were 
included and general care, rather than glucose testing, was considered.  
6.2 Aim  
In light of recently-published studies about screening plus changing guidelines for GD and 
T2D diagnosis and management (1,2,19,119,248,249), I aimed to synthesise the literature 
regarding the views and experiences of women with a history of GD on follow-up glucose 
testing. I particularly focused on barriers and facilitators to attendance. Furthermore, I 
developed recommendations to adjust testing protocols and inform interventions for improving 
long-term follow-up based on the findings. 
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6.3 Methods 
The complete methods for this systematic review and qualitative synthesis are described in 
detail in Chapter 3.1. I developed the protocol and registered it on PROSPERO in May 2018 
(record ID CRD42018092386). 
I was assisted in this work by Rachel Fox, a clinical medical student. Under my supervision, 
Rachel screened the full texts. She undertook the role of second reviewer in coding the findings, 
quality assessment and interpretation, and wrote the first draft of the theme ‘Concern about 
diabetes’ (Section 6.4.3.4) for the publication. 
6.3.1 Search strategy 
In brief, the search strategy shown in Table 3.1 was used to search five electronic databases. 
This was developed for a group of literature reviews concerning GD, including the studies in 
Chapters 4 and 7, and this chapter. We also screened reference lists of included studies for 
citations not identified by this search. 
6.3.2 Inclusion criteria and study selection  
We included peer-reviewed journal articles that examined women’s experiences following GD 
in relation to postpartum glucose tolerance testing or diabetes screening, or experience of 
interventions to promote attendance at screening. All qualitative and mixed methods study 
designs were eligible. We excluded studies exclusively reporting views of healthcare providers 
and about postpartum lifestyle in order to focus on screening.  
After removing duplicates, Rebecca Ward and I assessed the titles and abstracts against these 
selection criteria. I then acquired full text articles and reassessed them against these criteria 
with help from Rachel Fox. Both authors reviewed and discussed an overlapping 10% of 
citations to ensure consistency at both stages.  
6.3.3 Quality assessment  
Rachel Fox and I used the CASP checklist for qualitative research shown in Table 3.3 (196) to 
assess the quality of the qualitative research in each study, and discussed the findings. We 
awarded scores of 0, 0.5 and 1 for answering ‘no’, ‘unclear’ and ‘yes’ to each of the ten 
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questions, respectively. We did not exclude studies based on quality in order to make use of all 
available information.  
6.3.4 Qualitative synthesis  
We conducted a thematic synthesis as described by Thomas and Harden (187) with the aid of 
NVivo 11. This involved coding the data, developing descriptive themes, and developing 
analytical themes. This process is presented in Figure 6.1 using an example from this review. 
 
Figure 6.1: Example of the use of thematic synthesis in the qualitative synthesis of diabetes screening after 
gestational diabetes. 
After familiarisation with the data through reading the studies and making notes and 
annotations, I formed a coding frame and used this to develop descriptive themes. Rachel Fox 
and I coded the data, including independently coding a subset of papers to check consistency. 
We developed descriptive themes to define the each concept in line with the primary studies. 
Next, we translated concepts from one study to another by making summaries and comparisons, 
and developed new concepts. I considered these independently, then with Rachel Fox and 
finally refined the analytical themes through discussion with the wider research team. 
6.3.5 Recommendations for promoting screening 
Based on the analytical findings and aided by Rachel Fox, I developed recommendations to 
promote uptake of screening that aimed to address the behaviours or beliefs that hindered 
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screening attendance and to make use of facilitators. I aligned each recommendation with 
standardised behaviour change technique taxonomy to enable greater consideration of the 
process by which the recommendations could be effective (190). 
We used the GRADE-CERQual approach to evaluate our confidence in each of these 
recommendations by considering the relevance, coherence, adequacy and methodological 
limitations of the included data (197).  
6.4 Results 
6.4.1 Included studies 
We included 16 qualitative papers after screening 23,160 citations and reviewing 129 full texts 
(Figure 6.2). Two papers published by Rafii et al. in 2017 reported data from the same set of 
interviews but used different analysis methods (250,251) therefore both were included in the 
analysis. 
The median number of participants was 22 (IQR 12 to 31) and 746 postpartum women were 
represented overall. Appendix 7 shows the characteristics of these studies. Fifty three percent 
of participants attended testing (97/184, based on seven studies reporting attendance). All the 
studies except the one by Morrison et al. (252) used interviews to collect data, with most 
conducted face-to-face. Most of the studies were set in high-income countries and some 
recruited ethnic minority populations; where populations with mixed ethnicities were recruited, 
often over half of participants were White European. Average age was approximately 35 years 
(range 24 to 56 years). When reported, the majority of each population was married. Using 
insulin during pregnancy, family history of diabetes and being overweight were common (the 
majority of participants in most of the studies had these characteristics). Data were collected 
between six weeks and nine years after pregnancy and, correspondingly, views towards both 
the first postpartum test and general testing were considered. 
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Figure 6.2: PRISMA diagram for the qualitative synthesis of diabetes screening after gestational diabetes. 
*Two of these publications report the same set of interviews using different approaches to the analysis. 
6.4.2 Quality assessment 
Most of the studies were considered to be good quality (mean CASP score 7.6/10), as detailed 
in Figure 6.3. Two studies scored below 6/10 because they did not report use of rigorous 
qualitative methods (253,254). The value of some studies to this review (CASP question 10) 
was unclear or low because they presented mixed results from both mothers and healthcare 
providers and some only had a small section about testing. The relationship between the 
researcher and participants (CASP question 6) and ethical issues (CASP question 7) were 
poorly considered in general.  

























































































































































































































Soares 2006 (253)           3.5 
Bennet 2011 (255)           8.5 
Sterne 2011 (254)           5.5 
Lie 2013 (256)           8.0 
Abraham 2014 (257)           7.0 
Morrison 2014 (252)           6.5 
Paez 2014 (258)           8.0 
Kilgour 2015 (259)           9.0 
Nielsen 2015 (260)           10.0 
Bernstein 2016 (261)           6.5 
Campbell 2017 (262)           9.0 
Pennington 2017 (263)           8.0 
Rafii 2017a (251)           7.5 
Rafii 2017b (250)           9.5 
Svensson 2017 (264)           7.5 
Zulfiqar 2017 (265)           7.5 
Score 
frequency 
Yes 15 15 13 11 12 2 6 10 13 5 
 Unclear 1 1 3 5 3 3 10 4 2 7 










Figure 6.3: Findings from the Critical Skills Appraisal Programme (CASP) checklist for the qualitative 
synthesis of diabetes screening after gestational diabetes (A) according to each included study, and (B) overall. 
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6.4.3 Findings of the qualitative synthesis 
Barriers and facilitators to attending screening after GD were translated into four themes and 
13 subthemes that are described below. Although not discrete categories, I organised the 
themes into quadrants according to the degree to which they related to the healthcare system 
or were personal factors, and the degree to which they supported attendance (permissive 
factors) or influenced attitudes towards testing (motivational factors). This is summarised in 
Figure 6.4. Influences were reported from the perspective of GD-affected participants but not 
all participants were influenced by each factor.  
 
Figure 6.4: Summary of the themes and subthemes of influences on attendance at postpartum glucose testing 
after gestational diabetes. 
The studies that contributed to each theme are shown in Table 6.1. All of the studies contributed 
to more than one theme, although sometimes this was just a small contribution such as listing 
that concept without explaining it in detail. The subtheme ‘Unpleasant, poorly understood 
procedure’ was the least well informed, with only one medium quality study reporting this as 
a barrier to attending testing (263) in detail.  
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Table 6.1: Studies that contributed to each theme and subtheme in the qualitative synthesis of diabetes 















































































































































































































































Soares 2006 (253)              
Bennet 2011 (255)              
Sterne 2011 (254)              
Lie 2013 (256)              
Abraham 2014 (257)              
Morrison 2014 (252)              
Paez 2014 (258)              
Kilgour 2015 (259)              
Nielsen 2015 (260)              
Bernstein 2016 (261)              
Campbell 2017 (262)              
Pennington 2017 (263)              
Rafii 2017a (251)              
Rafii 2017b (250)              
Svensson 2017 (264)              
Zulfiqar 2017 (265)              
Large dot: CASP score ≥8.5, medium dot: 7.5–8.0 (median=7.75), small dot: ≤7.0.  
Open dots indicate where a study briefly contributes to the theme, or lists the theme. 
In the text below, quotations from the primary studies are presented in italics. Participants’ 
quotations are reported in double quotation marks (“/”) and the authors’ descriptions or 
explanations are reported in single quotation marks (‘/’). Additionally, I report whether the 
participant attended the screening test if this was reported in the primary study. 
6.4.3.1 Relationship with healthcare 
Participants’ interaction with the healthcare system influenced their intentions towards 
screening.  
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Behaviour of clinicians 
The behaviour of clinicians could conflict with or reinforce prioritisation of screening. 
Pregnancy and postpartum care could imply that GD and the associated diabetes risk were not 
important after delivery therefore there was no need for further testing. For example, the 
message that GD would resolve after delivery could appear inconsistent with messages about 
postpartum screening: “…my diabetes midwife said it normally goes away after the pregnancy 
so I didn’t get anything afterwards” (256). Glucose monitoring and dietary restrictions stopped 
immediately after delivery, reinforcing that they no longer had diabetes: “I sat there in the 
hospital eating a big huge piece of chocolate cake…” (257). Furthermore, some clinicians had 
“no time” for glucose testing (260) but focused on the baby or non-diabetes-related maternal 
care at postpartum appointments. On the other hand, clinicians ‘promoting’ follow-up (263) 
helped women to understand its importance, for example, “I think that [postnatal follow-up] 
was explained to me both pre and post that that needed to happen. It was explained by both the 
hospital and the GP” [screened] (259). 
Process of booking tests 
Participants additionally commented on the process of booking tests. Many were surprised to 
discover that this was their responsibility rather than doctors’, and that missed appointments 
were not chased. They often needed to act on generic information, such as “…[the leaflet] said 
it was something I was supposed to take care of myself…” [screened] (260). Although many 
did arrange the test, some considered that invitations and reminders should be sent from their 
general practice: “Well, it would be a lot easier if I got a letter that said, now it’s time – like 
they do for that cervix cancer screening” [screened] (260). Positively, proactive clinicians 
encouraged attendance: “…[my doctor] even wrote it down in my insurance booklet” [screened] 
(250). Participants would be reassured to know that GPs were involved in this part of their care 
because “…You tend to forget… so much occurs after the childbirth” (265). At an extreme, 
some women perceived that their GP did not know about routine follow-up care after GD 
(“Even for blood test I had to tell him I have to do a blood test for diabetes” [screened] (259)), 
or explicitly gave incorrect advice. One participant concluded that “[GPs] don’t really 
understand it, GD, at all” [screened] (259).  
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Continuity of healthcare 
In addition, continuity of healthcare was frequently discussed. Some women were distressed 
by lack of continuity: “…You see all different [doctors] and then they didn’t have my record 
and… everybody just seems so confused here, like they don’t know what’s going on with their 
patient” [attended visit] (255). Conversely, consistency in relationships meant that they knew 
and trusted their clinicians, and could feel safe with predictable appointments: “It meant a lot 
to me that I didn’t have to see a new person every time I was there. That would definitely have 
made me feel all confused – it wouldn’t have been fun at all…” (260). Fragmented care was 
particularly obvious between pregnancy and returning to the GP postpartum, where Bernstein 
et al. referred to a ‘chasm between specialities’ and ‘professional silos’ (261). Consequently, 
women needed to take on the role of ‘information broker’ (259) and communicate their 
pregnancy history with their GP; electronic medical records were not sufficient (259,261). 
Additionally, Bennett et al. reported that relationships built with administrative staff facilitated 
follow-up: “…when I called to reschedule [the clerk]’s like, ‘Oh, I was hoping you’d bring the 
baby so I could see him.’ So I told her I’d bring him” [screened] (255). 
Ability to understand diabetes risk 
Finally, clinicians played an important role in women’s understanding of diabetes risk. A lack 
of patient-focus prevented participants from asking questions about GD because there was only 
time for clinicians’ agenda in consultations (“She [GP] basically said don’t eat any carbs, any 
sugar, don’t eat any fruit… I was sort of like a bit overwhelmed. I came home and I just cried 
because there is nothing I can eat now…” [not screened] (259)), or because it was explained 
using medical terminology that they could not understand (259). Some clinicians were too keen 
to refer them to websites and/or leaflets (260). Inability to learn about GD could leave women 
anxious and uninformed about their risk of diabetes or the need for screening. Several identified 
the need for “good education antenatally as well as once you’ve had the baby [and] your 
brain’s working again…” (263). 
6.4.3.2 The appointment and test 
Practical aspects of both the appointment and the glucose test itself affected opportunity to 
attend.  
Chapter 6  Women’s views on screening for type 2 diabetes after gestational diabetes 
136 
Logistics of the appointment 
Logistics of going to and being at the appointment could create several barriers to attendance. 
These included the appointment time, needing to travel long distances or needing to use public 
transport, which one participant experienced all of: “It was a long and tiring day and I was 
exhausted when I got back home” (262). Some factors were inherent to OGTT procedures such 
as the long appointment: “because it took two hours of my time I kept putting it off” (254). 
Furthermore, lack of health insurance or the ability to pay for testing prevented attendance: “I 
don't really need [testing]… only because of how much it costs, since we are in a terrible 
financial position” [not screened] (251). 
Unpleasant, poorly understood procedure 
Women found the testing procedure unpleasant or did not understand its purpose therefore 
wanted to avoid having to go through it. In particular, many in one study reported that fasting 
then drinking a glucose solution made them feel ill, and some disliked needles (261). Some 
respondents indicated that they did not understand how the test worked, meaning one 
participant had eaten breakfast so had to come back another time (255), and another questioned 
the procedure saying, “…How can you give somebody sugar to drink and then you’re going to 
have to test it? They’re definitely going to find the sugar” (261). Several suggested using more 
pleasant tests (254). 
6.4.3.3 Family-related practicalities 
Respondents reported various personal challenges to attending screening tests. As illustrated 
by the response “…everything is about your baby…” (260), these tended to relate to children. 
Bernstein et al. said that ‘most women opt to plan activities around the needs of the newborn, 
not around the needs of the medical care system’ (261) therefore if the two were not 
compatible, they did not attend. 
Care for their child 
Mothers said that needing to care for their child prevented screening attendance: “I don’t think 
there was anything that made me hesitate other than, you know, life with a newborn and two 
other children…” (258). Several mentioned their schedules: some reported that a new baby led 
to a lack of a schedule (“…[getting things] done happens in the window of opportunity on the 
spur of the moment” (263)) whereas others struggled around feeding and sleep routines. 
Importantly, the clinic was not seen to be a suitable place to wait with children or to breastfeed. 
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Few women in one study brought their children to the test (255); when others spoke about the 
need to find childcare, it appeared that bringing them was not considered an option (due to the 
anticipated challenges of the waiting room and during the procedure). ‘A “separate room to 
facilitate breast feeding, toys for kids, nappy changing facilities” at the testing centres may 
also facilitate screening attendance’ (254). This theme was more important in unusual or 
unexpected circumstances: “I guess [I didn’t come be]cause [I was] seeing the baby [at the 
hospital] every day… It’s the only thing I did…” [not screened] (255). 
Adapting to life with the baby 
Unsurprisingly, adapting to life with the baby was difficult and women described feeling “just 
tired… because I’m burnt out, frustrated” [not screened] (255) and that “life is stressful. With 
a new baby, mum gets no sleep and has no energy and… may be feeling overwhelmed” (262). 
In the context of “trying to get showers in and get food in is an issue right now” [screened] 
(255), mothers’ own health and arranging testing were forgotten or simply too much, although 
many intended to go at a later date or when things were more under control (“I had no time to 
go… Always I tell I do it tomorrow… But I do not gone again, because I have to do another 
duty…” [not screened] (251)). 
Support  
The support that women received at home affected their ability to take time away from 
childcare and attend testing: several mentioned that their husbands or parents had looked after 
the children whereas others did not have this option. One participant explained that “Because 
of my children, I cannot go out much… There is no one to keep an eye on them while I'm gone” 
[not screened] (251). 
Work 
Finally, the need to work presented a further barrier to attendance because women were not 
able to take time away for the test: “I couldn’t leave work because they could take it away and 
I knew the situation I was in, I needed to work” (261), and it presented another demand on their 
time: “…I’ve been running around trying to get stuff done before I go back to work” [screened] 
(255).  
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6.4.3.4 Concern about diabetes 
Lastly, participants’ level of concern regarding diagnosis of diabetes was a key factor affecting 
motivation to attend screening. 
Unconcerned about glucose status 
Some participants were unconcerned about discovering their glucose status so were not 
motivated to attend screening. This represented apathy (“could not be bothered” and “having 
a slack attack” (262)) or a lack of urgency (259). Others were untroubled by the possibility of 
a diabetes diagnosis because they did not deem themselves to be at risk. One participant denied 
her GD diagnosis, which was outlined in her medical record, saying “My glucose level was not 
too high. It wasn’t GD…” [not screened] (250). Some had concluded that they did not have 
diabetes due to reassuring results of self-monitoring that they continued postpartum 
(“everything is normal” [not screened] (255)) and because they felt healthy or were “very 
careful and compliant” with lifestyle recommendations [not screened] (250). Other women 
were unconcerned but were nevertheless tested as screening coincided with other postpartum 
appointments or marked ‘closure with their care’ (255). 
Concerned about T2D so want to know 
Concern regarding a diabetes diagnosis and understanding the need for management most often 
encouraged screening. In particular, understanding the significance of diabetes was a motivator 
to attend (“…so I am afraid of diabetes… That’s why I’m screening” [screened] (250)). This 
could be reinforced through knowing friends and family with diabetes, or their own experience: 
one participant considered the implications of a diagnosis very seriously: “…I would have to 
ask for counselling or something to help me cope with that…” (261). Additionally, plans for 
future pregnancies motivated some to be tested ‘…to avoid any complications that might 
jeopardize her ability to do this successfully’ (258). Abnormal results of self-monitoring 
increased concern about diabetes risk and stimulated formal screening.  
Fear of T2D discouraged screening 
Occasionally, women’s fear of diagnosis of diabetes discouraged screening as they tried to hide 
from it: “It’s, like, oh my gosh, I don’t want to have it. And so, I guess, in my mind, it’s been, if 
I don’t get checked, maybe I won’t develop it” (258).  
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6.4.4 Recommendations for promoting postpartum testing 
In light of the findings, I developed ten recommendations for approaches to support attendance 
at glucose testing, both at six weeks postpartum and beyond (Table 6.2). These aim to promote 
ideas that the participants of the included studies explained helped them to attend, or thought 
would help them to attend, and suggest ways of overcoming barriers. 
To illustrate, the first recommendation is to educate clinicians to, and how to, promote 
screening throughout GD and postpartum care. This was made because I found that clinicians 
who endorsed testing during pregnancy and postpartum encouraged women with GD to attend 
because the mothers understood its importance. On the other hand, emphasising that the 
symptoms of GD would cease after delivery with no mention of T2D risk could be misleading. 
Therefore I anticipated that promoting the effective behaviour and changing the ineffective 
behaviour would be likely to promote attendance. 
These recommendations reference behaviour change techniques and are directed at both 
women with GD (for example, ‘9. Educate women about the purpose of screening and how the 
procedure works’ using technique ‘5.1 Information about health consequences’) and clinicians 
or the healthcare system (for example, ‘5. Make clinics more child and nursing-friendly, and 
encourage mothers to bring children to appointments’ using technique ‘12.1 Restructuring the 
physical environment’) (190).  
I had high confidence in three, moderate confidence in six and low confidence in one 
recommendation(s) in accordance with the GRADE-CERQual assessment; this is summarised 
in Table 6.2 and fully explained in Appendix 8. I had highest confidence in the 
recommendations if there were lots of data and the concept was addressed both positively (as 
a facilitator) and negatively (as a barrier). 
Table 6.2: Ten recommendations for promoting postpartum glucose testing after gestational diabetes, and our 
confidence in each recommendation made using the GRADE-CERQual approach. 
Recommendation 
Behaviour change 
techniques relating to 
recommendation (190) 
Confidence in evidence and 
explanation 
Relationship with healthcare 
1. Educate clinicians to, and how 
to, promote screening 
throughout GD and subsequent 
care 
1.1 Goal setting 
(behaviour), 
4.1 Instruction on how to 
perform the behaviour, 
9.1 Credible source 
High: Lack of information (during 
pregnancy and postpartum) and 
seemingly conflicting advice about 
postpartum screening from clinicians 
were clearly reported, while the 
opposite encouraged screening 
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2. Implement recall systems for 
postpartum testing from general 
practice or obstetric care, and 
send reminders to non-
responders/for missed 
appointments 
1.4 Action planning, 
1.6 Discrepancy between 
current behaviour and 
goal, 
2.2 Feedback on behaviour 
High: Benefits or anticipated benefits 
of invitations and reminders were 
reported in many studies 
3. Establish standard protocols for 
communicating gestational 
diabetes history within the 
healthcare system 
12.5 Adding objects to the 
environment [for 
clinicians only] 
Moderate: There was a clear need to 
ensure sharing of patient history within 
the healthcare system, which would 
improve follow-up care; one benefit 
may be improved screening uptake 
4. Promote patient-centred 
approaches to care in order to 
facilitate building relationships 
and opportunities to ask 
questions 
4.1 Instruction on how to 
perform the behaviour [for 
clinicians only], 
9.1 Credible source 
Moderate: Improving experience of 
care would make it more pleasant and 
may improve screening attendance 
(directly or indirectly) 
The appointment and test 
5. Make clinics more child and 
nursing-friendly, and encourage 
mothers to bring children to 
appointments 
1.4 Action planning, 
12.1 Restructuring the 
physical environment,  
12.5 Adding objects to the 
environment 
Moderate: It is clear that clinics/long 
appointments are not considered 
suitable places to bring children but 
how to improve this was rarely 
discussed in the studies 
6. Seek innovative, personalised 
options to make it easier for 
hard-to-reach women to attend 
testing (e.g. drop-ins, alternative 
locations) 
12.1 Restructuring the 
physical environment 
Moderate: Too inconvenient 
appointments discouraged testing but 
the studies did not clearly suggest 
alternatives 
7. Utilise more pleasant, less time-
consuming testing procedures 
and protocols 
None  Moderate: OGTTs discourage 
screening; a shorter test without fasting 
or a glucose drink is desired and may 
increase uptake 
Personal and family-related practicalities 
8. Schedule postpartum glucose 
testing to coincide with other 
postpartum check-ups (both 
mothers’ and children’s 
appointments) 
10.5. Social incentive, 
10.7. Self-incentive 
Low: Glucose tests were difficult to 
attend; it is assumed that combing them 
with appointments that women are more 
motivated to attend would facilitate 
attendance 
Concern about diabetes 
9. Educate women about the 
purpose of screening and how 
the procedure works 
4.1 Instruction on how to 
perform a behaviour, 
5.1 Information about 
health consequences 
High: Often knowledge of the purpose 
of screening increased attendance; 
apathy and fear of diagnosis were 
barriers but could be reduced through 
education 
10. Educate women that postpartum 
self-testing, behaviour 
compliance or one negative test 
result is not sufficient to rule out 
T2D in the long term 
5.1 Information about 
health consequences 
Moderate: Many studies explored how 
postpartum self-testing influenced 
concern about diabetes; education that 
this is not sufficient to rule out diabetes 
could increase screening attendance 
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6.5 Discussion 
Through a synthesis of qualitative studies, I have explained how multiple healthcare and 
personal factors influence attendance at postpartum glucose testing after GD. Although barriers 
were dominant in the studies I included, the factors can operate as both barriers and facilitators. 
Some influenced practical aspects whereas others affected desire or motivation to attend 
screening. I focussed on postpartum testing yet several influences were clearly being 
established during pregnancy. 
This sheds light on the low uptake of diabetes screening that is often observed: only women 
with high intention for testing may be able to overcome certain logistical barriers and attend, 
whereas these same barriers may stop less motivated women. Furthermore, motivation may 
decrease over time, corresponding to a decline in attendance at annual testing. Postpartum, the 
contact that most women have with clinicians is focused on the baby, rather than their own 
health, and their concern about T2D may be replaced by other worries or busyness. 
Accordingly, I have identified and assessed my confidence in the effectiveness of multiple 
strategies to increase attendance by reducing logistical barriers and increasing motivation, most 
with high or moderate confidence.  
6.5.1 Strengths and limitations 
I completed a rigorous literature search and qualitative synthesis as the lead member of a small 
multidisciplinary team for this review. In order to minimise personal bias, I discussed the 
analysis with other researchers, and used CASP and GRADE-CERQual checklists when 
evaluating the quality of studies that contributed to the synthesis and my confidence in the 
resulting recommendations. I utilised the behaviour change technique taxonomy to describe 
strategies to promote screening in this population. Additionally, I have included perspectives 
from different populations and healthcare systems and found influences that could be relevant 
across multiple settings. For example, the cost of testing in the included studies related to 
paying for the test, yet in settings with free healthcare, costs associated with travel (e.g. parking 
charges) may be a barrier. 
Some of the 16 papers that I included were poor quality and/or only contributed a small amount 
to the review findings. There was inevitable selection bias whereby people with stronger views 
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were more likely to participate than those who did not. However, participants included both 
women who had attended screening and those that had not. Interpretation was also limited by 
the data that were reported: I sought to focus on attendance at screening rather than postpartum 
care seeking more generally, but I was not always able to distinguish between the two. 
Similarly, use of OGTT, FPG or HbA1c tests was not reported, although descriptions from 
participants suggest that most were offered an OGTT. Fewer studies specifically discussed how 
to increase screening attendance therefore the recommendations were primarily suggestions of 
how to overcome barriers.  
In addition, it was difficult to identify patterns in influences on screening attendance. For 
example, although some will be similar, it is likely that influences will vary between the first 
test at approximately six weeks postpartum and diabetes screening several years after 
pregnancy, yet it was often unclear how long after pregnancy participants referred to. I was 
also not able to consider individual-level interactions such as whether first-time mothers were 
more influenced by certain factors than experienced mothers. Although participants criticised 
or identified gaps in their care, or conversely praised the system, the extent to which this 
contributed to their decision to attend screening or not was not clear. In practice, it is likely that 
the influence of the factors I describe varied according to the individual situation. For example, 
whether there was someone available to take care of the children while the mother went to the 
test, or it would be simple to arrange this. It is likely that this is socially patterned, where 
mothers who face childcare barriers are more likely to also experience financial barriers. I 
anticipated that mothers with higher motivation for testing, such as those with high concern 
about their risk of T2D, will be more determined to overcome logistical barriers than those 
with less incentive. However, the primary studies did not state this explicitly. 
6.5.2 Comparison to other literature 
6.5.2.1 Theory  
Although I analysed the data using thematic synthesis rather than a framework-based approach, 
the influences I identified operate in a way similar to those described in the COM-B model of 
behaviour (266). In this model, capability, opportunity and motivation interact to influence, 
and are influenced by, performance of the behaviour of interest.  
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On one side of Figure 6.4, I identified motivational influences: emotions such as worry about 
diabetes and relationships with healthcare. On the other side, the permissive themes could be 
described as opportunity and capability to attend, where I consider external factors that prompt 
or inhibit screening such as employment, and psychological and physical potential such as 
degree to which they are overwhelmed in caring for their baby.  
6.5.2.2 Related literature reviews and quantitative studies  
These findings echo many of those identified by Van Ryswyk et al.’s review of qualitative and 
quantitative studies (87). However, while they covered the wider context of healthcare seeking 
after GD, I was able to develop a more detailed understanding that was specifically related to 
postpartum testing, as well as attending appointments. Although Van Ryswyk et al. identified 
‘a need for clinicians to take a more pro-active approach to postpartum care’ (page 114), they 
did not describe that failure to so could confuse the participants or be understood to mean that 
screening was not important. In addition, I was able to explain their finding that ‘The oral 
glucose tolerance test was a barrier for some women, with a more convenient, pleasant test 
being desired’ (page 114–115) and how it related to postpartum testing: I described how the 
OGTT was a barrier to testing because it took a long time (particularly when travelling time 
was also considered), made the participants feel unwell, and that some did not understand how 
the test worked or what it measured. This meant that the discomfort and inconvenience that 
most had already experienced at least once during pregnancy did not seem to be worthwhile, 
therefore they wanted to avoid having the test again postpartum. 
Additionally, a lack of time was the most frequently reported reason for non-attendance in a 
survey of 36 postpartum women, followed by losing the invitation (267). Similarly, Sterne et 
al. also quantified their findings, and inconvenience (such as the test takes too long) and lack 
of awareness of the need for testing were the two most common barriers to attendance (254). 
6.5.2.3 Other populations 
I found that attendance was closely associated with experience of the healthcare system and 
put forward strategies to adjust care. The views of clinicians about how to treat and support 
women with GD postpartum are therefore important, and help to further understand some of 
the experiences described. Several of the influences that I identified were also recognised by 
healthcare providers, as reported in a literature review assessing clinicians’ views towards 
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postpartum testing (268), in a subsequent qualitative synthesis completed by a medical student 
under my supervision (269), and by three of the studies analysed in this chapter (261–263). 
In Lithgow et al., we described three challenges identified by GPs, midwives and obstetricians 
to postpartum follow-up that closely match to the theme ‘relationship with healthcare’ (Section 
6.4.3.1) (269). As identified by mothers, individual clinicians found it hard to communicate the 
long-term risk of T2D after GD to mothers because they did not want to scare or overwhelm 
the mothers, and wanted to prioritise the pregnancy or baby. In addition, the postpartum test is 
recommended at the time when mothers transition from hospital care back into the community, 
and current protocols lack guidance about whether hospital or community is responsible for 
ordering tests so mothers fall into the gap. Adding to this, it is challenging to communicate the 
GD pregnancy history back to the GP, in part due to inability to share electronic medical 
records between systems. As described above, women reported that they needed to 
communicate their pregnancy history to their GP and identified challenges with medical 
records (259,261). 
Van Ryswyk et al. 2014 add that clinicians considered that mothers should take more 
responsibility for their diabetes risk, and they were hindered by incomplete knowledge of their 
patients’ pregnancy history (268). While there is agreement that long-term follow-up should 
take place in primary care, they also identified inconsistency and lack of clarity regarding 
responsibility for short-term follow-up (158,268).  
6.5.3 Implications  
A key component of this study was to develop a set of recommendations to increase attendance 
at screening. An important aspect of many of these recommendations is developing women’s 
understanding of both the necessity and procedure of screening therefore increasing capability 
and motivation. Positively, many report awareness of the risk of developing T2D (256,258–
261,265) but this did not always sufficiently impact on screening knowledge or attendance. 
While information and intention are rarely sufficient for behaviour change, they are nonetheless 
necessary and may be more effective in promoting attendance at infrequent screening 
appointments than influencing habitual behaviours. I therefore suggest reinforcing the 
following key messages to address different perspectives and promote screening, without false 
assurance or exaggerated concern: 
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1. Having had GD means you are at a higher risk of developing of T2D, which is a 
serious condition (addressing apathy); 
2. We want to diagnose diabetes early (apathy) but, typically, it is initially 
asymptomatic so formal testing is needed. This differs from the glucose monitoring 
in pregnancy (self-testing reassurance); 
3. We can manage T2D effectively through medication and changes to lifestyle. Early 
diagnosis improves long-term outcomes (fear) and knowing your diagnosis enables 
proactive management of your health (using proactiveness); 
4. Blood glucose control usually returns to normal after delivery but this needs to be 
checked postpartum as part of routine GD follow-up (informing risk perception); 
5. Diabetes can affect subsequent pregnancies (tested for other reasons). 
Sharing this information with women with a history of GD is already included in many 
guidelines. However, this study suggests that communication must be optimised to increase 
understanding. The key messages outlined above could be included in a guide through and 
beyond GD using specific wording developed by consultation with patients with GD. The guide 
could refer back to experiences from pregnancy in order to improve relatability and 
understandability (e.g. the postpartum FPG test could be described as the first part of the OGTT 
that they had during pregnancy, and they would not need to drink a glucose solution). This 
information could be available to women with GD and their clinicians in order to reduce 
fragmentation of care and confusion over who is responsible for testing. 
Additionally, I suggest several changes to healthcare provision that may increase screening. 
Aside from improving clinicians’ awareness of agreed protocols, steps could be taken to adapt 
usual practice to remove some barriers to screening. I had high confidence that inviting mothers 
to postpartum testing and following up missed appointments (recommendation number 2) 
would improve uptake, yet it was unclear from this study how this might work best in practice. 
Other systematic reviews have found that reminders and recall systems, such as phone calls or 
letters to both mothers and GPs, are associated with higher uptake of screening compared to 
usual care (145,146). However, a recent evaluation from the Australian National Gestational 
Diabetes Register in the states of Victoria and South Australia suggested that mail outs had 
negligible impact on postpartum and annual follow-up (161). While the reasons for this warrant 
investigation, the authors suggest that more personalised, local invitations might be more 
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effective than national recall. Furthermore, an evaluation of a trial of text message reminders 
for T2D screening after GD reported mothers’ preference for electronic reminders, particularly 
text messages that were sent by the study team (270) (this study was not included in this review 
because it used quantitative methods). Clinicians also had positive views towards reminders 
(268) and some advise their patients to have a blood test in the month of their child’s birthday 
[personal communication]. It should be considered whether combining glucose testing with 
other appointments, such as newborn check-ups child vaccination schedules or cervical cancer 
screening could be both manageable for general practice and offer benefits to women in the 
long-term.  
This qualitative synthesis also supports the need for further consideration of more acceptable 
screening tests due to the length and inconvenience of the OGTT and the need to fast then sugar 
load. The HbA1c test is an accurate measure of chronic glycaemia in the general population that 
requires one non-fasting blood sample (271) although it is not suitable for use shortly after 
pregnancy and in certain populations, and questions about its sensitivity remain (272,273). 
Similar to the change in the NICE guidelines in 2015 (2), recent guidelines in Australia and 
New Zealand have recommended HbA1c testing after the postpartum period. Small-scale 
analyses suggest that HbA1c testing can have a higher uptake than OGTTs, yet uptake remains 
suboptimal in the long-term (274,275). My findings provide additional evidence that HbA1c 
testing could reduce some motivational barriers to screening and make it easier to complete 
alongside other tests or appointments. In addition, novel strategies such as very early 
postpartum testing (e.g. before leaving hospital) could be considered. Although less accurate 
than a test at six weeks, very high uptake can be achieved and therefore identify the highest-
risk women for targeted follow-up (276). Further research over longer periods is needed to 
evaluate the benefits and harms of increased use of other tests. 
6.6 Summary 
After a pregnancy with GD, women are advised to have regular tests in order to identify glucose 
intolerance or diabetes. Most studies report suboptimal attendance. In this chapter, I sought to 
understand why some women do not attend and identify approaches to support attendance using 
a systematic review and qualitative synthesis. Higher uptake will enable earlier detection and 
management of diabetes and improve long-term outcomes. 
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I found that logistical difficulties associated with attending appointments and a need to focus 
on their family can affect women’s ability to attend glucose testing postpartum and in the long-
term. Concern about risk of developing diabetes and experiences of healthcare can increase or 
limit intentions towards testing. Alongside clearer education about GD and T2D, I have 
suggested ten amendments to healthcare provision during and after pregnancy that may 
decrease these practical barriers and improve motivation for testing.  
These findings informed the interview study reported in Chapter 8, in which I asked women 
with a history of GD about their views on the suggestions and preferences for delivery of 
interventions or information. In the next chapter, I have used a similar approach to synthesise 




 Women’s views on lifestyle changes to 
reduce type 2 diabetes risk after gestational 
diabetes 
A systematic review, qualitative synthesis and recommendations for 
practice. 
This qualitative literature review was completed in order to synthesise the published literature 
about women’s attitudes towards and experience of healthy diet and physical activity 
(described as lifestyle behaviours) after a pregnancy affected by GD. It was also based on the 
literature search described in Chapter 3.1. I used the same approach and methods as in the 
previous chapter. Again, I wanted to present the implications of the findings clearly, thus 
recommendations for practice is a significant element of this work.  
The findings from this review and the recommendations that I suggested for promoting healthy 
diet and physical activity informed the DAiSIeS interview study (Chapter 8). 
This study was published in 2019 (209): Dennison RA, Ward RJ, Griffin SJ and Usher‐Smith 
JA. Women's views on lifestyle changes to reduce the risk of developing type 2 diabetes after 
gestational diabetes: A systematic review, qualitative synthesis and recommendations for 
practice. Diabetic Medicine. 2019;36(6):702–17. 
7.1 Background 
A healthy diet and physical activity after pregnancy are strongly associated with T2D risk, yet 
most women do not attempt or sustain behaviour change but maintain lifestyles that increase 
their T2D risk (172). Interventions to prevent T2D have potentially positive effects for women 
with GD: they can facilitate behaviour change that leads to lower T2D incidence. For example, 
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women with GD in the intensive lifestyle intervention group of the US DPP lost weight and 
increased their physical activity levels up to an average 1.5 hours per week more than at 
baseline, although these changes peaked within one year of starting the intervention (164). 
Progression to T2D was reduced by 50% over three years and 35% over ten years compared to 
placebo (164). However, the effectiveness of interventions can be limited by poor engagement 
outside of rigorous trial settings (166–168). In the DPP, the intensive lifestyle intervention 
involved 16 initial individual in-person meetings with a case manager, followed by meetings 
at least every two months for the remainder of the study and additional support for those who 
did not meet the goals within the specified time frame (165). This type of intervention is 
unlikely to be feasible on a large scale in most health systems including in UK primary care. 
In the UK, women with GD are managed according to the guidelines for preventing T2D (170). 
These include referral to weight-loss or exercise programmes. These programmes have been 
developed for the general population, which tends to be older and not have young families, 
therefore presenting barriers to attendance for women who recently had GD. They are not 
currently eligible for the NHS Diabetes Prevention Programme unless they are diagnosed with 
hyperglycaemia. 
Previous qualitative or mixed methods reviews have explored women’s views on reducing 
diabetes risk postpartum as part of broader investigations into their experience of GD.  
 Jones et al. 2009 found that many studies reported a gap between knowledge of the 
association between GD and T2D, and individuals’ behaviour (particularly physical 
activity and fruit and vegetable intake) and perception of their own risk (174). 
 Parsons et al. 2014 reported the experience of GD alongside women’s perceptions of 
their future risk and prevention of diabetes, including varying views towards lifestyle 
changes, prioritisation of children and the family, and community/support-focussed 
interventions (77). 
 Nielsen et al. 2014 investigated determinants of GD care from GD screening and 
diagnosis to postpartum follow-up. After pregnancy, they found that women who were 
well informed could have intention for a healthy lifestyle but adherence was 
challenging (147). 
 Van Ryswyk et al. 2015 similarly reported barriers including cost, lack of time and lack 
of knowledge (87). 
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However, no comprehensive review has focused on postpartum lifestyle. This means that the 
understanding of exactly how these positive attitudes and barriers influence diet and physical 
activity after GD lacks the depth and detail required to develop effective interventions.  
7.2 Aim 
I aimed to systematically synthesise the literature reporting the views of women with a history 
of GD on reducing their risk of developing T2D, including women participating in 
interventions. This was with the view to identify gaps in the understanding of the acceptability, 
feasibility and practicality of intervening postpartum and to inform the development or 
tailoring of effective approaches for this high-risk population. 
7.3 Methods 
In summary, I used the approach described in Sections 3.1 and 6.3 to identify papers relevant 
to the review question, conduct a thematic synthesis and develop recommendations for 
interventions as a result of the findings. This is detailed below.  
I registered the protocol on PROSPERO in January 2018 (record ID CRD42018082049). 
7.3.1 Search strategy 
I used the search strategy described in Chapter 3.1.3 for this review. I also screened the 
reference lists of the included studies for citations that were not identified by the literature 
search and considered further papers that were suggested by a journal reviewer when 
submitting the manuscript for publication. 
7.3.2 Inclusion criteria and study selection 
I focused on influences on lifestyle behaviours in this review, including studies that examined 
women’s experiences of healthy eating and physical activity after GD, views on T2D risk 
management or experience of attending a T2D prevention programme. Healthy diet and 
physical activity needed to be the key behaviours that were promoted. All qualitative methods 
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were eligible, including mixed methods, in order to access as much data on the topic as 
possible. I only included full text studies published in peer-reviewed journals. 
Studies exclusively reporting the views of healthcare providers were excluded in order to focus 
on the views of women with a history of GD. I also excluded studies that focused solely on 
experiences during pregnancy because this had been reported in detail by previous studies 
(77,78). Views towards postpartum T2D screening only were noted for consideration in the 
qualitative synthesis reported in Chapter 6. 
Following deduplication, titles and abstracts of all citations were assessed against these criteria 
by Rebecca Ward or myself. We independently reviewed approximately 10% of the citations 
to ensure agreement and refine the selection criteria. I then acquired full text articles and 
rechecked them against the selection criteria. Juliet Usher-Smith reviewed all articles that were 
included and those excluded for reasons other than article type, and agreed with my 
classification. 
7.3.3 Quality assessment  
I assessed the quality of each study using the CASP checklist for qualitative research. 1 point 
was awarded to studies that met the criteria, 0.5 points where it was unclear and 0 points where 
they did not. Scores were agreed following discussion with Juliet Usher-Smith. 
7.3.4 Qualitative synthesis  
As described previously, I used thematic synthesis to analyse the qualitative findings (18). This 
involved three key steps: coding the findings, developing descriptive themes, then developing 
analytical themes. 
Due to the large amount of data available for this review, I completed the primary coding in 
two steps: firstly, data were categorised into anticipated or experienced barriers and facilitators 
to healthy diet, physical activity and participating in an intervention programme. I then 
developed a coding scheme for each section based on its content. Juliet Usher-Smith 
independently coded a subset of papers at multiple stages to check consistency. To develop the 
descriptive and analytical codes, concepts were translated from one study and category to 
another in order to understand the statements made. I did this by making summaries, 
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comparisons and contrasts, and testing new concepts across the data. Themes were discussed 
with all authors throughout. 
An example of this process is summarised in Figure 7.1. 
 
Figure 7.1: Example of the use of thematic synthesis in the qualitative synthesis of healthy lifestyle after 
gestational diabetes. 
Actual and anticipated barriers and facilitators were combined in this diagram and not all codes are 
presented for simplicity. 
7.3.5 Recommendations for promoting behaviour change 
I developed 20 recommendations for promoting healthy postpartum lifestyle based on the 
findings of the qualitative synthesis. I considered which behaviour change techniques could be 
used to implement them in line with the behaviour change technique taxonomy (190). I 
assessed my confidence in each recommendation using the GRADE-CERQual approach (197) 
and discussed this with the other authors in order to inform the final interpretation. 
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7.4 Results 
7.4.1 Included studies 
Alongside the other authors, I screened 23,160 citations, reviewed 129 full texts and included 
21 articles. Seventeen articles were identified in the literature search and four were added after 
reviewing the reference lists and reviewers’ recommendations. The PRISMA diagram is 
presented in Figure 7.2.  
 
Figure 7.2: PRISMA diagram for the qualitative synthesis of healthy lifestyle after gestational diabetes. 
Appendix 9 shows the characteristics of these studies and the 926 postpartum women 
represented. The median number of participants was 17 (IQR 11 to 26 per study). Most studies 
were set in high-income countries and involved face-to-face interviews. Of 17 studies 
specifying the timing of data collection, 12 were conducted one year or longer after the affected 
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pregnancy. The study populations had similar characteristics: women in their mid-30s who 
tended to be overweight and have more than one child. Where reported, more than half of the 
population in each study were employed, married and had gained a secondary education or 
higher. 
7.4.2 Quality assessment 
I found all of the studies to be medium or good quality (mean CASP score 8.0/10), shown in 
Figure 7.3. They were appropriate for qualitative methods with clear aims, results and 
implications. Generally, data collection was suitable, although sometimes important details 
were missing: authors rarely commented on their relationship with participants or 
implementation of ethical procedures, even though approval had been granted. Mixed methods 
studies scored lower because qualitative aspects were less well reported or supplementary to 
quantitative methods. 
7.4.3  Findings of the qualitative synthesis 
Actual and anticipated barriers and facilitators of healthy postpartum lifestyle codes were 
translated into six themes: role as mother and priorities, support from family and friends, 
demands of life, personal preferences and experiences, diabetes risk perception and 
information, and finances and resources, in addition to a seventh section on views on the 
practicalities of interventions. These are described below and summarised in Table 7.1.  
I decided not to include a theme specifically relating to culture but discussed it in the context 
of the other themes. 
The studies that contributed to each theme are shown in Table 7.2. Some studies made a small 
contribution to the findings (263,277,278) and seven studies contributed to six or seven of the 
seven themes (256,257,264,265,279–281). Each theme was based on at least eight studies and 
all but one study reported on diabetes risk perception and information.   

























































































































































































































Graco 2009 (282) 
          
8.0 
Doran 2010 (277) 
          
6.0 
Evans 2010 (283) 
          
8.0 
Lindmark 2010 (284) 
          
8.0 
Razee 2010 (285) 
          
8.0 
Bandyopadhyay 2011 
(278)           
7.0 
Nicklas 2011 (279) 
          
8.5 
Gaudreau 2012 (280) 
          
8.5 
Hjelm 2012 (286) 
          
9.0 
Jones 2012 (287) 
          
7.5 
Dasgupta 2013 (281) 
          
9.0 
Lie 2013 (256) 
          
8.5 
Abraham 2014 (257) 
          
8.0 
Morrison 2014 (252)           6.5 
Jones 2015 (288)           8.5 
O’Dea 2015 (289)           7.5 
Tang 2015 (290)           8.5 
Lim 2017 (291)           8.0 
Pennington 2017 (263) 
          
7.5 
Svensson 2017 (264) 
          
8.0 
Zulfiqar 2017 (265) 




Yes 21 20 20 16 20 1 4 15 16 11 
 Unclear 0 1 1 5 1 5 17 5 5 7 
No 0 0 0 0 0 15 0 1 0 3 
 










Figure 7.3: Findings from the Critical Skills Appraisal Programme (CASP) checklist for the qualitative 
synthesis of healthy lifestyle after gestational diabetes (A) according to each included study, and (B) overall. 
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Women’s identity was as 
a mother, requiring them 
to prioritise their family; 
most guilt was felt for 
not doing this 
This was a barrier 
when giving 
families what they 
wanted and not 
having time for 




important for their 
family 
“[My child] already goes to occasional care 
on Friday mornings… but that's mainly so I 
can do the housework… the thought of 
putting him in care so I can do exercise, 
yeah, that's a big guilt on me” (282) 
“I don’t [change my eating habits] so much 
for protecting me from getting diabetes; I do 
it so that my son, as he is learning to eat, he 





Family could provide 
support by reducing 
burdens and, particularly 
affecting diet, providing 
information and being 
involved. Friends could 
offer encouragement for 
exercise and make it 
more pleasant. 
Societal/cultural norms 
influenced ability to have 




absence of support 
was identified as 
barrier 
“Maybe [you need] help from your 
significant other because it’s hard when they 
are eating cake and ice cream, all the stuff 
you can’t have, and maybe just don’t even 
have it in the house” (257) 
“If the other women can do it so can I. If 
others with three children can exercise, I 
with one can also change” (291) 
Demands 
of life 
Lack of time and energy, 
busyness and work 
influenced lifestyle 
choices, as did how 
convenient and easy to 
integrate into daily life it 
was  
This was mainly a 




part of daily life 
and saved time 
“I was exhausted and already feeling so 
guilty for being away from my child while I 
was working, so I did not exercise” (279) 
Meal planning ‘to reduce the number of trips 





Food played an 
important role in 
women’s personal and 
social lives. Both diet 










“Everything’s back to normal so I’ve sort of 
been making up for lost time a little bit with 
all the chocolate I couldn’t have” (256) 
“…If I'm not active then I find I don't cope 






Women learned about 
diet during their GD-
affected pregnancy; 
knowledge included risk 
of T2D, how to prevent 
it, repetition of messages 









identified as a 
barrier 
‘The women felt neglected by healthcare 
providers and were left with unanswered 
questions about what to do next’ (283) 
“…So the plan is to try and live healthy, get 
rid of the extra pregnancy kilos and return to 
my normal weight again, and then to be 




Resources were needed 
to help women sustain a 




“…[Healthy foods] are not the cheap items; 
they’re a kind of more in the pricy end. It 
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their lifestyle affected 
the family’s finances  
help them to be 
more healthy 
could be a bit irritating to prioritize your 
money in that way…” (264) 
“I didn’t eat out as often. It became less 
expensive to eat out because I cut down on 
my portions” (280) 
Underlining highlights key components of the themes (subthemes). 
 
 
Table 7.2: Studies that contributed to each theme and subtheme in the qualitative synthesis of barriers and 
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Abraham 2014 (257)        
Morrison 2014 (252)        
Jones 2015 (288)        
O’Dea 2015 (289)        
Tang 2015 (290)        





Pennington 2017 (263)        
Svensson 2017 (264) 
       
Zulfiqar 2017 (265) 
       
Large dot: CASP score ≥8.5, medium dot: 8.0 (median), small dot: ≤7.5.  
Open dots indicate where a study briefly contributes to the theme, or lists the theme. 
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As in Chapter 6, quotations from the primary studies are presented in italics in the text below. 
Participants’ quotations are reported in double quotation marks (“/”) and the authors’ 
descriptions or explanations are reported in single quotation marks (‘/’). 
In these studies, a healthier diet usually involved trying to consume more fruit and vegetables, 
and less sugar, fat and processed foods such as by making substitutions: for example, “…I take 
light milk…we have changed…so it’s low-fat…” (286) and Algonquin women, a native North 
American people group, mentioned adapting or adding to their traditional diet (280).  
Walking was the most frequently mentioned form of physical activity because it was seen as 
“…the easiest exercise you can do – because you do it, to go to the bathroom, to clean the 
house” (281), and several mentioned running. It was notable that no studies reported women 
being able to commit to regular gym sessions or classes, but activities that were flexible. 
7.4.3.1 Role as mother and priorities  
Prioritising their children and being what they perceived to be a good mother had one of the 
greatest influences on women’s views of healthy postpartum behaviour; preventing T2D was 
rarely the primary motivation.  
Identity as a mother 
Many women’s identity was as a mother and partner (the “matriarch” of the family (288)), 
which meant caring for their children (for example, cooking, transporting older children and 
nursing) and taking responsibility for providing food and doing housework. They wanted to do 
a ‘good job’ at this. However, carrying out these tasks acted as a barrier to healthy lifestyle by 
increasing their busyness, tiredness and shifting their priorities (explained in the sections 
below). Specifically, many women found it difficult to exercise while a child was present 
because the child demanded attention or the mother wanted to take care of them. Some got 
around this by exercising at home, for example, by ‘“get[ting] creative” by holding her baby 
and doing squats’ (279). Some also thought that their lifestyle was less important after 
pregnancy because it was ‘no longer seen as having a direct impact on the child’ (264).  
On the other hand, other women considered that being a good mother meant being a role model 
of healthy behaviour, providing healthy food and maintaining their own health in order to care 
for their children: “I don’t [change my eating habits] so much for protecting me from getting 
diabetes; I do it so that my son, as he is learning to eat, he learns to eat healthier” (290) and 
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‘to discourage “them from being obese”’ (285). Many wanted to include their families and 
children in healthier lifestyles or programmes. 
Prioritising family 
Similarly, women’s priorities were influenced by motherhood, particularly prioritising their 
family’s wants or finances. Some experienced objection when they gave their family, 
particularly the children, healthy foods or thought that it jeopardised their family’s cultural 
identity not to eat their traditional foods: “…What are the things that I can change without 
changing the culture of the food? What are the things that you can limit so your family doesn’t 
feel like they can no longer eat what they like?” (281).  
When talking about participation in physical activity, this feeling was even stronger in some 
women: as part of putting themselves last or forgetting about themselves, some even thought 
that it was inappropriate to think about exercise while caring for a small child: “All my time is 
devoted to them now, and yeah, I base myself around them, what their needs are and stuff you 
know. Forget about myself I guess sometimes” (282) and “Either I have to get up at five o’clock 
and do it before they wake up or it is taking time away that I could be spending with them” 
(290). Mothers thought that they would be able to exercise more when their children were older 
because they would be less dependent or at school, or they would be able to exercise together.  
Conversely, some women in Lim et al.’s programme evaluation did prioritise attendance at a 
diabetes prevention programme: “Brought baby to session. I forced myself” and “I gave up 
working on Thursdays to come to the sessions” (291). 
Guilt  
Probably resulting from their strong sense of identity, guilt was common across several themes. 
Women felt guilty if they did not prioritise caring for their family or were away from their 
children, such as to exercise or attend a diabetes prevention programme, and did not see this as 
a legitimate reason to use external childcare. For example, one participant said, “[My child] 
already goes to occasional care on Friday mornings… but that's mainly so I can do the 
housework… the thought of putting him in care so I can do exercise, yeah, that's a big guilt on 
me” (282). They also felt guilty towards their wider family for inconveniencing them with 
childcare when they believed they should do it, even if it was offered: “…I feel I have really 
leaned on my mother a lot for sitting so I don’t want to over-do it” (290).  
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On the other hand, others felt guilty when they did not exercise when they thought they should. 
7.4.3.2 Support from family and friends  
In general, the presence of support acted as a facilitator to healthy behaviour whereas its 
absence was barrier, but the impact was also dependent on the support-giver’s own knowledge 
and T2D risk perception.  
Support from family 
Support from family involved helping with childcare or housework to reduce busyness and 
tiredness, and to provide general support and encouragement for physical activity. A mother of 
two children said, “[The partner needs to consider that] if I don’t help with this then she might 
be too tired to actually get out for the run she actually would like to go for. I have to make sure 
she gets the one hour to do so – it’s my responsibility too – …[the partners] need to think about 
how to organise everyday life around [healthy lifestyle]” (264). Families supported healthy 
diet in a similar way, but were also a source of information, for example, “[My sister] told me: 
‘That has too much sugar in it...’ Because my sister is diabetic” (280), and partners and children 
could join in eating healthily because it would be beneficial to them and “…because I can’t 
make two separate meals” (279). In some cases, the whole family’s diet became healthier to 
prioritise children’s health. In addition, the benefits of (or need for) partners to be involved in 
behaviour change at home, or even attend part of the intervention was identified: “…So I can 
explain to him really what’s going on but if he would hear it from elsewhere, maybe, it’ll be 
different” (281). 
Support from friends 
Unlike support from family, support from friends acted in quite different ways for diet and 
physical activity. People outside of the family encouraged exercise: “I like having a buddy 
system. I’ve never liked to do exercise on my own… I can’t go there alone” (281) and some 
thought, “If the other women can do it so can I. If others with three children can exercise, I 
with one can also change” (291). Furthermore, exercise became an opportunity for socialising. 
Women did not tend to mention that they were able to participate in exercise with their families. 
Conversely, friends did not so clearly support healthy eating: this tended to be discussed in 
terms of culture, as explained below.  
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Women frequently appreciated the social support received at programmes. Motivation and 
accountability were experienced with regards to healthcare providers or programme 
facilitators, and mutual encouragement and sharing experiences with fellow participants: 
“Being accountable to someone – having someone to ‘check in’ with will help me” (291). A 
couple of women mentioned continuing this relationship outside of the programme, showing 
how it can provide a contact for continued support (281). O’Dea et al. reported that the need to 
look after children or lacking childcare was the biggest barrier to attending the lifestyle 
interventions, that women without a partner could not attend, and “I couldn’t have done it if my 
husband hadn’t been supportive of it” (289). Consequently, women reported that interventions 
should either include the children or provide childcare. 
Societal and cultural norms 
Lack of support, particularly in migrant populations, could result in isolation, depression and 
abandonment because women avoided eating in company or dropped their diets in certain 
situations (265). Razee et al. explained that Arabic-speaking women ‘felt duty bound to eat 
whatever was offered to them when they visited their family or friends. Such cultural 
expectations “created more problems” even when the family or friends’ intention was to be 
helpful’ (285). 
7.4.3.3 Demands of life  
Lack of time and energy, and busyness 
Women frequently reported lack of time and energy as key barriers to healthy behaviour – 
specifically lack of time to think about, prepare for and do physical activity and to plan and 
cook healthy meals. This resulted from caring for children and doing housework, potentially 
without support: “You’re so busy and so tired and the last thing you want to be bothered 
thinking about is whether you’re eating properly and exercising enough” (256). This may have 
been exaggerated when considering physical activity because it was frequently viewed as 
distinct from the other demands of being a mother: for many it required them to ‘set aside time’ 
(278) and ‘taking time out for themselves’ (282) away from children and doing housework 
(their priorities). Similar views were held when considering attending a programme, 
particularly if they needed to travel or the time was inconvenient (289); one women explained, 
“Time constraint is a big one. Like with people with kids, I know I can’t with a drop of a dime 
just take off and go somewhere” (281). 
Chapter 7  Women’s views on lifestyle changes to reduce type 2 diabetes risk 
164 
On the other hand, some reported physical activity becoming easier and more maintainable 
when it became a ‘daily habit’ (289) that was integrated into daily life. For example, one 
participant ‘always walked upstairs to change her baby’s diaper and one always used the stairs 
at work’ (279).  
Women also felt that they needed to prioritise their energy, not use it on exercise. This was in 
contrast to diet because the role of a mother involved providing family meals, although many 
also noted struggles with shopping with their children: “Confusing nutrition labels in store and 
with kids pulling on you, there is no time to read labels” (279). On the other hand, some 
reported the added bonus of saving time through meal planning, such as ‘to reduce the number 
of trips per week to grocery stores’ (281). Others wanted to know how to integrate physical 
activity into their daily lives, and also how to save time through healthy diet such as cooking 
quick, healthy meals.  
Work  
For similar reasons, work was only reported as a barrier to healthy lifestyle, specifically by 
increasing busyness. It also increased opportunities for unhealthy eating, such as snacking 
because “meetings have danishes and muffins, cheese plate” (279) and in work canteens. Work 
also took women away from their children, exaggerating the feelings of guilt and the desire not 
to access childcare, as explained above. One informant said, “I was exhausted and already 
feeling so guilty for being away from my child while I was working, so I did not exercise” (279). 
Convenience 
Finally, a healthier lifestyle was thought to be hard due to the convenience of and possibility 
to save time through unhealthy options. For example, the convenience of having a car verses 
having to walk and unhealthy food that was quick and readily available: “For me, [the 
pedometer] does not change anything because I am always in a car. I walk very little so I will 
feel even guilty for not having walked” (281). 
7.4.3.4 Personal preferences and experiences  
Role of food  
Food was considered as an important part of life. Acting as a barrier to healthy eating, it was a 
key aspect of many social gatherings and celebrations: “Everything revolves around food, and 
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a lot of native peoples, that’s their highlight of any kind of social gathering is that you’ve got 
to have food to celebrate” (287).  
Furthermore, some women viewed unhealthy food as a pleasure, reward or comfort (e.g. home 
cooking helped a South Asian woman living in Australia to “…feel closer to your home and 
that you still have this power and that you’re still free to choose…” (265)). Some considered 
their right to eat what they wanted, perhaps as a response to the controlled pregnancy diet; for 
example, the women in their early twenties in another study said they were too young to be on 
a restricted diet (278). While they were breastfeeding, additional hunger was experienced 
therefore women ate more. Some had cravings, such as for chocolate.  
Other women felt pleasure from having a healthy diet; for example, “The diet plan that I used 
with GD has benefited me now as I still follow it. I felt very healthy when I was pregnant due 
to the good foods that I had to eat for the wellbeing of both my baby and myself” (252). 
Emotional effects 
Some women reported positive experiences of exercise, which helped them to maintain it. 
Exercise helped them relax or feel less stressed, energised them and helped them to eat a 
healthy diet. For example, “…if I'm not active then I find I don't cope as well with things. If I 
get out there and get active, feel fitter, then little things don't seem to bother me as much” (282). 
On the other hand, others did not enjoy exercise (“exercise is something I could think about 
more but I find it so boring” (284)) or struggled to do it in winter and bad weather. 
7.4.3.5 Diabetes risk perception and information 
Lack of information was reported in most of the studies. After the intense monitoring of 
pregnancy, women felt “abandoned” (252,264,283), that “…you’re left high and dry” (256), 
“neglected by healthcare providers and were left with unanswered questions about what to do 
next” (283). For some, there was a lack of repetition of health messages after delivery so that 
“…it was so long ago, I don’t remember clearly” (265). Conversely, some noted that they heard 
the same health messages again, which could either be annoying or “…even if it is old 
knowledge it is good to hear it once more” (284). 
Risk of T2D 
Women in most studies reported awareness of the link between GD and T2D. However, some 
women in half of the studies also did not recognise their personal risk (256,263–
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265,279,283,284,286,290). ‘One woman described having GD as an interruption in her life 
and that life does get back to normal so that you can “put it behind you and just kind of go 
on”’ (283). This could be because they were distracted by caring for the baby so they put it out 
of their minds, but it was clear that others lacked understanding; for example, “I am confident. 
Nobody in my family ever had it” and “it’s going to be hard to get [T2D]” (290), or were given 
incorrect or unclear information by healthcare professionals; for example, “…before I was 
worried… but …he (the doctor) said it is gone now… that makes me feel calm” (286). 
On the other hand, many women felt worried, scared or helpless because they thought T2D 
was inevitable; for example, “I’ve got this cloud hanging over us… there’s not a great lot more 
I can do” (256). Others thought they could “postpone getting diabetes as long as possible’ 
through diet and physical activity (264). This often resulted in a desire but not ability to make 
lifestyle changes. “The risk of getting T2D is in the back of your mind, you think about what to 
eat and to exercise, struggling to reduce weight. It is really that simple but also so hard” (284). 
Some women focused on their diet to prevent T2D because they thought that the benefits of 
physical activity were mediated through weight loss alone. Others discussed how to have a 
healthy diet, rather than whether it was a good idea. Unlike for physical activity, many women 
were able to use dietary knowledge from their GD pregnancy: some did this with confidence 
after being encouraged by their GD lifestyle, whereas others were uncertain and used their 
pregnancy knowledge in response to not knowing what else to do, asking “do you follow strictly 
[the plan] like you were pregnant or do you deviate from it a little because your body’s 
handling it differently… Am I going in the right direction?” (281). Diabetes prevention 
programmes were useful for learning about T2D, exercise, diet and weight loss.  
Culturally-relevant information 
Women often lacked information that was specific to them and were not able to benefit from 
postpartum follow-up, such as how to plan and cook culturally-specific meals. It appears that 
women become torn between a healthier, alternative diet and maintaining their cultural identity. 
Others, illustrated by the Algonquin community, benefitted from being able to adapt their 
traditional diet to be healthier – for example, switching cooking oil or using alterative meats. 
Provision of the information was also delivered in a culturally-appropriate way because ‘They 
adapted appointments to the Algonquin way of life: instead of making appointments for a fixed 
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time and date, they intervened immediately, adapting to a culture-specific concept of time 
described by the general informants as “now or never”’ (280). 
7.4.3.6 Finances and resources 
Lacking resources, and the need to prioritise financial ones, were frequently quoted as barriers 
to healthy behaviour. A healthy lifestyle was perceived to be more expensive than an unhealthy 
one: healthy food was more expensive than junk food and going to the gym was more expensive 
than not exercising (particularly when external childcare was needed). “…[Healthy foods] are 
not the cheap items; they’re a kind of more in the pricy end. It could be a bit irritating to 
prioritize your money in that way…” (264). None mentioned that they were able to use gyms 
to exercise; if gyms were available, they were seen to take up women’s time and away from 
their children and one woman said that she still did not have time to use the gym even though 
it was in her building (279).  
They anticipated that access to cheaper or free healthy food and facilities would increase their 
healthiness. Resources such as recipes and home exercise equipment or DVDs would equip 
and motivate them to be healthier. Gaudreau et al. found that women were able to sustain a 
healthier diet because they found that it was cheaper: ‘Some said they went to restaurants less 
often or ate differently when they did go out to eat: “I didn’t eat out as often. It became less 
expensive to eat out because I cut down on my portions”’ (280). 
7.4.3.7 Format of interventions  
Finally, women discussed the format of diabetes prevention programmes or interventions in 
five studies, and briefly mentioned it in three others.  
There was no consensus of the best mode of delivery: web-based interventions were thought 
to be flexible, which could address some of the time and childcare barriers explored above. 
They could be used to provide support and encouragement, however others were less interested 
because they wanted face-to-face contact or did not want to spend any more time on computers. 
Telephone interventions were not popular, despite women in Lim et al. finding that it was 
personal and flexible to their requirements (291). The greatest appeal of face-to-face group 
interventions was that they could provide social support, including accountability, motivation 
and fulfilling the social needs of women. Mental health could be a barrier to group settings 
however – one woman reported that it was awkward to discuss depression and another did not 
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attend a group because of her depression. One participant suggested “have a peer group in-
person to start, to get to know each other, then use chat rooms/email to access at all times of 
the night” (279) to utilise the benefits of multiple approaches. Graco et al. reported that women 
could be flexible with a physical activity programme as long as it was “family-friendly” (282), 
highlighting their priorities.  
Little was described about women’s preferred timing for intervention. Dasgupta et al. reported 
that interventions should start during pregnancy or immediately postpartum (281), which was 
supported by my finding that women felt unsupported after pregnancy. Conversely, Lie et al. 
concluded that weaning provided a “window of opportunity for intervention to promote more 
healthy eating habits” (256).  
Several considered that lifestyle coaches, trainers or counsellors could provide support while 
medical staff were seen as a trustable source of knowledge, but the studies did not discuss who 
should deliver a programme. 
7.4.4 Recommendations for promoting behaviour change 
I developed 20 recommendations for promoting healthier lifestyles after GD based on these 
findings (reported fully in Appendix 10 and summarised in Table 7.3). I mapped them onto the 
behaviour change technique taxonomy to suggest a range of behaviour change techniques that 
could be included in future interventions, if appropriate to the setting.  
To illustrate, recommendation 7 (‘provide guidance about how to buy and prepare healthy, 
tasty food efficiently’) is a ‘non-specific incentive’ in itself by incentivising women to save 
time and money through dietary changes. The physical activities suggested in recommendation 
17 could be implemented through ‘goal setting (behaviour)’ by helping women to create 
personal daily walking targets or playing with their children at the park four times a week rather 
than sitting and watching. 
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Table 7.3: Twenty recommendations for promoting healthier lifestyles after gestational diabetes, and our 
confidence in each recommendation made using the GRADE-CERQual approach. 
Recommendation 
Behaviour change 
techniques relevant to 
recommendation (190) 
Confidence in evidence and 
explanation 
Role as mother and priorities 
1. Highlight the benefits to the family 
of the mother being healthier and 
role modelling healthy lifestyle to 
children as the incentive for 
change, alongside preventing 
diabetes 
5.1 Information about health 
consequences,  
5.3 Information about social 
and environmental 
consequences,  
10.5 Social incentive, 
10.7 Self-incentive, 
13.1 Identification of self as 
role model  
Moderate: Women directly or 
indirectly reported that their 
children were their incentive for 
change; whether it is appropriate 
for all should be considered 
2. Include the option of childcare in 
face-to-face interventions if 
children are not part of the sessions 
12.2 Restructuring the social 
environment,  
14.1 Behaviour cost 
Moderate: Few studies 
contributed to this recommendation 
but some directly suggested it; it is 
supported by general concern about 
children/childcare 
Support from family and friends 
3. Promote healthier lifestyles in the 
wider family (and friends) 
7.3 Reduce prompts/cues, 
12.2 Restructuring the social 
environment 
Moderate: It is clear that women 
need support for a healthy diet but 
few studies clearly discussed 
family and friends exercising 
4. Encourage the wider family (and 
friends) to promote healthy 
lifestyles in mothers and support 
them practically (such as relieving 
housework burdens)  
3.2 Social support 
(practical),  
3.3 Social support 
(emotional) 
High: Many studies explained the 
benefits of or need for support for 
lifestyle change 
5. Include the family in interventions 
(e.g. information or modules for 
partners and children) 
3.2 Social support 
(practical),  
3.3 Social support 
(emotional) 
Moderate: Inadequate data 
reduced our confidence that this 
recommendation would be useful 
to postpartum women 
6. Encourage and facilitate women to 
exercise with others/a buddy 
3.3 Social support 
(emotional) 
Moderate: This recommendation 
was developed from the general 
need for support, plus a few studies 
that specifically addressed it 
Demands of life 
7. Provide guidance about how to buy 
and prepare healthy, tasty food 
efficiently 
1.2 Problem solving, 
4.1 Instruction on how to 
perform a behaviour,  
10.6 Non-specific incentive 
High: Many women reported the 
lack of and need for more guidance 
for having a healthy diet 
8. Provide guidance about how to 
exercise around the house and as 
part of regular daily routines 
4.1 Instruction on how to 
perform a behaviour,  
8.3 Habit formation,  
10.6 Non-specific incentive  
Moderate: It is clear, and stated, 
that women need help to increase 
exercise; however, there is some 
contradictory suggestions about the 
best form(s) of exercise to promote 
and how 
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Personal preferences and experiences 
9. Support women to maintain healthy 
behaviour/diet in challenging 
situations – eg. social gatherings, 
breastfeeding, at work (particularly 
for vulnerable groups) 
1.2 Problem solving, 
1.4 Action planning, 
4.2 Information about 
antecedents 
Low: Certain situations affect 
women’s ability to maintain 
healthy diets; the best way to 
address this is unclear 
10. Highlight the wider benefits of 
healthier lifestyle (such as reducing 
stress and weight as well as 
diabetes risk)  
9.2 Pros and cons,  
9.3 Comparative imagining 
of future outcomes,  
13.2 Framing/reframing 
High: Women had identified many 
benefits of adopting healthier 
lifestyles that helped them to 
maintain them (perhaps after 
awareness of diabetes risk declined 
over time) 
Diabetes risk perception and information 
11. Make information, resources and 
training easily accessible and make 
interventions available to start 
immediately after pregnancy (or 
during pregnancy) 
4.1 Instruction on how to 
perform a behaviour,  
5.1 Information about health 
consequences,  
5.2 Salience of 
consequences 
High: This recommendation 
resulted from many studies that 
were in agreement, with few 
exceptions 
12. Ensure that interventions are 
culturally appropriate and 
recommendations allow 
maintenance of women’s identity 
13.2 Framing/reframing, 
13.5 Identity associated with 
changed behaviour 
High: It was clear that women 
wanted culturally-relevant 
interventions and that they were 
beneficial to those who received it 
13. Ensure that care providers consider 
women’s attitude towards diabetes 
and advise them on their risk 
appropriately  
5.1 Information about health 
consequences,  
5.2 Salience of 
consequences 
Low: This recommendation is a 
step on from women’s attitudes 
towards behaviour change and their 
clinician  
14. Promote a long-term perspective 
about maintaining healthy lifestyle, 
with an ‘every little helps’ 
approach, rather than ‘all or 
nothing’, and include the 
importance of both diet and activity 
5.1 Information about health 
consequences 
Moderate: Paucity of data has 
reduced our confidence in this 
recommendation  
Finances and resources 
15. Provide information about low-cost 
or money-saving healthy 
behaviours and resources; 
interventions should be free 
4.1 Instruction on how to 
perform the behaviour 
High: There was agreement across 
studies but this was not reported in 
detail 
Format of intervention and other 
16. Recommend increasing fruit and 
vegetable intake, reducing sugar 
and substituting with healthier 
ingredients or methods to improve 
diet 
1.1 Goal setting (behaviour), 
1.4 Action planning 
Moderate: Several studies briefly 
reported women being able to 
makes these changes 
17. Recommend flexible exercise such 
as walking and those performed 
around the home or with the baby 
to increase physical activity (rather 
than attending gyms or classes) 
1.1 Goal setting (behaviour), 
1.4 Action planning 
High: Women across several 
studies reported how and why they 
did these types of exercises 
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18. Ensure interventions have web-
based components but encourage 
additional face-to-face contact 
(they should not depend on women 
attending sessions) 
6.2 Social comparison Low: There was no agreement 
across studies; this 
recommendation attempted to 
consider what women wanted but 
also what was most practical 
19. Deliver and promote interventions 
from recognised/trusted sources 
(e.g. the healthcare provider or a 
dietitian) 
9.1 Credible source Low: Preferred source of the 
intervention was not discussed; 
however women reported benefits 
from their interactions with various 
professionals 
20. Promote establishment of systems 
to monitor progress and 
accountability (through an 
intervention or ensure the 
participant establishes this 
themselves) 
2.2 Feedback on behaviour, 
2.3 Self-monitoring of 
behaviour,  
2.4 Self-monitoring of 
outcome of behaviour,  
3.2 Social support (practical) 
High: Accountability facilitates 
behaviour change, but the best way 
to promote this remains uncertain 
Recommendations frequently result from findings within multiple themes but have been presented under the 
primary contributing theme. 
I had high confidence in eight, moderate confidence in eight and low confidence in four 
recommendations in the GRADE-CERQual evaluation. The recommendations were based on 
many good-quality, relevant studies; confidence was therefore largely influenced by coherence 
and agreement between studies and richness of the data. I tended to have higher confidence 
about information that women wanted and the need for support and accountability, but lower 
confidence in recommendations about equipping women in situations such as at work, the 
behaviour of friends and family (other than offering support) and interactions with 
professionals because continued contact is not common. I felt that it was important to adapt 
interventions to the target population and facilitate family-friendly changes because the 
mother’s own diabetes risk was unlikely to motivate change without her perceiving benefits 
for her children. Some of the most beneficial aspects of groups (such as forming supportive 
relationships) mean that they are impractical for most to commit to in the long-term. 
Consequently, a combination of approaches could be most appropriate: for example, online 
information, target-setting and accountability plus options to arrange video calls with 
healthcare professionals such as dieticians, and connections with local mothers’ groups. 
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7.5 Discussion 
This review shows that adopting and maintaining a healthy lifestyle after a pregnancy affected 
by GD is complex. An identity as a mother who prioritised family above herself influenced 
many women’s ability to care for their own health, in addition to the need for resources, time, 
energy, information and support. Taking into consideration the significant impact that having 
new children has, these barriers frequently appeared to outweigh the perceived benefits of 
behaviour change by those maintaining established unhealthy behaviours, particularly when a 
negative effect on family life was anticipated.  
Influences on the two key behaviours were similar. One difference was that diet could be 
adapted because meal preparation and eating were already necessary, whereas exercise was an 
additional task. Some influences were both positivity and negatively reported: for example, 
lack of culturally-specific information inhibited healthy diet (information as a barrier) plus 
guidance about adapting traditional foods helped women to make changes (information as a 
facilitator). In contrast, some facilitators were only anticipated: for example, women suggested 
giving gym passes to increase exercise, but none reported regularly using the gym. 
7.5.1 Strengths and limitations 
This is the first comprehensive qualitative synthesis to focus on the views of women with a 
history of GD on having a healthy lifestyle and to make clear recommendations for 
implementing the findings. Alongside a multidisciplinary team, I conducted a comprehensive 
literature search and thematic synthesis to identify repeated themes across studies and 
recognise those that may have previously been overlooked. Concurrent comparison of positive 
and negative influences and different behaviours permitted a more representative 
understanding than if barriers and facilitators had been analysed separately. I observed diverse 
perspectives and variety between and within study populations (such as ethnicity, social norms, 
other children and family members). Congruence between high-quality studies increased my 
confidence in my recommendations, which I transparently evaluated using GRADE-CERQual 
and linked to standard behaviour change techniques.  
There are also limitations. I was not able to specifically investigate how experience of 
pregnancy, such as struggling to manage blood glucose control through lifestyle modifications 
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or feeling guilty for having GD (78), influenced postpartum behaviour based on these studies. 
Furthermore, I did not distinguish between timepoints but collated studies that collected data 
from six weeks to ten years postpartum, therefore could not explore changes over time as 
reported by Hjelm et al. (286). Most data were from educated or employed women recruited 
from medical settings in developed countries, meaning that I probably missed some 
experiences of motherhood (although the populations were quite different, as discussed). 
Although it is possible that participants felt that mental health did not influence behaviour, it 
is also possible that they avoided this topic and that women experiencing mental health 
difficulties did not participate in these studies. I did not access the primary data therefore was 
reliant on how the primary studies’ authors interpreted and reported their data, nor did I 
examine quantitative literature. Barriers made the greatest contribution to analytical themes, 
perhaps because they were emphasised by researchers or respondents. Fewer studies reported 
experiences of diabetes prevention programmes but they were consistent with other themes.  
Although the studies were good quality, quality did affect the results of the synthesis and 
recommendations. Authors rarely adequately considered their role as researchers, which could 
have led to bias in the formation and evaluation of research questions and social desirability 
bias among respondents. Furthermore, although I did not influence the participants or original 
analyses, my analysis was inevitably affected by my own preconceptions. In recognition of 
this, I developed the coding frame from the study findings in order not to impose a framework 
from the review question, used structured CASP and GRADE-CERQual checklists, and all 
authors discussed the themes and findings. 
7.5.2 Comparison to other literature 
7.5.2.1 Related literature reviews and quantitative studies  
Whilst my findings broadly agree with previous literature reviews, I have added more studies 
and data, described the phenomena in more detail and put forward recommendations resulting 
from the findings. In 2014, a meta-synthesis found that, in the context of preventing diabetes 
in the future, women prioritised children and families and listed barriers and facilitators (77). 
They noted that few studies contributed to this whereas I identified 11 studies published since 
their search. Two other reviews, which had a greater focus on healthcare seeking, commented 
that many women have knowledge regarding diabetes prevention that affects their desire to 
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live healthily (87,147). They also list numerous barriers, including some that I found less 
emphasis on such as poor body image and an unsuitable neighbourhood. There is a growing 
recognition of the important influence that the environment exerts on population diet and 
activity. It is likely that women with a history of GD are subject to this influence to some degree 
and that interventions are likely to be more effective in a more supportive environment. 
Consistent with my findings, a discussion of a recent symposium (where speakers presented 
their experiences in Denmark, Australia, Canada and Ireland) concluded that postpartum 
behaviour is affected by women’s beliefs about their susceptibility to diabetes, is considered at 
the cost to their family, and that healthcare systems gave disjointed care so women lack 
information (292). 
My recommendations are comparable to those identified in the development of the ‘STAR 
MAMA’ intervention (293). In that study, focus groups (including overweight women or those 
with GD), alongside experts, were used to adapt the DPP to Latina women through the 
behaviour change wheel framework. In the adapted programme, techniques such as modelling 
narratives and role-playing were used to help participants overcome barriers to behaviour 
change through automated weekly telephone calls and coaching. The initial evaluation of the 
intervention was positive, with participants engaging with the telephone calls and the health 
coaches giving individualised tips (294). Sharing information about GD follow-up and more 
general postpartum support was a key element of this intervention, which may be less effective 
in populations with higher health literacy.  
7.5.2.2 Other populations 
There are also similarities between the experiences and needs of women with GD and those 
with normoglycaemic pregnancies. Postpartum mothers in the general population also report 
barriers to physical activity including lack of energy, time for housework and the responsibility 
of childcare (295,296). In Graco et al., women with GD did not want to be seen as a separate 
group but to attend classes with mothers who had had a normoglycaemic pregnancy (282). This 
raises the question of whether interventions should be specifically targeted at women with 
previous GD or mothers seeking healthy lifestyles in general. 
In a letter to a journal, Lim et al. compared my publication to their own systematic review that 
looked at characteristics of weight management interventions in postpartum women without 
GD, with the view to inform implementation (297,298). They introduced the Consolidated 
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Framework for Implementation Research (CFIR) (299), in which interventions have core 
components (such as those identified in other populations or systematic reviews) and an 
adaptable periphery that is population- and context-specific. The format and timing of the 
intervention were suggested to be part of the periphery that could be adapted to women with a 
history of GD. They also highlighted the important role of the healthcare provider as a trusted 
source of information in both groups of mothers. 
My results also broadly agree with determinants of healthy behaviour and corresponding 
intervention approaches in the wider adult population, where the behaviour change techniques 
of goal setting and self-monitoring of behaviour have been suggested to be effective (300,301). 
Nonetheless, there appears to be a different emphasis: mothers with previous GD appear to 
weigh relational factors (like the possible impact of their behaviour on others) higher than other 
populations, and place less emphasis on environmental factors and personal health benefits. 
7.5.3 Implications  
As outlined in Table 7.3, this qualitative review informs approaches for promoting healthier 
lifestyles among this population. These recommendations could be used to develop new 
interventions or adapt existing ones. For example, although the DPP intensive lifestyle 
intervention was effective, it may be difficult for women to commit to because it includes 
repeated face-to-face meetings with a case manager (163). Indeed, it has already been adapted 
for the STAR MAMA intervention by using telephone calls including pre-recorded education 
and supportive narratives so that women could engage with the intervention in their own 
language from their homes (294). Total diet replacement and stepped food reintroduction in a 
population with diabetes (DiRECT trial) resulted in diabetes remission in half of their 
participants (302), but a diet that is so controlled and different to the rest of the family’s may 
not be attractive to mothers. Web-based interventions with additional face-to-face or remote 
support from a nurse (POWeR+ trial) have led to weight loss in the general population (303), 
and could be adapted to meet the specific requirements of this population.  
I have also identified areas that need further research. Despite including a number of recent 
studies, I was not able to examine the use of technologies like smartphone applications and 
social media, which is growing across the world. In a study that was published after we 
conducted our literature search, participants suggested that more support should be provided 
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via online forums and information on general practice websites (304). The authors reported 
that technology could provide information, enable personalised self-management and meet 
social needs, with flexibility noted as a benefit. Additionally, I was unsure whether promoting 
change in the wider family would specifically facilitate mothers to be healthier based on this 
review. However, the risk of diabetes is higher in partners and children of mothers with GD 
(305,306) and maternal behaviour strongly correlates with childhood obesity (307) therefore it 
should be carefully considered.  
Furthermore, how best to apply these recommendations should be given careful attention. For 
example, tailoring for working and single mothers or those experiencing postpartum mental 
health disorders, and the appropriateness of additional behaviour change techniques (such as 
‘14. Scheduled consequences’ (190)).  
7.6 Summary 
Maintaining a healthy diet and regular physical activity after GD can help women mitigate their 
future risk of developing T2D. In this chapter, I sought to understand the influence that different 
factors had on lifestyle choices in this population and corresponding approaches to support 
them using a systematic review and qualitative synthesis.  
I found that many factors make it difficult to adopt and maintain healthy lifestyles after GD, 
yet how women interpret these situations can motivate or prevent changes that reduce their 
diabetes risk. Women’s needs and experiences should be considered when designing strategies 
to promote healthier lifestyles. I made key recommendations based on a synthesis of qualitative 
data that will inform the development of feasible interventions, or adaptation of existing ones, 
to educate and support women in achieving and maintaining a healthy postpartum lifestyle in 
order to reduce their risk of developing T2D. 
Together with Chapter 6, these findings informed the interview study reported in the next 
chapter in which I sought to understand the attitudes of a local population who had recently 





 The DAiSIeS study 
Diet, Activity and Screening after gestational diabetes: an Interview Study 
In the final study of my thesis, I extend the findings of my previous systematic reviews with 
primary research. Using qualitative interviews, I wanted to understand the experiences of 
women with recent GD and their views towards potential interventions in order to develop 
practical, appropriate and useful approaches to improving postpartum support. 
In this chapter, I report the findings relating to healthy diet and exercise, and attending diabetes 
screening tests concurrently. This follows the sequence of the interviews and facilitates a 
broader overview and discussion of the views of these participants. Nevertheless, I will submit 
the findings for publication as two papers. 
8.1 Background 
As I identified in Chapter 4, development of T2D after GD is a serious problem that tends to 
be underappreciated by mothers and clinicians. Screening for the anticipated glucose 
intolerance after pregnancy is important to reduce exposure to hyperglycaemia and hence 
reduce risk of longer-term complications. BMI is a modifiable diabetes risk factors that is 
associated with 18% higher diagnoses for each unit higher BMI, highlighting the importance 
of weight management through diet and exercise. 
In the UK, screening should occur at around six weeks postpartum, followed by lifelong annual 
screening in order to monitor glucose levels and to identify those at highest risk of progressing 
to diabetes and with prevalent undiagnosed diabetes (2). FPG tests are recommended up to 13 
weeks postpartum, and HbA1c tests should be used thereafter (2). Short term follow-up in the 
UK has been reported between 19% and 80% (153,154,240,241) (and Chapter 5), with even 
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lower annual rates thereafter (154,155). In the qualitative synthesis reported in Chapter 6 (208), 
I found that women’s experience of the healthcare system and personal factors influence both 
opportunities and motivation to attend testing. They understood the importance of testing based 
on the maternity care received; were put off by an unpleasant procedure that could be 
inconvenient to attend; were focused on childcare; and had varying levels of concern about 
T2D that could increase or decrease motivation to attend testing. 
In addition, most women either do not attempt or are unable to sustain behaviour changes to 
reduce modifiable risk factors; instead, many maintain lifestyles that increase their diabetes 
risk (172). Existing behaviour change interventions have had positive effects but their impact 
has been limited due to poor engagement (166–168). In the second qualitative synthesis in 
Chapter 7 (209), I found that after GD, women identified themselves primarily as mothers who 
prioritised their family above themselves. This motivated some to adopt healthy diets and to be 
active, whereas this identity plus a need for resources, time, energy, information and support 
prevented many others from making changes.  
Based on the findings of the literature reviews, I developed recommendations for promoting 
healthy lifestyle and attendance at screening after GD (Table 6.2 and Table 7.3). I evaluated 
my confidence that these recommendations were suitable according to the literature, but 
understanding the views of women living in the UK was identified as an area requiring further 
investigation, such as what they would emphasise as most beneficial to them and how to deliver 
such interventions. Furthermore, I was not able to identify how personal circumstances or 
characteristics may influence behaviour after GD. 
8.2 Aim 
The objective of this study was to explore and develop practical approaches to promote 
behaviour changes in women who have had GD that would reduce their risk of going on to 
develop T2D and of prolonged exposure to hyperglycaemia. This focussed on adopting a 
healthy lifestyle (in terms of eating a healthy diet and being physically active) and attending 
regular diabetes screening. 
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The aims were: 
1. To understand how GD has or has not affected women’s diet and participation in 
physical activity; 
2. To understand women’s views towards making changes to their lifestyle after GD;  
3. To understand women’s views towards attending diabetes screening after GD; 
4. To elicit women’s evaluation of strategies for promoting healthier diet and physical 
activity levels; 
5. To elicit women’s evaluation of strategies for promoting attendance at diabetes 
screening; 
6. To explore their preferences for delivery of these messages. 
8.3 Methods 
The methods are described in detail in Section 3.3. The relevant study materials are presented 
in Appendices 1 to 4. 
8.3.1 Recruitment and inclusion criteria 
Research staff from the Rosie Hospital and Peterborough Hospital identified eligible 
participants using their medical records and sent them an invitation and information sheet. 
Those who were interested in taking part responded to the research staff, who passed their 
contact details onto me to arrange the interview. 
We invited participants who were: 
 Diagnosed with GD during any previous pregnancy; 
 12 weeks to four years postpartum; 
 Over 18 years old. 
We did not invite those who: 
 Would be unable to give informed consent or were considered unsuitable to take part 
for any other reason at the discretion of the hospital research staff; 
 Did not have a successful, uncomplicated, full-term pregnancy at the discretion of the 
hospital research staff; 
 Had a diagnosis of T2D or T1D before GD; 
Chapter 8  The DAiSIeS study 
180 
 Had participated in a pregnancy-related intervention. 
8.3.2 Semi-structured interviews 
I interviewed each participant face-to-face at a time and place of their choice, with their child 
or children present if preferred. The interviews were audio-recorded after the participants 
confirmed they understood the plan and purpose of the interviews, and gave informed consent. 
Each interview was guided by the interview schedule (Table 3.5). I began by introducing 
myself and the purpose of the interview (an opportunity for them to share their experiences and 
opinions). Initially we discussed their experience of GD. I then invited them to describe their 
current eating and physical activity habits, whether they felt that their previous GD diagnosis 
had influenced their diet and physical activity, and any preferences for support that would help 
or have helped them to be healthier. These questions were then repeated for attending diabetes 
screening: whether they had attended, plans for future screening, and what might help them 
attend. I first asked if they had any ideas for support, then sought their opinions on 20 
suggestion cards (if I considered this to be appropriate according to their earlier responses) that 
were based on the findings of the qualitative literature reviews (Chapters 6 and 7) (208,209). 
The interview ended with a short demographic questionnaire. I then recorded field notes. 
8.3.3 Analysis  
The interview recordings were transcribed, then I checked the transcriptions for accuracy. After 
the first few interviews, I began analysis using a framework approach (210,211). This involved 
familiarisation with the data, identifying a thematic framework, coding, charting, and mapping 
and interpretation.  
I used NVivo 12 for the coding and charting stages. The thematic framework, including 62 
codes in total, is reported in Table 3.6. Rachel Fox also coded and charted four interviews. 
Table 8.1 shows a sample of one of the 21 charts. These included general comments on the 
topic (to give the context for each response), their prompted response to the corresponding 
suggestion card(s), and any relevant unprompted suggestions that the participant initiated. 
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Table 8.1: Excerpt from the chart ‘information and understanding’ used in the thematic framework analysis of 
the DAiSIeS study.  
06. General comments 07. Prompted #1 
More information 
about the impact of 
healthy diet/exercise 
on your diabetes risk 
08. Prompted #2 
More information 
about the impact of 
healthy diet/ 





Age: ≥41 yrs 
Med: Yes 
PP test: Yes 
Ethnicity: W 
Has diabetes in the family, so 
aware/worried about prevent-
ion. Especially worried her 
children will develop it. 
Frustrated that she might get 
T2D when is careful to look 
after herself – wants to do 
what she can to limit it. Is 
there anything else she should 
do? 
Agreed - always 
welcome to receiving 
more and new 
information (e.g. 
influence of 
processed food is big 
at the moment). 
Agreed? Finds that 
exercise and yoga 
are good for stress 
relief and help you 
lose weight too. 
None. 
Suzanne 
Age: 31–35 yrs 
Med: No 
PP test: Yes 
Ethnicity: A 
Did lots of their own research, 
and are now more health- 
conscious and changed their 
lifestyle. Especially after the 
first 2 months, because when 
her baby was littler, she was 
too busy just trying to brush 
her teeth. Important for her to 
take time to be healthy. 











exercise needs to 
be, about rice). 
Kimberly 
Age: 31–35 yrs 
Med: No 
PP test: Yes 
Ethnicity: W 
At the start of the interview, 
she was more concerned 
about being healthy to prevent 
cancer. 
“100% it would 
help... I didn’t even 
know I had an 
increased risk, to be 
honest, I didn’t know 
anything... Well 
hence why I ate all 
those Easter eggs. I 
probably would have 
only eaten half.” 
Feels that there is 
already lots of 
advice available – 
less important in 
support for GD. 
Had a long 
discussion about 
T2D – she asked 
lots of questions 




more info if 
there is a link. 
A: Asian ethnicity; med: medication for GD; PP: postpartum; W: White European or British ethnicity; yrs: 
years. 
Figure 8.1 illustrates the relationship between the recommendations developed in the 
qualitative syntheses, the interview schedule suggestion cards and the thematic framework. For 
example, the first recommendation for increasing uptake of diabetes screening after GD in the 
qualitative synthesis was ‘educate clinicians to, and how to, promote screening throughout GD 
and postpartum/subsequent care.’ I sought to understand whether the participants felt that it 
was important for their clinicians to promote screening during and after GD (that is, whether it 
would be beneficial to educate the clinicians to do this) by suggesting ‘discussing postpartum 
tests during pregnancy’. Alongside reminders for tests, this informed the theme ‘booking tests’, 
where some participants appreciated that their postpartum test was booked during pregnancy. 
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8.4 Results 
Firstly, I report an overview of the participants who took part in the interviews, describing the 
demographics of the group then a profile or summary of each participant (Section 8.4.1). 
Secondly, I describe the findings of the analysis in the remainder of Section 8.4, with an 
emphasis on the participants’ views towards improving the healthiness of their diet and 
physical activity (Section 8.4.3), diabetes screening attendance (Section 8.4.4), and what 
support might help them (Section 8.4.5). I record personal reflections on this study in the 
discussion (Section 8.5.3). 
Participants’ quotes are presented in italics. For each participant referenced, I report their 
ethnicity (simplified as White [British or European] or Asian), whether they were on 
medication for GD, and whether they had attended a diabetes screening test since pregnancy. 
8.4.1 Included participants 
Between June 2019 and February 2020, I interviewed 20 participants who were between three 
months and four years postpartum. Their characteristics at the time of the interview are reported 
in Table 8.2. According to their preference, 18 interviews took place in participants’ homes, 
where children were often present, and two took place in a private hospital room. Eleven 
participants had been patients at Peterborough Hospital during their pregnancy and nine were 
at the Rosie Hospital, Cambridge. The median (IQR) number of pregnancies per participant 
was 2 (1 to 2.25), with 1 (1 to 2) pregnancy affected by GD. No one had been diagnosed with 
T2D.  
The interviews lasted for a mean 38 minutes (range 21 to 62 minutes). 
A brief profile of each participant is given in the text below, including a summary of their diet, 
physical activity and the screening behaviours discussed in the interview. As described in the 
methods, each participant was assigned a pseudonym and age from within the appropriate age 
category. They are presented in alphabetical order. 
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Table 8.2: DAiSIeS participant characteristics at the time of the interview. 
  N (percent)  
 Age band   
 26 to 30 years 3 (15)  
 31 to 35 years 9 (45)  
 36 to 40 years 6 (30)  




 White British or European 14 (70)  
 Asian* 6 (30)  
 
Education level  
 
 Secondary or further 5 (25)  
 Higher 6 (30)  




 Full-time 10 (50)  
 Part-time 9 (45)  
 Home parent 1 (5)  
 
On maternity leave 11 (55) 
 
 
Lives with partner 18 (90) 
 
 
Number of children  
 
 1 6 (30)  
 2 9 (45)  
 3 or more 5 (25)  
 
All pregnancies affected by GD 13 (65) 
 
 
On medication for GD (metformin and/or insulin) 10 (50) 
 
 
Experience of GD pregnancy and postpartum**  
 
 GD management required significant/challenging lifestyle changes 17 (85)  
 They were attempting to maintain a healthy postpartum lifestyle 14 (70)  
 They felt adequately supported to maintain a healthy postpartum lifestyle 10 (50)  
 
Attended any postpartum diabetes test 16 (80) 
 
 Intended to attend future testing** 13 (65)  
*Including Chinese, Japanese and Indian ethnicities. 
**Elicited from transcripts. 
Amber 
Amber was 31 years old, lived with her husband and had a postgraduate degree. She worked 
full time, and was on maternity leave at the time of the interview. She was diagnosed with GD 
at the end of her second pregnancy, and managed blood glucose levels by diet. 
She described herself as very active and her usual diet was low in carbohydrates to help 
symptoms of irritable bowel syndrome. Postpartum she had been keen to maintain the dietary 
changes to mitigate T2D risk, and saw this risk in the future. Over the course of the interview, 
she became aware of the limited advice about diet and exercise she had received postpartum. 
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Amber’s GP sent her for the diabetes screening test around six weeks postpartum. She had not 
realised that annual testing was recommended therefore we discussed this at the end of the 
interview. 
Christine 
Christine lived with her husband and recently had their first baby. She was Asian ethnicity, 32 
years old and on maternity leave. She was not on any medication for GD during pregnancy, 
managing it by strictly controlling her diet and walking, which she did not enjoy. Christine 
found that as teacher, it was hard to follow some of the advice and to fit glucose monitoring 
around lessons. She felt that GD was the focus of her pregnancy and managing it took over her 
life. 
She was keen to keep up a healthier lifestyle but was also realistic about the long-term 
challenges postpartum. At the time of the interview, she was eating more due to breastfeeding, 
but had learnt that she might not need to eat as many carbohydrates as before pregnancy. She 
had started walking with the baby in the sling after recovering from a caesarean. She had 
benefitted from support from antenatal and social media groups during and after pregnancy. 
Christine attended the six weeks postpartum test, saying that it brought GD to an end. She 
thought that subsequent testing would help motivate a healthy lifestyle. This would be 
important because T2D was common in her family. 
Danielle 
Danielle was a primary school teacher with two children. She usually worked part time but was 
on maternity leave at the time of the interview. She was 29 years old, White British, and lived 
with her husband. She found her blood glucose was unpredictable and managed her second GD 
pregnancy with insulin. While some clinicians had been supportive, she felt unhelpfully judged 
by others. 
Danielle was aware of the increased risk of T2D. Danielle had become more conscious of what 
she was eating so tried to lower her carbohydrate intake and eat more vegetables since 
pregnancy. This was a big change, motivated by wanting to lose weight and be healthy for her 
children. Exercising was difficult after a recovering from complications at the end of 
pregnancy, and she hoped that when her youngest child sleeps better she would have more 
energy for walking. Previously, most of her activity came from work. 
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At the time of the interview (several months postpartum) she had not had a diabetes screening 
test and had not been invited for one. She felt that there needed to be much more general 
postpartum support, including emotional support. 
Emma 
Emma was 38 years old. She had a postgraduate education, and experience in biological and 
social sciences research. She was on maternity leave from her full-time job. She was White 
British and lived with her husband and their baby. She was diagnosed with GD late in 
pregnancy after having a normal first OGTT, and was not on diabetes medication. 
Emma had always cooked food from scratch, and made changes during pregnancy about how 
much and when she ate. Although Emma returned to eating lots of sugar after the birth, she 
hoped to start to some of the elements of GD diet again now that life with the baby was settling 
down and she started to think about weaning. She also planned to exercise more. 
She had been tested for diabetes postpartum and intended to go for annual testing. She felt that 
if it was worth NHS resources for her to be tested, it was important for her to attend. 
Francesca 
Francesca was 39 years old. She was White European ethnicity and lived with her husband. 
She had a higher education and worked part time, and was on maternity leave at the time of the 
interview. She had GD with both pregnancies, and managed the latter with metformin and 
insulin. 
Francesca admitted that after six months of eating the same foods to manage GD, she had eaten 
what she wanted to over Christmas. She was starting a calorie-controlled diet to lose weight by 
the time of the interview. Exercise was difficult at that time because of tiredness (her older 
child did not sleep well), so most of her activity was pushing her double pushchair. She 
considered diet to be most important for weight loss, so was keen to maintain it in the long-
term and not develop T2D in the next few years. 
Her postpartum test was booked for that week. She was apprehensive about the test, but eager 
to find out the result rather than being in denial about it. 
Holly 
Holly was 29 years old and lived with her husband. She worked part time in a healthcare-
related role and was on maternity leave at the time of the interview. She had three children, 
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with GD diagnosed in her first pregnancy only. She had controlled her blood glucose through 
diet alone. She then fell just below the GD cut-off in her second pregnancy, and monitored her 
blood glucose in the third pregnancy until an OGTT confirmed that she did not have GD.  
Holly found the GD pregnancy confusing and challenging. She felt unsupported during and 
after all three of her pregnancies. She particularly hated attending the appointments because 
she felt that she was told off for having high readings rather than helped to lower them. She 
also said that no one checked on her postpartum, or only asked how she was in a patronising 
way. Holly struggled to exercise and made sporadic changes to her diet causing her weight to 
fluctuate. 
She had not had a test for diabetes after having GD (apart from pregnancy OGTTs). She was 
vaguely aware of postpartum testing, and the interview reminded her to follow this up. 
Jennifer 
Jennifer was 38 years old, White British and lived with her husband. She had one child. 
Because she was a full-time midwife, Jennifer had access to blood testing equipment and found 
that her FPG was high early during pregnancy. She felt upset that metformin and overnight 
insulin medicalised her pregnancy. She reported having no support postpartum, but that she did 
not want or need any. Jennifer felt that reducing medicalisation of pregnancy was the most 
important thing to change about GD care.  
She reported a restricted diet during GD. She could not eat any carbohydrates without her 
sugars going very high, even though she had been advised to eat a small quantity. Postpartum, 
she had returned to a similar diet as before pregnancy, and she was aware of the impact that 
carbohydrates had on her blood sugar when making food choices. Work made it difficult to 
exercise, such as walking after meals. 
Jennifer had attended diabetes screening postpartum, and received text messages reminding 
her to book a blood test. The tests reassured her that her blood glucose control was okay, and 
she described how it would give her to time to make changes if she became ‘pre-diabetic’. 
Kelly 
Kelly was 38 years old and White British ethnicity. She had a further education and worked a 
few days in each week. She lived with her partner and had three children. She had GD in the 
last two pregnancies, which she managed by a strict diet, metformin and insulin. She found the 
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diet challenging, and followed a high protein, high fat and very low carbohydrate diet in the 
last pregnancy, which was advised by a recommended Facebook group and not the NHS.  
Kelly’s doctor did not advise her to make further changes to improve her T2D risk because she 
usually had a healthy lifestyle; regaining the weight lost during pregnancy was positive for her. 
Kelly tried to eat healthily, cooking from scratch and being sensible about treats. Since having 
children, she had not had time to play sport or go to the gym so most of her exercise was 
walking. 
She attended her annual diabetes screening tests, and had kept a record of the level so that she 
could detect any increases over time, even if it remained in the normal range. It had been 
straightforward for Kelly to attend, including taking her children along. 
Kimberly 
Kimberly was a secondary school teacher who was on maternity leave at the time of the 
interview. She was 33 years old, White British and lived with her husband. She was diagnosed 
with GD during her second pregnancy, although assumed that she also had GD in the first 
because of her child’s high birth weight. She managed diabetes by diet. She felt as if she had 
been left to look after herself during pregnancy, and relied on websites and a relative who was 
a midwife for advice.  
After delivery, she ate lots of sweets that she had saved up during pregnancy. Her weight was 
stable due to breastfeeding, and her overall diet was similar to that before pregnancy. GD had 
not had a lasting impact on her, but pregnancy had: before having children, she was very active 
and loved running and going to the gym. At the time of the interview, she was starting to walk 
more after recovering from a caesarean section and subsequent surgeries. She planned to 
increase walking after taking her older child to nursery each day. 
Kimberly wanted to be healthier in order to reduce her risk of cancer, but was not aware that 
GD is associated with T2D. She asked lots of questions about this during the interview, and 
felt that more information about this was very important. 
Kimberly had an HbA1c test at 16 weeks postpartum at the GP, after receiving a letter, but was 
not contacted about the results so assumed she was okay. She had not been aware of the 
recommendation for annual testing, but was keen to initiate this with the GP when the time 
came. 
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Komal 
Komal was 32 years old. She was working full time as a nurse. She was Indian ethnicity and 
lived with her husband and two small children. She had GD with both pregnancies and was on 
metformin. 
Komal was working with her GP to lose weight. Her diet had changed from eating lots of white 
bread and rice to seeded bread and avoiding rice as much as she could. She also wanted to 
finish meals earlier in the evening as this had helped her to lose weight in the past. She was 
strict not to have takeaways and sometimes made healthier versions of unhealthy food that her 
children and husband wanted to eat. She enjoyed doing yoga but found it hard because she was 
tired because one child did not sleep well. She also hoped to walk more. 
She had attended postpartum diabetes testing, and recently had an HbA1c test. She described 
herself as health-conscious and concerned to prevent T2D. 
Laila 
Laila was 42 years old and of Asian ethnicity. She had a postgraduate education, worked part 
time, and was on maternity leave at the time of the interview. She lived with her husband. She 
had two children and had GD with both pregnancies. This was managed by metformin in the 
second pregnancy. 
She found GD harder to manage the second time; for example, it was harder to exercise when 
she had a toddler. Postpartum, she put on lots of weight although had been losing it through 
the Slimming World diet. Normally, Laila and her family were fairly healthy but enjoyed sweet 
things. She used to do lots of exercise (such as aerobics classes at the gym) before having 
children. She currently went for walks and a weekly dance class, although she hoped to do 
more when the children were older. 
Laila attended the screening tests after GD, and planned to book it each year at around her 
child’s birthday. She was confused because she had an HbA1c test at six weeks postpartum, 
then was told by the nurse to go back a few weeks later to have it again so that the pregnancy 
blood glucose would not be taken into account. 
Lizzie 
Lizzie was 39 years old and White British ethnicity. She had a postgraduate education and 
worked full time, although was on maternity leave at the time of the interview. She was a single 
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mother and lived with a family member. She had recently had her first baby, and was diagnosed 
with GD but was not on diabetes medication. 
Lizzie said she learnt a lot about diet and diabetes during pregnancy. She hoped to lose weight 
postpartum in order to reduce her risk of diabetes. She had planned to follow a diet similar to 
her GD diet because she had lost weight during pregnancy, but was currently restricted in what 
she could eat because she was breastfeeding and her baby had severe food allergies. She also 
wanted to be more active even though she did not like exercising, saying that she needed to 
stop using the excuse of having a new baby. She was keen for her child to be active, and was 
planning to take her child swimming. Previously, she walked to work but now lived in a small 
village where a car is needed to leave the village. 
Lizzie’s first postpartum test, which she attended, was booked for her while she was pregnant. 
Her GP planned to do a diabetes test at her annual medication review. 
Megan 
Megan was 28 years old. She was White British and had a secondary level education. She was 
single and a home parent for her two children. She had GD in the second pregnancy and was 
treated with insulin. She felt that GD had ruined her pregnancy and now it was ruining her life, 
due to the impact on her relationships, the lifestyle changes she needed to make, and the 
ongoing uncertainty. 
Megan described her second pregnancy as “horrific”, including time spent in hospital and a 
lack of awareness of what was happening. Since pregnancy, she had undergone more tests for 
what she felt was hypoglycaemia. As a result, she had made large changes to her diet: 
previously she used to eat whatever she wanted, and now was careful to eat a more balanced 
diet of fruit and vegetables, more meat, carbohydrates and not have sugar in her tea. However, 
she felt abandoned by her doctors in trying to understand and manage these symptoms outside 
of pregnancy. She went to the gym, which was financially possible because of a referral from 
her GP for depression. 
Megan attended her diabetes screening tests, but felt that annual testing was too infrequent. 
Monika 
Monika was 31 years old and of White European ethnicity. She worked full time and was 
currently on maternity leave, lived with her husband, and had a further education. She had four 
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children and had GD during the last two pregnancies (although she did not have an OGTT 
during the fourth pregnancy and questioned having GD). She controlled GD by diet, although 
was confused by inconsistent results when self-monitoring her blood glucose. 
Monika did lots of cooking for the family. She liked to walk and was busy around the house. 
She felt that she had a good understanding of how to be healthy and had wisdom that she 
wanted to share to support other women, especially if they were struggling during GD. 
She was not invited for a postpartum test after the third pregnancy, which was worrying because 
she expected to be, but was invited by the GP after the fourth. However, she understood that 
her blood sugar level was “perfect”, which meant she was no longer at higher risk of T2D. 
Nicole 
Nicole was 34 years old and White British. She worked part time and had a higher education. 
Nicole and her husband (who was nearby and occasionally joined in with the interview) had 
two children. She was diagnosed with GD in the second pregnancy but thought she had in it 
the first one too. Although metformin helped her to manage GD, she found the pregnancy diet 
hard, and felt like she could not eat anything. 
Nicole said that her diet had always been quite healthy; for example, they did not eat processed 
food and were trying to eat less sugar. Although it was not as much exercise as before 
pregnancy, Nicole did classes at the gym and tried to run at weekends, as well as staying active 
as a family. 
Nicole knew but had forgotten the increased risk of T2D, but was not concerned because she 
kept a healthy lifestyle. Although she initially thought that they did not need more information 
or advice about healthy lifestyle, she agreed with many of the suggestion cards. 
Her GP tested her HbA1c alongside another blood test ordered at approximately 15 months 
postpartum, but she had not had any other glucose test and was not aware of further follow-up. 
Puja 
Puja was 32 years old and a secondary school teacher working part time. She was Asian 
ethnicity and lived with her husband and toddler. She was prescribed metformin for GD. 
She found that the advice for a healthier diet during GD pregnancy was helpful and tried to 
maintain some of these changes after pregnancy, such as eating 50/50 white and wholemeal 
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bread and reducing the sugar in her tea. She wanted to avoid diabetes in the future because she 
found the diet very restrictive. She did not do specific exercise, but would have liked to go for 
a walk with the pushchair once a week, but not every day like she had to during pregnancy. 
Puja’s blood glucose was measured immediately after giving birth in the hospital. She was 
unaware of the possibility of having another postpartum test, but felt that it would be reassuring 
to find out whether she was back to normal rather than assuming that she was fine. She planned 
to contact her GP to ask. 
Rachael 
Rachael worked part-time in her family business. She was 40 years old, White British and lived 
with her husband. She had a further education. She had two teenage children and two younger 
children, having GD in the latter two pregnancies. She was prescribed metformin and insulin 
to manage her blood glucose. She was worried about whether GD would increase the likelihood 
of her children developing diabetes. 
Rachael had family members with T1D: she had witnessed the impact that diabetes had on 
daily life therefore was concerned about preventing T2D. She felt that she looked after herself, 
therefore GD was a surprise and she was frustrated that her blood glucose control was 
deteriorating. She had been doing Slimming World because she had recently given up smoking 
and wanted to be careful not to eat sweet snacks instead. She described her diet as healthy, but 
previously with too large portion sizes. Exercise was part of her weekly routine, particularly 
walking or cycling with her children in the summer. 
She had attended all of the diabetes screening tests that she was eligible for and saw these as 
an opportunity for advice and support.  
Overall, she felt that the emphasis should be on individuals to look after themselves. She also 
said, “I would welcome any sort of additional support, but then if I wasn’t following the 
guidelines I would expect to be chucked off course.” 
Saki 
Saki was Japanese ethnicity and 39 years old. She had a postgraduate education and was on 
maternity leave from working full time. She lived with her husband. Saki had GD in both 
pregnancies, and controlled GD by diet. Monitoring her blood glucose was challenging but it 
helped her to remember to stick to the diet. 
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She was trying to keep up some of the healthy changes from pregnancy, particularly walking, 
to avoid T2D. Exercise could be hard to plan around breastfeeding, but she noticed the benefits 
related to sleep and stress. She was also eating fewer treats, like chocolate and biscuits, and 
much less rice. 
Saki’s diabetes team discussed the risk of developing T2D with her towards the end of her 
pregnancy and booked the six week test before she delivered, which was helpful. She knew the 
advice to be tested annually, although did not know how it would work (she assumed she would 
need to flag it to the GP). 
Samantha 
Samantha worked part time as a midwife. She was 35 years old, White British, and lived with 
her husband. She had three children, with GD in each pregnancy. The diagnosis was a surprise 
because she was otherwise healthy, but she felt supported by the midwifery and diabetes teams. 
She managed GD by diet, cutting out carbohydrates, and lost weight during pregnancy. 
Although she made up for the sugar she had not had during pregnancy while she was 
breastfeeding, Samantha said that her diet has improved: she was more aware of what she ate 
particularly regarding carbohydrates. She was careful during night shifts when she craved 
sugar. She was not able to go to the gym as she did before having children, but liked to be 
active with them and did a daily home workout. She hoped to be more active when her youngest 
child went to school. 
Samantha had attended all of her postpartum diabetes screening tests. Although it was a bit 
hard to attend and take the children to school, testing was a priority so she managed. 
Suzanne 
Suzanne was 35 years old, Chinese ethnicity, had a higher education and worked part time. She 
was currently on maternity leave. She lived with her husband, who was present for part of the 
interview. She found GD diagnosis scary and overwhelming, and was particularly fearful about 
the consequences for her baby. She managed it by diet, cutting carbohydrates and walking lots, 
because she was keen to avoid taking medication. 
On one hand, Suzanne was concerned about developing T2D in the future; on the other hand, 
she had been so busy since the pregnancy she had hardly thought about diabetes – particularly 
in the first two months postpartum. She and her husband had been more health conscious after 
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the pregnancy, such as eating more wholegrains and fewer carbohydrates and smoothies, and 
doing more exercise. Suzanne tried to walk for at least an hour each day, and planned to build 
in higher intensity exercise. This was informed by their own research about diabetes. 
Suzanne attended the first postpartum test, which was booked during pregnancy. However, she 
needed to rearrange the first one after not being able to fast overnight at that time. She planned 
to book her annual diabetes check. However, she was not completely convinced that she did 
not have diabetes still.  
8.4.2 Overview of qualitative findings 
I developed 16 themes considering healthy diet and exercise, diabetes screening and format of 
interventions. These are discussed in Sections 8.4.3 to 8.4.5, in addition to the experience of 
GD pregnancy (Section 8.4.2.2). 
Table 8.3 indicates the participants’ agreement with each suggestion card, if they responded to 
it. 
8.4.2.1 Participant trends 
As shown in Table 8.3 below, 12 participants were positive towards several of the suggested 
ways to increase postpartum support, six had mixed reviews and two tended not to want further 
support. 
Nearly half of the participants were positive towards all or almost all of the support suggested 
for diet and exercise, despite some of these participants reporting making healthy changes 
themselves. Some identified where they had already benefitted from the areas suggested, 
whereas the others wanted any support. Some went on to agree with all of the suggestions for 
increasing uptake of screening for the same reasons. 
Other participants disagreed with many of the suggestions for supporting healthy diet and 
exercise. Jennifer held the strongest of these views, and said “I think they’re [the suggestion 
cards] all quite similar, aren’t they? You know, I think I know those things already…” [White, 
GD metformin and insulin, tested]. Kimberly felt that she already had this support available 
through other sources [White, no GD medication, tested but no plans for another test]. Megan 
and Monika had identified specific areas that they wanted more support in [White, GD insulin, 
tested; and White, no GD medication, tested but no plans for another test respectively]. 
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During the interview, I did not follow all lines of questioning with all of the participants. In 
particular, if women were not aware that they should have had postpartum screening tests, it 
did not feel appropriate to ask them about support for attendance. In this case, I tended to 
suggest they discuss diabetes screening with their GP because it is recommended by the 
national guidelines. I then asked them what benefits they anticipated from a test. 
8.4.2.2 General comments 
Before discussing their postpartum behaviour, I sought to grasp an understanding of the 
experience of GD pregnancy to facilitate rapport and explain some of the context of their 
feelings, attitudes and behaviours after pregnancy. The participants found GD pregnancy to be 
a challenging time, with many making significant lifestyle changes and feeling as if their lives 
revolved around blood glucose levels. GD was the “focus” of pregnancy (Christine [Asian, no 
GD medication, tested]), or even “ruined” it (Megan [White, GD insulin, tested]) and caused 
them to “hate” being pregnant (Holly [White, no GD medication, not tested]). Several 
mentioned not wanting to have another child because they did not want to experience GD again 
or in fear of impact on their health. Nevertheless, most felt that the care they received during 
pregnancy was good. 
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Table 8.3: DAiSIeS participants’ agreement with whether the suggestion cards will support healthy diet, 
exercise and screening attendance (based on the authors’ interpretation of their responses). 











































































































































































































































































































































































































































































































Amber                     A 
Christine                     M 
Danielle                     A* 
Emma                     A 
Francesca                     A 
Holly                     A* 
Jennifer                     D* 
Kelly                     M 
Kimberly                     M* 
Komal                     A 
Laila                     M 
Lizzie                     A 
Megan                     M* 
Monika                     D* 
Nicole                     A* 
Puja                     A* 
Rachael                     M 
Saki                     A 
Samantha                     A* 
Suzanne                     A 
Overall 
response 
A M M M A A A A M A A A M M M A D A M M 
 
Not all participants were shown each card, and some did not comment or agreement was unclear.  
* Based on diet and exercise cards only. 
Dark green: strongly agree; green: agree; red: disagree; dark red: strongly disagree; grey: not shown or 
agreement is unclear. A: overall agreement; M: overall mixed response; D: overall disagreement.  
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Seven participants were also happy with their postpartum care, generally having sufficient 
knowledge of how to have a healthy diet and exercise going forward, or where to find more 
support if required. Seven other participants acknowledged that more postpartum GD follow-
up “would be helpful” (Francesca [White, GD insulin and metformin, tested]), but they were 
able to manage. Christine said, “...after birth you have breastfeeding support, you have weaning 
support, a lot of different support but maybe that is another thing, post-GD support kind of 
thing would be really good for mothers if I am honest” [Asian, no GD medication, tested]. The 
remaining six participants felt the absence of postpartum support strongly, particularly in 
comparison to the close monitoring of pregnancy: “I don’t feel like I've been given the help that 
I think there should be really out there” (Megan [White, GD insulin, tested]). Kimberly said, 
“I’m not being unkind, I know the NHS is busy, no-one really cares about me anymore… don’t 
feel sorry for me, but in terms of, is anyone checking on me? Absolutely not” [White, no GD 
medication, tested but no plans for another test]. No one talked to Nicole about the future risk 
of diabetes [White, GD metformin, tested but no plans for another test], and Kimberly was 
unaware that there was an association between GD and T2D [White, no GD medication, tested 
but no plans for another test]. It was particularly challenging for those who also struggled 
through pregnancy. 
Overall, the participants were eager to make changes to and take responsibility for their health. 
They spoke about the individual’s mind set “because it’s just you know what you need to do 
and it’s just trying to make sure you’re staying healthy isn’t it, that’s the main thing” (Jennifer 
[White, GD metformin and insulin, tested]). Rachael felt that whether someone wanted to be 
helped was a key factor, and that resources should not be wasted [White, GD metformin and 
insulin, tested]. This sentiment was particularly strong in those who felt that they did not need 
more postpartum support than they had received. 
8.4.3 Healthy diet and physical activity 
The following sections describe the findings of the interviews regarding improving the 
healthiness of diet and increasing exercise. These covered seven themes: information and 
understanding, improving diet, improving exercise, family, money, monitoring and 
sustainability. 
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Conversations that arose in response to specific questioning and suggestion cards are reported 
alongside things that the participants brought up. This is not always reported in the order that 
occurred during the interview.  








Family Money Monitoring 
Sustainab-
ility 
Suggestion card 1 (overall agreement): the participants wanted more information about the impact of healthy 
diet and exercise on their diabetes risk. 
Suggestion card 2 (mixed agreement): the participants had differing views regarding more information about 
the impact of healthy diet and exercise on their wider health. 
Most of the participants felt that they would benefit from more information about the impact 
of healthy diet and exercise on their diabetes risk, and opinions varied about information for 
their wider health (suggestion cards 1 and 2). Despite existing knowledge, some participants 
welcomed any extra information because, for example, it would help them to make good 
choices (Komal [Asian, GD metformin, tested]). Others had poor awareness of the long-term 
implications of GD because they had not been told or had missed it at GD diagnosis (Amber 
said, “But it's a small enough detail that it could be easy for someone to forget about it or not 
notice it in the first place. And because there's no sort of specific attention given to it 
postnatally” [White, no GD medication, tested but no plans for another test].) Some were 
therefore particularly keen for more information. Kimberly, who was unaware of any link 
between GD and T2D, said, “100% it would help... I didn’t even know I had an increased risk, 
to be honest, I didn’t know anything... Well hence why I ate all those Easter eggs. I probably 
would have only eaten half” [White, no GD medication, tested but no plans for another test]. 
Although most participants agreed with both suggestions, they tended to anticipate more 
benefits from information about their future risk of diabetes (card 1) than about the broader 
health benefits of healthy diet and exercise (card 2). They already had general awareness of the 
wider benefits or found that existing postpartum support focused on this, such as that provided 
by children’s centres.  
It was important that information was adapted to postpartum mothers who had had GD and 
perceived themselves to be knowledgeable (“not sort of trivial, such as ‘eat a healthy balanced 
diet, exercise more’” [Emma; White, no GD medication, tested]), and practical, as described 
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in the themes below. With the exception of those with no awareness of T2D risk, they preferred 
information that focussed on how to be healthy in relation to T2D, rather than on why they 
were at a higher risk. Several had specific questions about how to do this, such as how strenuous 
the exercise should be and the impact of different exercise durations. 
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Suggestion card 6 (overall agreement): the participants wanted more advice about how to have a healthy diet. 
The majority of the participants were attempting to eat a healthier diet, but felt that further 
advice or tips would help them to do this (card 6). Many commented that the GD dietary 
guidance that they were given was comprehensive, helping them to become very aware of what 
they were eating and make quite radical changes (e.g. it was an opportunity for Lizzie to “learn 
how to eat properly… literally I had no idea about food from the sounds of it” [White, no GD 
medication, tested]). In contrast, they received little or no advice about what to eat after 
delivery. They tended to intend to continue selected elements of the GD diet, for example, 
increasing their intake of fruit, vegetables and wholegrains, and/or reducing treats, sugar and 
carbohydrates.  
There was a range of views among those who wanted more advice. At one extreme, Rachael 
thought she was managing diet appropriately by following the Slimming World diet but 
adapting it to be lower in carbohydrates, but wanted reassurance about whether there was 
anything else she should do [White, GD metformin and insulin, tested]. Conversely, Megan 
was anxious for professional input, saying “…if you did have issues or problems you could 
speak to them and find out how to go about it, again, I just don't feel like the doctors take into 
consideration” [White, GD insulin, tested]. 
A couple of participants commented that the GD diet was not a ‘normal’ healthy diet, such as 
eating peanut butter instead of fruit. Emma therefore asked, “What are we defining as being a 
healthy diet in this [postpartum] context?” [White, no GD medication, tested]. Others wanted 
advice that was relevant to other aspects of their new situations, including managing cravings 
and hunger during night feeds (Holly [White, no GD medication, not tested]), about balancing 
a healthy diet with the calorie intake needed when breastfeeding (Christine [Asian, no GD 
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medication, tested]), and with children of different ages and a husband who came home from 
work at variable times (Samantha [White, no GD medication, tested]). It was important for this 
to be individualised (e.g. “how to keep your diet… right for you” [Megan; White, GD insulin, 
tested] and in accordance with their palate or ethnic background.  
The three participants who did not want any more advice about having a healthy diet were 
attempting to be healthier, like many other participants, but felt that they already had enough 
information by drawing on previous experiences and GD diets, and that any more advice would 
not help them. Two participants thought that they had knowledge about having a healthy diet 
themselves, but that other people needed this.  
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Suggestion card 5 (overall agreement): the participants wanted support to exercise with others. 
Suggestion card 7 (overall agreement): the participants wanted advice about how to exercise with a busy 
schedule. 
Although many of the participants reported doing less exercise than before pregnancy, four 
considered themselves to be active and enjoyed exercise. Some had particular support, such as 
their husband looked after the children so that they could go running or a gym referral for 
another condition. Four participants reported exercise that was part of their routine, such as 
dance classes or daily home workouts. Others did regular but lower intensity activity, such as 
pushing the buggy up the hill on her way home from town. Many wanted to do more exercise, 
and felt this would be achievable when the children were older, at school or they finished 
breastfeeding. Six participants were not active at the time of the interview: some were waiting 
to recover from caesarean sections or pregnancy in general (which some participants above had 
previously experienced), while others just found it too much at that time. Two participants were 
not interested in increasing exercise at all. 
Amber, who ran regularly, said, “I think you have to [prioritise exercise], otherwise it just 
doesn't happen. It is so easy to just go, ‘oh I haven't got the time’ because most, pretty much 
every single new mum does not have the time… [it] is really good for your mental health as 
well as your physical health… it is a bit like once you start doing it you get into it… but starting 
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out is really difficult, definitely, and it can be quite demoralising because your body doesn't 
quite move in the same way when you've just had a baby. Everything is a bit clunky and a bit 
wobbly and not quite how it used to be and it can be quite hard to get over that initial starting 
block. Yes, and perhaps does need to be a bit more dedicated support for that…” [White, no 
GD medication, tested but no plans for another test]. 
The majority of the participants were positive that help for them to exercise with others (card 
5) might facilitate physical activity. Several mentioned how exercising with other people (such 
as friends) had been helpful for them in the past, or was anticipated to help by making exercise 
less boring. Others had preferences for specifically parent-friendly or mother-and-baby classes, 
or postpartum GD groups. Such classes would be much more accessible for them and provide 
an opportunity for socialising and meeting other mums with GD to share experiences. 
Exercising at home “tend[ed] to be quite isolated” at a time that was already isolating (Danielle 
[White, GD insulin, not tested]). These groups might need signposting or prompting; e.g. the 
health visitor could give information about local activities, because the participants thought 
they existed but did not know where to find them or had not thought to look. Conversely, a few 
did not like to exercise with others because it was distracting or they liked to exercise at their 
own pace. 
Almost all the participants were eager for advice about how to exercise with a busy schedule 
(card 7), saying that was what would help the most or was the thing they had issues with. 
Several said that they had not received any advice about this. Specifically, they wanted 
guidance about how to fit physical activity in amongst busyness, how to do it around the home, 
and ideas that were suitable for the whole family to do together. Appropriateness for 
postpartum period was important: Danielle suggested cards with postpartum-friendly exercises 
“like little diagrams and exercise routine that build the further on you get in your health… 
especially to what kind of birth you've had” [White, GD insulin, not tested].  
Several participants shared what had helped them, including: 
 “Split[ing] my exercise schedule so I did exercise for 15 minutes in the morning and 30 
minutes in the evening” after work (Komal [Asian, GD metformin, tested]); 
 “Having a baby carrier… you can keep an eye on them and they are happy because 
they’re [at your chest]. But also it gives you both your hands free to do stuff. Also it is 
exercise because you’re carrying them around and they’re getting heavier and heavier. 
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Just make sure you get a good one that supports your back” (Francesca [White, GD 
insulin and metformin, tested]); 
 “Try to use the pushchair more than the car seat” (Saki [Asian, no GD medication, 
tested]). 
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Suggestion card 3 (mixed agreement): the participants had differing views regarding more information about 
the impact of diet/exercise on their family. 
Suggestion card 4 (mixed agreement): the participants had differing views regarding suggestions for being 
healthier as a family. 
The participants found that their young family made having a healthier lifestyle harder than it 
was before they had children. Several used to play sports or go to the gym, and had to stop this 
because they had less spare time or now wanted to spend it with their children instead. As a 
result, most did less intense exercise, such as family walks or generally running around with 
the children. Similarly, they had to try to balance family members’ dietary preferences or 
compromise on menu choices (Komal said, “…sometimes [my children] won’t agree to what 
you give… there’s green food – ‘I don’t want’, they want some kind of pizza or burger all those 
things but still I somehow try to convince them with this kind of food” [Asian, GD metformin, 
tested]). On the other hand, parenthood could provide new opportunities for a healthy 
postpartum lifestyle: Komal’s older child encouraged her to exercise, saying “it’s your time for 
exercise, come, we do it together” [Asian, GD metformin, tested], and Christine met other 
mothers from her antenatal group for walks [Asian, no GD medication, tested]. Some also 
found that their children motivated them to be healthier because they wanted to stay well for 
their family and/or wanted to prevent unhealthy habits in their children (e.g. teaching them to 
eat well). Some were supported in healthy changes by their husbands (e.g. Suzanne and her 
husband “both changed our lifestyle” [Asian, no GD medication, tested]) whereas Francesca’s 
husband was “more of a cheerleader than a participant” [White, GD insulin and metformin, 
tested] and others even disagreed over getting a takeaway (Komal [Asian, GD metformin, 
tested]). 
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The participants had mixed views regarding whether more information about the impact of 
healthy diet and exercise on their family (card 3) would be helpful to them. Some participants 
reasoned that it was important for children to be healthy too: it was something they would do 
as a family. Others felt that they already knew this or the information had already been provided 
by their health visitor (although not everyone had received this kind of guidance). In addition, 
Samantha felt that the children “don’t struggle with blood sugars, they don’t struggle with not 
being able to get out and get fresh air” [White, no GD medication, tested] and Puja did not 
want to influence or restrict other adults in the family [Asian, GD metformin, not tested]. 
The suggestion of ways for their children and wider family to be healthier (card 4) received 
mixed agreement in a similar light to card 3. Some participants suggested practical support that 
would be helpful: practicalities of how to fit a healthy lifestyle in with family life, ideas for 
activities involving wider family and friends, and recipes that were suitable for children and 
how to easily adapt them for parents. 
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Suggestion card 9 (mixed agreement): the participants had differing views regarding advice about saving 
money. 
Twelve participants were in favour of advice about saving money and maintaining a healthy 
lifestyle (card 9). Amber didn’t “think there’s much useful guidance about maintaining that 
kind of healthy, diabetes-friendly diet on a budget actually” [White, no GD medication, tested 
but no plans for another test].  
Healthier food (such as that which is higher in wholegrains and proteins and low in 
carbohydrate) was frequently perceived, or experienced, to be more expensive than unhealthy 
food. Amber went on to say that some of the normal advice about saving money through batch 
cooking was not “necessarily the right thing for someone who is trying to like minimise diabetes 
risk to be eating” [White, no GD medication, tested but no plans for another test], and Suzanne 
suggested looking at the ingredients list rather than buying from the more expensive ranges 
[Asian, no GD medication, tested]. Exercising at home was beneficial because it was free or 
much cheaper than going to the gym or exercise classes. There was also a need for healthy 
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options for the family to do, particularly as costs increase with a larger family and as they get 
older. 
The participants who disagreed that this suggestion would help them to be healthier tended to 
find that cost was not associated with diabetes; that is, that it did not prevent people from being 
healthy because cheap or free options were available. Cooking from scratch was already 
cheaper than buying prepared food, therefore they had fewer options for saving more money. 
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Suggestion card 10 (overall agreement): the participants wanted advice about monitoring their progress. 
Almost all of the participants had positive views towards monitoring their progress after 
pregnancy (card 10). Several felt that is was the thing that would make the biggest difference 
to them. They discussed either monitoring themselves (by recording their weight, diet, exercise 
levels, calories in and out, or ‘nice’ things like going out to the park) or through meeting with 
a health professional. Importantly, it was seem as a way to maintain motivation for changes or 
to get more information and feedback on their efforts. 
Monitoring was perceived to be helpful because it would stimulate them to see their 
achievements and the benefits, or repeatedly reinforce the need to be healthy. Christine, who 
discussed in length that one of the reasons that she could maintain the GD diet was that there 
was “something imminent”, thought that a monthly weight check would provide a “destination” 
to keep her on track [Asian, no GD medication, tested]. However, monitoring calories or steps 
might not be as motivational as self-monitoring blood glucose because the results would not 
be immediate (Emma [White, no GD medication, tested]). Several were also cautious that 
monitoring could have the opposite effect: Lizzie was wary of tracking her weight in case she 
became demoralised and gave up [White, no GD medication, tested]; Komal’s GP had set her 
weight loss goals but this was too stressful at that time due to changing jobs [Asian, GD 
metformin, tested]; Lizzie felt that Slimming World was too judgemental [White, no GD 
medication, tested]. 
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Others wanted monitoring as an opportunity for more guidance. They thought it would help 
them to keep track of how their body was doing with regards to diabetes risk factors and blood 
glucose control. Danielle thought that the option to attend an appointment with a specialist in 
the first few months postpartum would make a big difference because it would enable them to 
discuss any problems and talk through ideas (because sometimes they do not know who to ask 
for advice) [White, GD insulin, not tested] and Megan wanted to discuss how to manage diet 
in relation to the diabetic symptoms that she felt [White, GD insulin, tested].  
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Suggestion card 8 (overall agreement): the participants wanted advice about sustaining healthy diet and 
exercise changes. 
The majority of the participants agreed with the suggestion of advice about sustaining changes 
(card 8). They felt that this would be helpful because they knew that maintaining a healthy 
lifestyle would be challenging. In practice, they felt that this could be facilitated through the 
earlier themes; for example, that advice about healthy food that was suitable for the whole 
family, exercises that could be done around the house, and more follow-up would all help them 
to maintain diets to reduce their risk of T2D. 
8.4.4 Attendance at diabetes screening 
Of the 20 participants interviewed, 16 had a postpartum diabetes test (and one was booked for 
soon after the interview). Three participants had not attended testing because they had not been 
offered or invited: Danielle and Puja did not know postpartum testing was possible and thought 
that no contact was normal [White, GD insulin and Asian, GD metformin, respectively] and 
Holly had not initiated it [White, no GD medication].  
During the interview, four more participants revealed that they were unware of the 
recommendations for subsequent, annual testing. Monika understood from her GP that her 
blood test results were so good she was no longer at higher diabetes risk [White, no GD 
medication]. Despite having had a postpartum test, Kimberly was not aware of her higher T2D 
risk and had not heard about lifelong testing [White, no GD medication]. Nicole only had a test 
approximately 15 months postpartum after her GP ordered a blood test for another condition, 
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and felt that this had been too long to wait [White, GD metformin]. Amber expected the six 
weeks postpartum test to be the end of GD follow-up unless she became pregnant again [White, 
no GD medication]. 
Six participants returned to the hospital for the postpartum test, four of whom had the 
appointment booked during pregnancy. Six had their first postpartum test at the GP: either 
because they had been invited to go to the GP, they had it as part of the six week check, or 
because they did not know where to go for testing so asked the GP who arranged it. Those who 
were longer than one year postpartum attended the GP for annual testing. Some received 
reminders while others initiated it themselves each year. 
Most of the participants initially said that they went for testing because they were invited to: “I 
thought, ‘Oh I’ve got an appointment.’ It didn’t really occur to me not to go” (Lizzie [White, 
no GD medication, tested]). This reason was often followed-up by the desire to find out whether 
the diabetes had gone (for interest or reassurance) and therefore whether they needed to take 
further action such as increasing exercise or initiating pharmacological treatment, because they 
understood diabetes to be a serious condition. Additionally, several participants commented on 
the lack of feedback on the outcome of the test, unless they were diagnosed with IFG or IGT. 
Kelly requested the specific numbers from the GP so that she could monitor and notice if it 
started to creep up [White, GD metformin and insulin, tested]. Other participants, including a 
midwife, felt that annual testing was not regular enough.  
Where I suggested that the participants who did not have plans to return annually contact their 
GP surgery to discuss this, they were keen to do so for similar reasons to the participants who 
had attended; that is, they wanted reassurance. In particular, Puja had been concerned that she 
still had diabetes [Asian, GD metformin, not tested]. 
Discussions regarding attendance at diabetes screening covered eight domains: booking tests, 
test location, test used, combining appointments, child-friendly clinics, GP awareness of 
pregnancy, understanding GD and postpartum testing, and stopping self-testing. I discussed 
what would have made it easier to go to testing with the participants who had attended a test, 
and what would help them to go in the future. Generally, the themes relate to the difficulty of 
attendance rather than preventing attendance altogether. 
Chapter 8  The DAiSIeS study 
208 




















Suggestion card 11 (overall agreement): the participants wanted to discuss postpartum testing during 
pregnancy. 
Suggestion card 12 (overall agreement): the participants wanted invitations and reminders for tests. 
Of the participants who attended their first postpartum test, most had been invited. Regardless 
of their booking experience, the participants agreed that the postpartum test being discussed by 
their clinical team during pregnancy (card 11) was important for follow-up, mostly because 
they had a positive experience or thought it would help for the clinical team to “be hotter on 
this” (Danielle [White, GD insulin, not tested]). 
The participants tended to be positive about having the postpartum test booked early (such as 
at the last pregnancy scan): although discussing postpartum follow-up during pregnancy was a 
bit of a surprise, it was not worrying and helped them to know what was coming. It also 
provided an opportunity for doctors to explain the importance of the tests in advance, which 
would “help people to prioritise it” (Lizzie [White, no GD medication, tested]). Four other 
participants arranged their own tests because they knew this was important after being told 
during pregnancy: several mentioned that midwives regularly reminded them to have a 
postpartum test, and another said it was emphasised while she was on the delivery ward.  
Several participants explained that they attended the first postpartum test because they received 
a letter with an appointment time or asking them to book it. Although many had not yet become 
eligible for annual testing, only Jennifer received text reminders to book a blood test, which 
she knows is for GD follow-up [White, GD metformin and insulin, tested]. Others were told 
that they would receive a letter but did not. Of those who were aware of the recommendations 
for subsequent testing, most mentioned that they were advised to book the test; that is, they did 
not anticipate any contact from the GP about this.  
In general, the participants were eager to be responsible for their own health (for example, by 
setting an annual reminder for the test on their phone and “pretend it’s a birthday” [Kimberly; 
White, no GD medication, tested but no plans for another test]). Nonetheless, they all felt that 
a reminder from the GP would be useful (card 12), including Rachael who worried whether 
postpartum interventions would be a suitable use of NHS resources [White, GD metformin and 
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insulin, tested]. Others considered this as the change that could make the most difference. They 
thought it would be helpful because life gets “hectic” with the baby (Danielle [White, GD 
insulin, not tested] and Christine [Asian, no GD medication, tested]), it was easy to forget 
(Komal [Asian, GD metformin, tested] and Lizzie [White, no GD medication, tested]), and it 
can be easy to put off (Kelly [White, GD metformin and insulin, tested]). In particular, Laila 
said, “Because they’re the ones that sent you for the test while you’re pregnant so you assume 
they have the same responsibility to look after you postpartum as well” [Asian, GD metformin, 
tested]. Additionally, a couple of participants said that annual testing was hard to remember 
because it was not frequent enough to form a routine. They suggested emails, letters, text 
messages, or a notification in their online GP portal. Several likened it to having a cervical 
smear test, where a letter is sent from the GP. 




















Suggestion card 16 (overall agreement): the participants wanted to be able to choose where to have their 
diabetes screening test. 
The participants either suggested or agreed when asked that the test should be available at a 
location of their choice (card 16). They thought that having blood taken at the general practice, 
alternative clinic, or even a local hospital (rather than the centre that managed their GD) would 
facilitate attendance. This was because it was not “trivial” to travel to the hospital with a small 
baby (Saki [Asian, no GD medication, tested]). It was often a long journey with a higher cost, 
and required them to make alternative arrangements for taking older children to school. In 
contrast, the GP surgery was closer, easier to get to, and had more availability and flexibility 
in appointment times.  
In the busyness of the early postpartum period, going to the hospital for the blood test did not 
seem like a worthwhile investment of their time. Lizzie lived less than 15 miles from her 
hospital and said “they need to offer that from your GP” because she got up at 5.00 am to attend 
the test at 8.30 am, and was still late for it. Anticipating the 2 hour OGTT, she was frustrated 
that the FPG test was so short compared to the preparation time and reacted with, “sod it, I 
don’t care about calories or gestational diabetes, I’m just going to go and eat [a] McDonald’s 
[breakfast]”. 
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The two participants who did not agree with this suggestion found it easy to attend either their 
hospital or general practice. 




















Suggestion card 17 (overall disagreement): the participants did not want more pleasant screening tests. 
The participants who had attended postpartum screening had had an FPG or HbA1c test. When 
asked whether a shorter or more pleasant postpartum blood test would make it easier for them 
to attend (card 17), a couple of participants noted how the postpartum FPG or HbA1c was better 
than the OGTT that was used during pregnancy. However, the majority were indifferent since 
“you are jabbed with needles so many times when you are pregnant, one more is really not an 
issue” (Amber [White, no GD medication, tested but no plans for another test]), or that it was 
“quick and easy” (Kelly [White, GD metformin and insulin, tested]) and “no one sticking a 
needle into you is [ever] pleasant so…” (Emma [White, no GD medication, tested]). 




















Suggestion card 18 (overall agreement): the participants wanted to be able to combine their diabetes 
screening test with another appointment. 
The participants felt that being able to have their blood test alongside another appointment at 
their general practice (card 18) would make it easier to be screened for diabetes. They described 
“having an awful lot of appointments just in life” (Nicole [White, GD metformin, tested but no 
plans for another test]) and with children generally, therefore one less trip would ease this 
burden. This challenge was exacerbated by the long time that it took to leave the house with 
the newborn (as described in Section 8.4.4.2) and some of the worries of being out with them.  
Some participants suggested that the six weeks check was a suitably-timed appointment to 
combine testing with, and considered that it might increase uptake because most women attend. 
Suzanne had wanted to discuss GD follow-up in more detail at this appointment, therefore it 
coinciding with the blood test may make it a salient time to discuss GD [Asian, no GD 
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medication, tested]. Laila thought that it could coincide with children’s vaccinations, saying, 
“If we're thinking HbA1c at three months, then the babies have their three month jabs don’t they 
so that would work. I think that would help” [Asian, GD metformin, tested]. 
On the other hand, Komal was concerned that her children would distract her from talking to 
the doctor [Asian, GD metformin, tested]. 




















Suggestion card 15 (mixed agreement): the participants had differing views regarding the benefits of more 
child-friendly clinics and waiting rooms. 
The participants had different experiences of attending appointments with their children, and 
held differing views towards the suggestion to make waiting areas more child-friendly (card 
15).  
The most common experience was that GP surgeries, which tended to be mentioned over 
hospital clinics, were already appropriate, such as with children’s books and toys. These kind 
of resources were valuable; for those without them, the surgery was a “nightmare” (Kelly 
[White, GD metformin and insulin, tested]) or taking a toddler “would be havoc” (Samantha 
[White, no GD medication, tested]). Emma, however, thought that parking facilities and a 
choice of appointment times made the appointment more child-friendly than the waiting room 
[White, no GD medication, tested].  
Other participants were not affected by the suitability of the clinic because they did not take 
their children to the appointment. Some made sure the appointment was at a time when their 
husband could care for the children, or that the children were at school. Komal said she did this 
so that she would not be distracted: “…you might be have hundreds [of] thousands of questions 
in your mind but when you go with your kid you can't ask even one or two” [Asian, GD 
metformin, tested]. 
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Suggestion card 13 (mixed agreement): the participants had differing views regarding the benefits of their GP 
knowing more about their GD pregnancy. 
Some participants thought that their GP knowing more about their pregnancy would improve 
their postpartum care (card 13) because GD could be mentioned at other appointments. They 
often linked this to needing more postpartum support – both in general because postpartum 
care was focussed on the baby, and in relation to blood glucose screening.  
Two participants, who agreed that this suggestion would help follow-up, had positive 
experiences of GPs initiating care. Nicole was impressed that her GP had noticed GD in her 
notes and requested the diabetes test as part of a blood test she was having for a different reason 
[White, GD metformin, tested but no plans for another test]; Lizzie, whose GP planned to do 
the test at her medication reviews, thought that the GP was well-placed to re-emphasise what 
was said during pregnancy because “that’s the person you’re used to seeing, so its definitely 
going to make it more likely that you will go to tests and things if your GP knows about it” 
[White, no GD medication, tested]. 
However, several disagreed that this would help or thought it would be inappropriate because 
it was the midwives’ role to manage pregnancy care and not the GPs’.  




















Suggestion card 14 (mixed agreement): the participants had differing views regarding more opportunities to 
understand GD 
Suggestion card 19 (mixed agreement): the participants had differing views regarding more opportunities to 
understand the diabetes screening tests 
There was disagreement among the participants about whether a better understanding of the 
implications of GD on their future health (card 14) and the purpose of postpartum testing (card 
19) would facilitate attendance. 
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Half of the participants asked felt that they already had enough information because they 
learned from their clinicians (therefore this area of care was already done well), did their own 
research, or were healthcare professionals with existing knowledge themselves. Saki explained 
that she had talked about the risk of T2D with the hospital team towards the end of pregnancy, 
and that “just hearing from the consultant directly, I think has a bigger effect on people, than 
just kind of reading about it on the leaflet” [Asian, no GD medication, tested]. She also noted 
that this might have been possible for her because her GD had been easy to manage, whereas 
others’ consultations might need to focus on glucose control. 
The other participants wanted more information and opportunities to understand GD or 
postpartum testing, although they did not always agree with both suggestions. Some 
participants wanted to understand the ongoing implications of GD – “how it affects you in the 
long-term as well” (Lizzie [White, no GD medication, tested]). A couple of participants raised 
specific questions about the tests, some of which suggested a high level of understanding, such 
as whether a FPG could tell you as much as an OGTT or whether a FPG was suitable for them 
because their fasting results had been normal throughout GD pregnancy. Laila had her HbA1c 
measured six weeks after both pregnancies: “I just don't understand why the doctors tell you to 
go and get it at six weeks after… but then that's not accurate because obviously it's taking into 
account when you're pregnant so I don't understand the point of me having had that test” 
[Asian, GD metformin, tested].  




















Suggestion card 20 (mixed agreement): the participants had differing views regarding removal of the option 
to self-monitor their blood glucose. 
The participants had mixed views about this suggestion, but none strongly felt that an inability 
to do finger prick tests would cause them to favour attending a screening test (card 20). Some 
participants said that they did not want to do any more self-testing: they did not like it so would 
prefer someone else to do it for them, and understood that the formal test was more accurate. 
Holly wanted the clinical team to take the self-testing kit back because it would mark the end 
of GD [White, no GD medication, not tested]. 
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On the other hand, some participants had or wanted the option to monitor their blood glucose 
postpartum. This tended to be out of curiosity because they had become accustomed to knowing 
what their blood glucose was immediately after a meal and were interested to see how different 
foods affected their blood sugar now they no longer had GD. Samantha said, “Then you can 
actually get a feel of what you're eating and how that affects your blood sugar… directly affects 
your blood sugar, rather than just putting it onto an average” [White, no GD medication, 
tested]. Some participant suggested that they would test their blood sugar again if they 
suspected symptoms of diabetes, and Saki was not sure that she did not have diabetes still 
because she had not monitored postpartum, even though she had the FPG test [Asian, no GD 
medication, tested]. Megan wanted a record of her blood glucose as evidence of the ongoing 
symptoms she experienced to show her GP “because then at least I've got the proof, look at 
these times I'm getting like this…” [White, GD insulin, tested]. 
8.4.5 Delivery of support or interventions 
To follow-up the discussions of what support the participants felt they would benefit from, I 
also asked about how this could be delivered. This was mostly considered in the context of diet 
and exercise support and included the preferred format, source and timing. 
8.4.5.1 In-person peer groups 
Seven participants wanted to be part of a peer support group. This could start during pregnancy 
and continue postpartum to share experiences from different stages of GD pregnancy because 
“unless someone else has been in that position you do feel kind of alone” (Megan [White, GD 
insulin, tested]). “Mum-centric” postpartum groups (Laila [Asian, GD metformin, tested]) 
could include tips for reducing diabetes risk and be linked to an exercise class. They could be 
hosted through children’s centres, where other information classes such as for breastfeeding 
and postpartum mental health already took place. 
8.4.5.2 Appointments with a healthcare professional 
Follow-up with a clinician or healthcare professional was the most frequently mentioned 
intervention. It could range from an instructive appointment to a casual conversation where 
they were signposted to other resources. Midwives, hospital diabetes teams, health visitors and 
GPs were the logical providers because they had provided GD care and were a trustworthy and 
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respected source of information. Emma said, “There is something about a medical professional 
saying, ‘You need to get a grip on this’” [White, no GD medication, tested]. 
During pregnancy 
Several participants discussed being given advice about postpartum diet and exercise, and long-
term diabetes risk during pregnancy, such as by the consultant. It was good for this to be 
introduced, knowing that more information would follow. Towards the end of pregnancy, 
Emma’s friends were cooking meals for her to eat after the birth and “at no point did we think, 
‘Right, what is the healthiest follow-up way we can do this?’” [White, no GD medication, 
tested]. Kimberly said that the advice should be given during pregnancy because that is when 
you are most aware of GD (because of monitoring blood glucose) and there are many 
distractions afterwards [White, no GD medication, tested but no plans for another test], whereas 
Samantha thought pregnancy was too early because there was so much going on already 
[White, no GD medication, tested]. 
On the ward and at discharge from hospital  
Similarly to during pregnancy, four participants felt that follow-up should be mentioned, in a 
casual way, while they were on the maternity ward or at discharge from hospital, whereas 
another disagreed because she lost all of the many discharge papers she was given. Amber 
explained that she had other conversations on the ward, such as guidance about recovery from 
the caesarean section and that GD could be mentioned among these [White, no GD medication, 
tested but no plans for another test]. Women who had more complicated births spent more time 
in hospital and generally felt abandoned with regards to GD at that time, therefore would like 
someone to take the opportunity to make sure that they “knew the plan of action” (Holly [White, 
no GD medication, not tested]) before discharge. Saki thought that there would be time to give 
them “a little leaving parcel of like here's a little pack of how to keep going with the good work 
you've done” [Asian, no GD medication, tested], along with the acknowledgement that it would 
be “hectic” (Danielle [White, GD insulin, not tested]). 
Postpartum 
Thirteen participants discussed a postpartum appointment with a clinician. Sometimes they did 
not know who to ask for support (Danielle [White, GD insulin, not tested]). Although some 
participants considered an optional follow-up appointment with a hospital specialist e.g. a 
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dietician or the diabetes team, many suggested GD follow-up become part of the six week 
mother-and-baby check, which would be after the initial, overwhelming stage.  
In practice, this appointment focused on the baby, which was very important, but they too 
needed to some time with an expert to be asked how they were and how things were going, to 
debrief and have some reassurance, and discuss what to do next. Holly was struggling by the 
time of her six week check but did not feel able to tell the GP this because they did not ask 
[White, no GD medication, not tested].  
As discussed in Section 8.4.3.6, they wanted this to be linked to their blood test results as an 
opportunity to receive feedback. Similarly, the annual blood test appointment was a chance to 
discuss what they had been doing and whether there is anything to be concerned about and gain 
any extra feedback or advice. 
8.4.5.3 Written information 
During pregnancy, the participants sought information about GD from a range of sources: 
information leaflets from the hospital, their own research on the NHS website, online forums 
such as Facebook groups, and other online GD resources (e.g. Gestational Diabetes UK 
website). Additionally, they sought more general diabetes and healthy lifestyle information 
postpartum (including from Dr Michael Moseley [diabetes dietary advice], Joe Wicks [‘The 
Body Coach’], Slimming World, and Eat Well for Less television programmes). NHS resources 
tended to be more trusted than forums, but forums or smartphone apps had the benefit of an 
interactive community with opportunity to share tips. 
Lizzie found that Facebook groups were useful for information [White, no GD medication, 
tested]. The groups had been recommended by a friend and someone on one of the groups. 
Online conversations were understanding and supportive (she left the groups that felt 
judgemental). Even if she did not participate by posting a question, it was reassuring to read 
about someone else who had had a similar experience. Komal used a calorie counting app that 
she inputted food and was linked to her smart watch, which she found very motivational [Asian, 
GD metformin, tested]. Emma felt that an app would be beneficial, although her baby was 
jealous of her mobile phone (which she used to track their routine) and was concerned about 
screen time [White, no GD medication, tested]. 
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Similarly, they thought that written information about postpartum lifestyle would be beneficial, 
such as a booklet, website or app. Suzanne proposed a “website that can make suggestions or 
to have a community of people with GD who share recipes, what their concerns are” [Asian, 
no GD medication, tested]. Several mentioned that written resources had the benefit of being 
available all the time: “especially when you’re doing feedings… late night feeds or whatever, 
you can sit and have a look at your phone and get that support 24/7” (Kelly [White, GD 
metformin and insulin, tested]). 
Many participants implied that information could be provided in a variety of formats; that is an 
intervention would not be required to cover all aspects of support. Written information, 
regardless of format, would be most beneficial if it was provided alongside face-to-face care. 
Similarly, if the clinician directed them to such resources or reinforced it, they would pay more 
attention to it. 
8.4.5.4 Delivery of messages 
Six participants felt strongly that the manner in which support was provided was important for 
it to actually be helpful; that is, information should be shared in an individualised and sensitive 
fashion. The participants who described specific struggles during pregnancy and/or postpartum 
particularly emphasised this. Danielle felt judged for her weight during pregnancy, and thought 
that information should come as part of a gentle chat in a positive frame, such as “here’s a few 
ideas, it’d be really good to keep it up” [White, GD insulin, not tested]. Lizzie said that 
postpartum diet and exercise should be managed delicately due to hormones and stress: “if 
somebody had said to me at that point, ‘You need to be eating this, this and this,’ I think I’d 
have probably cried”, and didn’t want to feel checked up on or “like you’re failing your child” 
[White, no GD medication, tested]. Although she was supported and knowledgeable about GD, 
Suzanne was particularly scared by the diagnosis and felt that clinicians should take more time 
to consider the mother’s viewpoint [Asian, no GD medication, tested]. Moreover, Emma was 
very positive about the GD experience, and felt that messages should “transition from a sort of 
deficit reaction of ‘I can no longer have this, this and this’ to a more positive reaction of ‘well 
I can have this, this and this if I do that’” [White, no GD medication, tested]. 
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8.5 Discussion 
In this study, 20 mothers with recent GD shared their experiences of pregnancy and postpartum, 
focussing on their diet, physical activity and screening attendance in relation to their risk of 
developing T2D. These women thought that additional advice about how to eat healthily and 
exercise when they were busy, and practical suggestions for making these changes sustainable 
in their context, would most help them to reduce their risk. Many wanted more specific 
information about long-term T2D risk, but they often knew enough about the universal benefits 
of a healthy lifestyle. Although written information in any format would be acceptable, access 
to other mothers with GD and a clinician talking to them about follow-up in a supportive 
manner was anticipated to be beneficial. Both the participants who had strategies to remember 
to book their annual diabetes test and those who were not aware that they were eligible for any 
follow-up felt that being invited to attend by a clinician would facilitate screening, particularly 
if they could choose the location. 
8.5.1 Comparison to Chapters 6 and 7 
This study was designed to build on the two qualitative syntheses reported in Chapters 6 and 7 
(208,209). In particular, I sought to further understand some of the observations from other 
qualitative studies, fill gaps identified in the literature and elicit the response of a local 
population to suggestions for promoting a healthy lifestyle after GD and attendance at diabetes 
screening. In this section, I compare the findings of the DAiSIeS study with these literature 
reviews. 
8.5.1.1 Healthy diet and physical activity 
The qualitative synthesis was based on 21 studies (209), one of which was set in the UK (256) 
and many of the others in high-income countries including Australia, Canada, Denmark and 
Sweden. I identified six barriers to and facilitators of healthy postpartum lifestyle (Table 7.1).  
Firstly, I had found that a woman’s identity and role as a mother was particularly influential on 
her views of healthy postpartum behaviours. The DAiSIeS participants had similar experiences 
of many of the practical aspects of motherhood. Many did less vigorous exercise so that they 
could spend time with their children instead and wanted suggestions for healthy food that the 
whole family could eat so that the children learnt healthy habits, if they had not already received 
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such advice. However, they tended not to discuss the emotional side, where participants in the 
review had referred to their “guilt” (282) or “moral tug” (288) for not staying with their 
children. I also found that, despite this identity and role as a mother, the majority of the 
participants did not support interventions that related to their family directly; instead, they 
tended to want help to fit diet and exercising around their families.  
Secondly, in the reviews I had found that social support facilitated healthy behaviour whereas 
its absence was a barrier. The participants I interviewed discussed how support from family 
and friends had helped healthy behaviours, and anticipated social support to help them. For 
example, Amber and Nicole’s husbands encouraged them to exercise, and most of them 
anticipated benefits from exercising with others. Additionally, many wanted more 
opportunities to share experiences with others with GD, echoing the sentiment from Jones et 
al. 2015 that “…we’re all in that group together” (288).  
Thirdly, I had identified the theme of ‘demands of life’ in the literature review, where lack of 
time and energy were barriers to healthy diets and particularly doing exercise. For the 
participants in the DAiSIeS study, this was particularly true for the early postpartum period, 
which was not considered a time for a healthy lifestyle but for learning to adapt to life with 
their new baby. Guidance could therefore be developed to help mothers to transition out of this 
stage to longer-term healthy lifestyle. While they shared the view from the review that exercise 
required “set[ting] aside time” (278) and “taking time out for themselves” (282), several 
identified the holistic benefits of doing this. In particular they wanted advice about how to 
exercise with a busy schedule (card 7), which had moderate confidence in the review 
(recommendation 8), and about sustaining the changes in the long-term (card 8; although 
informed by the reviews, this was not explicit in previous studies). 
Fourthly, I had found that personal preferences and previous experiences (such as their food 
preferences, cravings, and whether they enjoyed exercising) influenced behaviour. In the 
interviews, many of the aspects relating to diet had been dealt with during pregnancy, e.g. 
learning to adapt their normal diet to be healthier but still eating what they wanted, to a degree. 
After pregnancy, the participants reverted back to their previous diets (as a relief or reward) 
while maintaining a selection of elements from the GD diet, because that had been healthier 
but too extreme to sustain in the long-term. Interventions may be able to focus on adapting 
previously tested elements of healthy lifestyle to be sustainable. 
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Fifthly, I had found that diabetes risk perception was associated with intention to prevent T2D 
through a healthy lifestyle. As in many of the studies in the literature review, I observed a range 
of views from fear of T2D to not knowing there was an association between GD and T2D. I 
also spoke to participants who would empathise with feeling “abandoned” (252,264,283) 
postpartum, whereas some had felt supported and knew how to proceed after pregnancy. 
Nonetheless, more information about T2D risk and risk prevention were seen to be important, 
particularly if it was adapted to them, in agreement with a participant in Lindmark et al. 2010 
who said “…even if it is old knowledge it is good to hear it once more” (284). 
Sixthly, I had found that a lack of finances and resources could be a barrier to healthy lifestyles. 
Some of the DAiSIeS participants reported similar challenges such as healthy food and going 
to the gym being expensive, although not all participants associated cost with healthiness. Other 
participants felt they already had cheaper or free options available and so some disagreed that 
advice about how saving money and maintaining a healthy lifestyle would be of use (despite 
this recommendation having high confidence). 
8.5.1.2 Attendance at diabetes screening 
The qualitative synthesis of attendance at diabetes screening was based on 16 studies (208), 
also only including the same study set in the UK (256) plus several in countries with similar 
healthcare systems such as Australia and Denmark. Influences on attendance at diabetes 
screening related to the healthcare system or were personal factors, and could be described as 
either permissive or motivational (Figure 6.4). 
Firstly, I had reported that interaction with the healthcare system influenced patients’ intentions 
towards screening in the review (specifically, the behaviour of the clinicians, the process of 
booking tests, continuity of healthcare, and ability to understand diabetes risk). Each of these 
subthemes affected the participants in the DAiSIeS study. Whether they had had their 
postpartum test arranged for them or a clinician emphasised that they needed to book it were 
particularly influential factors; that is, this could be the reason that they did or did not attend. 
The clinician would discuss why testing was recommended, here combining the behaviour of 
the clinicians and the process of booking tests and sometimes ability to understand diabetes 
risk. I had high confidence based on the review that invitations for tests would facilitate 
attendance, and almost of the participants in this study agreed for similar reasons (reassurance 
and busyness). Additionally, several participants felt that the clinician had some responsibility 
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for their care. This could be positive, such as when the GP was informed about the GD 
pregnancy (such as for Nicole) and planned subsequent follow-up (such as for Lizzie), or 
negative as in the case of Monika. Although it is unclear whether it was the GP’s intention, 
Monika understood that she was not required to attend testing again due to one good result. 
This false reassurance is perhaps more dangerous than Svensson et al. reported, where one 
participant was left confused or unconvinced by her GP: “I thought I should book an 
appointment for [the diabetes test]. Then [GP] said that there was no need to go more into 
that, and then she didn’t talk about it any further” (264). Unseen in the review, this study also 
found that mothers were less likely to engage with clinicians if they had had a negative 
experience during pregnancy. 
Secondly, I had reported that the appointment and test influenced opportunity to attend 
screening in the review (specifically the logistics of the appointment and an unpleasant, poorly 
understood testing procedure). I found that logistics were also an issue for some of my 
participants: travelling to a specific hospital could be associated with a financial and time cost. 
They also emphasised that morning appointments, which were required due to an overnight 
fast, could be particularly inconvenient when they had a young baby (e.g. being up in the night 
caring for them and taking a long time to leave the house) and other children that need taking 
to school. In the literature review, I classified the appointment as a permissive barrier to 
attendance whereas this current study suggests that it could more of an issue of inconvenience 
and motivation. On the other hand, the test itself was not often a barrier to attendance in the 
DAiSIeS study, like it was in other studies. Many did understand the testing procedure and 
although it could be unpleasant, this was not a major issue. Most of the studies in the literature 
review referred to a postpartum OGTT, whereas a postpartum FPG has been recommended in 
the UK since 2015 (2). These participants were already benefitting from a shorter, more 
pleasant test (recommendation 7). 
Thirdly, I had reported that family-related practicalities influenced their opportunity to attend 
screening in the review (such as caring for the baby, support and work). In the DAiSIeS study, 
the participants discussed challenges relating to each of these subthemes, but they also tended 
not to relate to the opportunity to attend screening directly. For example, two participants 
included in the review felt “just tired... because I’m burnt out, frustrated” (255) and “I had no 
time to go... Always I tell I do it tomorrow... But I do not gone again, because I have to do 
Chapter 8  The DAiSIeS study 
222 
another duty...” (251) and did not attend screening, yet in the DAiSIeS study, feelings of 
tiredness and being overwhelmed were experienced but seemed to have affected daily activities 
of diet and exercise more than rare events of attending screening appointments. As such, 
associated suggestions such as child-friendly clinics and combing appointments received 
mixed reviews. 
Fourthly, I had reported that concern about diabetes influenced their intentions towards 
screening in the review (in general that those who were concerned about T2D tended to attend 
whereas those who were not concerned did not). The positive view was shared among most of 
the DAiSIeS participants: they were interested or wanted reassurance that GD had resolved, 
and otherwise would start treatment for the serious condition. Those who hadn’t been tested 
were keen to be for these same reasons. No participants in the DAiSIeS study knowingly 
decided not to be tested because they “could not be bothered” (262) or were too scared to find 
out the result, although some were less concerned about T2D after taking the test. Furthermore, 
although it was more subtle and tended not to prevent attendance like reported in the review, I 
found that the participants’ concern about T2D risk was influenced by how healthy they 
perceived their lifestyle to be and they, too, placed high importance on self-monitoring. 
8.5.1.3 Delivery of support or interventions 
Finally, this study came to a similar conclusion to the qualitative synthesis: that the need for 
further support was more important than how the support was provided (209). Similar to 
Nicklas et al. 2011 and a study published after completion of the review (279,308), multiple or 
a combination of formats including online and face-to-face resources would meet different 
needs. These could deliver both individualised and generalised advice. 
Other studies have reported different preferences regarding the timing of intervention initiation 
– during pregnancy (281,288) or postpartum (256,308). Based on different participants’ views, 
I suggest that women with GD should be prepared for more specific follow-up interventions 
during their pregnancy, provided that this is done in a sensitive manner. In general, any 
healthcare professional involved in the care of women with GD can have a role in promoting a 
longer-term view.  
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8.5.2 Strengths and limitations 
8.5.2.1 Strengths 
This study used qualitative interviews in order to understand the participants’ own views and 
experiences, which is important for any future support to be relevant and suitable for them. 
While the nature of semi-structured interviews allowed discussion of what the participants felt 
was important (for example, one participant took the opportunity to recommend 
hypnobirthing), the aims of the study, the interview schedule and the thematic framework used 
in the analysis were based on systematic review evidence. This theory of the post-GD context 
meant that the interview could be guided to key questions for support to improve care. This 
structure continued to the analysis, where I used a thematic framework based on the suggestion 
cards but adapted to the participants’ responses. Additionally, I asked for participants’ own 
suggestions for better support before prompting them with the suggestion cards. 
Data were collected until I felt that the interviews provided little or no further insight into the 
views of this population. As a result, lots of data were available for analysis (20 interviews and 
12.4 hours of recordings). A range of experiences and opinions were explored in detail, such 
as support that some participants found beneficial and could be extended to those who were 
lacking it. Overall, the participants were very engaged in the interviews, which allowed 
understanding of the subtleties and complexities of their views. They were also realistic about 
some of the challenges anticipated, that external support would be beneficial but not remove 
the need for them to work hard, and the time and financial cost that such interventions would 
pose on health services. This is presented context of the individual experience of GD 
pregnancy. 
Finally, the study had few participant exclusion criteria, meaning that many postpartum women 
were eligible to take part (unless a clinically-trained person with access to their medical records 
considered they were unsuitable). They therefore represented a range of ethnicities, religions, 
single or living with their partner (their spouse, for the participants of this study), occupations, 
number of pregnancies overall and with GD, GD management, time since pregnancy, etc.  
8.5.2.2 Limitations 
Despite the range of demographics represented, there was higher representation of mothers 
with graduate or postgraduate degrees (75% in total; 8/9 [89%] of women from Cambridgeshire 
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and 7/11 [64%] of those from Peterborough) and income level was not recorded. In the UK in 
2017, 42% of adults aged 21 to 64 years old had a degree (309) therefore this study population 
may not be representative of the UK. It is expected that those with a greater level of education 
and/or socioeconomic status will have higher health literacy and a better understanding of their 
long-term health risks (310). Recently, self-care skills and knowledge (domains of health 
literacy) have been associated with improvements in weight, diet, and physical activity in 
postpartum women (311). Other women across the UK may therefore have even stronger views 
or greater needs for follow-up. Many participants in this study had a higher or medical 
education, but this was not necessarily associated with lower requirements for support. Jennifer 
(a midwife) had access to the postpartum knowledge that she needed, whereas Holly (who 
worked in maternity care) felt generally unsupported. Additionally, Kimberly stated in 
reference to GD care that “I’m quite fortunate because I’m quite educated, I’ll do my research, 
my mum is a midwife, but I don’t think that was that great for other women”, but later revealed 
that she was unaware of the association between GD and T2D.  
In addition, there will have been recruitment bias, with women who are more health-conscious 
more likely to engage in the study. Holly said that she knew other women with GD who “cheat 
the system... they’ll have their little food and they’ll do their blood sugar and then they’ll have 
their big food”. In contrast, the DAiSIeS participants were diligent with blood glucose control, 
particularly during pregnancy. Women with these experiences are likely to have different 
attitudes postpartum that I did not capture, and may be less eager to be healthy and not seek 
out support. In addition, the invitation letter stated the aim ‘to find ways to help women to 
reduce their risk of developing diabetes in the future’ therefore those who recognised their T2D 
risk or were particularly in need of support might have been more likely to respond. This was 
seen in some participants who wanted to highlight specific areas of their care that they felt 
could be improved. However, the majority were positive and one participant did not want any 
more support. The numbers of women invited to the study and reasons for not taking part were 
not collected, therefore this could be a highly selected population. 
Furthermore, social desirability bias may have influenced the participants’ responses in this 
study. The ‘tendency to present oneself and one’s social context in a way that is perceived to 
be socially acceptable, but not wholly reflective of one’s reality’ can lead to more positive and 
homogenous responses than would be observed without this bias (312). This may have caused 
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the participants to exaggerate how healthy they were before or after pregnancy, or say they had 
made more changes than they had. Some participants reported a similar diet as before 
pregnancy with a few elements of the GD diet carried forward; some participants introduced 
this as a big change whereas others perceived the same behaviour as a small thing. Similarly, 
they might have been wary of criticising their care yet, as discussed below, this did not appear 
to be the case for many and I was careful to introduce myself as someone who was there to 
listen to them. Social desirability bias may explain some of the high frequency of agreement 
with the suggestion cards, despite me saying that it is very useful to hear if they disagreed with 
them. Bergen and Labonté 2020 suggest strategies to reduce social desirability bias including 
explaining the purpose of the study, humour, self-disclosure where appropriate, and carefully 
worded questions (312). I used these approaches in the DAiSIeS interviews, such as inviting 
the participants to share what might help them or someone like them based on their own 
experiences. 
8.5.3 Reflexivity 
It is valuable to consider the relationship between myself as a researcher and the research 
participants, and the influence this had on the interviews and analysis. At the start of each 
interview, I introduced myself as a non-clinical PhD student. This lay role tended to help me 
probe the participants about what they had said, giving me insight to their actual experiences 
because they did not assume that I had expertise in GD care. I thought that they disclosed their 
experiences in ways that they would not have done to a clinician, particularly one who was 
involved in GD care. Although many were eager to share positive experiences, several also 
mentioned painful things and where there ‘needed’ to be changes. One participant had had 
unpleasant experiences with her clinicians, and said that the conversations should be non-
judgemental such as the one we were having. Since I sought to understand their experiences in 
order to improve postpartum care, it felt as if we were ‘on the same side’. I had a good rapport 
with some participants, particularly those who were approximately the same age as me. Despite 
being younger than the remaining participants, I had the role of a professional/university 
researcher with others. Although I could not relate to pregnancy and motherhood, I could relate 
on other levels such as enjoyment of certain foods and the local area.  
After the initial interviews, I changed the start of the interview schedule from asking about 
their current diet (which I had expected to be an easy, less delicate starting point) to their 
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experience of GD. The first participants (those given the pseudonyms Komal and Monika) 
appeared surprised to be asked about their diet because they had expected to talk about GD, 
which remained the stand-out memory of their pregnancies. I also included more signposting 
to the flow of the interview, such as saying ‘Before we talk about [X]…’ and ‘So that I can 
understand if GD has had a lasting impact…’. I also tried to summarise the key points before 
moving on, which provided an opportunity to add more information or correct my 
understanding. 
Some of the participants disclosed specific and personal challenges. These tended to arise at 
the start of the interview, as if they had been waiting to tell me (or somebody). To a certain 
extent, this affected the whole interview. They also tended to keep coming back to it in response 
to later questions, such as Holly’s distress during antenatal appointments and how Megan felt 
unsupported by her GP. I found this could be upsetting, and valued debriefing with colleagues 
after the interviews. It also highlighted the importance of giving the participants time to say 
what they wanted to rather than trying to follow my interview schedule. Monika kept referring 
back to pregnancy, and it is unclear at some points of the interview whether she is referring to 
GD or follow-up. Jennifer had interesting views: she did not want any postpartum support for 
a healthy lifestyle after GD – which is an opinion that might be held by many women who did 
not want to take part – yet had a low engagement in the interview that made it hard to 
understand why she had such a different experience. 
In the survey at the end of the interviews, I asked whether the participants had any comments 
on the interview. Most did not, but a couple gave feedback such as “Informal, laid back, 
friendly. Appropriate in length. Accessible (came to home)”. 
In acknowledgement that the participants may have consciously or unconsciously said what 
they thought I wanted to hear, I considered this in reflecting on and interpreting the interviews, 
such as looking for inconsistencies across the transcripts. In the analysis, I gave more weight 
to the suggestions for improving care that the participants initiated themselves, rather than the 
suggestion cards that may have incited agreement. Overall, I feel that the participants were 
honest because they wanted to benefit other mothers through the study findings. Also, it has 
been valuable for other researchers to read the interview transcripts as they may have had 
alternative interpretations to what I or the participant said. 
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If I were to begin the study again, I would make some changes. Firstly, I would collect more 
quantitative data from the medical record or questionnaire (such as time since each pregnancy, 
where the postpartum test took place and NHS number for administration purposes) as well as 
asking the research nurses to record and report the number of women approached. These data 
were not collected in order to minimise the amount of personally identifiable information held 
but would have facilitated interpretation of the interviews. Moreover, I was unsure whether 
Megan should have been recruited due to her very challenging pregnancy (prolonged 
hospitalisation for sickness, hypoglycaemia and distressing psychological symptoms). On one 
hand, she understood the purpose of the interview, consented to take part and it was important 
for her to be able to share her experiences and suggestions for follow-up. On the other hand, 
her abnormal pregnancy acutely shaped her postpartum experience and was the focus of the 
interview. The Patient Advice and Liaison Service (PALS) may have been a more appropriate 
way for her to give feedback. Suitability to take part could have been discussed when I spoke 
to the participants to book the interview. Finally, not all of the participants understood the focus 
on postpartum follow-up in the earlier interviews (for example, some seemed to think that some 
of the suggestion cards were for GD pregnancy support). While I could address this during the 
interview (such as asking if they also held the same views towards the postpartum test), it 
would be beneficial to clarify this in all recruitment information and during the interview to 
ensure they understood the postpartum focus after discussing their pregnancy experiences. 
8.5.4 Implications  
In this study, the participants were keen to have a healthier diet and increase their physical 
activity after pregnancy, in addition to attending T2D screening. Some wanted to be a healthier 
family and others wanted to mitigate their increased risk of T2D. Many recognised the 
challenges that this would pose, and the dedication that they would need to sustain changes that 
many of them had achieved during pregnancy. This emphasis on how to maintain a healthy 
lifestyle over time had not previously been presented in detail in this population. 
Intention and self-efficacy have been associated with exercise and healthy diet at one and two 
years postpartum (313,314), indicating the importance of nurturing these attitudes. Lipsky et 
al. 2016 (314) go further to discuss how self‐efficacy is influenced by past experience (315); 
i.e. that women who have previously been successful in controlling their diet are more likely 
to report higher self‐efficacy. The participants in the DAiSIeS study referred to the GD diet 
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that they initially had not thought was maintainable and some were even surprised to have lost 
weight during pregnancy, which will help to form their attitudes towards continuing changes. 
Similarly, the experience of care during pregnancy, as well as postpartum, was influential on 
follow-up. 
In the exploration of strategies for promoting healthier diet and physical activity levels, I 
identified a need for a better understanding of their long-term T2D risk and the role of diet and 
exercise on risk management. Alongside support to exercise with others and advice about how 
to exercise with a busy schedule, eat healthily, sustain changes and monitor progress, the 
participants wanted this information to focus on how to be healthy in relation to T2D rather 
than why. Postpartum, they felt they would benefit from being able to be tested for diabetes at 
a more convenient location, perhaps alongside another appointment, and felt that it was 
important to receive reminders to attend testing. The only recommendation that the participants 
were not favourable towards was about the type of test used: they were happy to have a single 
test as recommended in the revised NICE guidelines. 
This wide range of requirements could be addressed through various multi-faceted approaches. 
I explore these in the final discussion of this thesis (Section 9.3), bringing together the findings 
from each chapter. 
8.5.5 Summary 
In the research reported in this chapter, I aimed to explore and develop approaches to promote 
behaviour changes (specifically increase healthiness of diet, increase physical activity levels 
and encourage attendance at diabetes screening tests) after GD to in light of the heightened risk 
of T2D. I used qualitative interviews with an interview schedule based on systematic review 
evidence to elicit the views of a local population and extend the literature by focussing on what 
specific support is required and when, how, where and who should deliver it. 
My findings highlight that changes to current practice and interventions throughout pregnancy 
and particularly postpartum are important. Each of these require further refinement, testing and 
evaluation. Some would be a relatively small change to current practice, such as healthcare 
providers preparing pregnant women with GD to receive subsequent information about 
postpartum follow-up in a sympathetic manner. Implementing other suggestions may require 
resources that are currently available to other populations being made available to women with 
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GD, such as reminders to attend annual tests, and investment of GP’s time for longer 
postpartum appointments in order to discuss blood test results and health behaviours. Directing 
women to existing trusted resources or groups, or adapting existing interventions to this 




The overall aim of this thesis was to better describe the problem of progression to T2D after 
GD, and to identify primary care-based approaches that can be used to reduce T2D risk in this 
population. In this final chapter, I summarise the findings of Chapters 4 to 8 and discuss the 
implications of this work as a whole. 
9.1 Thesis summary 
There were three main streams of this thesis, as illustrated in Figure 2.1. Firstly, I reported the 
incidence of T2D after GD (Chapter 4). Secondly, I focussed on postpartum diabetes screening 
by describing uptake (Chapter 5), exploring reasons for (non-)attendance (Chapter 6) and 
gauging approaches to increase attendance among women with GD (Chapter 8). Thirdly, I 
focussed on promoting a healthy lifestyle after GD by exploring barriers and facilitators to 
healthy diet and physical activity (Chapter 7), and informing approaches to influence these 
behaviours (also Chapter 8). The key findings and implications of each stream are outlined 
below. 
9.1.1 The incidence of type 2 diabetes after gestational diabetes 
I completed a systematic review and meta-analysis of T2D incidence in women with GD to 
improve understanding of the natural history of T2D after GD. When starting this study, no 
review had focused on absolute estimates of the progression to T2D after GD in the last 20 
years, and no reviews had yet synthesised the findings through a meta-analysis. Inclusion of 
more recent studies enabled incorporation of the important changes in GD prevalence, and GD 
and T2D diagnosis and management over time. I therefore wanted to assimilate all of the data 
Chapter 9  Discussion 
232 
that were available to date regarding this question, and explore the impact of co-variables on 
absolute and relative T2D risk (thereby investigating heterogeneity). 
I included 129 studies reporting T2D outcomes after GD. These studies represented each major 
world region and followed up over 310,000 women with a history of GD, plus 4,000,000 parous 
women without GD. Overall, 17.0% (95% CI 15.1 to 19.0%) of women across the studies 
developed T2D; mean duration of follow-up was 5.7 years (range 0.6 to 29.9 years). Using 
multivariable random-effects meta-regression, the percentage developing T2D was 12% higher 
for each additional year of follow-up after pregnancy and 18% higher for each additional unit 
of BMI at follow-up, and White European populations had 57% lower proportion developing 
T2D compared to non-White European populations. Women with GD had a relative risk of 
T2D of 8.3. Heterogeneity between studies was substantial throughout. 
These findings strengthen the need for T2D risk to remain a focus for women affected by GD 
and the clinicians who care for them. In particular, it is important for diabetes screening to be 
sustained over time because the number of women diagnosed with T2D increased each year 
since pregnancy (i.e. it was not true that if someone had not progressed to T2D by five years 
postpartum, they could be assumed to have reverted to the population risk). In addition, 
postpartum BMI had a clinically significant impact on T2D progression therefore women 
should be supported to maintain a healthy weight after GD. Reflecting a higher background 
T2D risk, screening and weight management may be even more important in women of certain 
ethnicities. 
9.1.2 Postpartum diabetes screening after gestational diabetes 
Data on uptake of diabetes screening after GD is sparse in the UK. Furthermore, there has been 
limited understanding of the reasons for poor attendance and women’s perspectives on how to 
facilitate attendance. 
In the first study of this stream, I sought to describe attendance at diabetes screening and 
characteristics associated with attendance in the women attending the Rosie Hospital in 
Cambridge. Of 556 women with GD, 74.6% had evidence of a postnatal test in the medical 
record up to one year postpartum, which was most commonly performed using an OGTT that 
is no longer recommended in the UK. Average interval between delivery and test attendance 
was 6.8±2.1 weeks; 70.8% of all of the postpartum tests were performed in the recommended 
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six to 13 weeks postpartum. Using two-level logistic regression analyses, greater parity was 
associated with a third lower odds of testing and women who received insulin and/or metformin 
treatment were more than twice as likely to undergo testing than those who did not. Higher 
patient satisfaction with their general practice was significantly associated with higher odds of 
testing, particularly using an HbA1c test. 
These findings highlight that a significant minority of women do not attend diabetes screening 
after GD, in line with analyses of hospital records from other parts of the UK, and that this is 
not necessarily carried out as recommended by NICE. This study was the first to investigate 
associations with attendance and general practice variables. It is therefore important to ensure 
that follow-up of these women – those who are most likely to progress and who are least likely 
to attend – is facilitated.  
Reasons for lower attendance was the focus of my next study, a thematic synthesis of women’s 
views on screening for T2D after GD (208). This study was the first to focus on this question, 
therefore I had an opportunity to present the findings in more detail than previous studies that 
have also considered lifestyle behaviours or quantitative studies. Based on 16 studies and 746 
women with a history of GD, I developed four themes. These could relate to the healthcare 
system or be personal factors, and be permissive or motivational factors affecting attendance: 
 Relationship with healthcare: the degree to which clinicians promoted postpartum 
screening, helped mothers to book a test, and the continuity between appointments 
influenced prioritisation of testing; 
 The appointment and test: logistics (such as distance to travel and time spent at the 
clinic) and the unpleasant test (such as painful and nauseating) meant that it was 
difficult for some women to attend screening;  
 Family-related practicalities: a focus on their baby and other children affected women’s 
opportunity to attend screening, such as caring for them and the implications of having 
more children on energy levels; 
 Concern about diabetes: women who were more concerned about T2D were, in general, 
more motivated to attend diabetes screening. 
An important part of the study was the resulting recommendations for improving attendance 
based on the barriers and facilitators identified. In accordance with the four themes, I suggested 
ten ways to promote prioritisation of testing and make it less burdensome for women with GD 
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to attend. I then elicited the views of women with recent GD in Cambridge and Peterborough 
on these suggestions. To facilitate diabetes screening, they felt that discussing postpartum 
testing with their clinician during pregnancy, invitations and reminders for tests, a choice of 
test location and combining appointments would be useful. The participants had mixed views 
towards improving their GP’s awareness of their pregnancy, more chances to understand GD, 
child-friendly clinics, better understanding of diabetes tests and removal of self-monitoring. 
They disagreed that changing the test itself would improve uptake. 
9.1.3 Lifestyle changes to reduce the risk of developing type 2 diabetes after 
gestational diabetes 
In the first qualitative systematic review to focus on this question, I synthesised women’s views 
towards sustaining a healthy diet and being physically active after GD to reduce their risk of 
T2D, including barriers and facilitators, with an aim to identify approaches to support these 
behaviours (209). Based on 21 studies and 926 women with a history of GD, I developed six 
themes relating to healthy lifestyles and one about the format of interventions. These were 
wide-ranging and interrelated: 
 Role as mother and priorities: women prioritised their families, meaning they focused 
on the children or partner’s needs; some were motivated to be healthy by their family;  
 Support from family and friends: practical support and encouragement facilitated 
healthy behaviours; 
 Demands of life: lack of time and energy, busyness and work were barriers to a healthy 
lifestyle; 
 Personal preferences and experiences: behaviour was determined by whether women 
had positive experiences or perceptions from healthy/unhealthy lifestyles; 
 Diabetes risk perception and information: relevant (including culturally-appropriate) 
information facilitated healthfulness; 
 Finances and resources: resources were needed to help women sustain a healthy 
lifestyle, and their lifestyle affected the family’s finances; 
 Format of interventions: advantages and disadvantages of multiple types of 
interventions were discussed. There was no consensus on intervention timing or 
provider. 
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I developed 20 recommendations for promoting healthier lifestyles based on the themes. As 
noted for the study above, I elicited women’s views on ten of these in the next study. Overall, 
the participants wanted more information about the impact of a healthy lifestyle on T2D risk, 
support to exercise with others and advice about how to eat healthily, exercise within a busy 
schedule, sustain changes and monitor progress to support healthy diet and exercise after GD. 
They had mixed responses regarding more information about the impact of diet and exercise 
on wider health and their family, suggestions for healthy families and advice about saving 
money. Peer support groups, meetings with a clinician and written resources (such as websites 
and apps) were all considered to be suitable means of providing support. 
9.2 Overall strengths, limitations and evaluation 
I have presented the strengths and limitations of each study in the discussion section of 
Chapters 4 to 8, therefore will not repeat them in this section. 
Overall, a strength of this thesis is that I have considered the two key, closely-related aspects 
of managing diabetes risk after GD (screening and lifestyle behaviour, focusing on diet and 
physical activity) separately and then brought these together into a cohesive set of strategies to 
improve care. Furthermore, the latter projects were informed by the earlier ones such that the 
final strategies are evidence-based. In particular, the observations made on synthesised 
systematic review findings informed the recommendations for promoting a healthy lifestyle 
and screening attendance. In turn, these informed the design (including interview schedule), 
analysis framework and interpretation of the DAiSIeS interviews.  
I led this research, but several medical students had an opportunity to contribute (in addition to 
the other researchers noted throughout this thesis). This strengthened the research through 
increased rigour in the systematic reviews and enabled a different viewpoint in interpreting the 
findings. It was also of value for the students themselves to gain research skills and experience. 
Overall, a limitation of this thesis is that the primary research was focused on Cambridge and 
the surrounding area. On one hand, it is important to study this region as much as anywhere 
else. On the other hand, the findings may not be generalizable to the rest of the UK because 
Cambridgeshire is an affluent area with a high average level of education, and Cambridge 
University Hospitals NHS Foundation Trust is a tertiary centre to which women with more 
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complicated pregnancies may be referred. If I were to do the DAiSIeS study again, I would try 
to engage women with a wider range of backgrounds who may express different views towards 
GD and T2D. This may be facilitated through recruiting in a different area, non-clinical setting 
or inviting women to take part during pregnancy when they interact with the recruiting 
hospitals most frequently (although this would require more time to wait for the postpartum 
period and may influence their behaviour). Alternatively, a research method that requires lower 
commitment, such as a questionnaire, may provide insights into the views of a broader 
population. 
9.3 Implications for practice 
An important output from the research in this thesis is a series of recommendations for future 
pregnancy and postpartum care of women with GD. Eight suggested amendments are outlined 
in Figure 9.1 and Table 9.1, in comparison to current practice, and explained below. 
9.3.1 Discussion about diabetes risk during pregnancy 
Similar to other research (149), the findings presented in this thesis indicate the valuable role 
clinicians play in education about GD, promoting a healthy lifestyle and screening, and 
signposting to resources during pregnancy and postpartum. My findings suggest that it would 
be acceptable for the longer-term implications of GD to also be discussed in an informal, low-
key manner throughout pregnancy and mentioned while new mothers are on the delivery ward. 
This could involve a conversation or giving an information leaflet, with the expectation of 
further follow-up. This is in contrast to many clinicians’ current practice, where they are 
cautious about overwhelming or frightening their patients and so focus on the pregnancy itself 
(269). 
Many studies have reported pregnancy to be a ‘teachable moment’ due to increased motivation 
and regular contact with health professionals for a range of behaviours from handwashing (316) 
to smoking cessation (317), therefore informing women with GD of postpartum 
recommendations early is likely to be beneficial. 
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Table 9.1: Summary of key proposed amendments to gestational diabetes pregnancy and postpartum care. 
Experience of current practice Suggested amendments 
Pregnancy   
 Daily blood glucose self-monitoring  
 Low glycaemic index diet 
 Regular/post-meal exercise 
 Metformin or insulin treatment as required 
 Regular diabetes team appointments (e.g. with a 
consultant and dietician) 
 Additional conversations about long-term T2D risk 
and follow-up as part of at least one appointment 
with the diabetes team [1] 
 Book postpartum screening test six weeks after due 
date [2] 
Delivery  
 Information such as about breastfeeding and 
recovery from caesarean surgery given at 
discharge from hospital 
 A GD follow-up information leaflet be given 
and/or a brief conversation outlining the 
importance of a postpartum test [1] 
Postpartum period  
 FPG test 
 Six week mother and baby check 
 Specification of the location of postpartum test [3] 
 Extended six week mother-and-baby check to 
cover [4]: 
 T2D risk after GD 
 Diet and exercise advice 
 Annual testing recommendations 
 Offer information regarding local (GD) mother-
and-baby groups and online resources from the GP 
and/or health visitor [5, 6] 
 A diabetes prevention programme for women with 
GD (postpartum period onwards) [7] 
Annual  
 HbA1c diabetes screening test  Reminder (e.g. text message or letter) to book a 
diabetes screening test [8] 
 Feedback on HbA1c result and opportunity to 
discuss diet and exercise [4] 
Numbers in square brackets refer to headings 9.3.1 to 9.3.8. 
9.3.2 Booking the postpartum test during pregnancy 
Despite recruitment from only two hospitals, a wide range of experiences in the process of 
arranging the first postpartum test were observed in the DAiSIeS study. This highlights 
inconsistencies in healthcare provision, corresponding to healthcare providers’ uncertainty 
about who is responsible for postpartum testing (158,269).  
Having a test booked for them during pregnancy, or their need to book it carefully reinforced, 
both appeared to be acceptable to women and conducive to screening. Those who were not 
aware of postpartum testing recommendations had a high chance of falling through the net. 
Ensuring that the postpartum screening test is booked during pregnancy for approximately six 
weeks after the due date may be a suitable way to make more women are aware of the test and 
remove the extra task of booking it themselves during the busy postpartum period. Based on 
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the finding of the qualitative synthesis in Chapter 6, it may also encourage women to place a 
high value on attending – particularly for the first postpartum test but possibly going forward.  
In one hospital where pre-arranged postpartum tests were the norm, one of the highest 
attendance rates in the UK was reported (76% attendance at the six weeks postpartum test) 
(157). Alternatively, although information and education alone do not lead to behaviour change 
(318), going to a screening test may be a rare enough event in a generally well-motivated 
population that instruction to do so may be of some benefit. 
9.3.3 Clarifying the location of the postpartum test 
Akin to the different experiences of booking the test, there appeared to be uncertainty about 
where it should take place, and women in different settings found returning to the hospital to 
be a significant barrier to attendance. Half of hospital clinicians reported that their patients had 
it at the hospital, whereas only 15% of GPs agreed (158). Currently, the NICE guidelines for 
the management of diabetes in pregnancy do not clarify location of testing (2), therefore a 
clearer delegation of responsibility for this test is needed. The findings of my studies suggest 
that specification of primary care may remove barriers to attendance for women with GD, and 
may mark the transition from hospital to primary care management of diabetes risk in this 
population. However, this recommendation is unlikely to be compatible with the hospital 
booking the test during pregnancy. As with management of all chronic conditions in primary 
care, there is a need for a register, recall system and regular review, as well as clear 
communication between primary and secondary care and defined responsibilities. 
9.3.4 Extending the postpartum consultation  
The DAiSIeS participants also expressed interest in a postpartum follow-up appointment. This 
would provide an opportunity to ask outstanding questions such as which of the changes to 
their diet or exercise they should continue, and the risk of GD in subsequent pregnancies. It 
would also allow the GP to raise specific issues such as the risk of T2D after GD and the 
lifelong screening recommendations.  
Discussing diet and physical activity with the GP has been effective for postpartum weight 
management (298). A six week check, where ‘…[clinicians should] offer consistent 
information and clear explanations to empower the woman to take care of her own health…’ 
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is currently recommended by NICE (238). If the blood was collected and analysed in advance, 
this consultation could be extended in women with GD to include feedback and follow-up 
based on their diabetes screening test result. Since half of mothers receive inadequate time to 
discuss their own mental and physical health at this appointment (319), both the mother and 
GP should have aligned expectations about this appointment (320). 
Similarly, feedback on the annual HbA1c result should also be offered and instruction on 
preventative behaviours given in light of the result. Although the DAiSIeS participants 
understood that they would not find out the result of their HbA1c test unless they fell into the 
IGT or IFG range, feedback on the HbA1c measurement has been found to be associated with 
improved blood glucose control (321,322). 
9.3.5 Signposting to existing resources 
The consultation is also an opportunity for the GP or health visitor to signpost mothers to other 
resources. The DAiSIeS participants expressed similar experiences and needs relating to 
physical activity as postpartum women without GD. Although some participants preferred to 
meet with other mothers with GD, flagging more generic resources could be beneficial for 
many of them. A recent study interviewed and surveyed mothers in Cambridgeshire and 
Hertfordshire, half of whom were defined as moderately active, in order to understand 
influences on their physical activity (323). They identified increasing capability through 
signposting to suitable mother-and-baby exercise classes (which would be an environment 
where they felt comfortable themselves and about bringing their baby), and guidance about 
how to exercise safely after the birth. Even though women with GD had more contact with 
clinicians than many of these women, the need for more guidance or signposting was not met. 
9.3.6 Providing online or mobile resources 
Postpartum women, including those with GD studied in this thesis, also reported accessing and 
interacting with websites, forums, social media and other sources of written information during 
pregnancy and postpartum. For example, mothers reported accessing Facebook more 
frequently in the postpartum period (324), such as during breastfeeding in order to connect with 
other mothers for advice (325,326). Information was accessible at all times and could be 
informative and supportive, but users raised doubts about trustworthiness (325,327,328). Apps 
received mixed responses (308). Instead of searching for such groups or resources themselves, 
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women with GD could be directed to reliable resources provided by a trusted professional or 
body. 
9.3.7 Offering a bespoke diabetes prevention programme 
Alongside these modifications to existing practice, a bespoke and potentially individually-
tailored diabetes prevention programme should be made available to all for mothers with GD. 
As informed by the research presented in this thesis, important elements include clear 
information about the effects of diet and exercise on diabetes risk, and advice about how to eat 
healthily and include exercise within busy daily routines so that these changes can be 
maintained in the long-term. Previous research suggests that interventions that start earlier than 
six months postpartum are most likely to be effective (169); my findings are in agreement 
although add that consideration of the postpartum stage is vital. 
This could involve adapting existing interventions, such as the NHS Diabetes Prevention 
Programme. As discussed in Chapter 7, one intervention modified the US DPP to Latina 
women with GD by replacing the intensive face-to-face counselling with telephone calls so 
that mothers with young children would not be required to travel (293). 
9.3.8 Sending annual screening test reminders 
Finally, and perhaps most importantly, prompts or invitations for on-going screening should 
be sent to women with a history of GD. This is routine practice for comparable and relatively 
infrequent screening appointments in the UK (such as cervical screening (329) and NHS Health 
Checks (330)), therefore an absence of invitations downgrades the perceived importance of 
testing. Invitations and prompts have been suggested to be the most important method for 
increasing uptake in multiple systematic reviews, and proactive contact can double screening 
attendance (143,145,146). Despite this potential, the benefits observed are inconsistent; one 
study suggested that contact from women’s general practice may be more effective than a 
central or national mail out (161). Consequently, research may be required to optimise the 
approach and include personalisation and behaviour prompts in letters (330), inviting people 
face-to-face (331), and raising general awareness (332) as is being done for NHS Health 
Checks. Electronic reminders can be sent from electronic health systems to reduce the burden 
on administrative staff and are acceptable to clinicians (268). 
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9.4 Implications for research  
This research has focused on generating data to inform improvements to current follow-up care 
and development of a specific complex intervention to promote healthy diet and physical 
activity after a pregnancy affected by GD. This intervention should now be developed, 
evaluated and implemented in line with guidance for developing complex interventions such 
as that published by the MRC (177). It is likely that an effective intervention will focus on one 
(or a small number) of the above elements. For example, a mobile app that provides information 
about postpartum-friendly exercises, dietary advice and an opportunity to interact with others 
with GD, or implementation of double-length appointments at the six week mother-and-baby 
check in order to dedicate time to discuss the mother’s future T2D risk and prevention 
behaviours. 
For instance, an app to support healthy postpartum lifestyle should be developed with input 
from mothers with GD to ensure that it is accessible for this population. If the information 
provided is overseen by a clinician or expert, my studies suggest that it is likely to be trusted 
by the users because it is seen to be more accurate. Women with diverse characteristics, 
including of various parity and ethnicity, should be included in piloting the app. Outcomes to 
evaluate effectiveness could include change in self-reported or objectively-measured diet, 
activity levels and weight, a qualitative evaluation such as usability and usefulness of the 
resources provided, and follow-up T2D outcomes in the long-term. 
My findings also point towards the utility of different diabetes screening intervals. In the US, 
screening is recommended every one to three years, although it is recommended every year in 
the UK (1,2). Although the DAiSIeS participants were eager for reassurance that they did not 
have T2D and that some felt that waiting until a year postpartum was too long, they were all 
within four years of GD and had not experienced several years of annual testing. If screening 
intervals were more flexible (e.g. every three years if they received a normal result) or risk-
stratified (e.g. more frequent in those with a higher risk according to their ethnicity or BMI), 
this may be perceived to be something that could be maintained for the rest of their lives. In 
addition to a feasibility study, modelling the implications of this approach on T2D outcomes 
and an economic evaluation, research should be conducted to evaluate women with GD’s 
perceptions of this. Focus groups would be valuable, and approaches such as community juries 
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have the advantage of presenting the participants with information about the proposed 
programmes before discussing it and coming to a conclusion from a collective, societal 
perspective (333). 
In addition, these studies have identified the need for more observational research in the UK. 
Firstly, long-term screening attendance remains largely unknown. Daly et al. is the largest 
study of this to date (153), examining screening attendance using a national database (the THIN 
database). However, only screening up to three years postpartum was reported. Other studies 
have reported uptake up to five years after pregnancy in primary care, with a maximum sample 
size of 2,016 women with GD (154). Consequently, significant unanswered questions remain 
including: patterns of screening attendance over time (e.g. time to the last or latest diabetes test 
and frequency of attendance), which screening tests are used, and predictors of long-term 
attendance (associated with the participant and general practice). This study could be conducted 
in the UK Clinical Practice Research Datalink (CPRD), which includes anonymised records 
from a large number of patients and can be linked to other databases such as the IMD. However, 
only women with a history of GD recorded in the medical records will be identified (thus 
screening attendance will be missed in women without this Read code), there will be missing 
data (on demographics, screening tests, and when women change general practice) and data 
will become more sparse as time since pregnancy increases. 
The UK is also missing information about healthy lifestyle behaviours after GD. The US has 
completed national surveys that elicit the population’s self-reported health behaviours and 
intentions (such as the Behavioral Risk Factor Surveillance System and the National Health 
and Nutrition Examination Survey). These suggested that women with GD were not meeting 
healthy lifestyle guidelines (171–173). Although these are subject to significant error and bias 
(e.g. recall and social desirability bias), similar research in the UK population might provide 
further justification for healthy lifestyle interventions after GD and may inform who to 
prioritise for support.  
There is also paucity of data regarding T2D diagnoses in a population that is screened regularly 
after GD, as recommended. These data will provide more accurate estimates of time to glucose 
intolerance than if testing occurs when symptoms of diabetes develop or women take part in 
cross sectional studies where everyone in a cohort is tested unless they have already been 
diagnosed. Northern Sweden is a suitable setting for such a study because OGTTs have been 
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offered to everyone at ages 40, 50 and 60 years through primary care as part of assessment of 
CVD risk factors and lifestyle behaviours in the Västerbotten Intervention Programme (VIP) 
(334). This can be used to better estimate time to T2D diagnosis than women who present with 
T2D symptoms. VIP was developed in the 1980s and data from over 140,000 individuals has 
been collected. In addition, the VIP database is linked to the Swedish Medical Birth Register 
that can be used to confirm details of the birth and GD status (in addition to self-reported history 
of GD in the VIP database) and the Diabetes Register in Northern Sweden (DiabNorth) to 
identify cases of diabetes through OGTT diagnosis and purchase of diabetes medication (335). 
On the other hand, there is a low incidence of GD in this population that will reduce the number 
of eligible records (0.6% in 2018 (336)) and there may be significant amounts of missing data. 
Identifying additional cohorts suitable for such analysis is therefore also needed.  
9.5 Conclusion  
In this thesis, I have justified the need for a focus on follow-up of GD in primary care. After 
exploring current influences on a healthy postpartum diet, exercise and attending diabetes 
screening, I have put forward and begun to evaluate various strategies for supporting these 
behaviours. Focused interventions, such as to enable women with GD to meet and exercise 
together, are desirable and have the potential to facilitate behaviour change. Other changes to 
healthcare provision will require clinicians and other healthcare professionals to consider and 
prioritise women’s history of GD, such as taking time to discuss behavioural changes to prevent 
T2D. I have shown that some of these strategies should begin during pregnancy and continue 
postpartum and beyond. These findings will also be useful to develop or adapt an intervention 
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Appendix 1: DAiSIeS study participant invitation letter. 
                                    
Diet, Activity and Screening after 
gestational diabetes: an Interview Study 
Date [date] 
Dear [invited participant]  
Invitation to take part in a research interview 
We are working with a team of researchers from the University of Cambridge to run a research 
study to find ways to help women to reduce their risk of developing diabetes in the future. The 
research team would like to speak to women who have had a pregnancy affected by gestational 
diabetes to hear their views and experiences of diet, physical activity and about blood glucose 
testing (diabetes screening) after pregnancy, and any suggestions that they have. This will help 
us to develop and improve approaches to best support mothers. 
Please see the information about the study included in this letter. Please read this carefully. If 
you would like to take part or ask any questions, contact us using the details below. 
Yours sincerely 
[Recruiting site] 




Appendix 2: DAiSIeS study participant information sheet and data transparency statement. 
 
Invitation
We would like to invite you to take part in an interview to discuss your
experience of gestational diabetes. We would like to find better ways of
helping women reduce their chances of developing diabetes in the future.
Joining the study is entirely up to you, and before you decide we would like
you to understand why the research is being done and what it would
involve. This Participant Information Sheet tells you the purpose of the
study and what will happen if you take part. Please feel free to talk to the
study team or others about the study if you wish. We will do our best to
answer any questions you may have.
Participant information sheet
Participant information sheet v1 12 Feb 2019 IRAS Project ID: 254300
Diet, Activity and Screening after
gestational diabetes: an Interview Study
What’s involved?
Why are we doing this study?
As your clinical team will have explained to you,
women who have had gestational diabetes are
more likely to develop type 2 diabetes in the
future compared to other women of the same
age. We are researching how to help women to
reduce their risk of developing diabetes after
having had a pregnancy affected by gestational
diabetes. In particular, we are interested in
hearing your views and experiences of diet,
physical activity and about blood glucose testing
(diabetes screening) after your pregnancy, and
any suggestions that you have. This will help us
to develop and improve approaches to best
support mothers.
Why am I being asked to think about taking part
in this study?
We are looking for women who have recently
had a pregnancy affected by gestational
diabetes to take part in this study. We hope to
recruit about 25 women with different
experiences and from different backgrounds, so
we may not be able to include everyone who
would like to take part.
What would taking part involve?
If you agree to take part in this study, we will
arrange an interview with a member of the study
team. This can take place at a time and in a
private location that is most suitable for you, and
you’re welcome to have your child or children
with you. The interview is likely to take between
30 minutes and an hour. You will be able to stop
the interview at any time or to choose to not
answer specific questions. With your permission
we will audio-record the interview so that we can
transcribe it and keep a written record of what
was said. This record will not include identifying
information.
What are the possible benefits of taking part?
There will not be any direct benefits to your
health from taking part and your healthcare will
not be affected in any way. However, it is an
opportunity to share your views and suggestions,
which we will consider carefully, and you will be
contributing to research that aims to support
and improve care for people like you.
What are the possible disadvantages and risks
of taking part?
We do not expect there to be any risks of taking
part, although talking about diabetes and your
diet or exercise can be sensitive issues. You can
choose which parts of your experience you tell
us about and will be free to pause or end the
interview at any time. If the questions raise
issues you would like support with, we can direct
you to some useful services.
Will I receive any payment for taking part?
You will receive no payment or compensation for
your time but we can reimburse reasonable





Participant information sheet v1 12 Feb 2019 IRAS Project ID: 254300
What do I do if I want to take part?
It is entirely up to you whether or not to take
part. Taking part in the study is completely
voluntary and you can withdraw from the study
at any time.
If you would like to take part, please reply using
the contact details supplied on the invitation
letter. The hospital team will pass your details on
the researchers who will contact you to arrange
an interview. You can also contact the hospital
team to ask any questions before you decide
whether to take part.
Other information
What will happen if I don't want to carry on with
the study?
You can choose to withdraw from the interview
any time before or during the interview. If you
choose to withdraw after the interview has been
completed, we will ask you if the interview data
we have obtained may be kept and used to
contribute to the study results. However, should
you request that your interview data be
destroyed, we will ensure that this takes place.
What if something goes wrong?
If you have any questions about the research or
any concerns about the way you have been
approached or treated, please contact Dr Claire
Meek, the Chief Investigator, by emailing
claire.meek@nhs.net.
How will my information be kept confidential?
The University of Cambridge and Cambridge
University Hospitals NHS Foundation Trust are
the sponsors for this study based in the United
Kingdom. They will be using information from
you in order to undertake this study and will act
as the data controller for this study. This means
that they are responsible for looking after your
information and using it properly. The sponsor
organisations will keep identifiable information
about you for 12 months after the study has
finished to ensure your safety and allow the
study to be reviewed by the authorities after it is
finished.
Your rights to access, change or move your
information are limited, as the sponsor
organisations need to manage your information
in specific ways in order for the research to be
reliable and accurate. To safeguard your rights,
we will use the minimum personally-identifiable
information possible.
You can find out more about how the sponsors
use your information using the information
below:
- For CUH NHS Foundation Trust, please visit:
www.cuh.nhs.uk/corporate-information/about-
us/our-responsibilities/looking-after-your-
information, or email the Data Protection Officer
at: gdpr.enquiries@addenbrookes.nhs.uk
- For University of Cambridge, please visit:
www.medschl.cam.ac.uk/research/information-
governance, or email the Information
Governance team at: researchgovernance@
medschl.cam.ac.uk.
What will happen to the results of this study?
When the study is completed, the results will be
presented at scientific meetings and published
in scientific journals. They will also make up part
of a PhD thesis. Your identity and personal
details will be kept confidential: no information
that could identify you, like your name, will be
published in any report about this study. We can
share these publications and a summary with
you.
Who is organising and funding this study?
The study is being organised by the University of
Cambridge and funded by the School of Primary
Care Research.
How have patients and the public been involved
in this study?
Patients and the public have helped with the
design of the research, and will be involved all
the way through the research process. This
includes managing the study, looking carefully at
the results and sharing the findings.
Who has reviewed this study?
All research in the NHS is looked at carefully by
an independent group of people, called a
Research Ethics Committee, to protect your
safety, rights, wellbeing and dignity. This study
has been reviewed and approved by the London
– West London & GTAC Research Ethics
Committee.
Research team
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DAiSIeS GDPR Transparency Statement
Version 1
Date 13/3/2019
Transparency Statement – Data Use in the DAiSIeS Study
FULL TITLE: Diet, Activity and Screening after gestational diabetes: an 
Interview Study
The use of your personal data in the DAiSIeS study
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge are the joint sponsors
for this study based in the United Kingdom. We will be using information from you and your medical records
in order to undertake this study and will act as the data controller for this study. This means that we are
responsible for looking after your information and using it properly. Cambridge University Hospitals NHS
Foundation Trust and the University of Cambridge will keep identifiable information about you from this study
for 1 year after the study has finished.
Your rights to access, change or move your information are limited, as we need to manage your information in
specific ways in order for the research to be reliable and accurate. If you withdraw from the study, we will
keep the information about you that we have already obtained. To safeguard your rights, we will use the
minimum personally-identifiable information possible.
You can find out more about how we use your information by contacting either:
Dr Claire Meek, the Chief Investigator on clm70@cam.ac.uk
Your local study team at <insert contact details>
How we collect and use your personal data
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge will use your name,
NHS number, date of birth and contact details to contact you about the research study, and make sure that
relevant information about the study is recorded for your care, and to oversee the quality of the study.
Individuals from Cambridge University Hospitals NHS Foundation Trust, University of Cambridge and
regulatory organisations may look at your medical and research records to check the accuracy of the research
study. They will pass these details to Cambridge University Hospitals NHS Foundation Trust and University of
Cambridge along with the information collected from you and your medical records.
The only people in Cambridge University Hospitals NHS Foundation Trust and University of Cambridge who
will have access to information that identifies you will be people who need to contact you about your results
or study participation or audit the data collection process. The people who analyse the information will not be
able to identify you and will not be able to find out your name, NHS number or contact details.
Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge will keep identifiable
information about you from this study for 1 year after the study has finished.





Chief Investigator: Dr Claire Meek
Email: clm70@cam.ac.uk
Office: 01223 274218
Local Research Nurse/Midwife: <insert details>
Email: <insert contact details>
Office: <insert contact details>
Use of data in future research
When you agree to take part in a research study, the information about your health and care may be provided
to researchers running other research studies in this organisation and in other organisations. These
organisations may be universities, NHS organisations or companies involved in health and care research in this
country or abroad. Your information will only be used by organisations and researchers to conduct research in
accordance with the UK Policy Framework for Health and Social Care Research.
Your information could be used for research in any aspect of health or care, and could be combined with
information about you from other sources held by researchers, the NHS or government.
Where this information could identify you, the information will be held securely with strict arrangements
about who can access the information. The information will only be used for the purpose of health and care
research, or to contact you about future opportunities to participate in research. It will not be used to make
decisions about future services available to you, such as insurance.
Where there is a risk that you can be identified your data will only be used in research that has been
independently reviewed by an ethics committee.
Local contact for information. Should you wish to discuss any issues related to this study, please contact the
study team using the details below. Thank you for reading this leaflet.
GDPR transparency statement v1 26 Mar 2019 IRAS Project ID: 254300
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Appendix 3: DAiSIeS recruitment poster. 
 
Diet, Activity and Screening
We are looking for women who have recently had
gestational diabetes
to take part in research
interviews
Your care team might send you an information pack if they think you are 
suitable to take part.




Poster v1 12 Feb 2019 IRAS Project ID: 254300
after gestational diabetes: an Interview Study
to discuss their postpartum experiences and
how we can help others to reduce their risk of 




Appendix 4: DAiSIeS participant questionnaire. 
 
Participant ID __________ Date __________
Closing questionnaire
Closing questionnaire v1 12 Feb 2019 IRAS Project ID: 254300
Diet, Activity and Screening after
gestational diabetes: an Interview Study
1) Which age band are you in?
⃝ 18–25 years       ⃝ 26–30 years ⃝ 31–35 years       ⃝ 36–40 years       ⃝ 41+ years
2) What is your ethnic group?
⃝ White
⃝ Mixed/multiple ethnic groups
⃝ Asian/Asian British
⃝ Black/African/Caribbean/Black British
⃝ Other ethnic group
3) What is your highest level of education?
⃝ Secondary education (GCSEs or equivalent) or below 
⃝ Further education (A levels, BTEC, apprenticeship or equivalent)
⃝ Higher education (Bachelor’s degree or equivalent)
⃝ Postgraduate higher education (Master’s degree, PhD or equivalent)
4) What is your current employment status?
⃝ In full time employment ( ⃝ and currently on maternity leave)
⃝ In part time employment ( ⃝ and currently on maternity leave)
⃝ Stay at home parent
⃝ Other full time role outside of the home
⃝ Other (please specify):  ______________________________________________
5) What is your current living situation?
⃝ Living with spouse or partner
⃝ Single





Closing questionnaire v1 12 Feb 2019 IRAS Project ID: 254300
6) How many children do you have?   _____
7) How many pregnancies have you had that have been affected by gestational diabetes?   
_____




9) Have you had a glucose tolerance test or test for type 2 diabetes since your most recent 
pregnancy? (Please tick all that apply)
⃝ No
⃝ Yes, at approximately 6 weeks postpartum
⃝ Yes, after the postpartum period
10) Have you ever been told that you have type 2 diabetes? 
⃝ No
⃝ Yes (If yes, when was this? ______________________________________)
Would you like to be made aware of the findings of this study?
⃝ No
⃝ Yes Please provide an email or postal address: ______________________________
___________________________________________________________







Thank you very much for completing this questionnaire.
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Appendix 5: Details of studies included in the incidence of type 2 diabetes screening after gestational diabetes systematic review. 
          Women with GD Women without GD   
             Study-level demographics      
      Diagnoses    Age (years)  % BMI (kg/m2) % with      
   Eligible Duration of follow-up GD T2D     Foll- % nulliparous  Pre- Foll- family     QA 
First author/   pregnancies (years)  Sensi-  Sensi-  n with % with Deli- ow- White at index preg- ow- history of  n with % with  score 
year Country Data source (years) Duration Category Method tivity Method tivity N T2D T2D very up European pregnancy nancy up diabetes N T2D T2D RR (/6) 













H 150 47 31.3 31.7 37.2 3.2 - - 34.9 76.8 - - - - 4 
Australasia                         
Lee 2007 (234) Australia Mercy Hospital for 
Women, Melbourne 







H 5,470 405 7.4 31.0 33.2 71.3 - - - 24.0 783 16 2.0 3.6 4 
Cheung 2006 
(338) 
Australia Westmead and Nepean 
Hospitals, Sydney 
1988–1994 Mean±SD: 






H 102 30 29.4 32.4 36.9 27.7 - - - 49.0 - - - - 3 
Moses 2017 
(339) 








H 421 72 17.1 31.2 - 86.2 - 27.5 - 26.0 - - - - 3 
Barden 2013 
(340) 
Australia King Edward Memorial 
Hospital and Joondalup 
Health Campus, Perth 




H 112 20 17.9 32.9 42.9 74.7 18.7 - - 60.7 48 0 0.0 - 3 
Chittleborough 
2010 (341) 
Australia South Australian 
Gestational Diabetes 
Mellitus Recall Register 




C 241 2 0.8 - - ≥50 - - - - - - - - 0 
Lappas 2015 
(342) 
Australia Mercy Hospital for 
Women, Melbourne 







H 104 21 20.2 23.8 32.5 ≥50 - - 25.9 - - - - - 4 
Chamberlain 
2016 (343) 
Australia Cairns Hospital, 
Queensland 




H 483 110 22.8 32.6 39.6 67.9 32.0 - - - - - - - 3 
Ingram 2017 
(344) 
Australia Launceston General 
Hospital, Tazmania 




H 148 9 6.1 31.8 37.3 86.6 - - - 58.2 - - - - 6 
Central and South America                       
Ali 1990 (345) Trinidad Mount Hope Women's 








L 60 37 61.7 32.5 37.4 0.0 - - - 68.3 - - - - 5 
Gabaldi Silva 
2003 (346) 









Mexico Hospital of Gynecology 
and Obstetrics, Medical 
Center La Raza, 
Mexico City 




H 52 25 48.1 32.4 33.4 <50 25.1 30.1 - 51.9 - - - - 3 
Europe                         
Dornhorst 1990 
(348) 










L 51 16 31.4 31.8 41.0 35.0 - - - 29.4 23 0 0.0 - 4 
Lauenborg 
2005 (349) 
Denmark Center for Diabetes and 
Pregnancy, 
Rigshospitalet 







H 481 171 35.6 32.0 42.9 75.0 - 25.1 27.9 - 910 30 3.3 10.8 3 
Cypryk 2005 
(350) 










H 200 34 17.0 30.9 34.0 ≥50 - - 26.5 - - - - - 1 
Fahami 2019 
(155) 




C 408 91 22.3 - - 17.4 - - - - - - - - 3 
Hanson 1996 
(351) 








L 97 3 3.1 31.3 37.8 ≥50 - - - - 23 0 0.0 - 4 
Wolff 1987 
(352) 








L 69 15 21.7 - - ≥50 - - - - - - - - 4 
Järvelä 2006 
(353) 
Finland Oulu University 
Hospital, Oulu 







C 435 23 5.3 31.9 37.5 ≥50 - - - - 435 0 0.0 - 4 
Pirkola 2010 
(354) 
Finland Northern Finland Birth 
Cohort 1986 




C 124 21 16.9 29.3 49.3 100.0 - 25.1 - - 6,359 68 1.1 15.8 5 
Albareda 2003 
(235) 
Spain Hospital de Sant Pau, 
Barcelona 







H 696 39 5.6 31.3 37.4 ≥50 35.7 23.3 24.5 53.7 70 0 0.0 - 4 
Sokup 1999 
(355) 
Poland Intensive Care 










L 140 26 18.6 30.7 31.6 ≥50 - - - - - - - - 3 
Ijäs 2013 (356) Finland Oulu University 
Hospital, Oulu 







H 61 40 65.6 35.9 52.2 ≥50 - 27.1 - - 55 3 5.5 12.0 3 
Ziegler 2012 
(357) 





















H 192 55 28.6 - - ≥50 - - - - - - - - 1 
Huopio 2014 
(359) 








H 489 28 5.7 32.0 37.8 100.0 36.6 - 28.4 81.0 385 1 0.3 22.0 6 
Dalfra 2001 
(360) 






L 70 10 14.3 - - ≥50 - 25.6 25.1 - - - - - 4 
Corrado 2007 
(361) 








H 58 6 10.3 34.9 41.8 100.0 - 28.5 - 39.6 56 1 1.8 5.8 6 
Daly 2018 
(153) 
UK The Health 
Improvement Network 
(THIN) database 







C 9,118 895 9.8 33.0 35.9 ≥50 - - - - 37,281 142 0.4 25.8 3 
Heida 2015 
(362) 
Netherlands European Prospective 
Investigation into 




9–11.9 Self-report C MR 
(registry) 










H 153 86 56.2 28.6 34.6 ≥50 - 26.0 26.6 - 155 2 1.3 43.6 3 
Eades 2015 
(364) 
UK Ninewells Hospital, 
Dundee 




H 164 41 25.0 30.3 - ≥50 35.0 - - 33.0 - - - - 5 
Olesen 2014 
(365) 








C 2,171 124 5.7 31.2 - 92.3 - - - - - - - - 4 
Hunger-Dathe 
2006 (366) 










H 173 16 9.2 30.1 35.9 100.0 - 25.6 27.5 62.4 - - - - 2 
Wahlberg 2016 
(367) 
Sweden Swedish Medical Birth 
Registry (MBR) 







C 1,324 216 16.3 32.1 43.4 79.3 - 27.1 - - - - - - 3 
Anderberg 
2012 (227) 
Sweden Skåne University 








C 579 180 31.1 - - ≥50 - - - - 1,131 13 1.1 27.0 4 
Sivaraman 
2013 (368) 
UK Worcestershire Royal 
Hospital, Worcester 









Denmark Danish National Birth 
Cohort (DNBC) 
1996–2002 Median: 13.0, 
range: 9.0–
16.0 
≥12 Self-report C Glycaemic 
test 




Spain University Hospital 
Complex of Ourense 




H 495 51 10.3 - - ≥50 - - - - - - - - 3 
Kousta 1999 
(371) 





and Central Middlesex 
Hospitals, London 






H 192 52 27.1 34.3 36.6 35.0 - - 28.1 - - - - - 3 
Costa 2000 
(372) 








H 120 3 2.5 33.6 34.2 100.0 - - 25.6 - - - - - 2 










H 182 16 8.8 34.0 40.5 100.0 55.7 24.3 - 48.9 161 4 2.5 3.5 4 
Hummel 2013 
(374) 
Germany Postpartum Outcomes 
in Women with 
Gestational Diabetes 
and their Offspring 
(POGO) 







H 102 8 7.8 - - ≥50 - - - - 15 0 0.0 - 5 
Zonenberg 
2006 (375) 


















H 110 23 20.9 - 32.7 89.1 - - 27.3 55.6 41 0 0.0 - 6 
Apostolakis 
2018 (377) 








H 1,336 83 6.2 33.9 35.3 100.0 - - 26.7 - - - - - 5 
Seghieri 2010 
(378) 
Italy Spedali Riuniti Viale 
Matteotti, Tuscany 








Portugal Hospital de Braga, 
Braga 







C 300 98 32.7 34.3 38.0 ≥50 31.0 - 29.5 50.0 - - - - 3 
Akinci 2011 
(380) 













Italy National administrative 
data 
2002–2010 Median: 5.4, 





C 3,851 773 20.1 30.0 35.4 ≥50 - - - - 11,553 128 1.1 18.1 5 
Bljajić 2009 
(382) 
Croatia University Hospital 
Centre, Zagreb 




H 89 7 7.9 - - ≥50 - - 27.9 - - - - - 3 
Claesson 2017 
(383) 




H 196 73 37.2 33.6 38.6 73.0 - - - - - - - - 6 
Moleda 2016 
(384) 








H 199 13 6.5 31.0 38.4 100.0 - 22.4 25.5 - 50 0 0.0 - 4 
Engeland 2011 
(228) 
Norway Medical Birth Registry 
of Norway (MBRN) 






C 2,198 308 14.0 32.3 36.0 ≥50 - - - - 224,634 899 0.4 35.0 3 
Prados 2018 
(385) 
Spain Hospital del Mar, 
Barcelona 




H 306 16 5.2 34.1 35.1 47.1 47.7 27.1 - 53.7 - - - - 4 
Kerimoglu 
2010 (386) 








H 78 27 34.6 31.8 32.8 ≥50 18.0 27.8 29.5 62.0 - - - - 4 
Andersson-Hall 
2018 (387) 

















H 305 16 5.2 32.3 - 100.0 - 27.9 - 75.0 - - - - 4 
Pellonperä 
2016 (389) 
Finland Turku University 
Hospital, Turku 




H 321 9 2.8 31.6 32.6 ≥50 42.5 - - 65.5 - - - - 4 
Pérez-Ferre 
2015 (237)*** 
Spain Hospital Clinico San 
Carlos, Madrid 













C 62,958 1,266 2.0 31.7 - ≥50 - - - - 1,452,429 1,674 0.1 17.4 5 
Noctor 2016 
(391) 
Ireland ATLANTIC-DIP 2, 







H 270 6 2.2 34.3 36.6 100.0 - - 29.7 65.2 388 0 0.0 - 2 
De Mori 2015 
(392) 








H 66 8 12.1 34.9 39.6 95.5 - 25.7 26.6 75.8 - - - - 5 
Ozuguz 2011 
(393) 
Turkey Ankara Numune 
Research and Training 
Hospital, Ankara 




H 55 5 9.1 31.0 32.0 100.0 - 27.0 - 70.0 - - - - 4 
Huvinen 2018 
(394) 
Finland Finnish Gestational 
Diabetes Prevention 
Study (RADIEL) 











Sweden Swedish Medical Birth 
Register (MBR) 




C 107 19 17.8 33.8 37.8 ≥50 - 26.2 - 7.2 333 0 0.0 - 1 
Benhalima 
2017 (396) 
Belgium “Sweet Pregnancy” 
project 




H 868 63 7.3 - - ≥50 - - - - - - - - 3 
Brink 2016 
(397) 
Netherlands Maasstad Hospital, 
Rotterdam 




H 52 10 19.2 33.3 38.3 29.4 - - - 58.8 - - - - 3 
Vince 2018 
(398) 
Croatia Medical birth 
certificates (MBC) 
registry 




C 853 32 3.8 31.0 36.0 ≥50 - 24.6 - - - - - - 4 
Gar 2018 (399) Germany Prediction, Prevention, 
and Subclassification of 








H 192 6 3.1 34.6 35.4 ≥50 - - 25.5 - 93 0 0.0 - 5 
Żurawska-Kliś 
2019 (224) 
Poland Outpatient Department 











Spain Virgen Macarena 








L 155 23 14.8 30.4 31.0 ≥50 17.0 27.0 - 53.0 - - - - 3 
Vambergue 
2008 (401) 






H 295 53 18.0 - - ≥50 - - - - 286 12 4.2 4.3 3 
Middle East and South Asia                       
Mahalakshmi 
2014 (402) 
India Diabetes Electronic MR 
(DEMR) 




H 174 101 58.0 29.3 33.8 0.0 - - - 70.0 - - - - 3 
Chodick 2010 
(403) 








H 11,270 1,067 9.5 33.0 38.6 <50 26.3 - - - 174,146 1,125 0.6 14.7 3 
Shahbazian 
2013(404) 
Iran Imam Khomeini 
hospital, Ahvaz 







H 110 46 41.8 34.5 42.3 <50 - - - - - - - - 4 
Minooee 2017 
(226) 
Iran Tehran Lipid and 
Glucose Study (TLGS), 
Tehran 
1998 Median: 12.1, 
up to 15.0 
≥12 Self-report L Glycaemic 
test 
H 476 49 10.3 24.4 36.5 0.0 - - 28.4 27.3 1,982 93 4.7 2.2 3 
Valizadeh 2015 
(405) 









H 110 36 32.7 - - <50 - - 28.3 34.5 - - - - 2 
Herath 2017 
(406) 








H 119 73 61.3 32.0 42.8 4.2 33.6 - - 47.1 240 14 5.8 10.5 3 
Ghajari 2017 
(407) 
Iran Rural health centers of 
Khuramshahr 









India All India Institute of 
Medical Sciences, New 
Delhi and MHRT-










H 366 119 32.5 28.6 30.2 0.0 - 23.6 - 27.9 - - - - 3 
Sreelakshmi 
2015 (229) 













Tertiary care center, 
Riyadh 




C 123 82 66.7 34.3 - 0.0 - - - 56.0 - - - - 3 
Goyal 2018 
(410) 
India All India Institute of 
Medical Sciences, New 
Delhi 




H 267 28 10.5 30.8 32.5 0.0 - - 27.3 47.6 - - - - 4 
Sudasinghe 
2018 (411) 
Sri Lanka Antenatal clinics, 
Gampaha 









King Khalid University 
Hospital, Riyadh 




H 133 15 11.3 - - 0.0 21.8 29.0 31.7 80.5 - - - - 4 
North America                         
Coustan 1993 
(413) 
US Women's and Infants' 







L 350 24 6.9 - - 91.0 - 25.2 - - - - - - 4 
Go 2001 (414) US Jefferson County 
Health Department 
Clinics, Alabama 







L 289 103 35.6 28.3 39.0 0.0 - - 35.0 85.0 - - - - 4 
Shen 2016 
(230) 








C 11,895 4,094 34.4 28.8 - ≥50 30.7 - - - 392,484 17,316 4.4 7.8 4 
Steinhart 1997 
(415) 
US Shiprock Hospital, New 
Mexico 







L 111 47 42.3 31.4 39.3 0.0 - - - - - - - - 5 
Kjos 1995 
(416) 
US Los Angeles County 
and University of 
Southern California 
Women's Hospital 




L 671 146 21.8 - - 0.0 - - - - - - - - 5 
Bao 2016 (417) US Nurses’ Health Study II 
(NHSII) 
1989–2001 15.3 ≥12 Self-report C Self-report 
or other 
H 4,502 722 16.0 27.5 38.0 92.5 81.1 - - - - - - - 3 
Russell 2008 
(418) 
Canada Nova Scotia Atlee 
Perinatal Database 
(NSAPD) 









Canada Ottawa Civic Hospital 








H 74 16 21.6 32.0 41.0 91.9 - - 29.6 58.1 - - - - 4 
Bond 2017 
(420) 
Canada Health insurance body 










C 34,686 6,147 17.7 30.5 43.0 80.0 49.3 - - - 34,686 472 1.4 13.0 4 
Wang 2012 
(421) 
US Louisiana State 
University Health Care 
Services Division 
hospitals 




H 1,142 327 28.6 27.1 35.7 31.2 46.5 - - - 18,856 1,067 5.7 5.1 5 
Malcolm 2009 
(422) 









H 88 25 28.4 - 41.0 91.0 - - - 60.0 - - - - 4 
Buchanan 1999 
(423) 
US Los Angeles County 
and University of 
Southern California 
Women's Hospital 







H 103 26 25.2 30.7 32.0 0.0 - 29.5 31.5 - - - - - 3 




1993–2001 Mean: 29.9, 
range 1.2–
74.0 
≥12 Self-report C Glycaemic 
test 
H 332 310 93.4 18.7 48.6 25.0 - - 34.4 100.0 662 419 63.3 1.5 4 
Reed 2002 
(424) 
US Yakima Valley Farm 
Workers Clinics, 
Washington 






H 90 14 15.6 30.8 33.1 0.0 - - - 48.9 - - - - 3 
Retnakaran 
2017 (425) 
Canada Ministry of Health and 
Long-Term Care of 
Ontario 




C 56,884 15,585 27.4 32.0 42.0 ≥50 - - - - 1,458,195 49,397 3.4 8.1 4 
Ferrara 2009 
(152)* 
US Translating Research 








H 5,524 191 3.5 32.3 32.9 28.0 40.4 - - - - - - - 3 
Aroda 2015 
(164)** 
US Diabetes Prevention 
Program Outcomes 
Study (DPPOS) 
1996–1999 Mean: 12.0 ≥12 Self-report C Glycaemic 
test 
H 100 65 65.0 31.3 43.3 54.0 - - 34.2 - 424 212 50.0 1.3 5 
Kaul 2015 
(231) 
Canada Alberta Perinatal Health 
Program (APHP) 




C 8,731 1,882 21.6 31.8 37.1 70.3 - - - - 231,352 3,196 1.4 15.6 5 
Lo 2017 (426) US Kaiser Permanente 
Northern California 
(KPNC) 









US Eunice Kennedy 
Shriver National 
Institute of Child 
Health and Human 
Development trial 







H 426 34 8.0 29.0 36.2 31.2 28.6 - 28.6 - - - - - 3 
Khan 2017 
(428) 
Canada Institute for Clinical 
Evaluative Sciences, 
Ontario 






C 40,902 7,461 18.2 37.0 41.0 8.5 25.1 - - - - - - - 2 
Mercier 2019 
(429) 
Canada Régie de l’assurance 







H 281 30 10.7 37.3 43.2 <50 - - 27.4 - - - - - 5 
Bernstein 2017 
(430) 
US OptumLabs Data 
Warehouse (OLDW) 




C 12,622 957 7.6 30.3 33.3 67.4 - - - - - - - - 3 
Casagrande 
2018 (431) 
US National Health and 
Nutrition Examination 
Survey (NHANES) 
2007–2014 Mean: 17.8, 
median: 16.0 
≥12 Self-report C Self-report 
or other 
C 568 112 19.7 - - 66.2 - - - 60.5 - - - - 3 
Gunderson 
2015 (432) 
US Study of Women, Infant 
Feeding, and Type 2 
















University Diabetes in 
Pregnancy Center, 
Chicago 




L 172 48 27.9 26.8 31.8 23.7 - - - - - - - - 4 
Nelson 2008 
(434) 
US Harbor-UCLA Medical 
Center, California 




H 188 88 46.8 31.7 - <50 - - 30.2 - - - - - 2 
Kramer 2014 
(435) 
Canada Mount Sinai Hospital, 
Toronto 




H 105 5 4.8 35.3 38.3 65.7 50.5 25.0 25.4 59.1 172 3 1.7 2.7 4 
Sodhi 2018 
(436) 
US Harbor-UCLA Medical 
Center, California 




H 151 28 18.5 - - <50 - - - - - - - - 3 
Western Pacific                        
Lee 1994 (437) Hong Kong Tsan Yuk Hospital and 
Kwong Wah Hospital 




L 193 18 9.3 31.0 37.0 0.0 - - 24.7 - 58 3 5.2 1.8 4 







L 909 116 12.8 31.2 33.3 0.0 38.8 - 23.4 43.0 - - - - 4 
Kwak 2013 
(439) 
South Korea Cheil General Hospital, 
Seoul 




H 475 193 40.6 31.8 35.8 <50 - 22.5 - 40.8 - - - - 4 
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H 152 15 9.9 - - <50 42.8 - - 52.6 - - - - 3 
Wanthong 2017 
(441) 










H 100 38 38.0 34.3 38.5 0.0 - 24.6 - 51.0 - - - - 5 
Kugishima 
2018 (442) 
Japan National Hospital 
Organization Nagasaki 








H 306 32 10.5 33.0 34.3 0.0 44.0 23.5 - 41.0 - - - - 5 
Han 2018 (443) South Korea National Health 
Insurance Service 
(NHIS) database 




H 4,970 470 9.5 28.3 38.3 0.0 100.0 21.0 - - 97,930 5,147 5.3 1.8 4 









H 146 38 26.0 32.3 37.6 0.0 - 22.3 22.7 43.0 - - - - 5 
Yang 2014 
(445) 









H 116 8 6.9 33.9 35.2 <50 - - 26.7 - - - - - 4 
Mai 2015 (446) China Guangdong Women 








H 453 24 5.3 - - 0.0 - - - - 1,180 0 0.0 - 3 
Chew 2012 
(447) 











H 448 159 35.5 38.5 45.1 0.0 - - - 60.8 - - - - 3 




H 71 29 40.8 32.0 - 0.0 53.5 24.9 - 74.5 - - - - 4 
Inoue 2018 
(449) 
Japan Chiba University 
Hospital, Chiba 




H 77 17 22.1 34.6 36.6 0.0 - 23.9 - 42.3 - - - - 4 
Multiple                         
Lowe 2018 
(450) 
Multiple Hyperglycemia and 
Adverse Pregnancy 
Outcome (HAPO) study 







H 663 71 10.7 32.2 43.6 40.2 43.0 - 28.9 53.9 3,946 63 1.6 6.7 4 
Ordered by date of pregnancy within each region. Duration of follow-up is planned follow-up unless otherwise specified (e.g. mean). 
*Practices were part of TRIAD intervention but participants were comparable to the rest of the region; **Only control arm included due to significant effect of intervention on 
diabetes incidence; ***Intervention and control arms included as no significant effect of intervention on diabetes incidence.  
-: not reported; C: clinical GD/T2D diagnosis; H: high sensitivity GD/T2D diagnosis; L: low sensitivity GD/T2D diagnosis; MR: medical records; QA: quality assessment; 
RR: relative risk of T2D; SD: standard deviation.    
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Appendix 6: The association between pregnancy and practice-related factors and postpartum diabetes screening (by OGTT or HbA1c testing) in 
women with a history of gestational diabetes. 
 OGTT HbA1c test 
 Univariable Multivariable Univariable Multivariable 
 N OR [95% CI] P N OR [95% CI] P N OR [95% CI] P N OR [95% CI] P 
Personal and pregnancy characteristics       
   
  
  
Maternal age (years) 553 1.02 [0.99–1.06] 0.180 362 1.00 [0.95–1.05] 0.857 553 1.00 [0.96–1.04] 0.948 362 0.98 [0.93–1.03] 0.349 
IMD decile1 (1, most deprived, to 10) 532 1.07 [0.99–1.16] 0.107 362 0.95 [0.84–1.07] 0.422 532 1.04 [0.94–1.16] 0.434 362 1.07 [0.94–1.22] 0.319 
Parity 553 0.72 [0.61–0.85] <0.001* 362 0.69 [0.54–0.87] 0.002* 553 1.04 [0.87–1.25] 0.650 362 1.04 [0.82–1.32] 0.742 
Pre-pregnancy weight (kg) 430 0.97 [0.96–0.98] <0.001* 
   
430 1.00 [0.99–1.01] 0.935 
   
Pre-pregnancy BMI (kg/m2) 429 0.93 [0.90–0.96] <0.001* 362 0.93 [0.89–0.96] <0.001* 429 1.01 [0.98–1.04] 0.665 362 1.01 [0.97–1.05] 0.630 
Premature birth (<37 weeks) 482 0.77 [0.38–1.53] 0.450 
   
482 0.55 [0.23–1.31] 0.178 
   
Gestational weight gain (kg) 366 1.02 [0.98–1.06] 0.365 
   
366 1.00 [0.96–1.04] 0.964 
   
Caesarean 489 0.99 [0.66–1.48] 0.953 
   
489 0.94 [0.61–1.45] 0.795 
   
Birthweight z-score 481 0.96 [0.79–1.17] 0.699 362 1.11 [0.86–1.44] 0.408 481 1.05 [0.85–1.29] 0.676 362 0.99 [0.77–1.28] 0.942 
Baby's gender (girl) 493 0.85 [0.57–1.26] 0.416 
   
493 1.47 [0.96–2.25] 0.079 
   
GD diagnosis 
            
First OGTT before 22 weeks gestation 555 0.63 [0.36–1.12] 0.116 362 0.62 [0.26–1.47] 0.278 555 1.04 [0.52–2.07] 0.907 362 1.30 [0.56–3.04] 0.543 
FPG at diagnosis (mmol/l) 554 0.68 [0.53–0.86] 0.002* 362 0.77 [0.52–1.13] 0.180 554 1.06 [0.82–1.39] 0.644 362 1.11 [0.75–1.64] 0.599 
120 min plasma glucose at diagnosis (mmol/l) 555 1.07 [0.96–1.18] 0.239 
   
555 1.04 [0.92–1.17] 0.518 
   
HbA1c at diagnosis (mmol/mol) 497 0.95 [0.91–0.98] 0.004* 
   
497 1.04 [1.00–1.09] 0.044* 
   
GD treatment by or at 36 weeks gestation 556 1.03 [0.72–1.47] 0.862 362 2.38 [1.31–4.33] 0.004* 556 1.37 [0.91–2.08] 0.134 362 1.23 [0.69–2.21] 0.478 
Insulin 556 0.97 [0.68–1.39] 0.873 
   
556 1.55 [1.03–2.34] 0.037* 
   
Metformin 556 0.93 [0.62–1.40] 0.728 
   
556 0.90 [0.55–1.45] 0.659 
   
Practice characteristics and performance2 
            
Number of registered patients (per 1000) 555 0.98 [0.94–1.02] 0.346 
   
555 0.94 [0.87–1.00] 0.054 
   
Practice IMD score1 (range 3 to 66, most 
deprived) 
555 0.97 [0.94–1.01] 0.123 
   
555 0.94 [0.88–1.00] 0.060 
   
Total QOF score 555 1.01 [0.95–1.08] 0.701 
   
555 0.98 [0.89–1.07] 0.615 
   
Percentage recommending practice 555 1.02 [1.00–1.03] 0.058 362 1.02 [1.00–1.05] 0.062 555 1.04 [1.01–1.08] 0.006* 362 1.05 [1.02–1.09] 0.005* 
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Percentage with blood test3 522 1.06 [0.97–1.16] 0.178 
   
522 1.18 [1.02–1.38] 0.026* 
   
Percentage with foot examination3 555 1.02 [1.00–1.04] 0.084 362 1.00 [0.97–1.04] 0.885 555 1.05 [1.01–1.10] 0.012* 362 1.01 [0.97–1.06] 0.546 
Percentage with HbA1c <59 mmol/mol (7.5%)3 555 1.01 [0.98–1.04] 0.497 
   
555 1.07 [1.01–1.12] 0.011* 
   
Percentage referred for education3 555 1.00 [1.00–1.01] 0.289     555 0.99 [0.98–1.01] 0.372     
All regressions are adjusted for clustering by practice. The multivariable regression considered all variables for which an outcome is reported. 
1 IMD is weighted and considers income, employment, education, skills and training, health and disability, and living environment deprivation, crime, and barriers to housing 
and services. 2 See Table 3.4 and https://fingertips.phe.org.uk/profile/general-practice for full definitions. 3 Percentage of diabetic patients with measure. 
95% CI: 95% confidence interval; BMI: body mass index; IMD: Index of Multiple Deprivation; N: number of participants; OGTT: oral glucose tolerance test; QOF: Quality 
and Outcomes Framework; OR: odds ratio.  
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Study aim(s) relevant to 



















visit (up to 
60 days) 
Discuss prevention of 
T2D after GD 
Women who were part of 




glycaemia >95 mg/dL 
during gestation or >2 
T2D risk factors, live in 
Metropolitan Region of 
Belo Horizonte 










perceived barriers to and 
facilitators of postpartum 
follow-up care after GD 
Consecutive sampling of 
women in third trimester 




during and beyond 













facilitators and potential 
facilitators to attendance 
at postpartum diabetes 
screening after recent GD 
Identified from a hospital 
database 




≥18 years old, no history 














Explore views on 
postnatal lifestyle change 





(contacted by diabetes 
obstetric clinic staff 
while attending 
appointments or from 
hospital records) 
hGD within 2 years, 
English-speaking, ≥16 
years old, successful 
pregnancy outcome, 
received antenatal care at 














experiences of women in 
rural communities with 
GD and gain insight into 
low screening rates 
Purposive sampling and a 
snowball approach via 
obstetric and healthcare-
provider offices 
hGD within 5 years, ≥18 
years, reside in a county 
eligible for rural 
community grants, not 












393 (NR) Australia General 
screening 
after GD 
Describe reflections on 
the experience of GD-
pregnancy 
Identified from NDSS 
database and contacted 
by mail 
hGD within 3 years, ≥18 
years old at time of 
registration, not residing 
in a Queensland 
postcode2 
Questionnaire 
















Explore what helps and 
hinders diabetes testing 
after GD 
Women not tested and 
those that were tested as 
part of ADAPT, recruited 
from a multispecialty 
group medical practice 
after a GD pregnancy 
from medical records 
GD in most recent 
pregnancy, ≥18 years 
old, patients of HVMA, 
no history of T1D or 
T2D, internet/telephone 
access, no significant 












13 (7) Australia First 
postpartum 
OGTT 
To explore and assess 
women’s communication 
experiences of postnatal 
GD follow-up, and 
interpret them with CAT 
Theoretical sampling 
from clinics and wards at 
a major maternity tertiary 
referral hospital 










7 (7) Denmark General 
screening 
after GD 
Understand experience of 
GD care and how this 
influenced participation 
in follow-up screening 
Random selection of 
women with previous 
GD eligible at Aalborg 
University Hospital 
hGD 2010–2012, first 
GD pregnancy, 










27 (NR) US General 
screening 
after GD 
Barriers and facilitators 
to testing and referral to 
testing (four domains: 
intervention attributes, 
individual characteristics, 
inner context and outer 
context) 
Convenience sample of 
women in an urban 
safety net hospital in 
third trimester 












7 (NR) Australia General 
screening 
after GD 
Enablers and barriers 
influencing screening 
after GD in Australian 
Indigenous women and 
how screening might be 
improved 
Recruited by health 
service staff and project 
flyers in waiting area of 
health service 

















(barriers and enablers) 
Purposive sampling 
(approached or 
advertisements at general 














Explore Iranian women's 
experiences of on 




from (governmental and 
private) hospital records 
after GD 
GD diagnosis by hospital 
records, delivered >6 













5 (NR) Denmark General 
screening 
after GD 
Examine the experience 
of transition from a GD-
affected pregnancy to 
postpartum 
Random sampling (sent 
invitation letters via the 
hospital patient registry 
and telephoned) 
hGD, recently delivered 

















Explore barriers and 








Women managed by a 
hospital DIP Service who 




live singleton delivery, 








1 In reference to/since GD pregnancy; studies collected data once postpartum unless otherwise specified; 2 Due to a concurrent study; 3 Face-to-face interview is implied; 4 
Rafii 2017a reported 10/22 while Rafii 2017b reported 11/22 attended screening; 5 ‘Almost all’ had 6 weeks, ‘most’ had first year, ‘few’ had second year tests. 
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ADAPT: Avoiding Diabetes After Pregnancy Trial; CASP: Critical Appraisal Skills Programme checklist; DIP: diabetes in pregnancy; FPG: fasting plasma glucose; (h)GD: 
(history of) gestational diabetes; HVMA: Harvard Vanguard Medical Associates; MCHN: maternal and child health nurse centres; NDSS: National Diabetes Service 
Scheme; OGTT: oral glucose tolerance test; T1D: type 1 diabetes.  
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Appendix 8: GRADE-CERQual qualitative evidence profile of recommendations for promoting attendance at diabetes screening after gestational 
diabetes. 
Objective: To systematically synthesise the literature focussing on the views of women with a history of GD on attendance at postpartum glucose testing 
Perspective: Views, experiences and ideas of any women who have had GD during any previous pregnancy 























Relationship with healthcare 
1. Educate clinicians 
to, and how to, 
promote screening 





Paez, Rafii a, Sterne, 
Svensson, Zulfiqar 
Minor concerns: the 
highest quality studies 
contributed most to 
informing this 
recommendation 
Minor concerns: these 
findings addressed 
attitudes towards 
screening (rather than 
general healthcare 
seeking, which was 
also sometimes 
considered) 
Minor concerns: for 
many participants, 
clinicians played the 





discussed in detail how 
women interpreted 
(lack of) information 
and others more 

























obstetric care, and 
send reminders to 
non-responders/for 
Kilgour, Lie, Nielsen, 
Paez, Pennington, 
Rafii a, Rafii b, 
Sterne, Zulfiqar 
Minor concerns: the 
highest quality studies 
contributed most to 
informing this 
recommendation 




towards arranging the 
screening test (rather 
than general healthcare 






reminders; many took 




tests: the majority 
discussed difficulties 
when they didn’t 






























Minor concerns: four 
high and two good 
quality studies 
contributed to this 
recommendation; two 
studies considered the 
researcher-participant 
relationship so this 
may have influenced 
the discussion about 
the healthcare system 
in the others  
Minor concerns: these 
findings were relevant 
to postpartum follow-
up including screening  
Moderate concerns: 
six studies clearly 
discussed fragmented 
care and women as 
information brokers, 
which lead to 
postpartum 
abandonment and 
getting lost between 
specialities; one 





women’s discussion of 
continuity of care were 
rich but explanations 
on the consequences 




There was a 
clear need to 
ensure sharing 





follow-up care;  





to care in order to 
facilitate building 
relationships and 
opportunities to ask 
questions 
Links to healthcare 




No or very minor 
concerns: the studies 
that directly 
contributed to this 
recommendation were 
the highest quality 
Minor concerns: these 
findings were relevant 
to postpartum follow-
up including screening 
Moderate concerns: it 
is clear and logical that 
patient-centred care 
improves healthcare 
experience but less 
clear from these 
studies that screening 
attendance would 
increase as a result  
Moderate concerns: 
few studies 
contributed directly to 
this recommendation, 
however, all of the 
studies that discuss the 
healthcare system 
inform patient-centred 





care would make 







The appointment and test 




to bring children to 
appointments 
Bennett, Kilgour, 
Paez, Rafii a, Sterne 
Moderate concerns: 
four studies were very 
high quality but Sterne 
contributed most to 
this theme and had 
many methodological 
limitations  
Minor concerns: these 
findings were relevant 
to postpartum follow-
up and screening 
appointments 
Moderate concerns: it 
was clear that many 
women did not 
consider taking the 
baby to the 
appointment so 





data about the need for 
childcare were rich, 
but there were fewer 
data about changing 
clinic environments 
and bringing children 
Moderate 
confidence 






to bring children 
but how to 






in the studies 
6. Seek innovative, 
personalised 
options to make it 
easier for hard-to-
reach women to 





Campbell, Paez, Rafii 
a, Rafii b, Sterne 
Minor concerns: 
several high quality 
studies contributed 
most to informing this 
recommendation 
Minor concerns: these 
findings were relevant 
to postpartum follow-
up and screening 
appointments 
Moderate concerns: 
how easy/convenient it 
was to attend the test 
affected uptake, 
highlighting this as an 
area for improvement; 
one study suggesting 
home testing 
Moderate concerns: 
data about the 
inconvenience of 
testing were rich but 








testing but the 
studies did not 
clearly suggest 
alternatives 






Pennington, Rafii a, 
Sterne 
Moderate/minor 
concerns: two of the 
five studies 
contributing to this 
theme were low 
quality but this is not 
expected to have a 
large impact on this 
recommendation 




towards arranging the 
screening test 
Moderate concerns: 
the need to fast, drink 
a glucose drink and 
wait were clear 
barriers to the OGTT 
and alternative tests 
were suggested, but no 
studies showed 
increased attendance 
using alternative tests 
Minor concerns: the 
data provide a clear 










or a glucose 






testing to coincide 
with other 
postpartum check-






motivation in general; 
specifically Bennett, 
Nielsen, Rafii a, Rafii 
b 
No or very minor 
concerns: the studies 
that directly 
contributed to this 
recommendation were 
the highest quality 




towards screening and 
arranging the test 
Moderate concerns: 
participants attended 
appointments for other 
reasons (eg. for 
vaccinations or to 
discuss contraception) 
and Rafii b describes 
‘accidental screening’, 
therefore we only 
assume that combined 
appointments are more 
convenient and worth 
attending  
Major concerns: only a 
few studies 
contributed to this 
theme, plus general 
inconvenience of 
appointments and 




were difficult to 





that women are 
more motivated 





Recommendations frequently result from findings within multiple themes but have been presented under the primary contributing theme. Only studies directly contributing to 
the recommendation have been cited. 
  
Concern about diabetes 
9. Educate women 
about the purpose 
of screening and 




Kilgour, Lie, Nielsen, 
Paez, Rafii a, Rafii b, 
Sterne, Zulfiqar 
Minor concerns: 
mostly high quality 
studies contributed to 
this recommendation 
Minor concerns: these 
findings showed that 
apathy and fear of 
diagnosis acted as a 
barrier to screening 
and understanding the 
need for screening as a 
facilitator to screening 
attendance specifically 
Minor concerns: 
findings show that 
knowledge about the 
purpose of screening 
increased attendance 
and so it is clear and 
logical that education 
of women on the 




several studies discuss 
the themes 











apathy and fear 
of diagnosis 
were barriers but 
could be reduced 
through 
education 




compliance or one 
negative test result 
is not sufficient to 
rule out T2D in the 
long term 
Bennett, Bernstein, 
Kilgour, Lie, Nielsen, 
Paez, Rafii a, Rafii b 
Minor concerns: 
mostly high quality 
studies contributed to 
this recommendation 
Minor concerns: these 
findings were relevant 
predominantly to 
postpartum screening, 
but did include other 
aspects of post-partum 
behaviour such as diet 




attendance in these 
studies 
Moderate concerns: 
four of the studies 
discuss the impact of 
self-testing on 
screening attendance 
whilst remaining have 
sparse findings 
addressing role of 
reassurance of 
postpartum readings 












this is not 















Study aim(s) relevant to this 














10 Australia Explore perceptions of PA 
among women with previous 
GD, in context of T2D 
prevention 
Purposive sampling 
(adverts at maternal and 
child health centres) 
hGD, English-speaking, ≥18 
years old, resident in selected 








11 Tonga Explore how GD diagnosis 
influenced change in diet and 
PA, influencing factors and 
support of sustained change 
Purposive sampling 
(hospital records) 
hGD within 1 year, delivered 









16 Canada Determine perceived health 
status and experiences in 
establishing and maintaining 
healthy lifestyle changes 
Purposive sampling (GD 
clinic) 
hGD, English-speaking, in 
the final trimester of 
















hospital clinic by mailout 
hGD within 1 year, Swedish-
speaking, 30–40 years old, 
no other known diseases 
Interviews 
(face-to-face) 
At 1 year 8.5 
Razee 2010 
(285) 
57 Australia Explore beliefs, attitudes, social 
support, environmental 
influences etc. on diabetes risk 
behaviours; preferred forms of 
program deliv-ery to inform 
health promotion  
Purposive sampling (GD 
hospital clinic databases 
via letter)  
hGD within 6–36 months, 
Cantonese-, Mandarin-, 
Arabic- or English-speaking, 












17 Australia Explore understanding of T2D 
risk, risk reduction, 
management strategies, and 
attitudes and behaviour 
Immigrant South Asian 
women recruited from 
GD clinic after diagnosis 
hGD, ≥18 years old, Hindi-, 










25 US Identify barriers and facilitators 
to healthy lifestyle changes, and 
approaches to facilitate 
participation in interventions 
Recruited through flyers 
and internet postings 
hGD within 7 years, 18–50 
years old, English-speaking, 










7 Canada Understand cultural factors 
contributing to maintenance of 
health behaviours encouraged 
during GD pregnancy 
Recruited by general 
informants contacts 
hGD within 2–10 years, ≥18 
years old, Algonquin 
peoples, GD/health care in 
Algonquin community, not 











14 Sweden Explore beliefs about health, 
illness and healthcare and study 
their influence on self-care and 
care seeking 
Consecutive sampling 
(women born in the 
Midd-le East living in 
Sweden recruited by staff 
at hosp-ital-based 
specialist clinic) 
hGD, ≥16 years old Interviews 
(face-to-face) 






17 US Describe knowledge, 
perceptions and self-efficacy 
beliefs related to preventing 
cardiometabolic disease 
Purposeful and snowball 
sampling (through fliers 
distributed by tribal 
health system care staff) 
hGD, self-identify as 
American Indian, 19–45 
years old, not pregnant or 
within 6 weeks postpartum 







29 Canada Identify factors that could 
enhance participation and 
engagement in a T2D 
prevention program 
Recruited from GD clinic 
via letter from physician 
(structured recruitment 
strategy) 
hGD, English- or French-
speaking, not pregnant or 
since developed T2D 





35 UK Explore views on postnatal 
lifestyle change to prevent T2D 





service contacted by 
clinic staff while 
attending appointments 
or from hospital records) 
hGD within 2 years, English-
speaking, ≥16 years old, 
successful pregnancy 
outcome, received antenatal 















10 US Explore lived experiences of 
women in rural communities 
with GD  
Purposive sampling and 
a snowball approach via 
obstetric and healthcare-
provider offices 
hGD within 5 years, ≥18 
years, reside in a county 
eligible for rural community 












393 Australia Describe reflections on the 
experience of GD-pregnancy  
Australian women 
recruit-ed from the 
NDSS databa-se for 
cross sectional survey by 
mailout 
hGD within 3 years, ≥18 
years old at time of 




At 3 years 7.0 
Jones 2015 
(288) 
26 US Elicit women’s perspectives on 
cardiometabolic risk reduction 
behaviours to inform the 
development of a postpartum 
lifestyle modification 
intervention 
Contact study team after 
advertising study through 
fliers and business card 
distribution at the CNDH 
hGD within 10 years, self-
identify as American Indian, 















17 Ireland Evaluate a lifestyle intervention 
programme (give context to 
quantitative findings) 
Women identified from 
the Atlantic DIP research 
data-base and Galway 
Universi-ty Hospital 
Group pregna-ncy 
service contacted by 
letters and telephone 
hGD within 1–3 years, 
English-speaking, not 
pregnant or since developed 










23 US Explore T2D risk perception 
and motivators and barriers to 
preventive health behaviours, to 




White wom-en recruited 
from hospital-affiliated 
academic clinics via 
telephone call from 
researcher or response to 
flyer) 
hGD within 1 year, English- 
or Spanish-speaking, no pre-











165 Australia Explore the acceptability of a 
diabetes prevention program 
and compare the characteristics 
associated with program 
engagement 
Women enrolled in the 
MAGDA trial 
hGD in most recent 
pregnancy, English-speaking, 
not pregnant, with pre-











16 Australia Investigate factors influencing 
engagement with diabetes 
preventative care (barriers and 
enablers), the GP’s role in care 
Purposive sampling 
(approached or advertise-
ments at general 









5 Denmark Examine the experience of 
transition from a GD-affected 
pregnancy to postpartum 
Random sampling (sent 
invitation letters via the 
hospital patient registry 
and telephoned) 










23 Australia Explore barriers and facilitators 
to following long-term healthy 
lifestyle recommendations, and 
whether there were differences 
between overseas-born- and 
Australian-born-women 
Women managed by a 
hospital DIP Service who 
attended a GD-related 
health education 
programme  
hGD, English-speaking, live 
singleton delivery, not 







1 In reference to/since gestational diabetes-affected pregnancy; studies collected data once postpartum unless otherwise specified; 2 Plus 1 during pregnancy; 3 Due to a 
concurrent study. 
CASP: Critical Appraisal Skills Programme checklist (score out of 10); CNDH: Chickasaw Nation Department of Health; DIP: diabetes in pregnancy; (h)GD: (history of) 
gestational diabetes; MAGDA: Mothers After Gestational Diabetes in Australia; MHCN: maternal and child health nurse centres; NDSS: National Diabetes Service Scheme; 




Appendix 10: GRADE-CERQual qualitative evidence profile of recommendations for promoting healthy lifestyles after gestational diabetes. 
 
Objective: To systematically synthesise the literature focussing on the views of women with a history of GD on reducing their risk of developing T2D postpartum 
Perspective: Views, experiences and ideas of any women who have had GD during any previous pregnancy 
Included studies: Studies that examine women’s postpartum experiences following GD relating to lifestyle/behaviour, views on T2D risk management and/or experience of a 
























Role as mother and priorities 
1. Highlight the benefits 
to the family of the 
mother being healthier 
and role modelling 
healthy lifestyle to 
children as the incen-
tive for change, along-






Minor concerns: the 
role of the research-




was unclear but this 
was expected to 
have little impact on 
answers to this 
question 
No or very minor 
concerns: many of 
these studies are di-
rectly relevant 
Moderate concerns: 
women in some 
studies explicitly 
reported that their 
children were their 
motivation for heal-
thy behaviour, while 
others reported prio-
ritising their childr-
en’s health; it is 
unclear whether this 
should be encourag-
ed and in all women 
Minor concerns: 
women in some 
studies explicitly 
reported that their 












ported that their 
children were 
their incentive for 
change; whether it 
is appropriate for 
all should be 
considered 
2. Include the option of 
childcare in face-to-
face interventions if 
children are not part 




some studies had 
methodological 
issues but this was 
expected to have 
little impact on an-
swers to this 
question 
No or very minor 
concerns: these 
studies are directly 
relevant 
No or very minor 
concerns: offering 
childcare is recom-
mended by women 
in multiple studies; 
this is also support-
ed by a general 
concern for children 
and about childcare 
Moderate concerns: 
relatively few 
studies contribute to 
this rec-
ommendation and it 





contributed to this 
recommendation 
but some directly 
suggested it and it 






Support from family and friends 
3. Promote healthier 
lifestyles in the wider 
family (and friends) 
Abraham, Dasgup-
ta, Gaudreau, 
Jones 2015, Lie, 
Nicklas, Svensson, 
Zulfiqar 
No or very minor 
concerns: high 
quality studies con-
tributed to this rec-
ommendation 
No or very minor 
concerns: these 
studies are directly 
relevant 
Moderate concerns: 
the studies all report 
that family must eat 
the same healthier 
diets (particularly 
partners) but 
exercise and the 
family was less 
clearly discussed 
Moderate concerns: 
the link between 
family and diet is 
well explained but 
has been 
extrapolated to 




It is clear that 
women need 
support for a 
healthy diet but 
few studies 
clearly discussed 
family and friends 
exercising 
4. Encourage the wider 
family (and friends) to 
promote healthy life-
styles in mothers and 
support them 











ered the role of the 
researcher or imple-
mentation of ethics 
but this was expec-
ted to have little 
impact on answers 
to this question  
No or very minor 
concerns: many of 
these studies are 
directly relevant 
No or very minor 
concerns: these 
studies specifically 
reported the crucial 
role of family and 
friends in behaviour 
and none of the 
studies contradicted 
the others 
No or very minor 
concerns: studies re-





because they lacked 








benefits of or 
need for support 
for lifestyle 
change 
5. Include the family in 
interventions (eg. 
information or 





No or very minor 
concerns: high 
quality studies con-
tributed to this rec-
ommendation 
No or very minor 
concerns: these 
studies are directly 
relevant 
No or very minor 
concerns: two stud-
ies suggested inclu-
ding family in inter-
ventions and the 




ncy) with lack of 
postpartum support 
Major concerns: 
only a few studies 
reported this recom-
mendation, suggest-







dence that this 
recommendation 





6. Encourage and 
facilitate women to 






high quality studies 
contributed to this 
recommendation, 
although the role of 
the researcher was 
poorly considered 
No or very minor 
concerns: these 




gested having help 
to find exercise 
buddies and others 
reported benefits of 
socialising while 
exercising; in addi-
tion to the general 
need for support 
Moderate concerns: 
the studies that 
directly contributed 








oped from the 
general need for 
support, plus a 
few studies that 
specifically 
addressed it 
Demands of life 
7. Provide guidance 
about how to buy and 




2012, Jones 2015, 
Lie, Nicklas, 
Razee, Zulfiqar 
Minor concerns: the 
role of the research-
er was poorly con-
sidered and implem-
entation of ethical 
processes was uncl-
ear but this was ex-
pected to have little 
impact on answers 
to this question 
Minor concerns: 
these studies were 
generally relevant to 
the review question 
Minor concerns: 
difficulties in meal 
planning and prepa-
ration were freque-
ntly reported, and 
many said they 
would like more 
help and infor-
mation (eg. sug-
gested recipe books) 
Minor concerns: 
this idea was 
common across 
studies although the 
specifics of imple-





reported the lack 
of and need for 
more guidance for 
having a healthy 
diet 
8. Provide guidance 
about how to exercise 
around the house and 




ta, Graco, Jones 
2015, Lie, Nicklas, 
Tang, Zulfiqar 
Minor concerns: the 
role of the research-




was unclear but this 
was expected to 
have little impact on 
answers to this 
question; there was 
agreement between 
Minor concerns: 
these studies were 
generally relevant to 
the review question 
Moderate concerns: 
this recommenda-
tion was made be-
cause time restrain-
ts, exhaustion and 
lack of information 
were reported to 
prevent exercise 
while many report-
ed doing simple 
exercise in their 




women’s views was 




It is clear, and 
stated, that 
women need help 
to increase 
exercise; howe-
ver, there is some 
contradictory 
suggestions about 
the best form(s) of 
exercise to 





sonal trainers or fa-
cilities. Some dif-
ferences may have 
been due to defini-
tions of exercise 
Personal preferences and experiences 
9. Support women to 
maintain healthy 
behaviour/diet in chal-
lenging situations – 
eg. social gatherings, 








the role of the 
researcher was 
poorly considered in 
these studies, which 
may have had a 





most of these stud-
ies were relevant to 
this review ques-




it is clear that 
women struggle to 
maintain healthy 
diets in challenging 
situations but none 
suggested how to 
help this 
Moderate concerns: 
although this is re-
ported in several 
studies, this it is 






ability to maintain 
healthy diets; the 
best way to 
address this is 
unclear 
10. Highlight the wider 
benefits of healthier 
lifestyle (such as re-
ducing stress and 




Graco, Jones 2012, 
Jones 2015, Morri-




these studies had 
variable quality, 
particularly around 
the role of the re-
searcher and imple-
mentation of ethical 
processes, but this 
was expected to 
have had a small 
impact on this 
recommendation 
No or very minor 
concerns: most of 










and serval reported 
both 
Minor concerns: 
this was discussed 






fits of adopting 
healthier lifestyles 
that helped them 
to maintain them 
(perhaps after 
their awareness of 
T2D declined 
over time) 
Diabetes risk perception and information 
11. Make information, 
resources and training 
easily accessible and 
make interventions 
Abraham, Dasgup-
ta, Doran, Evans, 
Gaudreau, Graco, 
Hjelm, Jones 2015, 
Lie, Morrison, 
Minor concerns: 
there was a range of 
methodological 
limitations in these 
studies, but there is 
No or very minor 
concerns: most of 



















available to start im-
mediately after preg-




agreement with high 
quality ones 
these suggested or 
implied that this 
should be addressed 
as early as possible 
(only Lie reported 
that an intervention 
should begin at 
weaning) 




12. Ensure that interven-










Minor concerns: no 
studies clearly con-
sidered the role of 
the researcher, 
which may have 
had implications for 
this question, but is 
unlikely 
No or very minor 
concerns: these 
studies include mi-
grant or ethnic mi-
nority populations; 
most of the studies 
included that 
include such popu-
lations report this 
theme 
No or very minor 
concerns: lack of 
culturally-specific 
information was 
reported as a bar-
rier, presence was a 





data is rich in many 
of the studies  
High 
confidence 




that they were 
beneficial to those 
who received it 
13. Ensure that care pro-
viders consider 
women’s attitude to-
wards T2D and advise 





ton, Jones 2015, 
Svensson, Tang, 
Zulfiqar 
Minor concerns: the 
role of the research-




was unclear but this 
was expected to 
have little impact on 
answers to this 
question 
No or very minor 
concerns: most of 
these studies are 
directly relevant 
Major concerns: this 
recommendation 
was based on the 
finding that women 
have different atti-
tudes towards T2D 
(eg. fear or apathy) 
and some engage or 
behave differently 
based on their rela-
tionship with 
clinicians  
Major concerns: the 
studies do not 









and their clinician  






Minor concerns: no 
studies clearly 
considered the role 
No or very minor 
concerns: many of 
these studies are 
Minor concerns: 
women reported 
that it was hard to 
Moderate concerns: 
this was not consid-
Moderate 
confidence 
Paucity of data 
has reduced our 
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lifestyle, with an 
‘every little helps’ 
approach, rather than 
‘all or nothing’, and 
include the 
importance of both 
diet and activity 
of the researcher, 
which may have 
had implications for 
this question, but is 
unlikely 
directly relevant; 
some were carried 




were daunted by the 
magnitude of chan-
ge suggested, and 
some thought diet 
was more important 
than exercise – 
which should be 
addressed 
ered by many stud-
ies or in detail; 
many women 
appeared to feel that 
it was just too hard 
to try (although this 
was not always 
explicitly stated by 
authors) 
confidence in this 
recommendation  
Finances and resources 
15. Provide information 








Svensson, Zulfiqar  
Minor concerns: 
these studies were 
considered high 
quality; none clearly 
considered the role 
of the researcher or 
implementation of 
ethics but this was 
expected to have 
little impact on 
answers to this 
question 
No or very minor 
concerns: many of 
these studies are 
directly relevant 
No or very minor 
concerns: women 
reported the cost of 
healthy lifestyle 
(particularly diet) as 
a barrier, that they 
wanted advice on 
saving money or 
found that they 





ed this thoroughly 
but many mentioned 
the cost of healthy 





studies but this 
was not reported 
in detail 
Format of intervention and other 
16. Recommend increas-
ing fruit and vegetable 
intake, reducing sugar 
and substituting with 
healthier ingredients 




Hjelm, Lie, Razee 
Minor concerns: no 
studies clearly con-
sidered the role of 
the researcher or 
implementation of 
ethics but this was 
expected to have 
little impact on 
answers to this 
question 
Moderate concerns: 
although the studies 
are quite directly 
relevant in terms of 
study population/ 
setting, the phenom-
enon of interest is 
only partially relev-
ant as studies rarely 
directly asked what 
Minor concerns: 
this finding is 
descriptive and 
none of the studies 
are contradictory, 
therefore we have 
little concern about 
suggesting it as an 
approach for others 
Minor concerns: 
women described 
what changes they 
had made but not 








women being able 






17. Recommend flexible 
exercise such as walk-
ing and those per-
formed around the 
home or with the baby 
to increase physical 
activity (rather than 









Minor concerns: no 
studies clearly con-
sidered the role of 
the researcher or 
implementation of 
ethics but this was 
expected to have 
little impact on 
answers to this 
question 
Moderate concerns: 
although the studies 
are quite directly 
relevant in terms of 
study population/ 
setting, the phe-
nomenon of interest 
is only partially rel-
evant as studies 




this finding is 
descriptive and only 
one woman was 
reported to be con-
cerned about walk-
ing; although 
women in different 
setting reported 
different types of 
exercise, these were 
all quite flexible 
No or very minor 
concerns: women 
described why they 
found walking/ 
flexible exercise the 






reported how and 
why they did 
these types of 
exercises 
18. Ensure interventions 
have web-based com-
ponents but encourage 
additional face-to-face 
contact (they should 
not depend on women 
attending sessions) 
Dasgupta, Graco, 
Jones 2015, Lie, 
Nicklas, O’Dea 
Moderate concerns: 
no studies clearly 
considered the role 
of the researcher, 




No or very minor 
concerns: evaluating 
an intervention or 




many benefits of but 
barriers to face-to-
face contact were 
reported; there was 
no agreement in 
studies regarding 
the ideal format 
(online, face-to-
face, text messages 
or telephone call) 
Minor concerns: 
this theme is 
reported in various 
levels of richness 
Low 
confidence 







but also what was 
most practical 
19. Deliver and promote 
interventions from 
recognised/trusted 
sources (eg. the 








Svensson, Zulfiqar  
Minor concerns: a 
variety of methodi-
cal limitations were 
included but the 
findings tend to be 
consistent with high 
quality studies 
No or very minor 
concerns: many of 
these studies are 
directly relevant 
Major concerns: 
these studies report 
benefits of support 
offered by various 
professionals (and 
some appear to have 
Moderate concerns: 
the findings that this 
recommendation is 
based on are rich, 
but no studies asked 
who should deliver 












Recommendations frequently result from findings within multiple themes but have been presented under the primary contributing theme. Only studies directly contributing to 






20. Promote establishment 
of systems to monitor 
progress and account-
ability (through an 
intervention or ensure 
the participant estab-






Minor concerns: no 
studies clearly cons-
idered the role of 
the researcher or 
implementation of 
ethics but this was 
expected to have 
little impact on ans-
wers to this 
question 
No or very minor 
concerns: most 
included studies 





ed on the need for 
or benefits of some-
one to motivate 
them, and mention-
ed both formal (eg. 
clinician) and 
informal (eg. peer) 
relationships 
Minor concerns: 
serval studies report 
this but not very 
richly; it is in 
agreement with the 






iour change, but 
the best way to 
promote this 
remains uncertain 
